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ABSTRACT 
 
  
Sub-Saharan Africa is thought to be undergoing a health (or epidemiological) and 
demographic transition, moving from a pattern of disease dominated by infection, 
perinatal illness and other diseases of poverty, to one dominated by non-
communicable disease, in particular vascular disease. If such a transition is occurring, 
then the burden of vascular disease including stroke will increase. Stroke is a 
heterogeneous condition and it is likely that the nature of stroke (pathological types, 
subtypes, and causes) will change during this transition. However, little is known 
about the burden and nature of stroke in Sub-Saharan Africa, as it is now. This 
information is essential to inform health services to appropriately plan and deliver 
health care for the future, to develop strategies for stroke prevention, and to test the 
theory of the health and demographic transition.  
 
My overall aim was to assess and compare the burden and nature of stroke in rural 
and urban South Africa, and to establish whether there is any evidence of a health 
transition. Specifically I aimed to:  
 
• review what is known about stroke in Sub-Saharan Africa;  
• establish the prevalence and nature of prevalent stroke in rural South Africa; 
• compare the nature of hospital-based stroke in urban and rural stroke patients;  
• compare the nature of urban hospital-based stroke in different population 
groups; and  
 ix
• validate two stroke scores in the urban stroke register to enable us to diagnose 
pathological stroke type in rural stroke patients who do not have access to 
brain imaging.  
 
Methods: The following methods were used to achieve these aims: 
 
• I systematically searched the literature for, and critically reviewed, studies of 
stroke from Sub-Saharan Africa (literature review). 
• The rural Agincourt Health and Population Unit demographic surveillance site 
was screened for stroke using two questions during the annual census. 
Anyone who screened positive for stroke was examined to decide whether 
they had had a stroke (stroke prevalence study). 
• The Tintswalo Hospital Stroke Register was established to ascertain and 
assess rural stroke patients over 20 months (rural hospital-based stroke), and 
• The Johannesburg Hospital Stroke Register similarly established to assess 
urban stroke patients over 23 months (urban hospital-based stroke). 
• The accuracy of the Siriraj and Guy’s Hospital stroke scores was compared to 
the CT brain scan “gold-standard” in the Johannesburg Hospital Stroke 
Register. 
 
 
 
 
 x 
Results: Using these approaches I found that: 
 
• Very little is currently known about the burden and nature of stroke in Sub-
Saharan Africa. 
• The prevalence of rural stroke was about half that found in high-income 
countries, and double that found in Tanzania. However, disabling stroke was at 
least as prevalent as it is in high-income countries.  
• Both rural and urban black South Africans are probably in early phases of the 
health transition, and this is impacting on the nature of stroke, particularly the 
cause of cardioembolic stroke.  
• Neither the Siriraj nor Guy’s Hospital stroke score are sufficiently accurate for 
use in epidemiological studies or clinical management of stroke in Sub-
Saharan Africa. 
 
Conclusion: There is already a heavy burden of stroke in Sub-Saharan Africa, and 
there is some evidence of a health transition in the black population. However, it is 
not possible to accurately assess the burden and nature of stroke without community-
based incidence studies using early brain imaging to distinguish ischaemic stroke 
from cerebral haemorrhage. Until we have these studies, we will never know the 
precise burden and nature of stroke, the effect of the health transition, or the optimal 
approach to preventing a stroke epidemic in our population.  
 xi
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CHAPTER 1   INTRODUCTION 
 
1.0  The purpose of this study 
 
In high-income countries stroke has been recognised as an important cause of death 
and disability for many years. Recently the importance of stroke in low- and middle-
income (developing) countries has also been appreciated, highlighted by the Global 
Burden of Disease study that two-thirds of stroke deaths occur in low and middle-
income regions of the world (Murray & Lopez, 1997; Bovet, 2002). Moreover, the 
burden of stroke and other vascular disease is likely to increase dramatically over the 
next few decades in these lower income countries because of their expected health 
and demographic transition (see section 1.6 for description of the health and 
demographic transition), so adding to the infectious and poverty related diseases 
already affecting these populations (Howson, Reddy, Ryan et al, 1998; Vorster, 2002; 
Bovet, 2002).  
 
Health services in Sub-Saharan African countries are used to dealing with acute 
disease such as infection and trauma. However, it is essential to encourage these 
health services and the governments that control them to adjust health services to 
take on chronic non-communicable disease management and prevention (Leeder, 
Raymond, Greenberg et al, 2004). This is not an easy task, given the limited 
resources available in most countries in Sub-Saharan Africa. Thus, to convince these 
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health services of the need for change, we need persuasive epidemiological evidence 
highlighting the growing burden of chronic non-communicable disease, and the 
changing nature of vascular diseases such as stroke which leads the way in the 
health transition. Furthermore, most Sub-Saharan African countries are faced with an 
enormous human immunodeficiency virus (HIV) epidemic, and the impact of HIV on 
the emergence and development of vascular and other non-communicable disease is 
not known.  
 
There is little high quality epidemiological data on stroke and particularly on the effect 
of the health transition on stroke, both in South Africa and in Sub-Saharan Africa in 
general. South Africa’s multi-ethnic population provides the opportunity to compare 
the nature of stroke (pathological stroke types, ischaemic stroke subtypes, risk factors 
and causes of stroke) in populations at different stages of the health transition. At 
least three hospital-based stroke registers have investigated stroke in South Africa, 
two of these in urban black South Africa populations (Kalafong n=212 and Medunsa 
n=304) before the HIV era (Rosman, 1989; Joubert, 1991), and one predominantly in 
white South Africans (n=1298). There are no community-based stroke studies from 
South Africa, nor any hospital-based studies that have investigated rural stroke or 
compared stroke across a representative sample of the country’s population (see 
chapter 2 and 5).  
 
The diagnosis of pathological stroke type (cerebral haemorrhage, ischaemic stroke 
and subarachnoid haemorrhage) is best made using computer tomography (CT) or 
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magnetic resonance imaging (MRI) scanning. Unfortunately scanners are seldom 
available outside major centres in South Africa or indeed the whole of Sub-Saharan 
Africa. Bedside scores to assist in diagnosing pathological stroke type have been 
produced but not validated in Sub-Saharan Africa. For many reasons (discussed in 
chapter 6) these scores may not work as well in Sub-Saharan Africans as in the 
populations in which they were developed.  
 
The purpose of this study was to: 
 
1. Systematically review the literature of stroke in Sub-Saharan Africa, in 
particular in South Africa    
 
2. Establish the prevalence of stroke in rural South Africa 
 
3. Establish the nature of prevalent stroke in rural South Africa  
 
4. Compare the nature of hospital-based stroke in different population groups in 
urban South Africa  
 
5. Assess the performance of two stroke scores in black South Africans for use in 
diagnosing pathological stroke type when brain imaging is not available  
 
6. Assess the nature of hospital-based stroke in rural South Africa  
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7. Compare the nature of stroke in urban and rural black South Africans.  
 
 
1.1 The rationale for the design of the study 
 
The ideal study to investigate stroke in a population is a community-based stroke 
incidence study (Warlow, 1998). However, these studies are expensive to perform 
and we did not have sufficient funding to conduct one in South Africa, though we 
applied for grants unsuccessfully on several occasions. We then decided to start the 
work presented here. It is less expensive to measure stroke prevalence in a 
community provided one has an accurate denominator. We were fortunate enough to 
have access to a defined population who were part of the University of the 
Witwatersrand / Medical Research Council (Agincourt) Rural Public Health and Health 
Transitions Research Unit, a demographic and surveillance site in the north-east of 
South Africa. This enabled us to accurately assess the prevalence of stroke in 
approximately 70 000 people, by screening for stroke using two questions during the 
annual unit census. We were then able to assess people who had likely had a stroke 
in detail, to determine both the nature of prevalent stroke in rural South Africa and the 
pattern of health seeking behaviour.  
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We assessed the nature of stroke in a representative sample of urban South Africans 
by establishing a stroke register at Johannesburg Hospital, one of the University of 
the Witwatersrand’s teaching hospitals. This hospital is attached to the University of 
the Witwatersrand, Faculty of Health Sciences, and close to our Division of 
Neurology. While it is a tertiary referral hospital, it also provides an extensive 
secondary care service to the Johannesburg inner city and surrounding suburbs. The 
population admitted to the hospital is representative of an urban South African 
population. We carefully ascertained all stroke patients, made a detailed clinical 
assessment and documented all available investigations on the patients.  
 
The Johannesburg Hospital had a CT brain scanner and this allowed us to validate 
the Guy’s Hospital and Siriraj Stroke Scores, which are used to assign the 
pathological type of stroke, in a black South African population. We were then able to 
use these scores in the Tintswalo Hospital stroke register, where CT scanning was 
not available. 
 
We chose to establish our rural hospital stroke register at Tintswalo Hospital in the 
Bohlabela region of Limpopo Province, because it is one of three hospitals that 
provides a service to the Agincourt community studied in the stroke prevalence study. 
The hospital also has close ties with the University of the Witwatersrand and many 
medical students visit this hospital as part of their rural medicine programme. As in 
the Johannesburg Hospital, we did not have sufficient funding to freely investigate 
stroke patients, though mid-way through the running of the register we did receive 
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funding for blood investigations. We therefore focused on the complete ascertainment 
of stroke patients, thorough clinical assessment and documentation of any 
investigations that were performed as part of their routine care.  
 
The individual components, i.e.  the rural stroke prevalence study, the urban stroke 
register at Johannesburg Hospital, and the rural stroke register at Tintswalo Hospital, 
all ran separately. We made a concerted effort to ensure that our method of 
assessing stroke patients in each component was the same or very similar. I 
established and ran each component, trained all staff who assisted with patient 
assessment and reviewed all cases prior to including them into the study data. All 
three components of the study used the same questionnaire which was modified and 
adapted for each component, e.g. by including questions regarding which village 
people came from in the Agincourt Unit for the prevalence study (Appendices B, D 
and G).  
 
We were then able to compare the nature of urban and rural stroke, the nature of 
stroke in different population groups, and more broadly the nature of prevalent rural 
stroke to assess whether there was any evidence to support a vascular health 
transition in South Africa.  
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1.2 The overlap between the Southern African Stroke Prevention 
Initiative (SASPI) study and other components of this study  
 
The Southern African Stroke Prevention Initiative is a collaborative study originally 
between the University of the Witwatersrand and the London School of Hygiene and 
Tropical Medicine, with collaborators from the University of Edinburgh. The University 
of Warwick later replaced the London School of Hygiene and Tropical Medicine. The 
study included a multidisciplinary team of neurologists, epidemiologists, public health 
specialists, social anthropologists and an occupational therapist. The aim of the 
SASPI study was to quantify the impact of stroke on the rural Agincourt community, 
understand the social setting of stroke, understand the nature of stroke in people 
admitted to hospital with stroke and in stroke survivors in the community, and to 
identify problems related to the prevention, diagnosis and management of stroke in 
the Agincourt population. The initial SASPI study included: a stroke prevalence study, 
a hospital-based stroke register run at Tintswalo Hospital, a community survey of 
vascular risk factors in adults over the age of 35 years, assessment of the social 
impact of stroke on stroke survivors, and the lay-beliefs and understanding of stroke 
and its related symptoms in Agincourt.  
 
I am an investigator on SASPI and was responsible for the stroke prevalence study 
and the Tintswalo Hospital Stroke Register. These two components, which form part 
of this thesis, were part of the SASPI study, while the Johannesburg Hospital Stroke 
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Register was not a component of the SASPI study. SASPI was funded by the 
Wellcome Trust (reference number 064762/Z/01/2). 
 
1.3 My role in the various components of the study 
 
Epidemiological stroke studies are invariably collaborative efforts, and the various 
components of this study could not have been performed by one person. However, as 
this work forms part of my thesis, it is prudent to outline exactly what my role was in 
each component.  
• Literature review (chapter 2): I compiled the systematic literature review 
(chapter 2) after receiving useful advice and training on methodology of 
systematic reviews and designing a literature search from the Cochrane Stroke 
Group in Edinburgh, United Kingdom.  
• Stroke prevalence study and nature of prevalent stroke (chapters 3 and 
4): I initiated and designed the prevalence study and together with the SASPI 
team wrote the grant application and obtained funding for this study. I trained 
the field-workers who screened the Agincourt population for stroke during the 
annual census, and performed an initial pilot study of stroke prevalence. I 
trained the two research fellows who assisted me with the assessment of 
individuals who screened positive for the stroke. As well as spending 
approximately 3 months in the field seeing people who had screened positive 
on my own, I also visited the research fellows approximately weekly and 
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reviewed all patients who the research fellows assessed as having had a 
stroke in person, any individuals in whom they were not sure of the diagnosis, 
and any individuals with neurological disease who required further 
assessment. I then reviewed all the questionnaires / data and discussed 
specific individuals with my supervisors (Professor Charles Warlow, University 
of Edinburgh, United Kingdom, and Professor Girish Modi, University of the 
Witwatersrand, South Africa),  to ensure that we correctly diagnosed and 
assessed the stroke patients prior to data entry. I cleaned the database and 
analysed the data with the help of Professor Margaret Thorogood the principal 
investigator of SASPI (Professor of Epidemiology, University of Warwick, 
United Kingdom).  
• Johannesburg Hospital Stroke Register (JHSR) (chapter 5): I designed the 
JHSR study and raised funding for the study. I trained the stroke register 
assistant who ascertained our stroke cases, and trained the doctors who 
formed part of the stroke team in the assessment of stroke patients. I assessed 
over a quarter of the patients referred to the JHSR without any assistance, and 
reviewed the majority of the remainder in person together with the other stroke 
team members who had assessed them initially. I reviewed all case notes prior 
to data entry and inclusion in the register to ensure that we accurately 
diagnosed and classified stroke patients. Again, I discussed difficult cases with 
my supervisors. I entered all the data, cleaned the database and analysed the 
data with occasional assistance from Professor Thorogood.  
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• Tintswalo Hospital Stroke Register (THSR) (chapter 7): I designed the 
THSR, and raised funds to start the study and later to continue it with further 
funding raised as part of the SASPI study. I trained the THSR nurse co-
ordinator who ascertained stroke cases and performed the initial assessment 
of the patients. On my approximately weekly visits to the hospital, I assessed 
the majority of the patients. Some patients died or rarely were transferred to 
other hospitals before I could assess them. I reviewed all the questionnaires 
and assessments as in the JHSR. I entered the data, cleaned the data base 
and analysed the data.  
• The validation of the Guy’s Hospital and Siriraj Stroke scores (chapter 6): 
This component is an integral part of the JHSR and my involvement is as 
stated for the JHSR. 
 
1.4 Time taken to complete the work 
 
We started the grant application process and literature review in January 1999. The 
Johannesburg Hospital Stroke Register commenced in mid-July 2000, the Tintswalo 
Hospital Stroke Register in mid-2001 and the stroke prevalence study in mid-2001. 
The work was completed in 2003 but I only completed the analysis of the data and 
writing up of this thesis in May 2006 as I did this in addition to a full time clinical 
neurology and teaching post. Figure 1.1 is a Gantt diagram of the work. 
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1.5  Organisation and style of the thesis 
 
Figure 1.2 shows the organisation of the thesis. The literature review (chapter 2) 
deals only with the burden and nature of stroke in black Sub-Saharan Africans. Stroke 
in white and Indian / Asian population groups living in Africa is likely to be similar to 
that found in studies from outside Africa. However, we have discussed relevant stroke 
studies including other population groups in South Africa in chapter 5.
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Figure 1.1  Gantt Diagram showing the time taken for each component of the thesis (note the mid-year detail is not 
shown) 
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A racial and urban-rural comparison of the nature of stroke in South Africa 
Chapter 1 Introduction 
 
• Organisation of the thesis  
• Description of the Health and Demographic Transition 
Chapter 2 Literature review   
 
• The burden of stroke in Sub-Saharan Africa 
• The nature of stroke in Sub-Saharan Africa 
 
Note: the review focuses on stroke in black Sub-Saharan Africans and the limited literature 
relevant to other population groups is discussed in chapter 5 
Chapter 7  Tintswalo Hospital Stroke Register – rural stroke 
 
• Aim, methods and results 
• Discussion: comparison with urban JHSR black stroke patients and recent 
stroke registers from the Gambia 
Chapter 8 Comparison of the nature of prevalent, urban and rural stroke 
 
• Comparison of pathological stroke type, ischaemic stroke subtype, risk factors, 
causes, and evidence for a health transition in South African stroke patients 
Chapter 9 Conclusion 
Chapter 3 Rural stroke prevalence study 
 
• Aim, methods, results and discussion of the prevalence of stroke in the 
Agincourt Health and Population Unit demographic surveillance site 
 
 
Chapter 4 Nature of prevalent rural stroke 
 
• Aim, results and discussion of the nature of rural prevalent stroke cases 
Note: the methodology of this component is discussed in chapter 5 
Chapter 5 Johannesburg Hospital Stroke Register – urban  
 
• Aim, methods and results 
• Discussion: comparison with other stroke populations in Africa, African-
American populations, Africans living in the United Kingdom, and 
community based predominantly Caucasian populations 
 
Chapter 6 Validation of the Siriraj and Guy’s Hospital Stroke Scores 
 
• Aim, methods and results 
• Discussion: comparison with other validation studies in Sub-Saharan Africa 
and non-African populations 
Figure 1.2 Organisation of the thesis 
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1.5.1 Terminology regarding population groups 
 
I have used the same terms to describe ethnic or population groups in South 
Africa as used by Statistics South Africa (Lehohla, 2005): black Africans 
(abbreviated to blacks), whites, coloureds (mixed ancestry), and Indian / Asians. 
Instead of referring to ethnic groups we will follow the example of Statistics South 
Africa and the South African Demographic and Health Survey and refer to 
population groups (Medical Research Council, 1998; Lehohla, 2005). I assigned 
population groups based on a stroke patient’s (or their carer’s) self-identified 
classification.  
 
1.5.2  Style of writing 
 
I have made every effort to use a modern active language style of writing 
throughout this thesis. Use of the personal pronoun is therefore inevitable. 
However, much of this work has been collaborative (as discussed in sections 1.2 
and 1.3) and use of the pronoun ‘I’ is not only inappropriate but sounds jarring in 
my opinion. I have thus rarely used the pronoun ‘I’ and so from now on have 
chosen to use ‘we’ instead, even when quite obviously the thoughts and decisions 
have been my own.  
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1.6   Stroke and the health and demographic transition  
 
The concept of ‘health transition’ (also termed epidemiologic transition) provides a 
framework for understanding changes in the pattern of disease that has taken 
place in all countries over the last few centuries (Bonita, 2001) (table 1.1). In low-
income countries that start with a disease burden dominated by nutritional, 
perinatal, and infectious diseases, economic development results in transition to a 
disease burden dominated by non-communicable disease, particularly vascular 
disease (Omran, 1971; Caldwell, 2001). Four phases of health transition were 
originally described by Omran (table 1.1). The initial pattern of cardiac and 
vascular disease changes from one dominated by rheumatic heart disease and 
cardiomyopathies caused by infection and nutritional deficiencies, to a pattern 
dominated by hypertension related disease. Then, as life expectancy improves, so 
atherosclerotic related disease including ischaemic heart disease and peripheral 
vascular disease emerge. A fifth stage of ‘health regression and social upheaval’ 
has been suggested by Yusuf et al to explain the resurgence of conditions seen in 
the first two stages, in regions where war or social upheaval break down existing 
social or health structures (Yusuf, Reddy, Ounpuu et al, 2001). This probably 
represents a separate subgroup rather than part of a natural transition for all 
populations.   
 
The population within a country or a region may be at different stages of the health 
transition. An ‘early-adopter’ community is one that is undergoing rapid 
socioeconomic development and has an earlier increase in vascular disease than 
other parts of the population (Yusuf et al., 2001).  
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Table 1.1  Stages of the health transition (adapted from Howson et al., 1998; Bonita, 2001; Omran, 1971 and Yusuf, 2001) 
 
Stage of Transition 
Percentage of all deaths 
caused by cardiac and 
vascular disease 
Predominant cardiac and vascular diseases Predominant nature of stroke Likely regional examples 
Age of pestilence 
and famine 
5-10 
Rheumatic heart disease, infections, and 
nutritional cardiomyopathies 
Cardioembolic 
Sub-Saharan Africa, rural 
India, and South America 
Age of receding 
pandemics 
10-35 
As above, plus hypertension, hypertensive 
heart disease; stroke more common than 
ischaemic heart disease. High rheumatic heart 
disease to atherosclerotic heart disease ratio 
As above, plus haemorrhagic stroke 
due to hypertension. Stroke occurring 
at relatively young age. Emergence of 
atherothrombotic stroke 
China 
Age of degenerative 
and man-made 
diseases 
35-55 
Ischaemic heart disease at relatively young 
ages. Heart disease more common than stroke. 
Very low rheumatic heart disease to 
atherosclerotic heart ratio 
Proportion of strokes due to 
haemorrhage decreases and 
atherothrombotic stroke increases 
Urban India, former socialist 
economies 
Age of delayed 
degenerative 
diseases 
<50 
Stroke and ischaemic heart disease at older 
ages 
Atherothrombotic stroke; 
cardioembolic stroke often secondary 
to effects of ischaemic heart disease 
(atrial fibrillation, mural thrombi, 
cardiomyopathy) 
Western Europe, North 
America, Australia, New 
Zealand 
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Gillum has suggested six stages to explain the evolution of patterns of vascular 
disease among people of Sub-Saharan African (SSA) origin (Gillum, 1996a). 
Stage 1 represents the situation in pre-colonial Africa and the few remaining 
traditional African societies. Stage 2 is found in modern urban Sub-Saharan 
Africans. Stage 3 occurs in the modern black populations of the West Indies, and 
is similar to stage 4 which is found in rural black populations in the United States. 
Stage 5 characterises poor, inner city black Americans and stage 6 represents 
affluent suburban or urban black Americans. Therefore, there is a steady increase 
in acculturation, urbanisation and affluence from stage 1 to 6. Vascular risk factors 
increase (saturated-fat intake, salt intake and cigarette smoking) from stage 1 to 
stage 5, with an associated increase initially in hypertensive vascular disease and 
from stage 3 onwards in atherosclerotic disease. In stage 6, however, there is a 
reduction in vascular risk factors, a marked reduction in hypertensive vascular 
disease and a less marked reduction in atherosclerotic disease. 
 
Stroke burden increases during health transition and is initially much more 
common than heart disease (Reed, 1990). Stroke also changes in nature (type 
and cause) as the population undergoes transition. Initially when hypertension is 
the major vascular risk factor, haemorrhagic stroke is common. Then as 
cholesterol levels increase, so ischaemic stroke due to atherothrombosis 
increases (Howson et al., 1998). Presumably, the early phase of the transition is 
also accompanied by small vessel ischaemic stroke caused by hypertension, 
cardioembolic stroke caused by rheumatic heart disease, nutritional 
cardiomyopathies, and perhaps by alcohol and idiopathic dilated cardiomyopathy. 
Hypertensive heart disease may add to ischaemic stroke by causing atrial 
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fibrillation in a small number of cases. If one accepts the entity of an end-stage 
dilated cardiomyopathy of hypertensive heart disease then this too may be an 
embolic source (Lip, Felmeden, Li-Saw-Hee et al, 2000). Unfortunately, the effect 
of the early stage of the transition on stroke was never well documented in the 
current high-income countries, and unless we document it accurately in 
populations currently undergoing transition much of the effect of the transition on 
vascular disease will remain mere conjecture.  
 
The changing structure of populations, or demographic transition, will also 
increase the burden of stroke (Walker, Unwin, & Alberti, 1998). Stroke 
predominantly affects an older population and, because it is estimated that in low 
and middle-income countries the number of adults aged 30-69 from 1990 to 2020 
will almost double, stroke incidence should increase dramatically for that reason 
alone (Murray & Lopez, 1996; Smith & Mensah, 2003). 
 
We will refer to the framework of the health transition frequently in the following 
sections, and relate our findings to this framework.  
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CHAPTER 2   LITERATURE REVIEW – A SYSTEMATIC REVIEW 
OF STROKE IN SUB-SAHARAN AFRICA 
 
2.0 Introduction 
 
There are no systematic reviews of the existing knowledge of stroke in Sub-
Saharan Africa (SSA). My aim was to systematically gather all the publications that 
relate to stroke in SSA and to assess what is known about the burden (mortality, 
prevalence, incidence and case-fatality) and nature (pathological types, sub-types, 
causes and risk factors) of stroke in the region.  
 
2.1 Critical appraisal of the literature 
 
We searched Medline from 1966 to December 2004 and Embase from 1980 to 
December 2004, using detailed search terms for stroke or related disease 
combined with terms relevant to SSA. We used forty-two terms to describe 
symptoms and signs of stroke, stroke types or subtypes, related cerebrovascular 
conditions such as migraine, as well as ‘exploding’ specific terms such as 
‘cerebrovascular disease’ and ‘stroke’ (Appendix A). We then combined this 
search with the articles retrieved from a second search designed to find all 
publications of any type related to Africa. This second search included 91 terms 
which might have been used in articles relevant to SSA and included terms for 
race (including terms that come from a previous political era), regions of Africa e.g. 
central Africa, countries in SSA (including former names of countries), with 
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particular but not exclusive use of MeSH terms used by Medline and Embase 
(Appendix A).  
 
We obtained articles from before 1966 and other relevant published articles by 
perusing reference lists from articles already obtained, from theses, discussions 
with colleagues working in Africa, and conference proceedings. Finally, the two 
journals with the highest yield were hand searched (East African Medical Journal 
and South African Medical Journal) for relevant publications during the last ten 
years that might have been missed by the other methods. 
 
This search yielded 3238 publications. We screened all abstracts, and read in full 
all articles that might contain relevant information. All articles and published 
abstracts in all languages, relevant to the burden and nature of stroke in SSA were 
included. In an attempt to obtain all useful information, we included publications 
whether they included original data or not.  
 
Conducting epidemiological studies in SSA is fraught with practical difficulties and 
so, while we considered it important to evaluate the available studies against 
accepted quality criteria, we also considered it important to include an accurate 
representation of the published literature on the subject. We highlighted the 
strengths and weaknesses of publications in each section, however, and in the 
section on the nature and risk factors for stroke, we detailed the reasons for 
including and excluding studies. Thus we combined a thorough search of the 
literature with critical evaluation of the literature (Stroup, Berlin, Morton et al, 2000) 
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with a narrative review (Slavin, 1995), and highlighted the quality of the evidence 
throughout.  
 
This resulted in 448 references germane to the scope of this review. We then 
excluded studies dealing with stroke in Africans living outside Africa unless they 
included comparisons with a population living in Africa, as well as publications 
dealing with stroke in non-African populations living in SSA. We also excluded 
studies that did not provide separate data for Black Africans and Africans from 
other populations. Finally, we excluded any published data from this thesis, which 
was already available at the time of the final literature search update. We specified 
our selection criteria in each section of the review when relevant.  
  
We have presented our findings using the following scheme:  
 
Section 2.2 The burden of stroke in Sub-Saharan Africa –  
 mortality, incidence, case fatality, and prevalence     
 
Section 2.3 The nature of stroke in Sub-Saharan Africa –  
pathological stroke type, subtype, causes (including autopsy       
studies), and risk factors 
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2.2 What is the burden of stroke in Sub-Saharan Africa? 
 
The burden of stroke in a community includes stroke mortality, incidence, 
prevalence, and long-term outcome of stroke survivors (Warlow, 1998). 
Although it is an important part of the burden of stroke on the individual and 
community, the estimation of the economic cost of stroke is beyond the scope of 
this review. We will now discuss each component making up the burden of stroke 
in depth. 
 
2.2.1  Mortality 
 
This section includes mortality data derived from vital registration, verbal autopsy 
studies and studies that have focused on stroke mortality in SSA populations.  
 
2.2.1.1 Vital registration based data 
 
In high-income countries death certificate data provide easily available, but not 
very accurate, information on stroke mortality (Warlow, 1998). The Global Burden 
of Disease study used available vital registration data from SSA and other regions 
to estimate mortality in 1990. However, vital registration data are unreliable and 
seldom available in SSA (Walker, McLarty, Kitange et al, 2000a). Indeed, Murray 
and Lopez found SSA to be the region with the lowest coverage of vital registration 
in the world (1.1%). As a result the Global Burden of Disease findings for southern 
SSA, and to a lesser extent northern SSA, were based on modelling of vital 
registration data from South Africa collected during the apartheid years (Murray et 
 23 
al., 1997). However, during the apartheid era vital registration for Africans was 
particularly unreliable (Wyndham, 1982; Botha & Bradshaw, 1985; Disler, Epstein, 
Buchanan-Lee et al, 1987). Despite these difficulties, and so rather surprisingly, 
the global Burden of Disease findings are supported by demographic surveillance 
sites (population-monitoring laboratories) throughout Africa (Murray et al., 1997). 
 
In 1999 the WHO estimated, using similar methodology to the Global Burden of 
Disease study and vital registration data from member states, that there were 
about 5 million stroke deaths (5% of all deaths) in Africa compared to almost 8 
million (14% of all deaths) in Europe. Stroke caused an estimated 45% of all 
vascular deaths in Africa compared to 25% of vascular deaths in high-income 
Europe (The WHO, 1999) – in other words Africa was at an earlier stage of health 
transition. 
 
2.2.1.2 Verbal autopsy data 
 
In many low-income regions where there is a void of health information and vital 
registration for the population, demographic and health surveillance sites have 
been established (INDEPTH network, 2002). Cause of death data on a sample of 
the population is derived from careful recording of all deaths during population 
census rounds and from verbal autopsies. Verbal autopsies consist of a 
questionnaire completed during an interview of a close caregiver who is able to 
describe - retrospectively - what happened during the hours, days or months 
preceding a death. A most likely cause of death is inferred from the sequence and 
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combination of systems and events, either by physicians or by computer 
algorithms (INDEPTH network, 2002).  
 
Two sites in SSA have published information on stroke deaths specifically. The 
Agincourt Health and Population Unit, based in Bohlabelo in the rural north-east of 
South Africa, found stroke caused 6% of all deaths in a population of 63 000 
between 1992 and 1995. Stroke was the second most common cause of death in 
the 35 – 54 year age group and over 75-year age group, and the most common 
cause in the 55 – 74 year age group (Kahn & Tollman, 1999a). The overall crude 
stroke mortality was 127 per 100 000 (95% CI, 93 to 160). 
 
In a much larger verbal autopsy study in Tanzania, the Adult Morbidity and 
Mortality Project found stroke caused 5.5% of adult deaths in three regions (urban, 
fairly prosperous rural and rural) with a total population of 307 820 (Walker et al., 
2000a). Age-adjusted mortality for individuals over the age of 15 in the prosperous 
rural and urban regions in Tanzania were higher than United Kingdom figures. 
This discrepancy was most striking in younger age groups (15-64 years) where 
rates age-adjusted to the Segi world population were three to ten times greater in 
Tanzania than in England and Wales, but the numbers were so small that any 
difference could be due to chance (Walker et al., 2000a).   
 
Figures 2.1 and 2.2 show age-specific stroke mortality in Agincourt, South Africa, 
the three regions of Tanzania mentioned above, for Tanzania and South Africa 
combined, and for England and Wales in the early 1990s.   
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Figure 2.1  Comparison of age-specific stroke mortality in males over 55 years of age in three regions of Tanzania (Dar es Salaam – urban, Hai – 
prosperous rural, and Morogoro – rural), in Agincourt South Africa, the SSA regions combined and England and Wales 
The numbers above the upper 95% confidence interval indicate the total numbers of strokes for SSA combined and England and Wales 
in each age group; SSA - Sub-Saharan Africa 
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Figure 2.2  Comparison of age-specific stroke mortality in females over 55 years of age in three regions of Tanzania (Dar es Salaam – urban, Hai – 
prosperous rural, and Morogoro – rural), in Agincourt South Africa, the SSA regions combined and England and Wales  
 The numbers above the upper 95% confidence interval indicate the total numbers of strokes for SSA combined and England and Wales 
in each age group; SSA - Sub-Saharan Africa 
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The figures demonstrate that age-specific mortality data from SSA are based on 
small numbers with associated large confidence intervals. Age-specific mortality in 
SSA may be as high as in England and Wales, and perhaps higher in younger age 
groups, but larger studies are clearly needed.  
 
While the sensitivity and specificity for the Tanzanian study verbal autopsy was 
100% and for Agincourt, South Africa, 87% and 97% respectively, these figures 
are based on small numbers (twelve strokes in the case of the Tanzanian study)  
and doubt has been cast on the accuracy of verbal autopsy data (Snow, 
Armstrong, Forster et al, 1992). In both studies the gold standard was a hospital 
diagnosis of stroke. This did not include brain imaging for the South African study. 
It is not clear whether the assessment included brain imaging for the Tanzanian 
study. But despite their shortcomings, verbal autopsies provide the only detailed 
mortality data for most of the SSA region and stroke is likely to be one of the 
conditions most accurately diagnosed by verbal autopsy. 
 
2.2.1.3 Other studies 
 
Between 1975 and 1980 a five-year follow-up study of 4075 people aged 15 – 64 
years in Accra, Ghana, found stroke caused about 8% of all deaths in that age 
group (Chukwumeka, Pobee, Larbi et al, 1982). This study probably 
underestimated stroke deaths because an undetermined number of subjects died 
outside the area. Cause of death was diagnosed using death certificates, health 
nurse inquiry and lay recorders. It is not clear whether the authors had validated 
their method of diagnosing stroke.  
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We excluded a review of death certificates in Sierra Leone between 1983 and 
1992 because only stroke caused by hypertension was included (Lisk & McEwen, 
1996). Published stroke mortality for Harare, Zimbabwe (Razum, 1996) and South 
African MRC mortality figures (Bradshaw, Schneider, Dorrington et al, 2002) have 
not been included as the figures were not classified by ethnicity. For many socio-
political reasons there are likely to be large differences in disease rates between 
whites and blacks living in Zimbabwe and South Africa. 
 
We also excluded studies that estimated stroke mortality on hospital-based figures 
because it is highly unlikely that these are representative of the community. Even 
in developed regions a large proportion of stroke patients are not admitted to 
hospital (Dennis, Bamford, & Warlow, 1994; Sudlow & Warlow, 1996). In SSA 
there are many factors that may increase this proportion including: limited access 
to healthcare, transport difficulties, non-biomedical interpretation of symptoms of 
stroke, and use of traditional and alternative healers (Hundt, Stuttaford, & Ngoma, 
2004).  
 
2.2.1.4. Is stroke mortality changing in Sub-Saharan Africa? 
 
Older studies based on vital registration data in South Africa suggest that stroke 
mortality was not always as high as in developed countries. The age-standardised 
cerebrovascular disease mortality for 45-64 year old Africans in Johannesburg 
between 1953 and 1956 was 108 per 100 000, similar to both white South Africans 
(128 per 100 000) and England and Wales (111 per 100 000) (Walker & Grusin, 
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1959; Walker, 1963). By 1970, however, age-standardised mortality for Blacks 
between 15 and 64 years of age (males: 65 per 100 000, females 92 per 100 000) 
was much higher than for whites in South Africa (males: 41 per 100 000, females: 
43 per 100 000) and in England and Wales (Wyndham, 1979; Wyndham, 1982). It 
is tempting to conclude that these figures demonstrate a progression along the 
health transition, but vital registration and census figures for Blacks living in South 
Africa were highly inaccurate (Botha et al., 1985). As long as accurate vital 
registration data remains unavailable for most of SSA, evidence of any change in 
stroke mortality in SSA is only likely to come from demographic surveillance sites 
using verbal autopsy data, although the inevitably small numbers of deaths in such 
areas will render any estimates rather imprecise. 
 
Although higher age-adjusted mortality is seen in SSA compared to developed 
regions, overall the absolute numbers of deaths due to stroke remain low. The 
population structure in SSA typically has far more young than elderly people with 
about 44% of the population under the age of 15-years and only about 3-6% over 
the age of 65-years (Kahn et al., 1999a; INDEPTH network, 2002). So total 
numbers of stroke and deaths due to stroke are small at present, but are likely to 
increase as the population undergoes economic development and the number of 
elderly increase (Omran, 1971; Walker et al., 1998; Warlow, 1998; Unwin, 2001; 
Caldwell, 2001).  
 
Of course, a high mortality is only one component reflecting the burden of disease 
and it may be caused by either a high incidence of stroke or a high case fatality  or 
both (Warlow, 1998).  
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2.2.2 Stroke incidence 
 
2.2.2.1 Community-based incidence 
 
Stroke incidence, based on representative community samples, and with rigorous 
case ascertainment and accurate diagnosis, provides far more information about 
stroke burden than either mortality or prevalence (Warlow, 1998), but such studies 
require considerable resources and rigorous methods (Feigin & Carter, 2004). 
Standardised criteria for the ‘ideal’ stroke incidence study have been established 
(Sudlow et al., 1996) and these have recently been updated (Feigin & Hoorn, 
2004) (table 2.1). Against these criteria there are no even nearly ideal stroke 
incidence studies available for SSA (Feigin, Lawes, Bennett et al, 2003b).  
 
Although their study does not fulfil the criteria, there has been one serious attempt 
at a community-based incidence study from SSA. Osuntokun and his colleagues 
(Osuntokun, Bademosi, Akinkugbe et al, 1979) established and ran a stroke 
registry in Ibadan, Nigeria for two years (1973-1975) as part of the international 
multicentric programme of the Cardiovascular Diseases Unit of the WHO. They 
attempted to cover the whole of Ibadan (803 098 people). They based population 
figures on the 1963 census projected for 1973 using a 2.5% annual growth rate. 
They ascertained stroke cases by notification from hospitals, general practitioners, 
private nursing homes, coroner’s offices and the office of the Medical Officer of 
Health for the city. First-ever-in-a-lifetime and recurrent strokes were included. 
One nurse visited these various institutions once a
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Table 2.1  Criteria for an ideal study of stroke incidence, from (Sudlow and 
Warlow, 1996), (Feigin and Hoorn, 2004) and (Feigin and Carter, 
2004) 
 
 
 
Standard definitions 
 
WHO definition of stroke 
Availability of data on first-ever-in-a-lifetime strokes 
At least 80% verification of stroke type by CT or MRI brain scan 
Classification of ischaemic stroke subtype* 
Availability of data on recurrent strokes* 
 
 
Standard methods 
 
Complete, community-based ascertainment, based on multiple overlapping 
sources 
Prospective study design, ideally with ‘hot pursuit’ of cases 
Large, well-defined, stable population allowing at least 100 000 person-years of 
observation 
Reliable method for estimating the denominator (census data ≤ 5 years old) 
Follow up of patients’ vital status for at least 1 month 
Ascertainment of patients with TIA, recurrent strokes and those referred for brain, 
carotid, or cerebral vascular imaging* 
Direct assessment of under-ascertainment by checking of alternative sources e.g. 
general practitioner databases, hospital admissions or referrals for vascular 
imaging or interventions* 
 
 
Standard data presentation 
 
 Whole years of data 
 Not > 5 years of data averaged together 
 Men and women presented separately 
 No upper age limit for the population studied 
 Standard mid-decade age bands used in publications 
Presentation of 95% confidence intervals around incidence rates 
Unpublished 5-year age bands available for comparison with other studies* 
 
 
Criteria marked (*) are considered supplementary rather than ‘core’ criteria (Feigin and Carter, 
2004)  
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cases, who were then invited to return to a clinic for evaluation by a neurologist. In 
situations where the cases were not assessed by the neurologist a diagnosis was 
based on case histories and results of available investigations. Computer 
tomography (CT) scanning was not available in those days.  
 
Over the two-year period 318 stroke patients were registered, resulting in a very 
low crude incidence of 25 per 100 000 for males and 13 per 100 000 for females 
(total 20 per 100 000). It is likely, however, that this figure is an underestimate 
because of difficulties with case ascertainment resulting from the very large, and 
likely mobile, population covered by a very small study staff. 
 
2.2.2.2. Hospital-based ‘incidence’ 
 
The vast majority of the studies available on stroke in SSA are hospital-based 
case series. Most often these studies document the proportion of patients admitted 
to medical and neurology services that have had strokes. While it is very difficult to 
conclude anything from individual case series with respect to stroke burden in the 
community (Feigin et al., 2004), some institutions have monitored their stroke 
admissions over time and shown a steady increase. In Tanzania statistics from the 
Ministry of Health (Haddock, 1965) indicate that stroke admissions increased from 
23 per 100 000 in 1935 to 86 per 100 000 in 1962. Nyame and his colleagues 
compared stroke admissions to Korle Bu Teaching Hospital in Accra, Ghana, 
during three periods: 1960-1968, 1976-1983 and 1990-1993 (Nyame, Bonsu-
Bruce, Amoah et al, 1994) and found that the number of strokes admitted per year 
increased from about 50 in 1960 to 622 in 1993. The percentage of total adult 
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medical admissions due to stroke increasing from less than 2% in 1960 to about 
12% in 1993. This may have been the result of population aging, a change in 
admission policy or criteria for diagnosing stroke, or a real increase in stroke 
incidence.  
 
Two hospital-based studies, from Southern Africa (Rosman, 1986; Matenga, 
1997), both urban, have attempted to estimate stroke incidence. Matenga 
ascertained cases for a year (1991) from all four general hospitals in Harare, 
Zimbabwe, the capital city with a population of 887 768 black Zimbabweans. The 
post-mortem register was also inspected monthly as were hospital discharge 
summaries. Stroke was defined according to the WHO definition and only first-
ever-in-a-lifetime strokes were included. The attending physician diagnosed stroke 
and in difficult cases reviewed the diagnosis with the investigator. None of the 
cases had CT scans of the brain. The crude stroke incidence was 31 (95% CI, 27 
to 34) per 100 000 per year. Standardised to the world population the incidence 
was 68 per 100 000.  
 
Rosman included all strokes (first-ever-in-a-lifetime and recurrent), excluding 
subarachnoid haemorrhage, admitted to Kalafong Hospital in Atteridgeville and 
suburban Pretoria, South Africa. Seventy-nine percent of all stroke cases had CT 
scans. The crude stroke incidence for over 20 year olds was 101 per 100 000 per 
year. 
 
The different methodology used in the South African and Zimbabwean hospital-
based studies, and in community-based studies from outside SSA, precludes 
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accurate comparison of incidence. Despite this, it is interesting to note that age-
specific stroke incidence is much higher in younger age groups in the SSA studies 
compared to the United Kingdom Oxford Vascular Study (Rothwell, Coull, Giles et 
al, 2004), but lower than figures for African-Americans from the North of 
Manhattan Stroke Study (Sacco, Boden-Albala, Gan et al, 1998) (table 2.2). 
Furthermore, stroke admissions to hospital are clearly rising in SSA although this 
could be due to changes in attitudes towards allopathic medicine, easier access to 
medical care, or ageing of the population, as much as to increasing incidence. 
While total stroke incidence is lower in SSA than in other parts of the world this 
may simply be because the population is so much younger.  
 
The available hospital-based SSA studies almost certainly under estimate stroke 
incidence. In order to accurately determine stroke incidence in SSA now and in the 
future, incidence studies fulfilling as many of the ideal criteria as possible (table 
2.1) are needed.  
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Table 2.2  Comparison of age and sex specific annual stroke incidence per 100 000 population (rates are not 
standardised). NB the South African and Zimbabwean studies are hospital-based  
 
 
 
  
 
   
 
  
Age 
(years) 
South Africa 
(Rosman, 
1986) 
Zimbabwe 
(Matenga, 
1997) 
OXVASC 
(Rothwell et 
al., 2004) 
South Africa 
(Rosman, 
1986) 
Zimbabwe 
(Matenga, 
1997) 
OXVASC 
(Rothwell et 
al., 2004) 
South Africa 
(Rosman, 
1986) 
Zimbabwe 
(Matenga, 
1997) 
NMSS 
(Sacco et 
al., 1998) 
OXVASC 
(Rothwell et 
al., 2004) 
20-24 8 - - - - - - - - - 
25-34 9 7 - 10 13 - - 10 0 - 
35-44 37 23 27 43 66 16 - 41 54 22 
45-54 107 126 73 109 102 54 - 118 184 64 
55-64 249 174 177 239 237 175 280 194 366 176 
65-74 643 402 646 583 563 408 837 469 636 526 
>75 445 619 - 611 957 - 726 788 - - 
Total 84 30 134 90 32 156 101 31 223 145 
 
OXVASC – Oxford Vascular Study; NMSS – North of Manhattan Stroke Study
Females (rate) Total 
 
Males (rate) 
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2.2.3 Case fatality 
 
Because of the heterogeneity of stroke type and severity, and the likelihood that 
many stroke patients are not admitted to hospital, one ideally needs to know case 
fatality from community-based studies. We excluded all retrospective hospital 
based studies of case fatality (Dada, Johnson, Araba et al, 1969; Abraham & 
Abdulkadir, 1981; Bahemuka, 1985; Bwala, 1989; Ndiaye, 1989; Lisk, 1993; 
Nyame et al., 1994; M'Buyamba-Kabangu, Longo-Mbenza, Tambwe et al, 1995) 
because these are likely to be hampered by missing and variably recorded data as 
well as hospital admission bias. We also excluded studies that did not provide the 
time after stroke when case fatality was assessed (Osuntokun, Odeku, & Adeloye, 
1969; Abraham et al., 1981; Abebe & Haimanot, 1990; Kwasa & Lore, 1990; Lisk, 
1993; Nyame et al., 1994; Longo-Mbenza, Phanzu-Mbete, M'Buyamba-Kabangu 
et al, 1999; Longo-Mbenza, Tonduangu, Muyeno et al, 2000; Sokrab, Sid-Ahmed, 
& Idris, 2002).  
 
The only community-based study, the Ibadan stroke register (Osuntokun et al., 
1979), found the case fatality at three weeks to be 35%, higher for cerebral 
haemorrhage and subarachnoid haemorrhage, 61% and 62% respectively, but 
stroke types, other than SAH, must have been diagnosed unreliably without CT 
scanning. Furthermore, the investigators had great difficultly with follow up and at 
three months only 76 of 318 patients could be traced. As a result, this case fatality 
figure is likely to be unreliable.  
 
 37 
Early stroke (haemorrhagic and ischaemic) case fatality i.e. up to about one 
month, derived from prospective hospital case series, is about 33% (Rosman, 
1986; Joubert, 1991; Matenga, 1997). Rosman found a higher case fatality in 
patients with cerebral haemorrhage (58%) than cerebral infarction (22%) but 
patients who died before they had a CT scan were assumed to have had an 
intracerebral haemorrhage which would have inflated that figure (Rosman, 1986).  
 
Only one study provided long-term follow up over four years to determine case-
fatality, time to death and likely cause of death. This study from the Gambia 
(Walker, Rolfe, Kelly et al, 2003) included all patients admitted to hospital with a 
diagnosis of stroke or who had a stroke as an inpatient over a one-year period. 
Both first-ever-in-a-lifetime and recurrent strokes were included and patients with 
subarachnoid haemorrhage were excluded. None of the patients had a CT scan. 
Patients were followed up at home or hospital at one and six months and again 
between three and four years after their stroke. Case fatality in the 106 cases at 
one and six months was 27% and 44% respectively, and 75% of patients had died 
by the final follow up. At the end of follow up cause of death in all patients was the 
initial stroke in 61%, further stroke in 7%, infection in 12% and another vascular 
cause (hypertensive encephalopathy) in only 1 patient. None of the patients had 
angina or myocardial infarction and only one patient died of a cardiac cause, a 
cardiomyopathy. Remarkably only four cases were lost to follow up.  
 
While this study provides the only available data on long-term follow-up of stroke 
patients, it is hospital-based and CT scanning was not available. As such, severe 
and mild strokes may have been excluded and it is not possible to differentiate 
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case fatality between haemorrhagic and ischaemic strokes. It does, however, 
provide the best data available of stroke case fatality and cause of death in SSA 
and suggests that in the Gambia at least one month case fatality is not much 
higher (27%) than in comparable stroke studies from the rest of the world (23%) 
(Feigin et al., 2003b). But the risk of a cardiac death following stroke was much 
lower than is found in high-income regions of the world (Dennis, Burn, Sandercock 
et al, 1993). 
 
Detailed stroke type specific (infarct versus haemorrhage) community based case 
fatality data are not available for SSA. Considering the importance of this figure in 
estimating stroke burden and quality of stroke care it is essential that studies and 
funders address this issue in the future.  
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2.2.4 Stroke prevalence 
 
Estimating the prevalence of stroke survivors in the community is complicated by 
the difficulty in making a retrospective yet accurate diagnosis of stroke and stroke 
type months or years after the event. It is also biased by under-representation of 
fatal cases, and even by disabling stroke which can be difficult to assess because 
of overlapping disability caused by other conditions such as osteoarthritis and 
dementia. Prevalence, which depends on incidence and case fatality, is therefore 
better estimated from incidence studies of first-ever-in-a-lifetime stroke and 
survival (Warlow, 1998). But in SSA high quality incidence studies are unavailable 
and anyway difficult to perform, so stroke prevalence studies in demographic 
surveillance sites which provide an accurate denominator have arguably provided 
the most accurate measures of stroke burden in recent years despite the 
limitations. 
 
In developed countries most studies of stroke prevalence have used a screening 
postal questionnaire for case finding (Aho, Reunanen, Aromaa et al, 1986; 
Mahony, Dobson, Rodgers et al, 1995; Geddes, Fear, Tennant et al, 1996). Poor 
or non-existent postal services in SSA make this approach unfeasible and, as in 
most low-income countries, door-to-door surveys have mainly been used (Walker, 
McLarty, Masuki et al, 2000b) . 
 
In 1982 and 1987 Osuntokun and colleagues published the results of three studies 
designed to establish the prevalence of neurological disease in rural Nigeria using 
door-to-door surveys performed by nurses, primary health care attendants and 
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medical students. In Aiyete, a community of about 2000, 903 individuals were 
screened to pilot a research protocol for measuring the prevalence of neurological 
disease in the community. Four people were found to have had a stroke 
(Osuntokun, Schoenberg, & Nottidge, 1982). In Udo, 2925 people were screened 
and two found to have had a stroke (Longe & Osuntokun, 1989). The largest study 
- in Igbo-Ora - took place in 1982. Teams drawn from teacher and non-doctor 
primary health care workers were trained for a month to administer the screening 
questionnaire for neurological disorders piloted in Aiyete and to make a simple 
neurological examination in everyone over the age of 7 years. Those who 
screened positive for neurological disease were examined by an adult or 
paediatric neurologist or neurosurgeon. Stroke was diagnosed in 11 of 18 954 
people screened, resulting in a crude prevalence of 58 per 100 000 (Osuntokun, 
Adeuja, Schoenberg et al, 1987). 
 
Although these studies were a brave attempt to assess the prevalence of stroke 
and neurological disease under difficult circumstances, the populations screened 
were far too small to establish stroke prevalence accurately, particularly as 
typically 44% of the population in SSA are under the age of 15 years old and 
stroke mainly affects older age groups. Furthermore, very little information was 
given in the publications about the criteria used to diagnose stroke. The accuracy 
of the stroke prevalence found is therefore questionable.  
 
Between 1986 and 1988 a door-to-door survey was conducted on a random 
sample of 60 820 rural Ethiopians of all ages. Lay health workers who had been 
trained by neurologists, conducted a census and identified cases with symptoms 
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and signs of neurological disorders, using a previously piloted questionnaire 
(Tekle-Haimanot, Abebe, Gebre-Mariam et al, 1990). Neurologists regularly visited 
the villages to examine people identified and validate diagnoses. Stroke was found 
in 9 people ranging in age from 28 to 85 years (crude prevalence: 15 per 100 000). 
The authors suggested that the low prevalence was the result of a high case 
fatality, but case fatality figures were not in fact available. In view of their 
seemingly sound methodology under difficult circumstances, the low prevalence 
may also reflect a low stroke incidence in rural Ethiopia in the mid-1980s, or simply 
that mild strokes that had recovered were not detected. 
 
The largest study, which was of the prevalence of disabling hemiplegic stroke, in 
SSA was conducted in 1994 in the rural Hai district of Tanzania (population 148 
135) (Walker et al., 2000b). This is one of the demographic surveillance system 
(DSS) project areas of the Adult Morbidity and Mortality Project, one of the 
members of INDEPTH (International Network for the continuous Demographic 
Evaluation of Populations and Their Health) (INDEPTH network, 2002), where a 
yearly census is carried out. In each village a specially trained ‘enumerator’ is 
responsible for data collection. During the 1994 census three questions were 
included to try to identify anyone who may have been disabled by a stroke viz.: ‘Is 
there anyone in the household with a history of stroke?’; ‘Is there anyone in the 
household with weakness down one side of the body?’; ‘Does anyone in the 
household require assistance with: dressing, eating or toileting?’ Everyone with 
one or more positive responses was seen by a physician with extensive 
experience of stroke who confirmed the diagnosis based on a detailed history and 
examination according to the WHO definition of stroke. 108 people were identified 
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as fitting the criteria for the study. This provided an age standardised (to the Segi 
World population) prevalence of disability resulting from stroke of 154 per 100 000 
in males and 114 per 100 000 in females over the age of 15 years (Walker et al., 
2000b). This study has the advantage of an accurate denominator and careful 
assessment of people who screened positive for stroke. But the accuracy of the 
census screening questions was not assessed and verification of this method of 
establishing stroke prevalence in SSA would be difficult and unreliable (Walker et 
al., 2000b). The investigators also assessed the prevalence of stroke survivors 
‘who required help with at least one activity of daily living’ for comparison with 
findings of a similar assessment performed in a study of stroke prevalence in 
Auckland, New Zealand (Bonita, Solomon, & Broad, 1997). This is an important 
measure because these people probably place the greatest burden on the family 
and health service.  
 
The prevalence of disabling hemiplegic stroke in Tanzania was about six times 
lower than that found in New Zealand, and the prevalence of stroke survivors ‘who 
required help with at least one activity of daily living’ about half. This may be 
because of a lower incidence of stroke or higher case fatality in Tanzania, or 
because of methodological differences. The prevalence of stroke in Auckland was 
modelled on the results of two community based incidence studies and therefore 
far more likely accounted for people with very mild strokes and those who 
recovered completely from their stroke. Only population-based incidence studies 
with long term follow up and assessment of case fatality will clarify these questions 
in SSA. (We discuss these two studies further in Chapter 3 following the 
results of the prevalence of stroke in rural South Africa). 
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2.3 The nature of stroke in Sub-Saharan Africa 
 
2.3.1 Stroke types and subtypes 
 
2.3.1.1 Methodological problems associated with stroke series in SSA 
 
Stroke is a heterogeneous condition consisting of three pathological types, 
ischaemic stroke, cerebral haemorrhage (CH) and subarachnoid haemorrhage 
(SAH). Ischaemic stroke is further divided into subtypes such as intracranial small 
vessel disease, large-vessel atherosclerotic disease, and embolism from the heart 
(Warlow, 1998). Haemorrhagic stroke too can be subtyped, but with more difficulty 
because so often more than one ‘cause’ appears to be acting in any one individual 
(for example, hypertension and presumed amyloid angiopathy). Pathological 
stroke types and ischaemic subtypes differ in terms of cause, outcome and 
appropriate treatment policies (Warlow, Dennis, van Gijn et al, 2001). The nature 
(pathological stroke type, ischaemic and haemorrhagic stroke subtype, risk 
factors, and causes) of stroke is also likely to change as SSA undergoes health 
transition – from haemorrhagic stroke to ischaemic stroke caused by 
atherosclerosis in large and medium sized arteries (table 1.1) (Gillum, 1996a; 
Howson et al., 1998).  
 
Theoretically at least, the cause of embolic stroke is also likely to change as the 
population undergoes health transition. Rheumatic heart disease and the dilated 
form of cardiomyopathy which results from hypertension as well as nutritional 
 44 
deficiency are the predominant causes of heart failure in populations in early 
transition. Later as ischaemic heart disease and extracranial atherosclerosis of 
large vessels develop, so these together with atrial fibrillation are likely to become 
the major sources of emboli (Howson et al., 1998). While this theory makes sense, 
there is little epidemiological evidence in the literature to support it; probably 
because most developed regions passed through the transition before 
documentation of change was possible.  
 
Ideally studies that distinguish between stroke types should have a high 
neuroimaging rate and patients should be scanned within days of symptom onset 
to reliably distinguish between cerebral haemorrhage and infarction if CT rather 
than MR brain scans are used (Sudlow et al., 1996). Clinical scoring systems such 
as the Guy’s hospital or Siriraj scores are sometimes used to complement a high 
but incomplete CT scan rate (Sudlow et al., 1996). These scores have not been 
validated by large prospective studies in SSA. (Chapter 6 covers a literature 
review of clinical scoring systems in general and the literature pertaining to 
SSA specifically). Subarachnoid haemorrhage is easier to differentiate because 
of the characteristic clinical syndrome backed up with blood in the cerebrospinal 
fluid, if CT is not available.  
 
The only community-based stroke study, the Ibadan stroke registry (Osuntokun et 
al., 1979) was undertaken before CT scanning was available.  This lack of 
community-based studies limits the usefulness of the data on the type and subtype 
of stroke from SSA, so hospital-based studies are more likely to include severe 
strokes and cerebral haemorrhages which have a more dramatic clinical 
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presentation than mild ischaemic strokes (Bamford, Sandercock, Warlow et al, 
1986; Dennis et al., 1994).  
 
Many retrospective and prospective hospital-based case series from SSA have 
documented stroke types and subtypes, but few have used neuroimaging. 
Retrospective studies while sometimes adding interesting anecdotal information 
may add to the bias of hospital-based series. Moreover, poor documentation often 
results in insufficient detail on stroke diagnosis, type and subtype, particularly in 
patients who die soon after admission (Walker & Ogungbo, 2003). We therefore 
excluded retrospective series and hospital-based series that did not use brain 
imaging when evaluating stroke types and subtypes.  
 
Table 2.3 lists all the prospective hospital-based stroke registers that have made 
use of CT scanning. We have not included a prospective hospital based study of 
1214 individuals from Kinshasa, Congo which did use brain imaging (Longo-
Mbenza et al., 1999; Longo-Mbenza et al., 2000). The main aim of that study was 
to assess the relationship between haematocrit and stroke and various 
meteorological variations and so 15% of the patients were excluded because they 
did not have demographic data or measurements of haematocrit available. 
Furthermore, although brain imaging was performed, it was not stated how many 
of the patients actually had a CT brain scan. We also excluded a prospective 
hospital based study of 96 stroke patients from Sudan from table 2.3, because 
only 18 had a CT brain scan (19%), well below the recommended 70 to 80% scan 
rate for stroke studies to differentiate pathological type (Sudlow et al., 1996; Feigin 
et al., 2004). 
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Table 2.3   Comparison of stroke types and selected subtypes from prospective hospital-based studies in SSA that used 
brain imaging 
 
    
 
   
 
  
Study details 
Number of 
strokes 
Brain scan 
No. (%) 
Time of stroke 
onset to scan 
CH (%) 
Ischaemic 
stroke (%) 
SAH (%) 
Unspecified 
(%) 
Small 
vessel No. 
(%) 
Cardio-
embolic No. 
(%) 
Comment 
Kalafong, 
South Africa 
(Rosman, 
1986) 
116 
92 
(79) 
(CT) 
? 38 (33) 77 (66) 
Not 
included 
1 (1) 24 (31) ? 
Recurrent and first-ever-in-a-lifetime 
strokes included  
Harare, 
Zimbabwe 
(Matenga, 
1986) 
93 
93 
(100) 
(CT) 
? 29 (31) 62 (67) 2 (2) 0 (0) ? 12 (19) 
100 consecutive patients with 
presumed stroke studied. 7 found to 
have non-stroke lesions 
Medunsa, 
South Africa 
(Joubert, 
1991) 
304 
250 
(82) 
(CT) 
Median 4 
days (range 1 
to 39) 
64 (26) 178 (71) 80 (3) 0 (0) 4 (2) 47 (46)† All first-ever-in-a-lifetime strokes 
Durban Stroke 
Data Bank, 
South Africa 
(Hoffmann, 
2000) 
100 
100 
(100) 
(CT, MRI or 
both) 
See text 10 (10) 90 (90) 0 (0) 0 (0) 3 (3) 7 (8) 
Durban Stroke Data Bank included 
1298 patients, 151 of whom were 
Black. Separate information on 
stroke type and subtype only 
available for 100 Blacks, all of whom 
were young (Hoffmann,1998; 
Hoffmann, Nath et al., 2000) 
 
CT – computer tomography; MRI – Magnetic resonance imaging; CH - Cerebral Haemorrhage; SAH – Subarachnoid haemorrhage; ? -  data not provided 
*The lack of data and use of different classification systems and methodologies in the studies makes the comparison of ischaemic stroke subtypes inaccurate. It is not possible to compare large 
vessel disease across the studies. See text for detail. 
† A subgroup of 102 patients underwent detailed cardiac assessment (what this entailed is not clear) and of these 47 had cardiogenic sources of embolism diagnosed. See text for detail.  
Pathological stroke types 
No. (% of all strokes imaged for all but the 
Kalafong study in which % is of all strokes) 
Subtypes of ischaemic 
stroke  
(% is of ischaemic 
strokes)* 
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Although, the Durban Stroke Data Bank (DSDB) included 1298 patients, only 151 
were black Africans (Hoffmann, Berger, Nath et al, 2000b). Brain imaging and 
stroke type and subtype data were only available for the 100 young (less than 50 
years of age) stroke patients within this group (Hoffmann, 2000) and these were 
included in table 2.3. 
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2.3.1.2 Cerebral haemorrhage  
 
Table 2.3 shows the proportion of cerebral haemorrhages in all the prospective 
hospital-based stroke series from SSA that used imaging. All were based in urban 
settings, three from South Africa and one from Zimbabwe.  
 
The low proportion of cerebral haemorrhages in the Durban Stroke Data Bank is 
surprising. In community-based studies of stroke incidence in young white stroke 
patients cerebral haemorrhage is relatively more common than it is in older 
patients (Marini, Totaro, De Santis et al, 2001). This Durban finding may reflect 
referral bias or late brain scanning. Although the timing to assessment and 
scanning is not available for the 100 young patients in table 2.3, only 44% of the 
entire DSDB were assessed within 7 days and 62% within 4 weeks (Hoffmann, 
1998). Thus some haemorrhages may have been missed in the approximately one 
third of patients who had a CT and not an MRI brain scan (Dennis, Bamford, 
Molyneux et al, 1987).  
 
Ninety-three strokes were confirmed following brain scan in a series of 113 
consecutive adult patients admitted to two Harare hospitals with a clinical 
diagnosis of stroke in the mid-1980s (Matenga, Kitai, & Levy, 1986). 13 died 
before being having a CT scan. The seven non-stroke lesions included subdural 
haematoma (4), cysticercosis (1), malignant glioma (1), and metastatic deposits 
(1). 27 of the 29 intracerebral haemorrhages were presumed to be the result of 
hypertension. It is not clear whether the haemorrhages occurred in what are 
assumed to be typically hypertensive sites, or whether angiography was 
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performed to exclude other potential causes of intracerebral haemorrhage. Of the 
two remaining patients, one had a mycotic aneurysm and no cause was found for 
the haemorrhage in the other. Two of the 13 patients who died underwent autopsy 
and both had intracerebral haemorrhage with subarachnoid extension. Of the 
remainder, 10 were thought to have had cerebral haemorrhages on clinical 
grounds (Matenga et al., 1986).  
 
Although the aetiology of cerebral haemorrhage was not discussed in detail in the 
Kalafong study, 82% of patients presenting with cerebral haemorrhage had 
associated hypertension diagnosed on the basis of a history of sustained elevated 
blood pressure (defined as >160/95 mmHg) requiring medical treatment and 
confirmed by medical records, or if hypertensive end organ damage was found 
(Rosman, 1989). No detail on the nature of cerebral haemorrhages was provided 
in the Medunsa study (Joubert, 1991). 
 
The high proportion (approximately a third of all strokes) of cerebral haemorrhages 
found in most studies (table 2.3) may fit with SSA being in an early phase of health 
transition, but may equally be influenced by hospital-admission bias. 
Haemorrhagic strokes are more dramatic in onset and more likely to be severe. In 
SSA, where for most people there are numerous barriers to accessing health care 
(Hundt et al., 2004), it is likely that the more severe presentation of a cerebral 
haemorrhage increases the likelihood of hospital admission.  
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2.3.1.3 Subarachnoid Haemorrhage 
 
Subarachnoid haemorrhage occurred infrequently (3% of stroke cases or less) in 
studies in SSA (table 2.3). This is within the range of 0.9% to 7% found in 
community-based stroke incidence studies outside SSA (Feigin et al., 2003b), but 
based on very small numbers. Therefore, one can say little about SAH other than 
it seems to be rare, or maybe it is more common than we found but rarely 
diagnosed for lack of CT scanning and even lumbar puncture availability. 
Moreover, stroke series may have missed subarachnoid haemorrhages if they 
were referred directly to neurosurgical departments on admission.   
 
2.3.1.4 Ischaemic stroke 
 
Ischaemic strokes may be subtyped using clinical classifications as in the 
Oxfordshire Community Stroke Project (OCSP) (Bamford, Sandercock, Dennis et 
al, 1991), or aetiopathogenic classifications as in the Trial of Org 10172 (TOAST) 
(Adams, Jr., Bendixen, Kappelle et al, 1993). Table 2.3 shows the ischaemic 
stroke subtypes reported in prospective studies that used brain imaging.  
 
The standardised OCSP and TOAST criteria were only used in the DSDB and all 
patients were extensively investigated (Hoffmann, 2000). Unfortunately, the level 
of investigation needed to assess patients using the TOAST criteria renders this 
classification unhelpful in the SSA setting as such a large proportion of stroke 
patients fall into the unclassified category (Connor & Warlow, 2001). Indeed, 
despite extensive investigation, 47 of the 90 young stroke patients with ischaemic 
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stroke (52%) were classified as having had strokes due to unknown causes using 
the TOAST classification.  
 
Stroke subtypes were classified according to the Harvard Cooperative Stroke 
Registry diagnostic criteria in the Kalafong study (Mohr, Caplan, Melski et al, 
1978) and  according to the Stroke Data Bank criteria in the Medunsa study 
(Kunitz, Gross, Heyman et al, 1984). In the study from Zimbabwe, the only 
subtype reported was cardioembolic stroke in patients with ischaemic stroke who 
presented with a potential cardiac source of embolism and without any other 
obvious cause for their stroke. Thus the assessment of subtypes was not uniform 
across studies.  
 
To add to the difficulty in interpreting the differences in ischaemic stroke subtypes, 
hospital-referral bias and age differences, notably the young patients in the DSDB, 
may have influenced the case mix in these studies. For example, cardioembolic 
strokes are usually more severe than small vessel lacunar strokes, hospital series 
are likely to over-represent severe stroke, and young stroke patients are less likely 
to have hypertensive small vessel disease and more likely to have ‘other’ less 
common causes of stroke, such as vasculitis. As a result, we recommend treating 
a direct comparison of the subtypes found in these studies with caution.  
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2.3.1.5 Large artery atherosclerosis 
 
2.3.1.5.1 Extracranial carotid atherosclerosis 
 
While atherosclerosis of the extracranial carotid arteries does occur in black 
Africans (Madiba & Robbs, 1990; Kadwa & Robbs, 1993) it is not as common as in 
whites (Moossy, 1993; Wityk, Lehman, Klag et al, 1996). This view is supported by 
autopsy (Reef & Isaacson, 1962; Lemercier, Quenum, Richir et al, 1970; 
Lemercier, Collomb, N'Diaye et al, 1970; Anim, 1987), angiographic (Inzitari, 
Hachinski, Taylor et al, 1990), and carotid Doppler studies (Kingue, Kuaban, 
Dongmol et al, 1998),  all in people who have not had strokes. However, even in 
African stroke patients, carotid atherosclerosis is not common. 
 
It is not possible to assess directly atherosclerotic involvement of the carotid 
arteries in stroke patients in the prospective stroke studies from SSA that used 
imaging (table 2.3). There was no clinical evidence of carotid artery disease in the 
Zimbabwean study, though no detail is provided on how this was assessed 
(Matenga et al., 1986). The study from Kalafong found 37 ischaemic stroke cases 
(48% of ischaemic strokes) to have been caused by ‘large artery thrombosis,’ 
however, only two patients were investigated with carotid Doppler in the Kalafong 
study, and no comment was made on the findings in the 11 patients who had 
angiograms, so it is not possible be sure of the extent of extracranial 
atherosclerotic carotid disease in these patients (Rosman, 1989).  
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On the other hand the DSDB found only 5 (5%) of their young stroke patients to 
have ‘large artery atherosclerosis’ using the more rigid TOAST classification which 
required documented stenosis of the extracranial carotid artery. Thus the low 
frequency probably reflects both the rigid diagnostic criteria (Adams, Jr. et al., 
1993; Adams, Jr., Kappelle, Biller et al, 1995) and the age (most less than 40 
years old) of the stroke cases (Bogousslavsky & Pierre, 1992). In the Medunsa 
Stroke Data Bank, 30 of the patients with carotid territory cerebral infarctions 
underwent angiography. Of these 4 (13%) had some evidence of atherosclerosis 
(plaques, stenosis or occlusion) (Joubert, 1991).  
 
Most studies from SSA have not commented on the presence or absence of 
cervical arterial bruits. In high-income populations they are present in about 5% of 
normal people over the age of 75 years (Sandok, Whisnant, Furlan et al, 1982), 
and in about 14% of patients with ischaemic stroke (Sandercock, Warlow, Jones et 
al, 1989). Those studies from SSA that have documented cervical bruits found 
them in only 1 to 4%, suggesting a very low prevalence of extracranial 
atherosclerosis (Rosman, 1989; Joubert, 1991). 
 
2.3.1.5.2 Intracranial carotid atherosclerosis 
 
None of the prospective stroke studies using brain imaging in SSA (table 2.3) have 
attempted to document intracranial atherosclerotic disease. There is, however, 
autopsy data that addresses this issue and this will be discussed later.  
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2.3.1.5.3 Peripheral vascular disease in stroke patients 
 
Large artery disease, if found in one arterial system, is likely to be found in others 
(Warlow et al., 2001; Duvall & Vorchheimer, 2004). Therefore, we looked at the 
prevalence of peripheral vascular disease (PVD) in stroke patients in SSA. There 
is very little. Two studies found none at all (Aho, Harmsen, Hatano et al, 1980; 
Matenga et al., 1986), one found clinical evidence of PVD in just 1% of stroke 
patients (Joubert, 1991) and in the Kalafong study 15% of patients had diminished 
or absent dorsalis pedis pulses (Rosman, 1989). Even this figure of 15% which is 
more than double that found in any other study, is low compared to the 9 to 25% 
found in high-income stroke populations (Sandercock et al., 1989; Rothwell et al., 
2004). In community-based prevalent stroke cases PVD was found in 1% in 
Tanzania (Walker et al., 2000b).  
 
As far as we can tell, therefore, stroke patients in SSA have very little evidence of 
large vessel atherosclerosis, either as the cause of stroke or elsewhere in the 
circulation. 
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2.3.1.6  Cardioembolic stroke and ischaemic heart disease 
 
Ischaemic heart disease (IHD) is uncommon in Sub-Saharan Africans (Walker, 
1963; Seedat, Pillay, & Marcoyannopoulou-Fojas, 1976; Wyndham, 1979; Walker, 
1980; Isles & Milne, 1987; Bertrand, 1995; Kahn, Tollman, Garenne et al, 1999b; 
Bradshaw et al., 2002; Walker, Walker, Sci et al, 2002; Akinboboye, Idris, 
Akinboboye et al, 2003). However, non-ischaemic heart disease such as 
cardiomyopathy and rheumatic valvular heart disease is common and an important 
cause of death, especially in the elderly (Wyndham, 1979; van der Horst, 1984; 
Kahn et al., 1999b; Bradshaw et al., 2002). The causes of cardioembolic stroke 
are likely to reflect this pattern. 
 
In the Ibadan Stroke Register (Aho et al., 1980) that did not have brain imaging but 
did attempt to ascertain community-based stroke cases, none of the 318 patients 
had a history of myocardial infarction, while 15% of females and 14% of males had 
a history of ‘other types’ of heart disease. It is not clear whether people with a 
history of ischaemic heart disease other than causing myocardial infarction were 
included in this ‘other types’ group.  
 
Stroke was thought to be due to cardiac embolism in 8-46% of the hospital-based 
stroke registers that used brain imaging (table 2.3). In the Kalafong study from 
South Africa, none of the patients had IHD and atrial fibrillation was the presumed 
cause of the ischaemic stroke in 8 of the 77 patients (10%) (Rosman, 1986). The 
likely cause of the atrial fibrillation is not clear from the study. In the extended 
Kalafong study which included 152 ischaemic strokes, cardioembolic causes 
included: 27 (18%) presumed to be due to rheumatic valvular heart disease, 5 
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(3%) due to infective endocarditis, 5 (3%) due to cardiomyopathy and the 
remainder 14 (7%) due to atrial fibrillation. In the Zimbabwean study, 12 of 62 
ischaemic strokes (19%) were cardioembolic, due to atrial fibrillation, 
cardiomyopathy or valvular heart disease (Matenga et al., 1986). Again the cause 
of the atrial fibrillation was not clear. Cardioembolic causes were responsible for 7 
(8%) of 90 ischaemic strokes in the DSDB, but no further detail specific to the 
black patients was provided (Hoffmann, 2000). 
 
In SSA, most hospital-based studies using imaging, and community-based 
studies, have found a low prevalence of IHD in stroke patients ranging from 0-7% 
(Aho et al., 1980; Matenga et al., 1986; Rosman, 1989; Joubert, 1991; Hoffmann, 
2000; Walker et al., 2000b). This is much lower than the 38% found in the 
Oxfordshire Community Stroke Project in the 1980s (Sandercock et al., 1989). 
 
However, the Medunsa Stroke Data Bank (MSDB) group have challenged this 
notion of a low prevalence of IHD in SSA stroke patients using an extended 
version of their data i.e. different numbers to those shown in table 2.3. 555 stroke 
patients (72% ischaemic stroke and 28% cerebral haemorrhage) underwent 
detailed cardiac investigation including clinical assessment and resting ECG, and 
a subgroup of 102 (78% ischaemic stroke; 22% cerebral haemorrhage) 
consecutively admitted patients underwent echocardiography, and multigated 
blood pool scanning (MUGA) (group 1) (Joubert, McLean, Reid et al, 2000). Sixty 
other, randomly selected patients (88% with ischaemic stroke and 12% with 
cerebral haemorrhage), underwent myocardial scintigraphic perfusion studies 
(group 2). Twenty-three patients (70% with ischaemic stroke; 30% cerebral 
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haemorrhage) underwent autopsy (group 3). The ECG assessment revealed 
evidence of presumed coronary artery disease (myocardial ischaemia, previous or 
acute myocardial infarction) in 17% of patients. In the first group, 13% of patients 
were found to have myocardial ischaemia and 6% evidence of previous MI.  This 
figure rose to 32% for myocardial ischaemia and 13% for MI in the scintigraphic 
study (group 2). Seventeen percent of autopsied patients (group 3) had evidence 
of previous MI and 50% had evidence of >50% stenosis in 1, 2 or 3 coronary 
arteries. But, despite the significant prevalence of IHD, less than 1% of the 741 
stroke patients from which this sample originated complained of angina and none 
was aware of a previous diagnosis of myocardial infarction. Nonetheless, the 
authors concluded that black stroke patients might have a similar risk of coronary 
artery disease to that of their white counterparts. In the light of the low prevalence 
of IHD found in other SSA stroke series, and in the population in general, these 
findings will probably only become widely accepted if confirmed by other studies.  
 
In a separate publication from the MSDB (Joubert, Van Gelder, Darazs et al, 1989) 
102 consecutive stroke patients, 24% with cerebral haemorrhage, were evaluated 
as in the first group above (it is not clear from either publication whether these are 
the same patients), and a structural or functional cardiac abnormality was found in 
27 of the 102 stroke patients of all types (27%). ‘Possible’ sources of cardiac 
embolism (mainly congestive, restrictive, and hypertrophic cardiomyopathy, mitral 
valve prolapse, sclerotic aortic valves and hypertension associated with myopathic 
ventricles) were found in 23 (23%) and definite sources in 24 (24%) of the 102 
stroke patients. Of those with definite sources of cardiac emboli: 5 had atrial 
fibrillation caused by rheumatic heart disease (2), hypertensive heart disease (1), 
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non-obstructive hypertrophic cardiomyopathy (1) and in 1 the cause was not 
known. A further 11 were caused by rheumatic heart disease, 4 by congestive 
cardiomyopathy, 2 by valvular heart disease and left ventricular thrombus, 1 by left 
ventricular thrombus alone and 1 by left atrial thrombus and a calcified mitral valve 
annulus. In 3 patients the rheumatic heart disease was associated with bacterial 
endocarditis. None of the patients had complained of a myocardial infarction but 
ischaemic heart disease was presumed to be present on ECG or 
echocardiography in 7 (7%) of the 102 stroke patients. Unfortunately, it is not clear 
from the study what proportion of the ischaemic stroke patients had likely 
cardioembolic sources.  
 
Thus, cardioembolic stroke probably occurs about as often in SSA as in developed 
regions. However, the underlying cardiac lesion is more likely to be due to 
rheumatic or other non-ischaemic cardiac disease than ischaemic heart disease at 
present. If the health transition theory holds (table 1.1), then the cause of cardiac 
embolism should gradually shift towards ischaemic heart disease and atrial 
fibrillation.  
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2.3.1.7  Lacunar infarction / complex small vessel disease 
 
In high-income countries about a quarter of all ischaemic strokes are lacunar. Most 
of these are caused by ‘complex’ small vessel disease or atheroma of the proximal 
parts of intracranial perforating arteries (Warlow et al., 2001). Occlusion of these 
arteries results in small deep, not cortical infarcts. While the majority of clinical 
lacunar syndromes are the result of infarction, haemorrhage also is responsible 
and imaging is needed for differentiation. 
 
If indeed Sub-Saharan Africans do have more intracranial than extracranial 
atherosclerosis, then one might anticipate lacunar infarction to be a common 
ischaemic stroke subtype. However, there is considerable disagreement on the 
proportion of lacunar strokes in the hospital-based series from SSA (table 2.3). 24 
(31%) ischaemic strokes in the Kalafong study (Rosman, 1986), 4 (2%) in the 
Medunsa study (Joubert, 1991) and 3 (3%) in Durban (Hoffmann, 2000) were 
thought to be due to intracranial small vessel disease. Of course, the discrepancy 
between these figures may be the result of different diagnostic criteria or case mix 
differences. It is not clear how rigidly the Medunsa Stroke Data Base group 
enforced the Stroke Data Bank (Kunitz et al., 1984) criteria for lacunes, which 
required evidence of infarction when a CT scan was performed. If they did apply 
the criteria rigidly then this would have reduced the frequency of small vessel 
disease in their study as it has in others (Kunitz et al., 1984). Small vessel disease 
is less common in young stroke patients than in older patients (Warlow et al., 
2001), which may in part explain the low frequency in the DSDB. 
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2.3.2  Other causes of stroke 
 
Of the studies included in table 2.3, only the Kalafong study and DSDB included 
details on strokes caused by infection, coagulopathy or causes usually classified 
as ‘other.’ In the extended Kalafong study six of 211 patients were considered to 
have meningovascular syphilis based on positive cerebrospinal fluid (CSF) 
serology, in the presence of inflammatory cells and an appropriate clinical picture 
(Rosman, 1989).  
 
All 100 patients in the DSDB young stroke series were between the ages of 15 
and 49 years. It was difficult to identify the causes of stroke within the young black 
patients, but 20 were HIV-positive. In three alternative explanations for the stroke 
were cardiac valvular disease, cryptococcal meningitis and tuberculosis related 
vasculopathy (Hoffmann, 2000). 
  
Many studies and case reports that did not meet our criteria for inclusion in table 2 
have described other less common causes of stroke in Africa. Two broad groups 
of causes are prominent, sickle cell disease and infection.  
 
2.3.2.1 Sickle cell disease 
 
Studies from Europe and the United States have reported ischaemic stroke and 
less commonly cerebral haemorrhage in children and young adults with 
homozygous sickle cell disease. The overall stroke risk is about 1% per annum 
(Ohene-Frempong, Weiner, Sleeper et al, 1998). Silent cerebral infarcts are more 
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common than overt stroke and are noted in about 20% of children by 14 years of 
age (Buchanan, DeBaun, Quinn et al, 2004). Heterozygous disease (sickle cell 
trait) rarely causes stroke in children and young adults unless there is an 
associated hypoxia-provoked sickle cell crisis (Greenberg & Massey, 1985; 
Partington, Aronyk, & Byrd, 1994).  
 
In a case-control study from Nigeria with 180 non-embolic strokes and 100 age 
and sex matched controls, none of the stroke patients had homozygous sickle cell 
disease (haemoglobin SS) and the frequencies of haemoglobin AS and AC 
(heterozygotes) were similar in strokes and controls (Danesi, Oyenola, & Ontiri, 
1983). All the participants were adults with an average age of 56 years in the 
stroke group and 55 years in the control group, which probably explains the 
absence of any sickle cell homozygotes as sickle cell disease usually results in 
death before 30 years of age in most parts of SSA (Diallo & Tchernia, 2002). The 
lack of association between sickle cell heterozygosity and stroke may be the result 
of the small sample size.  
 
Although both sickle cell disease and sickle cell trait are very common in Western, 
Central and Eastern SSA (Akinyanju, 1989; Diallo et al., 2002) neither have 
formed a prominent part of the stroke literature in adults in SSA. None of the 
prospective stroke series in table 2.3 or the WHO-Nigerian community-based 
stroke incidence study (all in adults) examined the role of sickle cell trait. Two 
retrospective and one more recent prospective hospital-based adult stroke series 
found that sickle cell disease and trait were uncommon causes of stroke 
(Haddock, 1970; Billinghurst, 1970; Longo-Mbenza et al., 1999). On the other 
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hand in a mixed prospective and retrospective series of stroke in 35 children 
admitted to two hospitals in the Cameroon over a six month period, homozygous 
sickle cell disease was the commonest cause of stroke (31%) (Obama, Dongmo, 
Nkemayim et al, 1994). 
 
In summary, sickle cell disease in SSA appears to play the same role in stroke as 
it does elsewhere in the world. However, this conclusion is based on very limited 
evidence from inadequately designed studies.  
 
2.3.2.2 Meningovascular syphilis 
 
The diagnosis of meningovascular syphilis is not simple. In the context of stroke it 
is diagnosed either at autopsy or if the syphilis serology is positive in the blood and 
the VDRL (Venereal Disease Research Laboratory) is positive in the cerebrospinal 
fluid (CSF) of a patient with a recent stroke (Timmermans & Carr, 2004). However, 
false positive VDRL results caused by contamination from serum are possible, and 
false negative results have also been described. A positive FTA-abs (fluorescent 
treponemal antibody) in the CSF is very sensitive but results in many false 
positives and is more useful when negative to exclude syphilis as a cause of 
disease.  Unfortunately, co-infection with human immunodeficiency virus (HIV) 
complicates the interpretation of the serological tests further. HIV positive 
individuals are more likely to have false negative blood serology and CSF VDRL 
results than HIV negative individuals, and repeat testing and a careful 
interpretation of the rest of an individual’s CSF findings, brain imaging and clinical 
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presentation is required to make the diagnosis of meningovascular syphilis (Lynn 
& Lightman, 2004). 
 
Few hospital-based stroke series have documented the CSF serology in patients 
with stroke and positive blood serology. Those that have, quote a low frequency of 
meningovascular neurosyphilis, in the same range as the Kalafong study (3%): 2 
of 150 (1%) in a study from Ethiopia (Abebe et al., 1990), 4 of 96 (4%) in Sudan 
(Sokrab et al., 2002), 1 of 44 (2%) in a retrospective study from Sierra Leone (Lisk, 
1993), and 3 of 105 autopsy cases of ischaemic stroke (3%) in Uganda (James, 
1975). In the Zimbabwean study of 93 stroke patients, all of whom had brain 
imaging (table 2.3), the stroke was attributed to neurosyphilis in 8 patients (all 
ischaemic strokes) (Matenga et al., 1986). 
 
2.3.2.3  Human immunodeficiency virus (HIV)  
 
There are many reasons why individuals who are infected with HIV may present 
with a stroke or stroke mimic, e.g. secondary to various opportunistic causes of 
meningitis, intracranial infective mass lesions, infective vasculitides or following 
cardiac manifestations of HIV (Connor, Lammie, Bell et al, 2000). Ischaemic stroke 
in HIV-infected individuals is not common in the absence of a non-HIV infection, or 
lymphoma in the brain or embolic sources, despite an underlying HIV related 
vasculopathy (Connor et al., 2000). Moreover, there is limited support for the role 
of HIV on its own as a cause for stroke (Cole, Pinto, Hebel et al, 2004). 
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Two studies in SSA have examined the association between HIV and stroke. In 
the DSDB (table 2.3) 20 out of the 100 young stroke patients were HIV-positive 
and in all but three this was the only identified cause for the stroke (Hoffmann, 
2000; Hoffmann, Berger, Nath et al, 2000a). The seropositivity rate was similar to 
the background population, however. In a case series of 35 predominantly young 
(mean age 32 years) HIV-positive urban South African stroke patients, an 
underlying non-HIV cause of the stroke was found in 30 of the 35 patients and 
included protein S deficiency, meningitis, cardiac embolism and hypertension 
(Mochan, Modi, & Modi, 2003). The authors felt that these causes were not 
significantly different to what one might expect to find in HIV-negative stroke 
patients in urban Johannesburg.  
 
So it is not clear whether HIV is an independent risk factor or cause for stroke in 
Sub-Saharan Africans and a large prospective case-control study as well as high 
quality post mortem studies are needed to resolve this confusion.   
 
2.3.3  Autopsy studies of stroke and cerebral atherosclerosis in Africa  
 
Autopsy series can be very useful, particularly for formulating hypotheses of what 
may cause stroke, but they are clearly subject to multiple selection biases. For 
example, haemorrhagic strokes which are more often fatal are likely to be 
overrepresented and lacunar strokes underrepresented. Therefore, they do not 
reflect stroke types and subtypes in the community. The autopsy studies from SSA 
have seldom provided a detailed description of selection criteria for autopsy, such 
as whether patients who had died of atherosclerosis related disease were included 
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or excluded, and techniques for assessing the degree of atherosclerosis were 
often subjective and varied from study to study. All of this made the interpretation 
of the results and comparison of studies challenging. We have included studies 
that specifically focused on the distribution of atherosclerosis in the cerebral 
vasculature in stroke populations in SSA and studies that have described the 
causes of ischaemic stroke and cerebral haemorrhage in SSA. We excluded 
studies that did not clearly distinguish between the pathological stroke types when 
assessing the cause of stroke.  
 
2.3.3.1  Atherosclerosis 
 
Although studies reporting on atherosclerosis in African populations (Baker, Flora, 
Resch et al, 1967; Walker, 1974) have been conflicting, most of the disagreement 
has come from South African studies (Reef et al., 1962; Meyer, Pepler, Meyer et 
al, 1964; Strong, 1972) and one Ugandan study (Owor, Resch, & Loewenson, 
1976) and may result from differences in populations across Africa (Anon., 1971), 
perhaps influenced by their stage in the health transition.  
 
From various autopsy studies in black Sub-Saharan Africans and studies that have 
compared this group with white SSA populations, African Americans and white 
Americans, a pattern of intracranial, carotid and coronary atherosclerosis emerges 
(table 2.4). This pattern suggests there is a progression from minimal intracranial 
or coronary atherosclerosis found in populations from Nigeria (Williams, Resch, & 
Loewenson, 1969; Williams, Loewenson, Lippert et al, 1975), 
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Table 2.4 Comparison of the pattern of atherosclerosis found in autopsy 
studies from populations in Sub-Saharan Africa and the United 
States of America 
 
 Autopsy studies in unselected populations 
Autopsy studies in Stroke 
populations 
 Atherosclerosis in: Atherosclerosis in: 
Region 
Intra- 
cranial arteries 
Extra-cranial 
carotid  
arteries 
Coronary 
arteries 
Intra-cranial 
arteries 
Coronary 
arteries 
Nigeria, 
(Williams et al., 1969; 
Williams et al., 1975)  
 
Senegal, 
(Collomb, Dumas, 
Lemercier et al, 1967; 
Lemercier et al., 1970; 
Resch, Williams, Lemercier 
et al, 1970) 
 
Ghana 
(Edington, 1954; Anim, 
1987; Anim & Kofi, 1989) 
- - * - + - 
South Africa, 
(Higginson & Pepler, 1954; 
Laurie & Woods, 1958; 
Sacks, 1960; Reef et al., 
1962; Meyer et al., 1964; 
Strong, 1972)  
 
Uganda 
(Owor et al., 1976) 
- / + - - + ? 
White Africans 
(Sacks, 1960; Meyer et al., 
1964)  
 
White Americans 
(Solberg & McGarry, 1972; 
Strong, 1972; McGarry, 
Solberg, Guzman et al, 
1985) 
+ ++ † ++   
African Americans 
(Williams et al., 1969; 
Resch et al., 1970; Solberg 
et al., 1972; Strong, 1972; 
Williams et al., 1975; Owor 
et al., 1976; McGarry et al., 
1985) 
++ ++ ++   
 
- little atherosclerosis 
+  atherosclerosis present but at low to moderate levels 
++  marked atherosclerosis 
 
*   One study from Senegal found some atherosclerosis in extracranial carotid arteries (see text for detail) 
†   no reference for autopsy studies in White Africans 
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Senegal (Resch et al., 1970), and Ghana (Anim, 1987; Anim et al., 1989) to similar 
amounts of intracranial atherosclerosis in blacks in South Africa (Meyer et al., 
1964) and Uganda (Owor et al., 1976) and whites in South Africa (Meyer et al., 
1964), though still without any evidence of an increase in coronary or carotid 
atherosclerosis in blacks (Higginson et al., 1954; Sacks, 1960; Reef et al., 1962). 
There is, however, one study from Senegal that found >50% stenosis of at least 
one carotid artery in 7 of 112 (6%) patients at autopsy (Collomb, Sankale, Courson 
et al, 1971). Finally, the most severe intracranial, carotid and coronary 
atherosclerosis has been found in African Americans (Solberg et al., 1972; Strong, 
1972; McGarry et al., 1985; Anim, 1987). In comparative studies both within South 
African and intercontinental, intracranial atherosclerosis in all populations is seen 
to increase in extent and severity with age and male gender (Williams et al., 1975; 
Anim, 1987). A history of hypertension (and increased heart mass) and diabetes 
mellitus has also been associated with an increase in the severity of intracranial 
atherosclerosis in SSA populations (Williams et al., 1975; Anim, 1987). 
 
In autopsy populations from SSA who had had a stroke, three studies found 
significant intracranial atherosclerosis (Laurie et al., 1958; Collomb et al., 1967; 
Lemercier et al., 1970). Perhaps people with increased intracerebral 
atherosclerosis who develop ischaemic strokes represent the vanguard of the 
health transition and in time populations in SSA will develop atherosclerotic 
disease in the carotids and coronaries similar to that seen in African Americans. 
Only further community-based studies with detailed imaging, and autopsy studies 
will be able to resolve this confusion.  
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2.3.3.2  Autopsy causes of stroke 
 
As mentioned above autopsy studies do not accurately reflect the nature of stroke 
in the community. However, a recent autopsy study from Accra, Ghana compared 
the proportion of ischaemic and haemorrhagic strokes (including cerebral 
haemorrhage and subarachnoid haemorrhage), reaching autopsy during two 
different time periods, 1972-1981 and 1994-1998 at the same institution (Wiredu & 
Nyame, 2001). The proportion of haemorrhagic stroke had fallen from 89% in 1981 
to 61% in 1998. This may reflect a downward trend in the number of haemorrhagic 
strokes in the population, altered referral patterns, or other influences which are 
not clear from the study. However, the decline in haemorrhagic stroke would be 
compatible with the health transition. 
 
Autopsy series of course may provide more detail on what causes strokes (or at 
least fatal strokes) in a population. The same study from Accra provided a 
retrospective analysis of the cause of 666 haemorrhagic strokes (7% 
subarachnoid haemorrhage), 397 ischaemic strokes and 23 in a poorly defined 
group termed ‘combined strokes’ which presumably included both haemorrhages 
and ischaemic strokes in the same patient. Haemorrhagic strokes were caused by: 
hypertension (90%), hypertension plus cerebral atherosclerosis (3%), other 
causes including ruptured berry aneurysm, bleeding disorder and vascular 
malformations (3%), bacterial endocarditis (0.5%) and miscellaneous conditions in 
4%. Ischaemic strokes were caused by: hypertension (24%) though the exact 
mechanism by which this was thought to have occurred is not clear, hypertension 
plus cerebral atherosclerosis (25%), cerebral atherosclerosis alone (35%), 
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cerebrovascular thrombosis (in the absence of atherosclerosis) (3%) and cardiac 
mural thrombi (2%), bacterial endocarditis (2%) and was undetermined in 8%. In 
the group with ischaemic and haemorrhagics strokes combined in the same 
patient  the cause was hypertension in 96% and undetermined in the remainder 
(Wiredu et al., 2001). Unfortunately the authors did not comment on extracranial 
atherosclerosis or the role of artery-to-artery or cardiac embolism to the brain in 
this series. However, an autopsy study performed at the same centre about ten 
years previously found almost no significant atherosclerosis in the extracranial 
carotid or coronary arteries (Anim, 1987).  
 
The same centre from Ghana had previously used the arteriographic technique of 
Ross Russell in 284 consecutive non-traumatic, unselected autopsy cases over 20 
years of age (Anim & Kofi, 1984). The authors suggested that the prevalence of 
microaneurysms was lower than in similar studies of white patients, even in 
hypertensive patients with haemorrhagic strokes, and suggested that the 
mechanism of hypertensive haemorrhage may be different in young black 
Africans. However, microaneurysms are very difficult to detect and there are 
numerous methodological pitfalls with this type of study (van Gijn, 2001). 
 
In a much earlier autopsy series in the 1950s, again from Ghana, hypertension 
was thought to be responsible for 23 of 53 cerebral haemorrhages, atherosclerosis 
for 13, unclassified causes for 12 and pregnancy, syphilis and sickle cell disease 
for 5 (Edington, 1954). 
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In Uganda stroke was the cause of death in 207 of a retrospective review of 5497 
autopsies performed between 1967 and 1971: 75 (48 males, 27 females) had 
cerebral haemorrhages, 105 (74 males, 31 females) ischaemic strokes and 27 (17 
males and 10 females) subarachnoid haemorrhages (James, 1975). The 
presumed cause of the cerebral haemorrhages was hypertension in 32 of the 75 
(43%) (essential hypertension in 24, hypertension secondary to renal disease in 7 
and ‘possible’ hypertension in 8). It is not clear exactly how the diagnosis of 
hypertension was made, however. The remainder were caused by: eclampsia (6), 
sickle cell disease (2), coagulation defects (7), unspecified ‘heart disease’ and 
‘other causes’ in 5, and in 9 no obvious cause was found. In the 105 ischaemic 
strokes the causes were: essential hypertension and secondary hypertension in 19 
(18%), cardioembolic in 47 (45%), atherothromboembolic in 5 (5%), syphilis in 3 
(3%), and in 31 (30%) the cause was not clearly identified. The cardioembolic 
sources, as previously found in SSA, were seldom related to ischaemic heart 
disease, and myocardial infarction was only present in 5 of 105 (5%) of ischaemic 
strokes. Other causes were: endocarditis in 25 (24%), endomyocardial fibrosis in 6 
(6%), rheumatic heart disease in 5 (5%), cardiomyopathy (unspecified) in 4 (4%) 
and myocarditis in 2 (2%). Finally, in the 27 cases of subarachnoid haemorrhage 
the cause was: berry aneurysm in 10 (37%), mycotic aneurysm in 2 and an 
aneurysm of uncertain origin in 1. Five were associated with either possible or 
definite hypertension, and in a further 5 no cause was found. The remaining 4 
included one case each of sickle cell disease, aplastic anaemia, anticoagulant 
therapy and bacterial endocarditis. 
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2.3.4  Major Vascular Risk Factors – Unmodifiable 
 
2.3.4.1 Age and Sex 
 
In SSA, as in high-income countries, increasing age is a major risk factor for stroke 
(table 2.2). Stroke incidence in the younger 35-54 year-old age groups, even in 
hospital series, is higher than in the United Kingdom, but not quite as high as in 
African-Americans. 
 
Early SSA hospital case series and the Ibadan Stroke Registry (Osuntokun et al., 
1979) found the male:female sex ratio to be as high as 3:1 (Osuntokun, 1994). 
Some authors considered this excess of males to reflect cultural practices in which 
men were more likely to go to or be admitted to hospital than woman (Osuntokun, 
1977). A recent stroke registry from Zimbabwe found a sex ratio closer to 1:1 
(Matenga, 1997), while others from Sudan, the Congo and the Gambia continue to 
find a higher proportion of men admitted with ratios ranging from 1.4 to 1.7:1 
(Longo-Mbenza et al., 2000; Sokrab et al., 2002; Walker et al., 2003). An 
exception to the male predominance was found in the MEDUNSA stroke data 
bank in South Africa where the male to female ratio was 0.8:1 (Joubert, 1991). 
This is not a consistent feature of South African registries though, because there 
was a male predominance in the Kalafong study, with a ratio of 1.3:1 a year 
previously in the same part of the country (Rosman, 1986). 
 
The community-based rural stroke prevalence study from Tanzania found age-
standardised stroke prevalence to be higher in men than women (ratio 1.4:1) 
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(Walker et al., 2000b), Some of the discrepancies seen across studies may be age 
related and reflect a younger population when an increased male predominance is 
found. In both the Oxfordshire Community Stroke Project and the OXVASC 
community stroke incidence studies males had a higher incidence of stroke in 
middle age but the incidence was similar in men and women over the age of 75 
(Rothwell et al., 2004).  
 
2.3.5 Modifiable Risk Factors 
 
There is only one published  but small case-control study of 180 patients and 100 
controls investigating non-cardioembolic ischaemic stroke risk factors in SSA 
(Danesi et al., 1983). The authors found a significantly elevated relative risk (in 
brackets) of ischaemic stroke from diastolic hypertension (5.5) defined as a 
pressure of ≥ 100 mmHg, systolic hypertension (5.2) defined as a pressure of ≥ 
160 mmHg, diabetes mellitus (2.5), low socio-economic status (2.2) and obesity 
(3.2). Random serum cholesterol, haemoglobin and random blood glucose were 
significantly higher in the cases than in the controls. The serum cholesterol in the 
cases was 5.0 mmol/l compared to 4.4 mmol/l in the controls (p<0.05). The 
haemoglobin was 13.9 g/dl in the cases and 13.2 in the controls (p<0.05) and the 
random blood glucose was 6.5 mmol/l in the cases and 5.1 mmol/l in the controls 
(p<0.01). Small numbers and the absence of brain imaging limit the study. It is 
also not clear whether patients were indeed hypertensive or simply had elevated 
blood pressure associated with acute stroke. 
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In the absence of any other case control studies, we are reliant on assessing risk 
factors from their prevalence in stroke registers and case series. Studies 
containing information on risk factors were included in our assessment if they were 
community-based stroke studies or prospective hospital-based stroke studies that 
included consecutive stroke admissions. We excluded studies without clearly 
defined risk factors. We found that risk factors were seldom if ever reported by 
stroke type. Where they were we have used pathological type specific data, 
otherwise results refer to the percentage of all strokes combined affected by the 
risk factor.   
 
2.3.5.1   Hypertension  
 
Hypertension is an important risk factor for stroke but definitions vary and it is not 
always clear whether investigators have relied on blood pressure measurements 
at the time of presentation which are more likely to reflect transient hypertension 
related to the acute stroke (Bath & Bath, 1997). Ideally one would like to know 
whether a stroke patient had a history of hypertension prior to their stroke or had 
ever been on treatment for hypertension. Unfortunately, the vast majority of people 
with hypertension in SSA are undiagnosed and so this is not a particularly helpful 
definition in this setting. Another way of determining whether a stroke patient had 
pre-existing hypertension is to look for clinical signs of end-organ damage such as 
left ventricular hypertrophy or hypertensive retinal changes (Warlow et al., 2001). 
 
In hospital-based studies that used brain imaging (table 2.3), hypertension was 
diagnosed in 43-70% (Matenga et al., 1986; Rosman, 1986; Joubert, 1991) of 
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strokes, although this was not surprisingly higher (93%) in patients presenting with 
cerebral haemorrhage in Zimbabwe (Matenga et al., 1986). 
 
In a community-based study that did not use brain imaging, hypertension was 
present in 68% of incident stroke cases in Nigeria (defined as sustained blood 
pressure >160/100 mmHg for at least one week or end organ damage) 
(Osuntokun et al., 1979). Other prospective hospital stroke series that did not use 
imaging have found a prevalence of hypertension in stroke admissions of about 
65% (Abebe et al., 1990; Roberts, Opare-Sem, & Acheampong, 1994). 
 
2.3.5.2   Diabetes mellitus 
 
In hospital-based studies using imaging diabetes mellitus was diagnosed in 3-10% 
of all strokes (Matenga et al., 1986; Joubert et al., 1989; Rosman, 1989). It was 
found in 5% of young stroke patients in the Durban Stroke Data Bank (Hoffmann, 
2000). In community-based studies the range was a similar 3-10% (Osuntokun et 
al., 1979; Walker et al., 2000b) with the lower figure from Tanzania and the higher 
one from Nigeria. Prospective hospital series have found diabetes mellitus in 3-5% 
of stroke admissions (Abebe et al., 1990; Walker et al., 2003).  So diabetes 
mellitus is not particularly common in SSA when compared to the finding of 
diabetes mellitus in about 10% of community-based incident stroke cases in the 
United Kingdom between 1981 and 2004 (Rothwell et al., 2004).  
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Atrial fibrillation 
 
 
In one hospital series atrial fibrillation was found in 2% of strokes (Abebe et al., 
1990) though it is seldom commented on in studies from SSA. It was found in 5-
7% of strokes in hospital series using imaging (Rosman, 1986; Joubert et al., 
1989) and in 7% of prevalent cases in Tanzania (Walker, 2002). So atrial 
fibrillation occurs less frequently in SSA than in high-income country stroke 
populations, but this may be because stroke occurs at a younger age in SSA than 
in high-income populations. 
 
2.3.5.4  Cholesterol 
 
None of the community-based studies have investigated blood cholesterol levels 
and it is difficult to interpret the results of the hospital-based studies as few define 
what is meant by hypercholesterolaemia or dyslipidaemia or how and when 
specimens were taken. As a result, findings vary widely. For example in a similar 
population at a similar time in South Africa total cholesterol was found to be 
elevated in <2% of stroke patients in one study (Rosman, 1989) and in 10% in 
another (Joubert et al., 1989). In a hospital series in Ethiopia the proportion of 
stroke patients with elevated cholesterol levels was 7% (Abebe et al., 1990). 
Despite this variation, the proportion is substantially lower than the 58% of incident 
strokes with total cholesterol ≥ 6 mmol/L found in the high-income UK population 
in Oxfordshire in the 1980s or even the 30% found in the same population in the 
OXVASC study twenty years later (Rothwell et al., 2004). 
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2.3.5.5  Smoking 
 
Current cigarrette smoking was found in 6-28% in hospital-based studies that used 
imaging (Matenga et al., 1986; Rosman, 1989; Joubert, 1991; Hoffmann, 2000). In 
Ethiopia cigarette smoking was found in 7% of stroke patients admitted to hospital 
(Abebe et al., 1990). In a hospital cohort study from The Gambia, half of the stroke 
patients had a history of smoking and 23% were current cigarette smokers at the 
time of their stroke. Smoking was significantly less common in age and sex 
matched controls selected from among hospital visitors, of whom 14% had a 
history of smoking, but only 8% were current smokers at the time they were seen 
(Walker et al., 2003). In Oxfordshire, UK, about 30% of all incident stroke cases 
were current smokers in the early 1980s, but this had declined to 18% in 2002 in 
the OXVASC study.  
 
2.3.5.6  Alcohol 
 
A number of studies have assessed alcohol use (Rosman, 1989; Nwosu, 
Nwabueze, & Ikeh, 1992; Walker et al., 2003). Unfortunately, few if any have 
attempted to quantify the amount of alcohol consumed (Joubert, 1991), which is 
particularly difficult in many parts of SSA where alcohol is brewed at home and the 
strength varies (Greenhalgh, 2004). The exact role of alcohol as a risk factor in 
SSA is not clear and none of the studies have used controls 
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2.4   Summary of the literature on stroke in SSA 
 
The literature on the burden and nature of stroke in SSA is limited (often because 
of a lack of brain imaging) and there are no community based incidence studies of 
stroke that come close to meeting accepted ‘ideal’ standards. Stroke mortality 
appears to be increasing, but there are no accurate longitudinal data from regions 
with good vital registration or where verbal autopsies were performed. The 
prevalence of stroke is lower than in high-income regions. Of course without 
community based incidence studies with follow up it is not possible to assess 
whether the low prevalence is the result of low incidence or high case fatality or 
both.  
 
The only stroke studies in SSA that provide information on the nature of stroke 
type and subtype, as well as causes and risk factors - because of the availability of 
brain imaging - are hospital-based and therefore are likely to be biased. Moreover, 
most of these studies lack clear definitions of risk factors and descriptions of how 
stroke subtypes were diagnosed. As a result, the nature and causes of strokes in 
SSA are very unclear. 
 
The literature does provide some support for the concept of the health transition. 
Stroke in hospital series is found at a relatively younger age than it is in high-
income regions. At present cerebral haemorrhage, in hospital studies at least, is 
more common than one would expect in a high-income region, constituting about a 
third of all strokes. Cardioembolic strokes account for about one fifth of ischaemic 
strokes but there is little evidence of ischaemic heart disease in stroke patients. 
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Indeed, extracranial atherosclerotic disease is uncommon in any form with carotid 
artery disease and peripheral vascular disease seldom found in stroke patients in 
SSA. This pattern of relative lack of atherosclerotic disease, particularly in the 
extracranial arteries is generally supported by autopsy studies. All of this would 
suggest that SSA has entered the health transition but has not yet developed a 
large burden of atherosclerotic disease and its clinical consequences. 
 
The pattern of risk factors in stroke patients likely reflects this pattern of stroke. 
Hypertension is by far the most common risk factor, while elevated cholesterol is 
found in fewer than 10% of stroke survivors. Diabetes mellitus is less common 
than one would expect in high-income populations but not markedly so, and in 
most studies current smoking was generally less common than in high-income 
populations. Based on small studies, homozygous sickle cell disease appears to 
be an important cause of stroke in children but not adults in endemic regions of 
SSA. The role of HIV / AIDS as a risk factor or cause for stroke has not been 
adequately investigated in this region. 
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2.5 Discussion and comment 
 
Without intervention, vascular and cardiac disease related deaths are set to 
increase from 3 million in 1998 to 5 million in 2020 in WHO developing regions 
(The WHO, 2001; Leeder et al., 2004). As risk factors for vascular disease 
increase, so the burden of vascular disease will increase. Typically the pattern of 
vascular disease fits the basic outline given by Omran’s theory of the health or 
epidemiologic transition (Omran, 1971) and stroke leads the way. However, the 
type and subtype of stroke and the relative proportion of extracranial 
atherosclerotic diseases (ischaemic heart disease, stroke due to carotid artery 
disease, and peripheral vascular disease) will probably change as the vascular 
risk factors change within the population. Stroke in SSA is entering the health 
transition and as the burden of risk factors increases, so the burden of stroke will 
increase to epidemic proportions unless interventions are set in place now. 
 
Many reports from influential groups have highlighted this impending epidemic and 
called for low and medium-income countries and research funders to act (Howson 
et al., 1998; The WHO-Wellcome Trust, 2001; The WHO, 2001; The WHO, 2002; 
The WHO, 2003; Leeder et al., 2004). Many have highlighted the need for high 
quality epidemiological research to establish the burden of stroke in SSA and 
monitor the effect of interventions. 
 
Unfortunately we have found little high quality epidemiological data on stroke in 
SSA. Stroke research has focused on hospital based studies, few with imaging 
and most retrospective. It is time to move on and ‘ideal’ community based 
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incidence and case fatality studies are needed, at least in a few sites, perhaps at 
different stages in the transition, to clarify both the burden and nature of stroke. 
While these studies are relatively expensive and logistically difficult to perform, 
and SSA particularly in rural and more remote regions is a difficult place to work in, 
the potential exists to do this type of research in demographic surveillance sites 
such as those that are part of the INDEPTH group (INDEPTH network, 2005). 
These sites provide not only an accurate denominator, but also very often a 
research infrastructure which supports the research. In countries and areas where 
this type of study is not feasible, surveillance of stroke in a STEPwise form as 
developed by the WHO will provide useful local and longitudinal information 
(Bonita, Mendis, Truelsen et al, 2004). But only detailed community studies of the 
nature of stroke in the region, with brain imaging, will provide insight into where the 
region is along the health transition and help direct the focus of interventions to the 
appropriate risk factors and causes. They would also help to clarify the effect of 
HIV / AIDS on stroke.  
 
While combating stroke and vascular disease will require action on a range of 
fronts, including government initiatives to change population risk by for example 
legislating against cigarette advertising and smoking, and interventions will have to 
be developed in consultation with local populations, it is essential that action be 
taken now to reduce the future burden (Leeder et al., 2004). The remarkable drop 
in stroke incidence found in the recent OXVASC study in Oxfordshire, UK, done in 
the same population twenty years after the OCSP study and associated with a 
drop in vascular risk factors, suggests that stroke prevention is both possible and 
effective, and can be surprisingly rapid (Rothwell et al., 2004). The challenge now 
 81 
is to accurately document the burden and nature of stroke, to implement stroke 
prevention appropriately, and to measure the outcome in Sub-Saharan Africa.  
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CHAPTER 3   THE PREVALENCE OF STROKE IN RURAL SOUTH 
AFRICA 
 
3.0   Introduction 
 
There are no stroke prevalence data available for South Africa and only very 
limited reliable data available for the rest of sub-Saharan Africa (see section 
2.2.4). The aim of this study was to establish the prevalence of stroke, and nature 
of prevalent strokes, in the University of the Witwatersrand / Medical Research 
Council (Agincourt) Rural Public Health and Health Transitions Research Unit 
demographic site, hereafter referred to as the ‘Agincourt Health and Population 
Unit’ (AHPU) or simply as Agincourt. The study formed one component of the 
Southern African Stroke Prevention Initiative (SASPI) study. This chapter will 
describe the methods used and the prevalence of stroke in the region, while the 
nature of prevalent stroke in the region will be described in chapter 4.  
 
Although I have presented the literature pertaining to the prevalence of stroke in 
Sub-Saharan African Africa in section 2.2.4, I will highlight the literature relevant to 
stroke prevalence studies elsewhere in the world in the discussion.  
3.1   Setting and population 
 
The Agincourt Health and Population Unit, located in a deprived rural area of 
South Africa (figures 3.1 and 3.2), has been monitoring the causes of death, births 
and inward and outward migration by means of a health and demographic 
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Figure 3.1  Situation of Agincourt Health and Population Unit field site 
Bohlabela region, previously 
known as Bushbuckridge, in 
the north east of South Africa 
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Figure 3.2  Houses in the Agincourt Health and Population Unit (AHPU) field site 
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 Figure 3.3  The government’s new Reconstruction and Development Project 
housing in the AHPU (above), and the team interviewing a woman who 
screened positive for stroke during the census but had hypocalcaemia 
with severe muscle cramping not stroke (below, with permission) 
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surveillance system in a population of around 70,000 people since 1992 (Tollman, 
Herbst, & Garenne, 1995). 
 
The Agincourt sub-district of Limpopo Province, in the northeast of South Africa, 
was formerly part of the homeland of Gazankulu. The population is Shangaan, 
although Mozambican refugees who settled in the area after the 1980s civil war in 
Mozambique, who are also Shangaan speaking and culturally affiliated with the 
South African population, make up about a third of the population. There are 
limited amenities. Although electricity is recently available in most villages, it does 
not reach all households, and access to clean water is severely restricted. As part 
of the legacy of the apartheid system, there is considerable labour migration, 
especially amongst men. Some migrant workers return home only at Christmas 
and Easter; while others return more frequently. Migrants are included in the 
annual census as they would consider ‘home’ to be the Agincourt Health and 
Population Unit villages, and almost all of them maintain a household in the area.  
If they become ill and unable to work, they usually return here. Figures 3.2 – 3.3 
include photographs of the Agincourt field site showing the range of dwellings from 
the typical Mozambican refugee hut to the new relatively high density government 
reconstruction and development programme housing.  
 
3.2  Case finding  
 
Each year, the Agincourt Health and Population Unit carries out a door-to-door 
census survey of all the households in the 21 villages in the area using an 
interview questionnaire administered by trained census workers (Collinson, 
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Mokoena, Mgiba et al, 2002). In 2001, we added two screening questions similar 
to those asked in the then recent stroke prevalence study in Tanzania (Walker et 
al., 2000b) (see section 2.2.4). The fieldworker questioned each household 
informant, named every individual in the household and asked: ‘Has …………. 
(person) ever had weakness down one side of the body?’ and ‘Has …………… 
(person) ever had a stroke?’ In the Tanzanian study, three questions were posed 
to each household: ‘Is there anyone in the household with a history of stroke?’; ‘Is 
there anyone in the household with a weakness down one side of the body?’ and 
‘Does anyone in the household require assistance with: a) dressing, b) eating and 
c) toileting?’ The Tanzanian investigators found that question three was very 
sensitive but not very specific and did not yield significantly more strokes than the 
first two questions (personal communication R W Walker). In Agincourt the term 
‘stroke’ has multiple interpretations and prior to the SASPI study we thought that it 
might perhaps be interpreted as bewitchment and influence the participant’s 
response. As a result we asked about weakness down one side before asking 
whether the person had had a stroke. In an effort to detect all prevalent strokes 
rather than to limit the findings to people with current disability or functional 
impairment, we asked whether people had ‘ever’ had weakness rather than 
currently had weakness as in the question used in Tanzania. Finally, in contrast to 
the Tanzanian study our fieldworkers asked the household informant whether each 
member of the household had weakness or a stroke, rather than asking about the 
household in general. 
 
We gave the census workers, an experienced team of trained local fieldworkers, 
specific training on stroke, including information on its causes and manifestations, 
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as well as instruction and practice in using the questions in the vernacular. We 
conducted a pilot study in 20 households and found a significant number of 
children with birth trauma related neurological conditions and cerebral palsy but 
almost none with stroke. The causes of stroke in children differ from those in 
adults and accurate diagnosis requires relevant paediatric skills (deVeber, Roach, 
Riela et al, 2000). As a result stroke prevalence studies seldom if ever include 
children (Feigin et al., 2003b). We planned to compare our findings with those 
from a similar stroke prevalence study from Tanzania (Walker et al., 2000b) and 
with a study from New Zealand (Bonita et al., 1997). Both these studies used 15 
years of age as the lower limit for inclusion. So for several reasons we selected 
the same threshold for inclusion. The census ran between August and November 
2001, and the date chosen for point prevalence was the day before the census 
started, the 31st July 2001.  
 
If either screening question was answered positively, then, accompanied by an 
interpreter, we (myself or one of two research fellows I trained in the assessment 
of stroke) visited the relevant individual in their home between January and 
October 2002 (see figure 3.3). We obtained informed consent before taking a 
detailed history and examining the individual. We held regular meetings 
(approximately weekly) to discuss and agree on the diagnosis in all cases. Where 
there was diagnostic doubt, I visited and assessed individuals, and made a final 
diagnosis. 
 
In this remote region, there are no reliable means of postal or other 
communication so we had to visit the households. If the relevant individual was not 
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available, we tried to arrange a future visit through other household members or 
neighbours. If initially unsuccessful, we made at least two further attempts on 
different occasions to visit any individual who on the basis of the census questions 
might have had a stroke.  
 
 90 
3.3   Clinical assessment 
 
We defined stroke according to the WHO criteria as ‘rapidly developing signs of 
focal (or global) disturbance of cerebral function, leading to death or lasting longer 
than 24 hours, with no apparent cause other than vascular’ (Hatano, 1976a; 
Asplund, Tuomilehto, Stegmayr et al, 1988), with one modification - we did not 
include any individuals who died prior to assessment. We also excluded people 
with transient ischaemic attacks. Computer Tomography (CT) and Magnetic 
Resonance (MR) scanning were far from readily available and the diagnosis of 
stroke was therefore made clinically. Indeed the nearest CT scanner was about 
300 km or four hours drive away by road. In making the diagnosis, we emphasised 
the sudden onset of focal neurological symptoms and lack of progression of the 
illness, to avoid including infective processes or space occupying lesions that 
mimic stroke. If the individual had suffered multiple events, we focused on their 
first-ever-in-a-lifetime event. We defined an individual as ‘needing help with at 
least one activity of daily living’ if they needed assistance with any of washing, 
dressing, bathing, feeding, transfer, or toileting. We used this definition of disability 
to compare our findings with a stroke prevalence study from New Zealand (Bonita 
et al., 1997) (mentioned in section 2.2.4) and the stroke prevalence study from 
Tanzania, discussed in section 2.2.4 (Walker et al., 2000b).  
 
We asked individuals found to have had a stroke about their demographic details, 
symptoms at onset and since the stroke, symptoms of other vascular disease, and 
risk factors for stroke, including smoking and alcohol intake (appendix B). If a 
stroke patient was uncertain of their age, we checked this both against the census 
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data and against their identity card when available. We listened for carotid bruits 
and felt all peripheral pulses, examined the heart for evidence of likely embolic 
sources, looked for hypertensive end-organ damage, and did a neurological 
examination.  
 
Although it was often months or even years since the first stroke event, we 
attempted to assess the likely stroke type based on the person’s symptoms at the 
time of the stroke. We were more likely to diagnose cerebral haemorrhage than 
ischaemic stroke if the person gave a history of severe headache, seizure (Burn, 
Dennis, Bamford et al, 1997) or loss of consciousness at the onset, as these 
presentations are unusual in ischaemic stroke (Warlow et al., 2001). We assessed 
the likely ischaemic stroke subtype using the Oxfordshire Community Stroke 
Project (OCSP) classification (Bamford et al., 1991).  
 
We also assessed the person’s current modified Rankin score (Rankin, 1957; 
Bamford, Sandercock, Warlow et al, 1989) and Barthel score (Mahoney & Barthel, 
1965). We recorded any medication that the stroke survivor was using and 
specifically noted whether they were using aspirin, whether they had experienced 
any complications of the stroke, as well as any other relevant findings on 
examination. 
 
We measured the blood pressure in the sitting position after five minutes rest with 
the appropriate cuff size using an OMRON 705CP or OMRON M5-I blood 
pressure monitor. We defined hypertension as systolic blood pressure greater than 
139 mmHg, or diastolic blood pressure greater than 89 mmHg, using the mean of 
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two measurements, or if the stroke survivor was taking antihypertensive treatment. 
We used two measurements as one measurement is generally considered 
inaccurate, and we felt that more than two measurements would unnecessarily 
add to an already lengthy assessment. We were reassured that a large 
international study investigating the role of antihypertensive agents following 
stroke required two measurements (Neal & MacMahon, 1995) at that time, and 
later by a similar recommendation by the European Society of Hypertension 
(O'Brien, Asmar, Beilin et al, 2003). We defined hypertensive subgroups as ‘mild 
hypertension’, if the systolic pressure was greater than 139 mmHg and less than 
160 mmHg and/or the diastolic pressure was greater than 89 mmHg and less than 
95 mmHg; and ‘moderate or severe hypertension’ if either the systolic pressure 
was greater than 159 mmHg or the diastolic pressure was greater than 95 mmHg. 
We defined ‘any evidence of hypertension’ as all hypertensive individuals plus 
those with clinical evidence of hypertensive end organ damage or previous 
antihypertensive treatment. Although clinical evidence of hypertensive end-organ 
damage would usually include electrocardiograph evidence as well as urine 
analysis for microalbumin / creatinine ratios, we were unable to perform these 
assessments. We based our evaluation on fundoscopic changes of hypertension 
and auscultation and palpation of the stroke survivor’s heart.  
 
We defined diabetes as a history of diabetes mellitus or treatment with oral 
hypoglycaemic agents or insulin. We did not perform electrocardiograms and we 
diagnosed angina and myocardial infarction on history, and atrial fibrillation on 
history or on examination of the pulse and auscultation of the heart. Peripheral 
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vascular disease was defined as a history of calf claudication, femoral artery bruits 
or both foot pulses absent on examination.  
 
Previous alcohol or cigarette smoking use was defined as no use during the last 
year; while current use was defined as use of either within the last year.  
 
Human immunodeficiency virus (HIV) infection has reached epidemic proportions 
in South Africa (Bradshaw et al., 2002) and HIV infection is associated with stroke 
(Connor et al., 2000; Mochan et al., 2003; Patel, Sacoor, Francis et al, 2005). 
Although we did not do any blood tests, at the end of the clinical examination we 
documented whether we had any reason to suspect HIV infection in the individual 
(appendix B). We considered a history of recurrent infections, recurrent diarrhoea, 
unexplained weight loss, or examination findings of oral candidiasis, generalised 
wasting, generalised lymphadenopathy, or HIV-related skin and hair disease as 
suggestive of HIV infection, particularly when we found these features in a young 
stroke survivor. 
 
Finally, we asked stroke survivors or their carers whether they had sought 
assistance from health care providers or healers following the stroke including: 
clinics, hospitals, traditional healers, or church groups, and if relevant, which they 
had visited first. Where appropriate, we referred individuals to local clinics or 
hospitals with suggestions for secondary stroke prevention or management of 
other specific conditions.  
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3.4 Data analysis  
 
We calculated the age specific prevalence of stroke survivors both according to 
the number of stroke survivors identified, and also with an adjustment factor to 
allow for the likely number of strokes among the individuals who screened 
positively but who we were not able to examine. For this calculation we assumed 
that the prevalence of stroke survivors in each 10-year age and sex stratum was 
the same amongst those examined and those not examined. We then calculated 
age-standardised prevalence in 10 year gender specific bands using the Segi 
standard population to enable comparison with published work, and with the new 
WHO standard population to permit comparison with future work in this area 
(Ahmad, Boschi-Pinto, Lopez et al, 2002). We used STATA software for the 
analyses including calculation of the confidence intervals for age-standardised 
prevalence (StataCorp, 2001). We calculated the 95% confidence intervals for 
crude stroke prevalence using Confidence Interval Analysis (CIA) software 
(Bryant, 2000).  
 
3.5 Ethics  
 
Ethics committee approval was granted by both the London School of Hygiene 
and Tropical Medicine (755) and the University of the Witwatersrand (M02-04-63) 
(appendix C).  
 
 95 
3.6 Results  
 
Figure 3.4 shows the screening process, the numbers of individuals examined and 
their diagnoses, both of stroke and other conditions.   
3.6.1 Response rates 
 
The population of the Agincourt subdistrict under health and demographic 
surveillance was 68,525 in 2001. Of these, 42,378 were 15 years of age or over. 
There were 982 positive responses to the screening questionnaire, and 724 (74%) 
of these individuals were examined (figure 3.4).  Reasons for failure to examine 
were that people had moved away (39), died (37) or refused (2). In addition, we 
were unable to locate one person, 101 were migrant workers, and we were unable 
to make contact with 73 despite at least 3 attempts. In 5 cases the reason for 
failure to examine was not recorded.  
 96 
 
Figure 3.4  Scheme of prevalence study outline including diagnoses in 
participants without stroke 
Total population of Agincourt Health and Population Unit in 2001 – 68,525 
Population > 15 years of age  42,378 
Two screening questions (weakness, stroke) asked of each household 
respondent about every member in the household during the 2001 census round 
982 positive responses (to one or 
both questions) 
724 examined 258 not examined – see text for detail 
103 strokes 621 not stroke; diagnoses included (some individuals had more 
than one diagnosis):  
 
Peripheral neuropathies: 88 
 
Cervical spondylosis: 54 
 
Trauma: 33 
 
Epilepsy: 18 
 
Spinal cord lesions: 15 
 
Congenital: 9 
 
Idiopathic Parkinson’s disease: 6 
 
Transient ischaemic attack: 3 
 
Likely intracranial mass lesion: 3 
 
Amyotrophic lateral sclerosis: 1 
 
Myaesthenia gravis: 1 
 
Bell’s Palsy: 1 
  
Polio: 1 
 
Non-specific musculoskeletal symptoms and arthritis: 204 
 
Other general medical conditions: 206 
 
No abnormality found: 41 
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Table 3.1.  Prevalence of positive answers to the two screening questions, and prevalence of stroke survivors by sex and age 
 
 
* calculated using the same proportion of stroke survivors diagnosed among those examined for each 10-year age-sex stratum 
 
 
 Population 
Number +ve 
respondents 
(prevalence / 100 
000) 
Number (%) +ve 
respondents 
examined 
Number of stroke 
survivors 
diagnosed 
Prevalence of stroke survivors (95% CI) / 
100 000 
Prevalence of stroke survivors (95% CI) 
adjusted for proportion not examined 
/100,000* 
Total population  
>15 years 
42 378 982 (2 317) 724 (74) 103 243   (198  to 295) 300  (250 to 357) 
Males 20 042 339 (1 691) 213 (63) 37 185   (130 to 255) 246  (181 to 323) 
Females 22 336 643 (2 879) 511 (79) 66 296   (229 to 376) 348  (276 to 436) 
Age: 15-24 15 358 41 (267) 32 (78) 2 13  (2 to 47) 16 (2 to 47) 
 25-34 10 315 88 (853) 50 (57) 6 58  (21 to 127) 83 (34 to 153) 
 35-44 6 855 137 (1 999) 75 (55) 8 117   (50 to 230) 170  (80 to 287) 
 45-54 4 340 203 (4 677) 155 (76) 21 484  (300 to 740) 598  (373 to 850) 
 55-64 2 497 198 (7 930) 150 (76) 19 761  (458 to 1 188) 945  (584 to 1 382) 
 65-74 1 925 166 (8 623) 136 (82) 22 1 143 (716 to 1 730) 1 349 (882 to 1 979) 
 75-84 901 131 (14 539) 112 (85) 22 2 442 (1 530 to 3 697) 2 796 (1,796 to 4 096) 
≥85 187 18 (9 626) 14 (78) 3 1 604 (331 to 4 688) 1 961 (583 to 5 477) 
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3.6.2 Prevalence of stroke  
 
We identified a total of 103 cases of stroke, including six Mozambican refugees, 
giving a crude prevalence of 243 / 100 000 aged over 15 (table 3.1), 300 / 100 000 
after adjustment for the individuals who screened positive but we did not examine. 
 
Of the 103 stroke cases 62 had answered positively to both screening questions, 
40 only to the question about weakness and 1 only to the question about whether 
they had ever had a stroke. The crude male to female ratio was 1:1.8. There was a 
steep age gradient (figure 3.5). Table 3.2 shows, after the adjustment for those we 
did not examine, the age-standardised prevalence using both the Segi (290 / 100 
000) and the new WHO (330 / 100 000) standard populations. After age 
standardisation the male / female ratio was about one. Sixty-eight (66%) stroke 
survivors seen needed help with at least one activity of daily living, giving a Segi 
age-standardised prevalence of 200 / 100 000 over the age of 15 (table 3.2) when 
adjusted for those that we did not examine. (The age specific crude prevalence of 
disabling stroke not adjusted for those we did not examine is shown in the 
following chapter (table 4.5) and will be discussed under the section on disability 
and handicap – section 4.2) 
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Figure 3.5  Prevalence of stroke by age group adjusted for the proportion 
not examined. 
(whiskers represent the upper 95% confidence interval and the 
number above the whisker is the number of stroke survivors in 
the age group) 
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Table 3.2.  Age standardised prevalence of stroke survivors and of stroke survivors ‘needing help with at least one 
activity of daily living’ by sex, using both the Segi and the new WHO standard populations*. 
 
 Population 
Age standardised using Segi population (95% CI) / 
100,000 
Age standardised using new WHO population (95% 
CI) / 100,000 
All stroke survivors: Male 281 (200 to 362) 324 (232 to 416) 
 Female 315 (243 to 387) 354 (275 to 434) 
 Total 290 (238 to 343) 330 (271 to 389) 
Stroke survivors needing help with at least one 
activity of daily living: 
Male 218 (145 to 291) 247 (165 to 328) 
 Female 188 (132 to 243) 221 (157 to 284) 
 Total 200 (156 to 244) 232 (182 to 282) 
 
* using estimated prevalence of stroke survivors adjusted for proportion not examined 
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3.7    Discussion   
3.7.1 Strengths and limitations of our study 
 
Our study had an accurate denominator because it was based in a demographic 
surveillance site with rigorous annual census surveys. However, we were not able 
to examine every individual identified as a possible stroke from the screening 
questionnaire. We had to assume an equal stroke prevalence in those examined 
(74% of those screening positive were examined) and not-examined and then 
adjust the crude prevalence figures accordingly. Of course, as it would be 
anywhere else, diagnosing stroke sometimes long after the event, and without the 
benefit of CT, is difficult and can be inaccurate (Warlow, 1998). However, in this 
study clinicians were skilled in diagnosing stroke and conducted detailed 
assessments. We carefully reviewed and discussed all cases before we accepted 
a stroke diagnosis.  
 
We do not know the sensitivity of the screening questions, since we did not have 
the resources to study a group who did not report either one-sided weakness or 
stroke. Furthermore, we do not know whether the screening questions missed 
posterior circulation strokes that did not present with typical ‘weakness down one 
side of the body’ as well as other strokes that did not involve long-term weakness 
e.g. speech loss, ataxia, isolated visuospatial problems, bilateral weakness, 
hemianopia, cortical blindness, retinal artery occlusion, isolated hemisensory 
lacunar strokes and amnesic syndromes.  However, from the list of false positive 
diagnoses it is clear that many people with bilateral weakness or other forms of 
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neurological weakness answered yes to the question. Further, it is also possible 
that people with more unusual neurological manifestations sought medical help 
and may have been told that they had had a stroke and therefore answered that 
question. Certainly, we may have missed very mild strokes with symptoms that 
people had forgotten or that had not presented with weakness as a prominent 
manifestation. 
 
Our finding that 102 of 103 people with stroke answered ‘yes’ to unilateral 
weakness at some time in their lives suggests that we missed stroke survivors 
who did not have significant weakness caused by their stroke and that we 
underestimated stroke prevalence. In an attempt to correct for this we assessed 
the proportion of patients in the Tintswalo (rural) Hospital Stroke Register (THSR) 
(chapter 7) and black stroke patients in the Johannesburg Hospital Stroke Register 
(JHSR)(chapter 5) without motor weakness (THSR: 6 (4%) of 135 patients and 
JHSR: 28 (9%) of 305 patients). We then assumed that these hospital data 
reflected the nature of stroke in the community (an unlikely assumption as 
previously discussed) and applied the corrections of between four and nine 
percent to our prevalent stroke data. We found that this increased our crude 
prevalence of stroke to: 250 per 100 000 (95% CI 205 to 303) using the rural 
THSR data and 264 (218 to 318) using the urban JHSR data. At most, therefore, 
we have underestimated the crude prevalence by 21 per 100 000 over the age of 
15 years. 
 
Many studies of stroke prevalence in high income countries have used a screening 
postal or telephonic questionnaire (O'Mahony, Dobson, Rodgers et al, 1995; 
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Geddes et al., 1996; O'Mahony, Thomson, Dobson et al, 1999), but this was not 
possible in our population because there is no postal or reliable telephone service. 
Stroke prevalence studies in general are limited, not only by the difficulty in 
diagnosing stroke long after the event, but also by accurate case finding and under 
representation of fatal cases and very minor strokes. As prevalence depends on 
incidence and case fatality, arguably the most accurate way of assessing stroke 
prevalence is from an incidence study with follow up of patients to assess case 
fatality (Warlow, 1998). 
 
Despite these shortcomings and given the challenging environment in which the 
study was conducted, we believe this study design with an accurate denominator 
and extensive effort to achieve an accurate numerator represents a reasonable 
starting point in estimating the prevalence and nature of prevalent stroke in rural 
Sub-Saharan Africa. The problem of migrant labour, which had a large influence 
on our response rate is likely to be experienced in any similar setting in South 
Africa. 
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3.7.2 Comparison of our findings with other stroke prevalence studies  
 
The age-standardised prevalence of stroke in high-income countries in a recent 
review of studies since 1990 ranged from 461 to 733 per 100 000 (Feigin et al., 
2003b) for people aged 65 years or more. The largest of these came (Bonita et al., 
1997) from Auckland, New Zealand where it was estimated that about 461 per 100 
000 people aged over 15 years had made an incomplete recovery from a previous 
stroke, of whom 173 per 100 000 needed assistance with at least one self-care 
activity. The total age-standardised prevalence for the population aged 15 years 
and older was 833 per 100 000. While the age-standardised overall prevalence of 
stroke survivors adjusted for those we could not examine was much lower in our 
study (table 3.3), the prevalence of survivors needing help with at least one activity 
of daily living (200 / 100 000) was higher, and even higher than in Tanzania 
(Walker et al., 2000b). The proportion of stroke survivors who needed help with at 
least one activity of daily living was similar to that found in Tanzania (66% 
compared with 60%), both much higher than in New Zealand (22%). (Note: as 
described in 3.3. all three studies used the same definition of ‘needing help with at 
least one activity of daily living.’) 
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Table 3.3.  Comparison of age standardised rates (Segi population / 
100,000) in three prevalence studies 
 
 
New Zealand (Bonita, 
Solomon & Broad, 
1997) 
Tanzania   (Walker, 
McLarty, Masuki, et al., 
2000) 
Agincourt (SASPI) 
All stroke survivors 833 n/a 290 
Males 991 154 281 
Females 706 114 315 
Male / female ratio 1.4 1.4 0.9 
Stroke survivors ‘needing help with at least 
one activity of daily living’ 
173 n/a 200 
Males 156 69 218 
Females 188 90 188 
Male / female ratio 0.8 0.8 1.2 
 
n/a – not available 
 
Note: The studies in Tanzania and South Africa (Agincourt - SASPI) used similar methodology to 
determine stroke prevalence i.e. screening questions asked of individuals during a census round in 
a demographic surveillance site, followed by clinical assessment of everyone who gave a positive 
answer. Stroke prevalence in Auckland was calculated using an actuarial model from two incidence 
studies conducted 10 years apart.  
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The lower prevalence of stroke in our population compared to Auckland, and other 
high-income countries (Feigin et al., 2003b), may reflect a lower incidence at this 
early stage of health transition, or a higher case fatality. Both are plausible, but 
there are no reliable population-based data on either incidence or case-fatality in 
Sub-Saharan Africa (section 2.3.2 and 2.3.3). Methodological differences must 
also account for some of the disparity. For example, in Auckland (Bonita et al., 
1997) prevalence was modelled from the results of two incidence studies and 
therefore would have included very mild strokes that recovered completely. We 
must have missed some mild strokes that had recovered and strokes that did not 
cause hemiparesis. This would also have been a problem in the Tanzanian study 
(Walker et al., 2000b), which used similar methodology to find strokes, but would 
not have occurred in Auckland as all incident strokes were included. That we 
missed some mild strokes is further suggested by the higher proportion of all 
identified strokes who were dependent in our study, although the cultural 
interpretation of ‘needing help with every day activities,’ including even the 
interpretation of the specific questions about needing help with specific activities, 
must be highly variable. Another explanation is that inadequate care after stroke in 
our study area leaves more survivors disabled.  
 
Our higher prevalence of stroke than in rural Tanzania might be explained by a 
higher case fatality in Tanzania. Some authors have pointed out that the 
methodology used in the Tanzanian study (Walker et al., 2000b) was likely to find 
people with residual hemiplegic impairment or disability rather than all prevalent 
strokes (Feigin, Lawes, Bennett et al, 2003a). Our screening questions asked 
about weakness and stroke at any time, while the Tanzanian study asked about a 
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history of stroke but current weakness. The prevalence of disabiling stroke in our 
study is, however, still two to three times higher than in the Tanzanian study; this 
difference is unlikely to be simply the result of the difference in the wording of the 
question in the two studies. Another possibility is that the rural South African 
population has been exposed to lifestyle risk factors for longer than the 
Tanzanians, is further along the health transition and so has a higher stroke 
incidence. Only population-based incidence studies will clear this up.  
 
The stroke prevalence we found in Agincourt is much higher than has been found 
previously in other studies from Africa. This is likely to be because of differences in 
the diagnosis of stroke used and completeness of case ascertainment in the three 
smaller Nigerian studies described in section 2.2.4 (Osuntokun et al., 1982; 
Osuntokun et al., 1987; Longe et al., 1989). The very much lower crude 
prevalence of 15 per 100 000 found in Ethiopia in the mid-1980s may be the result 
of incomplete ascertainment of mild strokes, but it may also reflect a low stroke 
incidence in Ethiopia as suggested above for Tanzania.  
 
There are very few studies that have investigated the prevalence of stroke in 
African-Americans, particularly in recent years (Gorelick, 1998). In older studies 
from the 1950s to 1970s the prevalence of stroke in African-Americans was 
consistently higher than in their white counterparts (Gillum, 1988; Gillum, Gorelick, 
& Cooper, 2003). In a household survey in Copiah County, Mississippi, 
neurologists examined all individuals who screened positive and identified 250 
strokes. The prevalence of stroke was 1341 per 100 000 in African-American men 
and 1228 per 100 000 in African-American women. In a more recent study of self 
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reported stroke from the 1999 to 2001 National Health Interview Study, the age-
adjusted prevalence of stroke in African-Americans over the age of 18 years was 
366 per 100 000 in males, and 313 per 100 000 in females (unadjusted crude 
prevalence: 287 and 274 per 100 000 respectively) (McGruder, Malarcher, Antoine 
et al, 2004). These findings are closer to the typical figures seen in high income 
countries. Indeed, although the prevalence was significantly higher in African-
Americans than in whites or Hispanic Individuals, it is lower than the range 
previously quoted for high income regions. Apart from other potential difficulties 
with case ascertainment in a self-reported survey, this is probably because the 
study excluded institutionalised stroke survivors.  
 
African-Americans are considered to be further along the health transition than 
Africans living in Africa (Gillum, 1996b). The large burden of stroke seen in 
African-Americans may represent an inevitable level that South Africans are 
headed towards, if appropriate interventions are not set in place to prevent an 
increase in stroke risk factors.  
 
The sex ratio of the survivors that we identified was different from that found in 
Tanzania and in New Zealand. Both of those studies found an overall male to 
female ratio of 1:1.4, declining to a ratio of 1:0.8 when only those survivors 
needing help with activities of daily living were considered (table 3.3). Indeed male 
stroke prevalence has consistently been higher than female prevalence in studies 
performed since 1990 in high income countries (Feigin et al., 2003a). By contrast, 
the overall sex ratio in our population was 1:0.9, and increased to 1:1.1 when only 
those needing help were considered (table 3.3). There is considerable labour 
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migration, predominantly in men, but these migrant labourers, are included in the 
local population denominator.  They consider the region home, maintain their 
families by sending money home and usually return to use local health resources 
when too ill to work. We had a higher rate of ‘non-contact’ in men aged between 
25 and 44 years (49 men, 54%) than in any other age and gender group.  
However, we adjusted our figures for each 10-year age strata and sex group to 
allow for those we had not examined, assuming the same proportion of stroke 
survivors as in those examined. Thus, we have assumed that there is the same 
proportion of stroke survivors in men in employment as amongst predominantly 
unemployed men. As a result, we have probably overestimated, rather than 
underestimated, prevalence of stroke in men.  
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3.8  Conclusion 
 
The prevalence of stroke in the rural Agincourt Health and Population Unit in 
north-east South Africa is about a half to a third of that typically found in high 
income regions of the world and about double that found in Tanzania using similar 
methodology. Based on limited data, it is lower than stroke prevalence in African-
Americans. However, the prevalence of stroke survivors ‘needing help with more 
than one activity of daily living’ is already at similar levels to that previously found 
in a high-income setting. Although, as in all prevalence studies, this study can only 
provide limited information on the burden of stroke in the region in the absence of 
data on the incidence and case fatality of stroke, it suggests that there is already a 
considerable burden of stroke, particularly disabling stroke, in the rural South 
African population. Further, if the theory of the health transition holds, then it is 
likely that this burden will increase as the population’s exposure to vascular risk 
factors increases. 
 
The prevalence we found, intermediate between that found in Tanzania and typical 
high income region prevalence figures, may suggest that rural South Africa is 
already further advanced along the health transition than Tanzania. Indeed South 
Africa may represent an ‘early-adopter’ region (see section 1.6) (Yusuf et al., 
2001) within Sub-Saharan Africa. The high prevalence of stroke in African-
Americans may represent a potential ‘end-point’ to which our population is headed 
in the absence of appropriate intervention to reduce risk factors for stroke.  
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3.8.1 What this study adds to the literature 
 
This is the first community based study of stroke performed in South Africa. It is 
also the first stroke prevalence study and first rural stroke study to be performed in 
South Africa. While it is the second, large community based stroke prevalence 
study from Sub-Saharan Africa, our methodology attempted to ascertain the 
prevalence of all strokes and not only disabling stroke. Furthermore, our finding of 
a much higher prevalence of stroke (including disabling stroke) in South Africa 
compared to Tanzania emphasises the need for stroke epidemiology studies 
across Sub-Saharan Africa. Varying socioeconomic influences are likely to impact 
on risk factor profiles in different countries and influence their progression through 
the health transition. Single country studies of the burden of stroke, be they 
prevalence, incidence or mortality studies will not give a true representation of the 
diversity of Sub-Saharan Africa’s population nor their health needs. 
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CHAPTER 4  THE NATURE OF PREVALENT STROKE IN RURAL 
SOUTH AFRICA 
 
4.0 Introduction 
 
Chapter 3 described the prevalence of stroke in the rural population of the 
Agincourt Health and Population Unit in north-east South Africa. This chapter 
describes the characteristics of the stroke survivors identified, including the nature 
of their strokes (pathological stroke type, ischaemic stroke subtype, risk factors 
and causes), their use of secondary stroke prevention, and their health seeking 
behaviour.  
 
The nature of prevalent stroke is seldom if ever reported. Prevalent strokes are 
usually assessed by self-reporting of individuals who have suffered a stroke, using 
postal or telephonic surveys (Aho et al., 1986; O'Mahony et al., 1995; Geddes et 
al., 1996), and the assessment of stroke type is likely to be inaccurate when based 
on self reported information. Even when studies have attempted to validate stroke 
type using hospital records this has seldom been successful for the majority of 
cases (Huang, Chiang, & Lee, 1997). Indeed, the assessment of stroke type, 
subtype, risk factors and causes, months and even years after the event is likely to 
be very inaccurate as stroke survivors and their family or caregivers will have 
forgotten the detail of what happened. Furthermore, survivors may have 
developed entirely new conditions unrelated to the original event, so confusing the 
clinical picture. Despite these potential short-comings, we decided to take a 
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detailed history and perform a detailed examination on the stroke survivors in our 
study. However, we considered it inappropriate to subject the stroke survivors to 
detailed investigations given the limited clinical yield in prevalent stroke cases. We 
then made every effort to assess the nature of their strokes in an attempt to add to 
the very limited data available on stroke in the community in Sub-Saharan Africa 
(section 2.2.4).  
 
As a result of the limited data available on the nature of prevalent stroke 
(Osuntokun et al., 1982; Osuntokun et al., 1987; Longe et al., 1989; Tekle-
Haimanot et al., 1990; Huang et al., 1997; Prencipe, Ferretti, Casini et al, 1997; 
O'Mahony et al., 1999; Nicoletti, Sofia, Giuffrida et al, 2000; Bermejo, Gabriel, 
Vega et al, 2001), we have compared our findings to the nature of stroke in 
Oxfordshire in the United Kingdom, using either the Oxfordshire Community 
Stroke Project (OCSP) (Sandercock et al., 1989; Bamford et al., 1991; Warlow et 
al., 2001) findings or those of the more recent Oxford Vascular Study (OXVASC) 
conducted in the same population twenty years later (Rothwell et al., 2004). We 
also compared our findings with those in African-American incident stroke patients 
in the Northern Manhattan stroke study (NMSS) or Greater Cincinnati / Kentucky 
Stroke Study (GCNKSS) (Broderick, Brott, Kothari et al, 1998; Sacco et al., 1998; 
White, Boden-Albala, Wang et al, 2005). The Rochester Study (Brown, Whisnant, 
Sicks et al, 1996; Petty, Brown, Jr., Whisnant et al, 1999; Feigin et al., 2003b), 
recognised as fulfilling ideal stroke incidence study criteria (Feigin et al., 2003b) 
consists predominantly of white Americans (96%)  and does not include sufficient 
African-Americans to provide a comparison with our findings. We have also 
compared our findings to data on non-institutionalised African-Americans with 
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stroke from the 1999 to 2001 National Health Interview Survey of self reported 
stroke (McGruder et al., 2004) in the discussion section.  
 
We described the methods for case finding and assessment of the 103 prevalent 
stroke cases in Chapter 3.  
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4.1      Results 
 
The mean time from the onset of stroke to our assessment was 7.9 years (range 
22 days to 56 years).  
 
4.1.1 Pathological stroke types and subtypes 
 
Table 4.1 shows the clinical assessment of stroke type and subtype and compares 
our findings with incident stroke cases in Oxfordshire in the United Kingdom and in 
African-Americans in Northern Manhattan in the United States of America. A 
higher proportion of our prevalent stroke survivors had cerebral haemorrhage than 
incident stroke patients had in both the UK population and African-Americans in 
the USA, but far fewer had ischaemic strokes. It is not surprising that we did not 
detect any subarachnoid haemorrhages as our screening questions would 
probably have missed this diagnosis unless it was associated with focal weakness. 
Even then we would probably have attributed it to one of the other two pathological 
stroke types – most likely to cerebral haemorrhage if we had been given a history 
of severe headache with neck stiffness at the onset. In nine cases, we could not 
reach consensus regarding the likely stroke type. We may have over-estimated 
cerebral haemorrhage, as ischaemic stroke may present with headache and less 
frequently even neckstiffness and seizures (Warlow et al., 2001). We would have 
been more likely to diagnose cerebral haemorrhage in the presence of these 
symptoms, particularly if the headache was severe. (See chapter 6 for further 
discussion on the accuracy of bedside diagnosis of pathological stroke type) 
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Table 4.1   Comparison of pathological stroke type and subtype found in  
prevalent stroke cases in rural South Africa with incident stroke 
cases in the United Kingdom and African-Americans (all figures 
are number of participants with percentages in brackets)  
 
 
 
 
 
Pathological stroke type: 
 
 
 
Agincourt (SASPI) 
(n=103) 
OXVASC  
(n=262 ) 
 
(Rothwell, et al., 
2004) 
NMSS*  
(1993 - 1996) 
(n=148) 
 
(Sacco, et al., 1998) 
    
Cerebral haemorrhage 31 (30) 17 (7) 21 (15) 
Ischaemic stroke  63 (61) 223 (85) 120 (81) 
Subarachnoid haemorrhage 0 (0) 16 (6) 6 (4) 
Unsure 9 (9) 6 (2)  0 (0) 
    
 
 
 
OCSP classification of ischaemic stroke subtype: 
 
 
 
Agincourt (SASPI) 
(n=63) 
OCSP 
(n=543) 
 
(Bamford, et al., 
1991) 
NMSS* (1993 - 
1997)  
(n=155) 
 
(White, et al., 2005) 
    
Total anterior circulation syndrome 4 (6)   92 (17)  - 
Partial anterior circulation syndrome 22 (35)  185 (34) - 
Lacunar syndrome 30 (48) 137 (25) 33 (21) 
Posterior circulation syndrome 7 (11)  129 (24)  - 
    
 
SASPI – Southern African Stroke Prevention Initiative; OXVASC - Oxford Vascular Study; OCSP – 
Oxfordshire Community Stroke Project; NMSS – Northern Manhattan Stroke Study 
 
* Data for the NMSS are only for African-Americans. The NMSS did not classify stroke cases using 
the OCSP classification and only lacunar strokes overlap with the classification used. 
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While we found about twice as many lacunar strokes as were found in Oxfordshire 
or in Northern Manhattan African-Americans, we found a similar number of partial 
anterior circulation syndromes to the OCSP study. However, we found less than 
half the number of total anterior circulation and posterior circulation syndromes 
when compared to the OCSP study. We could only compare lacunar ischaemic 
stroke subtypes with the NMSS study because they did not use the OCSP 
classification, and the modified Stroke Data Bank classification (Kunitz et al., 1984; 
Foulkes, Wolf, Price et al, 1988) used in the NMSS only overlaps with the OCSP 
(Bamford et al., 1991) in the definition of lacunar stroke (table 4.1). Even in the 
lacunar stroke group there is a marked difference between the proportion of 
lacunar strokes in the OCSP (25%) and in whites in the NMSS (16%). This may 
represent the case mix in the NMSS e.g. milder lacunar strokes not detected, a 
true difference between the two populations or a difference in the diagnosis and 
classification of lacunar stroke. So the comparison of lacunar strokes between 
Agincourt and Oxfordshire, and the Northern Manhattan Study should probably be 
made with caution.  
 
4.1.2  Risk factors in prevalent stroke cases 
 
Table 4.2 shows the major risk factors associated with all strokes combined in our 
study population. Hypertension stands out as the dominant stroke risk factor in 
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Table 4.2  Risk factors for stroke in our prevalent stroke population. Data are 
number of stroke survivors (%) 
 
 
Male 
(n=37) 
Female 
(n= 66) 
Total 
(103) 
On history    
Diabetes mellitus 2 (5) 10 (15) 12 (12) 
Symptoms of angina 5 (14) 6 (9) 11 (11) 
Current cigarette smoker 8 (22) 1 (2) 9 (9) 
Never smoker 17 (46) 62 (94) 79 (77) 
Currently drink alcohol 11 (30) 10 (15) 21 (20) 
    
On Examination    
Hypertensive* 24 (65) 49 (74) 73 (71) 
‘Any evidence of hypertension’† 31 (84) 56 (85) 87 (85) 
Carotid bruit 1 (3) 3 (5) 4 (4) 
Peripheral vascular disease 2 (5) 3 (5) 5 (5) 
    
 
*Hypertension defined as: systolic blood pressure greater than 139 mmHg, or diastolic blood 
pressure greater than 89 mmHg, using the mean of two measurements, or if the stroke survivor 
was taking antihypertensive treatment 
 
†’Any evidence of hypertension’ defined as: all hypertensive individuals (above) plus those with 
evidence of hypertensive end organ damage or previous antihypertensive treatment 
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both men and women. Two blood pressure readings were available for 97 
individuals. The mean systolic pressure was 158 mmHg (95% CI, 151 to 165 
mmHg), and mean diastolic pressure was 92 mmHg (95% CI, 88 to 95 mmHg). 
Twenty eight (67%) women and 15 (33%) men (difference not significant) had a 
blood pressure ≥ 160 mmHg systolic or ≥ 95 mmHg diastolic. Eight stroke 
survivors were taking anti-hypertensive medication, but only one of them had a 
blood pressure within the normal range (BP 116/74 mmHg). The mean systolic 
blood pressure in these eight survivors on medication was 172 mmHg (95% CI, 
147 to 198 mmHg), and mean diastolic pressure was 96 mmHg (95% CI, 86 to 
107 mmHg). Diabetes mellitus was moderately frequent in woman but not in men. 
 
Cigarrette smoking was not very frequent in the stroke survivors, nor had it ever 
been, particularly in women. Only six of the eight men who smoked did this daily 
and the mean daily consumption of cigarettes for the men was five (range 3 to 10). 
The use of snuff (inhaled tobacco) is more common in Agincourt particularly 
amongst woman, and we found 16 (16%) stroke survivors were current users of 
snuff at the time of our assessment (15 females and 1 male). There are conflicting 
findings from the limited number of reports on the effect of snuff use, ranging from 
increased risk of stroke death (Henley, Thun, Connell et al, 2005) to no effect on 
stroke risk (Asplund, 2001; Asplund, Nasic, Janlert et al, 2003). Most have studied 
the effect of oral not inhaled snuff use. While almost a third of men drank alcohol, 
half the number of women drank alcohol. It is almost impossible to quantify the 
amount of alcohol consumed. Even knowing the number of drinks consumed per 
day is not sufficient to calculate the amount of alcohol ingested, as so much of the 
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alcohol used is brewed at home in this area and is of varying strength 
(Greenhalgh, 2004).  
 
Evidence suggesting large vessel atherosclerosis, namely symptoms of angina, 
carotid bruits and peripheral vascular disease, were not common (table 4.2) and 
no one gave a history of myocardial infarction. None of the stroke survivors gave a 
history of elevated cholesterol, eight gave a family history of stroke and none gave 
a history suggestive of prior transient ischaemic attack. No one had ever used 
recreational drugs. 
 
4.1.2.1 Risk factors associated with particular stroke types 
 
 
Table 4.3 compares the frequency of both unmodifiable and modifiable risk factors 
associated with cerebral haemorrhage and ischaemic stroke. Although 
hypertension, male sex, a history of angina, current smoking and alcohol use 
appeared to be more common with cerebral haemorrhage, there was no 
statistically significant difference between the two groups. This may well be 
influenced by the difficulty in determining stroke type accurately and in determining 
risk factors that were relevant at the time the stroke occurred.  
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Table 4.3.   Presence of risk factors by type of stroke. Data are number of 
stroke survivors (%) unless otherwise specified  
 
 
 
Variable 
Cerebral 
haemorrhage (n=31) 
Ischaemic stroke      
(n=63) 
Significance of 
difference 
Mean age at first stroke (years) 55 (SE 2.5) 55 (SE 2.5)  
Male  14 (45)  19 (30)  p=0.2 
Hypertension  25 (81)  43 (68)  p=0.2 
‘Any evidence of hypertension’* 27 (87)  54 (86)  p=0.9 
Diabetes mellitus  3 (10)  9 (14)  p=0.5 
History of angina  5 (16)  5 (8)  p=0.2 
Current smoker  5 (16)  2 (3)  
Previous smoker  5 (16)  8 (12)  
Never smoked  21 (68)  52 (84)  
p=0.07 
Currently uses alcohol 10 (32)  9 (14)  
Previous alcohol use  6 (19)  15 (24)  
Has never used alcohol  15 (48)  39 (62)  
p=0.125 
 
* see text for definition   
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Table 4.4   A comparison between risk factors in prevalent stroke cases in 
Agincourt and incident stroke in the OXVASC study (Rothwell, et 
al., 2004) and in African-Americans in the Greater Cincinnati / 
Northern Kentucky Stroke Study (GCNKSS) (Kissela, et al., 2004) 
(Data are the number of patients (%) unless otherwise indicated) 
 
* Age at time of stroke 
** Mean age for a smaller data set of the African-American subgroup of NMS based on data 
published in (Di Tullio, et al., 1999); no other separate data on mean age available for the African-
American subgroup 
† Hypertension defined as: (1) Agincourt (SASPI) >139 / 89 mmHg or on antihypertensive 
treatment (2) OXVASC: ≥ 150 / 85 mmHg, and (3) hypertension noted on record review (no further 
detail provided) 
 
 
 
Risk Factor 
Agincourt 
(SASPI) 
(n = 103) 
 
OXVASC 
(n = 262) 
 
GCNKSS 
(n = 969) 
Male  37 (36) 126 (48) n/a 
Mean age (SD) 60.6 ± (16.5)* 73.6 ± (11.9) n/a 
Mean systolic BP mmHg 
(95% CI) 
158 
(151 to 165) 
148 
(145 to 150) 
n/a 
Mean diastolic BP 
(95% CI) 
92 
(88 to 95) 
82 
(81 to 84) 
n/a 
Proportion with hypertension 
(see definition below)† 
73 (71) 118 (46) 661 (68) 
Diabetes mellitus 12 (12) 25 (10) 318 (33) 
History of angina 11 (11) 32 (12) n/a 
Atrial fibrillation 1 (1) 44 (17) 70 (7) 
Current smoking 9 (9) 47 (18) 257 (26) 
Never smoker 79 (77) 117 (45) n/a 
Peripheral vascular disease 5 (5) 22 (9) n/a 
Previous myocardial infartion 0 33 (13) n/a 
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4.1.2.2   Comparison of risk factors with other stroke populations 
 
 
Table 4.4 compares risk factors in our prevalent stroke population with risk factors 
found in the OXVASC study in the UK (Rothwell et al., 2004) and in African-
Americans in the Greater Cincinnati / Kentucky Stroke Study (GCNKSS) (Kissela, 
Schneider, Kleindorfer et al, 2004). Although we have used the Northern 
Manhattan Stroke study for previous comparisons, there are no data published of 
all stroke (ischaemic and haemorrhagic) risk factors found in the NMS and so we 
used the GCNKSS data for this comparison.  
 
The possible reasons for the lower proportion of men in our study to that found not 
only in the OXVASC study but in many other studies has been discussed in 
section 3.7.2. The mean age at the time of stroke in our study was considerably 
lower than that found in Oxfordshire. This is typical of low-income region 
population stroke studies, and is the result of both the population demographics 
with a younger population at risk (only 7% of our adult population was over the age 
of 65 years), and possibly to a lesser extent an increased incidence of stroke at 
younger ages in the population (table 2.2).  
 
Both the mean systolic and diastolic blood pressure were 10 mmHg higher in the 
Agincourt population compared to the Oxfordshire population. This, together with 
the much higher proportion of hypertensive individuals in Agincourt again 
highlights the importance of hypertension as a risk factor in our study. However, 
the different definitions of hypertension used by the three studies should be noted. 
Our systolic blood pressure cut-off for hypertension was 10mmHg lower than the 
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OXVASC study and our diastolic blood pressure cut-off was 5 mmHg higher. This 
may have influenced the comparison, though it is unlikely to have accounted for 
anything near the 25% difference in the proportion with hypertension. It is not clear 
exactly how hypertension was defined in the GCNKSS (Kissela et al., 2004).  
 
Diabetes mellitus, diagnosed on history or if the stroke survivor was on treatment 
in our study, on history or record review in OXVASC, or on nurse record review in 
GCNKSS, was about as frequent in Agincourt and Oxfordshire, but almost three 
times as common in African-Americans. In terms of large vessel atherosclerotic 
disease, a history of angina was about as common in Agincourt and Oxfordshire, 
though we must point out that it is very difficult obtaining a reliable history of 
angina in rural South Africa. None of the tools used to diagnose angina at the 
bedside or in epidemiological studies, such as the Rose Angina Questionnaire 
(Rose, 1962), have been validated in our population, and the prevalence of 
ischaemic heart disease remains low in rural areas (Walker & Sareli, 1997; Kahn 
et al., 1999b). We diagnosed angina when we were unsure whether the pain was 
of cardiac ischaemic origin based on the history, and so probably over-diagnosed 
angina. Peripheral arterial disease occurred infrequently and was about half as 
common as in Oxfordshire. This is particularly significant as we included 
asymptomatic patients with absent pulses or femoral bruits, and these patients 
were not included in the OXVASC study.  
 
Atrial fibrillation was rare in our population, only occurring in one individual. In both 
African-Americans and particularly in whites in the OXVASC study, atrial fibrillation 
was far more frequent, possibly as a result of a higher prevalence of ischaemic 
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heart disease and the older age of both populations. Thirteen percent of stroke 
patients in the OXVASC study had had a previous myocardial infarction and in the 
ischaemic stroke subgroup of the GCNKSS 100 of 362 (28%) African-American 
patients had coronary artery disease in some form (coronary artery disease, 
myocardial infarction, or angina) though it is not clear exactly how this was defined 
(Schneider, Kissela, Woo et al, 2004). None of the stroke survivors in Agincourt 
had a history of myocardial infarction. 
 
Our stroke survivors were far less likely to be current smokers or indeed ever to 
have smoked than either African-American stroke patients who were relatively 
heavy smokers and even Oxfordshire stroke patients. As mentioned previously 
(section 4.1.3), even when our stroke survivors did smoke this was not heavy.  
 
4.1.3  Likely causes of the prevalent strokes 
 
In the 31 stroke survivors that we diagnosed as having had a cerebral 
haemorrhage, hypertension was the only identifiable risk factor and deemed the 
most likely cause in 24 (77%). In one individual who did not have hypertension the 
stroke followed an alcohol binge which may be relevant, although the role of an 
alcohol binge as a cause of cerebral haemorrhage is controversial, as most case-
control studies that have addressed the issue were subject to bias (van Gijn, 
2001). In the remaining six, we could not determine a cause.  
 
In the 63 stroke survivors with ischaemic stroke, 30 were found to have a lacunar 
syndrome. Of these, hypertension was the only relevant risk factor in 24 
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individuals (80%). Two of the 30 (7%) had diabetes mellitus without any other 
vascular risk factors or likely cause for the stroke. One individual had both 
diabetes mellitus and hypertension.  
 
We found potential cardioembolic sources in five individuals with ischaemic stroke: 
2 had valvular lesions, one of whom had been diagnosed at an academic hospital 
and was on warfarin (the only stroke survivor on anticoagulation), 2 had features 
of a dilated cardiomyopathy, and 1 had atrial fibrillation.  
 
Three individuals gave histories suggestive of arterial dissection. Four strokes 
were associated with pregnancy or the puerperal period. Although we could not 
determine the mechanism of the stroke in this study, stroke has been associated 
with both pregnancy and the puerperal period in multiple ways including: cerebral 
venous thrombosis, paradoxical embolism and arterial dissection during labour 
(Mas & Lamy, 1998). Two people gave histories suggestive of migrainous stroke 
(Bousser & Welch, 2005).  
 
4.1.3.1 Human immunodeficiency virus in stroke survivors 
 
Although we did not test the stroke survivors for human immunodeficiency virus 
(HIV) infection, we added a question at the end of the questionnaire which asked 
the examining clinician whether they had any reason to believe that the individual 
may have retroviral disease based on their history and examination findings 
(appendix B). We only suspected HIV infection in two individuals, one aged 26 and 
the other 42 years. Although HIV is often associated with intracranial space 
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occupying lesions which may present as stroke (Connor et al., 2000; Kumwenda, 
Mateyu, Kampondeni et al, 2005), in these two patients the deficit had not 
changed in 2 and 3 years respectively, making stroke the more likely diagnosis.  
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4.1.4  Disability and handicap in prevalent stroke cases 
 
We assessed the prevalence of disabled stroke survivors who ‘needed help with at 
least one activity of daily living’ as described in section 3.3. The age standardised 
prevalence of disabling stroke was presented in table 3.2. Table 4.5 shows more 
detailed results for the age specific prevalence of disabling stroke. The prevalence 
of disabling stroke increases with age, with a marked increase over the age of 55 
years and then again in the over 75 year old age groups. Of course it is unlikely 
that we were simply measuring stroke related disability, particularly in the elderly 
who are likely to suffer from other disabling conditions such as arthritis.  
 
Figure 4.1 shows the percentage of males and females who required help with 
specific activities of daily living (ADL). Men had less impairment and disability than 
women using this assessment, though they were more likely to require help with 
transfer, climbing stairs and bathing. In both males and females incontinence was 
not common, but loss of independence in dressing, grooming and feeding was 
very common. It is difficult to know to what extent the pattern seen in figure 4.1 
reflects cultural differences (Ali & Mulley, 1998) in the interpretation of ‘needing 
help’ with these specific activities or indeed reflects difficulties we may have had 
with the process of interpretation and understanding the response from the stroke 
survivor or their carer.  
 
We used both the Barthel Index (Mahoney et al., 1965) and the modified Rankin 
scale (Rankin, 1957; Bamford et al., 1989) also known as the Oxford Handicap 
Scale, to assess disability and handicap in our stroke survivors.  
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Table 4.5 Age specific crude prevalence of stroke survivors needing help 
with at least one activity of daily living (ADL), by sex (not 
adjusted for the proportion we did not examine) 
 
 Population 
Number of stroke 
survivors needing help 
with ADL 
Prevalence of stroke survivors 
needing help with ADL  
(95% CI) / 100 000 
Total population >15 years 42 378 68 161 (125 to 203)* 
Males 20 042 27 135 (89 to 196) 
Females 22 336 41 184 (132 to 249) 
Age: 15-24 15 358 1 7 (0 to 36) 
25-34 10 315 0 0 
35-44 6 855 4 58 (16 to 149) 
45-54 4 340 9 207 (95 to 394) 
55-64 2 497 16 641 (366 to 1041) 
65-74 1 925 16 831 (475 to 1350) 
75-84 901 19 2109 (1270 to 3293) 
≥85 187 3 1604 (331 to 4688) 
 
*  Age standardised (Segi World Population) prevalence (95% CI) per 100 000:  200 (100 to 200) 
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Figure 4.1  Percentage of male and female survivors requiring help with activities of daily living (actual percentages  
shown above the bars) 
 131 
Although the Barthel Index is useful as a measure of disability and dependence in 
ADL, it does demonstrate a ‘ceiling’ effect (Dennis, 2001) and does not describe 
difficulties in key areas such as language. The modified Rankin scale, although 
designed as a measure of handicap, measures a combination of symptoms, 
dependency and change in lifestyle (Bamford et al., 1989; Dennis, 2001). It is 
often used as a measure of independence in everyday activities. A score of 0 to 2 
is associated with independence.  
 
To add to the profile of disability and handicap in our stroke survivors, table 4.6 
provides further detail on the proportion of individuals with specific Barthel Index 
and modified Rankin scale scores, as well as specific disabilities that would 
interfere with function and independence. All but one of the stroke survivors 
(modified Rankin scale 3) had been independent at the time of their stroke. 
Although 68 (66%) individuals needed help with at least one activity of daily living 
(table 4.5 and figure 4.1), we only found 44 (43%) to be dependent using the 
modified Rankin scale. This is almost certainly the result of different interpretation 
of the measures, with the modified Rankin score providing a more ‘global’ 
assessment by the clinician than the individual items scored on the Barthel Index 
(used in our definition of ‘needing help with at least one activity of daily living’). It 
was not surprising, given the screening questions used to ascertain cases, that 
motor weakness was very common.  
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Table 4.6  The proportion (percentage) of stroke survivors with various 
measures of impairment and disability 
 
 
Scale / Impairment 
 
n 
Percentage of 
all stroke survivors 
Barthel Index <20 75 73 
Barthel Index <15 38 37 
Barthel Index <10 19 19 
mRankin scale 0-2 59 57 
mRankin scale 3-5 44 43 
Decreased level of consciousness 1 1 
Motor weakness 96 93 
Unable to lift arm against gravity 13 13 
Sensory deficit 65 63 
Cerebellar signs 5 5 
Dysarthria 24 23 
Dysphasia 13 13 
Dysphagia 4 4 
Neglect 9 9 
Visual field defect 28 27 
Disorder of eye movement 3 3 
Facial palsy 70 68 
Urinary incontinence 10 10 
 
mRankin – modified Rankin score  
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The small proportion of patients with cerebellar signs and disorders of eye 
movement, in contrast to the large proportion with motor and sensory deficit, as 
well as facial palsy, is probably in keeping with the low frequency of posterior 
circulation syndromes we found. This may be a true reflection of the pattern of 
stroke in the region, but may also reflect insensitivity in our screening questions or 
perhaps some difference in outcome in patients in our area with posterior 
circulation strokes compared to other stroke subtypes.  
 
Dysarthria was present in about a quarter of stroke survivors, but was only severe 
i.e. interfered with intelligibility of speech, in 6 (6%). Dysphasia was less common 
and was mild in half of those diagnosed with dysphasia i.e. only word finding 
difficulty, paraphasia or grammatical errors. Dysphagia was uncommon. This is 
probably not surprising given the remote nature of the area and limited medical 
facilities. It is unlikely that anyone with marked swallowing difficulty would survive 
very long both because of inadequate nutrition and the risk of aspiration 
pneumonia.  
 
Visual field deficit occurred in almost a third of individuals which is just slightly less 
than the number of partial and total anterior circulation strokes identified i.e. the 
stroke subtypes in whom this finding would be most likely. Urinary incontinence 
was found in 10 individuals. This is somewhat surprising as we recorded 17 who 
complained of loss of continence using the Barthel Index. This difference is likely 
the result of the Barthel Index inclusion of ‘occasional accident’ as a form of ‘loss 
of continence’ while on our direct assessment of incontinence we only recorded 
complete loss of bladder continence.  
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We did not make any effort to formally assess the stroke survivors’ cognition. 
None of the screening tools such as the Mini-Mental Status Examination (Folstein, 
Folstein, & McHugh, 1975) or Hodkinson Abbreviated Mental Test (Hodkinson, 
1972) have been validated for use in Africa. Furthermore, by the start of the stroke 
prevalence study we already had experience in using the Hodkinson Abbreviated 
Mental Test in the pilot phase of the Johannesburg Hospital Stroke Register 
(chapter 5) and had found it almost impossible to use in our population. 
  
4.1.5 Stroke related complications in prevalent stroke survivors 
 
It is extremely difficult to be sure that associated findings in prevalent stroke cases 
are indeed complications of the stroke and not co-existent or new conditions that 
developed subsequent to the stroke. Despite this, we felt that four individuals had 
conditions that might be related to the stroke. These included: painful shoulder 
syndrome (2), thalamic pain syndrome (1), and dementia (1). The diagnosis of 
dementia was made after detailed discussion with relatives and assessment of the 
patient, as the currently available screening tools for dementia are not useful in 
rural South Africa (see section 4.1.4 above). In one individual who had 
Parkinsonism we were unable to tell whether this was related to vascular disease 
or some other cause.  
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4.1.6   Recurrent stroke 
 
When assessing stroke survivors we focused on the history related to any first-
ever stroke event. It is often difficult to decide whether a deterioration in weakness 
or other neurological symptom is indeed a recurrent stroke, or rather precipitated 
by another condition such as infection or seizure. For this reason it is best to 
concentrate on the first-ever-in-a-lifetime stroke events, both when ‘counting’ 
strokes for epidemiological studies, and when assessing the nature of strokes. 
Interestingly though, the pathological type of recurrent stroke is the same as the 
index stroke in most cases (Yamamoto & Bogousslavsky, 1997; Hankey, 
Jamrozik, Broadhurst et al, 1998).  
 
We diagnosed 12 (12%) stroke survivors as having had recurrent strokes. In 7 this 
was a single recurrence and in 3 we thought the individuals had had more than 
one recurrence.  
 
 
4.1.7  Use of medication for secondary prevention in stroke survivors 
 
 
Eight of the 103 stroke survivors were taking blood pressure lowering medication 
when we assessed them, although a further 10 had been on treatment for 
hypertension at the time of the stroke. Thirty (29%) individuals had been on blood 
pressure lowering therapy at some point in their lives. One individual was taking 
daily aspirin, the only person taking antiplatelet therapy and no one was taking 
lipid lowering therapy. As mentioned in section 4.1.3, one stroke survivor with 
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valvular heart disease, who been admitted to an academic hospital in another 
province for their stroke, was taking warfarin.  
 
4.1.8  Health seeking behaviour  
 
 
Ninety-four stroke survivors (91%) had sought assistance from health care 
providers or healers following the stroke. Of these 10 (11%) said that they had 
only sought help from traditional healers, and 3 (3%) had only sought help from 
faith healers or church groups. Forty-two (45%) had only sought help from clinics 
or hospitals. The remainding 39 (41%) had sought help from both allopathic care 
and traditional or faith healers / church groups.  
 
We asked where the stroke survivors or their care givers had sought help first. 
Unfortunately in retrospect this question was poorly worded. We received 78 
responses: hospital or clinic first (49), traditional healer first (21), and church / faith 
healer first (8). It is thus not possible to assess whether these responses included 
all the individuals that had sought more than one source of assistance. It is clear 
from our findings, though, that 79% of stroke survivors had sought assistance from 
clinics or hospitals at some time following their stroke. This is valuable information 
in advising further health care planning and research in the area.  
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4.1.9     Home care 
 
Fifty-seven (55%) of the 103 stroke survivors felt that they needed home care. Of 
these 53 (93%) had a carer available at home. In 17 cases (32%), the carer was 
the individual’s partner.  
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4.2   Discussion 
 
We based the assessment of pathological stroke type in our stroke survivors on 
our clinical assessment, as no CT scans were available. Using this approach we 
found cerebral haemorrhage to constitute almost a third of the pathological stroke 
types, roughly three times the number seem in the UK and double the number in 
African-Americans with incident strokes. We also found about twice the 
percentage of lacunar strokes in our stroke survivors as has been found in the UK 
or African-Americans. Hypertension was by far the most important risk factor in our 
stroke survivors. There was much less coronary artery disease and large vessel 
atherosclerotic disease (carotid bruits and peripheral vascular disease) than one 
would find in high income countries (Sandercock et al., 1989; Rothwell et al., 
2004). We did not find many cardioembolic strokes or much evidence for HIV 
infection; although admittedly our assessment was based on our examination 
findings and we did not investigate directly for either.  
 
It is important to emphasise that we almost certainly underestimated strokes 
without motor weakness (as highlighted in section 2.7.1). Similarly it is probably 
wise to interpret our large proportion of lacunar strokes compared to other studies 
with caution. Contrary to popular belief hypertension increases the risk of all 
subtypes of ischaemic stroke (Jackson & Sudlow, 2005a), and certainly the high 
prevalence in our population would not explain our finding of double the lacunar 
strokes found in other studies. This finding probably reflects the ascertainment 
bias towards strokes that caused long-term motor weakness as well as the 
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difficulty inherent in characterising the ischaemic stroke subtype at a point long 
after the stroke event.  
 
We did not measure blood glucose because of resource limitations, and based our 
diagnosis of diabetes mellitus on a history of the condition or use of insulin or oral 
glucose-lowering agents. We did not assess body mass index (BMI), waist 
circumference, weight or height in stroke survivors. The relationship between 
obesity and stroke is likely to be confounded by several variables including 
hypertension, physical activity, smoking and indeed diabetes (Hankey, 2002). 
Since our study, however, abdominal obesity has been increasingly recognised as 
an independent risk factor for stroke (Hankey, 2006). At the time of our study we 
had several practical concerns related to the measurement of weight, height and 
waist circumference which we felt would impact on the stroke prevalence study as 
well as on other components of the SASPI (Southern African Stroke Prevention 
Initiative) study. Preliminary work in the Agincourt demographic surveillance site 
had suggested that individuals may not respond well to being measured. An earlier 
study in the site had run into difficulty when rumour spread that the researchers 
were providing undertakers with the measurements in order to prepare coffins, 
raising the concern that being measured implied imminent death. We planned to 
start the SASPI study of cardiovascular risk factors six months after the stroke 
prevalence study and these measurements were an integral part of the former 
study. SASPI anthropologists had not yet started their work on understanding local 
beliefs related to stroke and vascular risk factors at the time of the stroke 
prevalence study. We therefore decided not to include measures of weight, height 
and waist circumference in thes troke prevalence study.   
 140 
As described in Chapter 1 (table 1.1), the health or epidemiologic transition theory 
provides a model for describing the shifts in disease patterns that occur in 
populations as they undergo industrialisation (Pearson, 1999; Bonita, 2001; Yusuf 
et al., 2001). It not only explains the shift from infectious to non-communicable 
disease, but also the changes in vascular disease patterns and the nature of 
stroke as the population moves through the transition. This may be an 
oversimplification, particularly given the rising burden of HIV infection in Sub-
Saharan Africa, but it is useful to explain the development and evolution of 
vascular disease due to traditional vascular risk factors within a population. The 
profile of stroke in our population, with a high proportion of haemorrhagic stroke 
and lacunar stroke due to hypertension, the high prevalence of hypertension as a 
risk factor, the relative absence of extracranial atherosclerotic disease, and the 
young age of stroke occurrence would place the population in stage 2 of the health 
transition (table 1.1). 
 
The levels of alcohol use amongst women and of cigarette smoking in men and 
women were particularly low and are likely to change. Twenty-six percent of 
African-American stroke patients smoke cigarettes (table 4.4). In a study of the 
prevalence of risk factors in the Agincourt community, we found the prevalence of 
cigarette smoking amongst males over the age of 35 years to be 31% (Thorogood, 
Connor, Tollman et al, 2005), and in a recent predominantly urban general 
practice study the prevalence of smoking in South African adult blacks was 59% 
(Connor, Rheeder, Bryer et al, 2005).  
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 It was difficult to compare risk factors in our population with an African-American 
stroke population because of methodological differences and the limited available 
data on stroke risk factors in African-Americans (Gorelick, 1998). However, 
African-Americans have a much higher incidence of stroke than their white 
counterparts (Broderick et al., 1998; Sacco et al., 1998; Kissela et al., 2004). In 
terms of risk factors, African-American ischaemic stroke patients have a higher 
prevalence of hypertension and diabetes mellitus, a similar or slightly lower 
prevalence of coronary artery disease and a lower prevalence of atrial fibrillation 
(Sacco, Boden-Albala, Abel et al, 2001; Schneider et al., 2004) compared to 
whites. The proportions of various stroke risk factors in non-institutionalised 
African-American stroke survivors found in the National Health Interview Survey 
1999 to 2001 (McGruder et al., 2004) are similar to those found in the GCNKSS. 
Hypertension was the most prevalent occurring in 79% of the approximately 800 
stroke survivors. Diabetes mellitus was found in 32%, coronary heart disease (an 
affirmative answer to questions on myocardial infarction and coronary heart 
disease) in 29% and 26% were current smokers (all risk factors were self 
reported). Thus the risk factor profile found in African-Americans is in keeping with 
Gillum’s (1996) modified health transition stage 4 and 5 (section 2.1.1). It is 
possible, or indeed likely, that without appropriate intervention, our population will 
end up with a similar vascular profile and high burden of stroke.  
 
It remains surprising that we found so little rheumatic heart disease and dilated 
cardiomyopathy. We were only convinced of a potential cardioembolic source in 
five ischaemic stroke survivors. From the literature review (section 2.3.1.6) we 
expected to find cardioembolic stroke in around one fifth (much the same as in 
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high income regions) (Warlow et al., 2001), though not as a result of ischaemic 
heart disease but rather from rheumatic valvular heart disease and dilated 
cardiomyopathy (Gaziano, 2005; Sliwa, Damasceno, & Mayosi, 2005; Essop & 
Nkomo, 2005). Our findings may be the result of the lack of detailed investigation, 
and the fact that we saw patients often years after their stroke, or it may reflect 
inadequate access to health care services adversely affecting survival. In this 
remote area anticoagulation is seldom prescribed because of the difficulty 
monitoring blood levels. Indeed, only one of our stroke survivors was on warfarin 
and this had been initiated in another province. 
 
South Africa has one of the highest HIV prevalence rates in the world. However, 
we found little evidence of HIV in our stroke survivors. This may be because we 
did not test HIV serology, but it may also be because the prevalence of HIV in the 
Limpopo Province (Agincourt was until recently a part of this province, now part of 
Mpumalanga) is known to be lower than the national average (Connolly, Shisana, 
Colvin et al, 2004; UNAIDS/WHO Working Group on global HIV/AIDS and STI 
surveillance, 2004).  
 
We found a high prevalence of impairment and disability, whether we measured 
this using the ‘needed help with at least one activity of daily living’ definition, the 
closely related Barthel Index or by loss of independence using the modified Rankin 
score. A similar proportion of stroke survivors were dependent in Tanzania (60% 
compared to our 66%) (Walker et al., 2000b) using the ‘needed help with at least 
one ADL’ definition, compared to 22% of all prevalent strokes or one third of those 
who had made an incomplete recovery in New Zealand (Bonita et al., 1997). The 
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median score on the Barthel was the same in both our study and the study from 
Tanzania.  
 
A stroke prevalence study in Newcastle, UK, that used a screening questionnaire 
and then door-to-door follow up of 76 stroke patients, found 71% were dependent 
using the Barthel Index (score < 20) compared to 73% in our study (O'Mahony et 
al., 1999). When they used the modified Rankin score of 3 – 5, 70% were 
dependent though in our study using this score only 43% were dependent. This 
difference may be methodological (Bamford et al., 1989).  
 
While it is tempting to say that the high proportion of disabled strokes in our 
population is the result of poor health service delivery or more severe strokes in 
the population, it may well be that this is just the result of our methodology. 
Indeed, prevalence studies often tend to overestimate disability because they miss 
strokes in people that have made a good recovery or recovered completely and so 
over-emphasise the severe strokes (Bonita et al., 1997). As prevalence is 
influenced by incidence, case fatality (or duration that the person remains alive), 
and changes within age and sex strata of the population, the best estimates of 
prevalence come from an actuarial approach as used in the New Zealand study 
which was based on two stroke incidence studies with long term follow-up of 
survivors.  
 
Twelve (12%) of our stroke survivors had had a recurrent stroke. Recurrent stroke 
usually constitutes about 25 to 30% of all stroke occurring in a population (Dennis, 
2001; Hankey, 2005) so our finding seems a little low. This may reflect the nature 
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of stroke in the population. For example lacunar strokes, which were very 
prevalent in our population, have the lowest recurrence rate of ischaemic strokes,  
and large artery disease which was not common in our stroke survivors the 
highest, at least up to 30 days post-stroke (Lovett, Coull, & Rothwell, 2004). 
However, two stroke prevalence studies from India have commented on the 
proportion of recurrent stroke in their stroke survivors. They found a similar low 
proportion of recurrent stroke: 14 of 118 cases (12%) in Bombay (Bharucha, 
Bharucha, Bharucha et al, 1988) and 6 of 91 cases (7%) in rural Kashmir (Razdan, 
Koul, Motta et al, 1989). Possibly recurrent stroke is not as easy to diagnose in 
stroke prevalence studies were it is difficult enough to be sure of the first stroke 
diagnosis, and of course those with recurrent stroke are less likely to survive 
(Hankey et al., 1998), so influencing their prevalence in the community. 
 
We found that alarmingly few stroke survivors were taking aspirin or blood 
pressure lowering medication following their stroke. Despite 79% having sought 
help from clinics or hospitals at some time for their stroke, only one person was 
taking daily aspirin, a medication which is theoretically available at all clinics as it 
is available on the South African primary health care essential drug list (National 
Department of Health (South Africa), 2003). Aspirin is also recommended by the 
South African Stroke Guidelines for the secondary prevention of stroke (Bothwell, 
Gatter, Van Rooyen et al, 2000). The study took place before the results of the 
PROGRESS study (PROGRESS collaborative group, 2001) could be put into 
practice in rural South Africa and we would not have expected many stroke 
survivors to be on blood pressure lowering therapy. However, this does not explain 
the high proportion of people with untreated hypertension. Indeed, although only 
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eight individuals were on antihypertensives, 30 had been on antihypertensives at 
some time in their life.  
 
In another SASPI study, a team led by social anthropologist Professor Gillian 
Hundt saw a sample of our stroke survivors. The team found that there were 
several barriers to accessing care in the community. These barriers included: side 
effects of medication, inconsistent drug supply to clinics, costs of transport getting 
to clinics or hospitals (though health care itself is free at clinics), poor blood 
pressure monitoring equipment in clinics, and a perception that prolonged therapy 
for hypertension was not necessary (SASPI Project Team, 2004). Negative views 
about allopathic care were not a barrier to care.  
 
We were not surprised that none of the stroke survivors were on cholesterol 
lowering medication. The BHF/MRC Heart Protection Study (Heart Protection 
Study Collaborative Group, 2002) had not yet been published and routine use of 
statin therapy as secondary prevention for stroke was unlikely to have been used 
at the time. Furthermore, given the generally low levels of cholesterol in this 
population, cholesterol lowering medication is seldom if ever used.  
 
Anticoagulation with warfarin was also seldom used. We only found five stroke 
survivors with evidence of cardioembolic stroke and of these only one was on 
anticoagulation. It is possible that difficulty with controlling levels of anticoagulation 
results in under-prescribing of warfarin in the area, and may lead to an increase in 
cardioembolic stroke and even in stroke related death.  
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Prior to commencing the study we thought that people presenting with stroke in 
rural South Africa were likely to present to traditional healers. Our findings from 
this study, as well as related work done by the social anthropology team 
mentioned above, showed that individuals who developed stroke symptoms were 
likely to present to both allopathic medicine and either traditional medicine or faith 
healers and church groups, as people believed that the disease required ‘double 
therapy’ (SASPI Project Team, 2004; Hundt et al., 2004). This has important 
implications for future studies of stroke in the area as well as for the management 
of stroke patients. Given the poor level of blood pressure control and secondary 
prevention, there is an opportunity to educate health care providers about blood 
pressure and stroke management, including secondary prevention. 
 
Finally, just over half our stroke survivors felt they needed a carer at home and in 
almost all cases this was available. We did not probe any deeper and cannot 
answer at what cost this care was provided. There are no social services in the 
area that would be able to provide care for anyone who has had a stroke. As such, 
families are forced to cope with their stroke survivors regardless of cost.  
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4.3  Conclusion 
 
We found a pattern of stroke risk factors, types, subtypes, and causes that 
suggest that the rural South African population is in stage 2 of the health transition 
with a high proportion of probable cerebral haemorrhage and lacunar infarction 
and little clinical evidence of large vessel atherosclerotic disease. We did not find 
that HIV / AIDS played a major role in prevalent stroke, possibly reflecting the low 
prevalence in this area at the time of our study. Prevalent stroke resulted in a 
significant burden of disability. Despite the majority of stroke survivors having 
attended clinics and hospitals at some time following their stroke, blood pressure 
control was poor and use of secondary prevention for stroke almost non-existent.  
 
4.3.1 What this study adds to the literature 
 
 
This is the first data on the nature of prevalent stroke in South Africa and Sub-
Saharan Africa. The study also provides: detailed information on the burden and 
nature of stroke related disability and impairment in rural South Africa; the first 
data on secondary prevention in rural South African stroke survivors; and data on 
the health seeking behaviour of individuals with stroke in rural South Africa. The 
findings provide evidence to support the theory of the health transition, and 
suggest that the nature of stroke does indeed change as a population progresses 
through the health transition. However, a more detailed community-based 
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assessment of incident strokes with imaging is required to clarify this, as well as to 
accurately document the nature of stroke in the region.  
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CHAPTER 5 THE JOHANNESBURG HOSPITAL STROKE       
REGISTER (JHSR) – URBAN STROKE 
 
5.0 Introduction 
 
Hospital-based stroke registers do not accurately reflect stroke occurring in a 
community because there are many reasons why someone who has suffered a 
stroke may not be admitted to hospital. These include: early death before hospital 
admission, limited resources influencing the person’s ability to get to hospital, and 
the pressures on the hospital service influencing admission criteria e.g. those with 
mild stroke being referred to outpatient clinics rather than admitted for 
investigation. Various other factors may influence the perceived advantage to 
hospital admission e.g. the elderly and disabled who are already in a nursing 
home or have care, someone with a very severe stroke who is unlikely to survive 
despite hospital care, and someone with a very mild stroke may not feel they need 
to seek medical help, or it may be perceived by their general practitioner, clinic or 
family that hospital admission is not required (Sudlow et al., 1996). As a result 
hospital-based stroke studies are more likely to include severe strokes and 
cerebral haemorrhages which have a more dramatic clinical presentation, than 
mild ischaemic strokes (section 2.3.1.1) (Bamford et al., 1986; Dennis et al., 
1994).  
 
However, despite these limitations, hospital-based registers are much cheaper 
and more practical to perform than community-based studies, provide useful 
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clinical and demographic data on the sort of patients being admitted, and give at 
least some idea of the current state of a local stroke service (Dennis, 2001). In 
countries such as South Africa, without community-based stroke incidence 
studies, hospital-based studies also provide the most detailed information on the 
nature of stroke (pathological stroke type, subtype, cause and risk factors) in the 
population; imperfect but at least a start. 
 
Although I discussed the literature, including prospective hospital-based stroke 
registers from Sub-Saharan Africa in chapter 2, I will highlight more recent 
literature in the discussion section of this chapter.  
 
5.0.1  South Africa – population demographics and socioeconomic factors 
 
South Africa has a multiethnic population comprising: 37 205 700 (79%) black 
Africans (after this referred to as blacks), 4 379 800 (9%) whites, 4 148 800 (9%) 
coloureds (mixed race), and 1 153 900 (3%) Indian or Asians (Lehohla, 2005). The 
country’s political history, in particular the apartheid regime between 1948 and 
1994, has resulted in vast differences in the socioeconomic status, profile of 
disease, and access to health care between these population groups. The 
socioeconomic impact on the population has influenced the health and 
demographic transition in particularly the black and coloured population groups. 
The white population exhibits a disease profile typical of high-income regions 
elsewhere in the world, while the black population, particularly in rural areas, 
exhibits many characteristics of a population affected by infectious, perinatal and 
other disease typical of low-income regions (Kahn et al., 1999b; Bradshaw, 
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Groenewald, Laubscher et al, 2003). There are little data available on the impact 
of the demographic and health transition on South African blacks, although the low 
level of atherosclerotic disease, particularly ischaemic heart disease, in the black 
population has been well documented (Rossouw, Weich, Steyn et al, 1984; Walker 
et al., 1997; Walker, Walker, & Adam, 2002; Steyn, Sliwa, Hawken et al, 2005), 
and was confirmed in our prevalent stroke cases (chapter 4). These differences in 
the country’s population groups are likely to impact on the nature of stroke, but 
none of the stroke registers previously performed in South Africa, or indeed in 
Sub-Saharan Africa, have compared stroke in different ethnic groups.  
 
5.0.2 Aim of the Johannesburg Hospital Stroke Register (JHSR) 
 
The aim of the JHSR was to audit the profile of stroke patients admitted to 
Johannesburg Hospital, including demographic and clinical characteristics, to 
provide data on the stroke types, subtypes, causes and risk factors seen in an 
urban South African population, and to compare the nature of stroke amongst the 
country’s population groups. A further aim was to assess the stroke service at 
Johannesburg Hospital. We did not have much funding for this study and could not 
therefore influence the investigations performed or treatment of stroke patients, 
although of course they were all assessed by the stroke team which may have 
influenced their care. Largely the findings therefore represent and are to some 
extent limited by the routine care available at the Johannesburg Hospital during 
the study.  
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We hypothesised that there would be differences in the nature of stroke between 
population groups, and that these differences would be most marked between the 
black and white population groups given the available data on the prevalence of 
risk factors and based on the theory of the health transition. 
 
Finally, we also thought the Johannesburg Hospital Stroke Register would provide 
us with experience in data collection form design and analysis, with a view to 
developing a stroke incidence study in South Africa. 
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5.1      Methods 
5.1.1   Setting and population 
 
The Johannesburg Hospital is a 1088 bed academic referral hospital (Gauteng 
Department of Health, 2005) that provides health care to predominantly indigent 
patients. Although it is a referral hospital, it also provides both primary and 
secondary level acute care to much of the population in Johannesburg (population 
3.25 million) who do not have access to private health care (Gauteng Department 
of Health, 2005; Lehohla, 2005).  
 
5.1.2 Case ascertainment and assessment 
 
The Johannesburg Hospital Stroke Register (JHSR) included all cases of stroke 
admitted to Johannesburg Hospital, or which occurred while in hospital, over 23 
months during two periods: from 1st July 2000 till 31st December 2000 and from 1st 
August 2001 till 31st December 2002.  
 
The JHSR was well advertised around the hospital using posters in emergency 
wards, general wards and the casualty area, as well as at academic meetings. We 
identified all patients likely to have had a stroke using multiple overlapping 
sources. These included: referrals to the JHSR from both medical and nursing 
staff using a dedicated stroke team phone line with answering machine if the 
dedicated stroke assistant was not available; direct questioning of doctors and 
nurses in the emergency department, admission wards and medical wards about 
 154 
admissions over the previous 24 hours; by reviewing ward admission books daily, 
and by daily reviewing of the files of patients who had died during the previous 24 
hours.  
 
After finding likely stroke patients, the stroke assistant informed the patient and / or 
their carers about the stroke register and asked for verbal permission for a doctor 
from the stroke team to assess them. The assistant also provided them with an 
information sheet about the stroke register in their language of choice (English, 
IsiXhosa, IsiZulu, Shangaan, Sesotho and Afrikaans available).  
 
Clinicians from the University of the Witwatersrand, Division of Neurology, then 
assessed all patients in detail (the stroke team). Patients were included on the 
register if they had had a stroke within the last 3 months or if the stroke was the 
main reason for seeking medical assistance. Patients who had had their stroke 
more than six months previously were excluded even if the stroke was the main 
reason for their admission. Only individuals with first-ever-in-a-lifetime strokes 
were included. 
 
The stroke team doctor on call for the day then took a full history, examined the 
individual and reviewed the medical notes and investigations. After confirming the 
stroke diagnosis, they then completed the JHSR questionnaire (Appendix D). I 
saw a large proportion of the cases entirely on my own, reviewed the majority of 
the remainder with the team member who had assessed the patient first, and 
reviewed the notes on all cases before we entered them onto the JHSR database. 
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I assigned a final diagnosis, stroke type and subtype. (See section 1.3 for a 
detailed account of my role in this study).  
 
We documented the stroke patient’s demographic details, a number of 
socioeconomic indicators such as education level and housing, their symptoms at 
onset of the stroke, known risk factors prior to the stroke (based on history from 
the patient or their carers), medication use and functional state prior to the stroke. 
Our examination focused on blood pressure at the time of our examination, the 
presence of any vascular disease including evidence of hypertensive end-organ 
damage affecting the heart and fundal vessels and any potential sources of 
emboli. We assessed the major neurological signs and the person’s level of 
consciousness as well as the severity of the stroke using the National Institutes of 
Health Stroke Scale (National Institute of Neurological Disorders and Stroke, 
2005) and the Scandinavian Stroke Scale (Scandinavian Stroke Study Group, 
1985). We assessed the person’s modified Rankin score (Rankin, 1957; Bamford 
et al., 1989) and Barthel score (Mahoney et al., 1965) as measures of their level of 
functioning and handicap. We documented the results of any investigations 
performed, any treatment provided, and any complications resulting from the 
stroke. Where possible we documented the person’s length of stay, where they 
were discharged to, and any in hospital deaths. Unfortunately, given the enormous 
service load, rapid turn-over of admissions to the medical wards and our lack of 
resources we were not able to accurately document case fatality and discharge 
data in all cases.  
 
 156 
We assessed the following risk factors: age, sex, hypertension (see definition 
below), diabetes mellitus (see definition below), cigarette smoking (current 
smoker, former smoker for more than one year, never smoked), alcohol 
consumption (never / hardly ever, ex-drinker for more than a year, current alcohol 
use), snuff use, ischaemic heart disease (defined as typical angina, symptoms of 
myocardial infarction accompanied by any signs of ischaemic heart disease on 
ECG, or clear ECG evidence of ischaemic heart disease), previous stroke or 
transient ischaemic attack (although we only included first-ever-in-a-lifetime 
strokes in the register), atrial fibrillation (confirmed on ECG) and family history of a 
first degree relative with a stroke.  
 
5.1.2.1    Other definitions used 
 
We defined stroke according to the World Health Organisation (WHO) criteria as 
“rapidly developing clinical signs of focal (or global) disturbance of cerebral 
function, leading to death or lasting longer than 24 hours, with no apparent cause 
other than vascular ” (Hatano, 1976a). 
 
First-ever-in-a-lifetime stroke was defined as the first symptoms of a stroke ever 
experienced by the individual based on the history obtained from the individual or 
their care givers and any available medical records. It did not take into account the 
brain scan findings, so someone without a history of previous stroke but brain scan 
evidence of previous stroke would still be considered to have had a ‘first-ever-in-a-
lifetime’ or ‘first-ever’ stroke. 
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Transient ischaemic attack: We defined transient ischaemic attack (TIA) as ‘a 
clinical syndrome characterised by an acute loss of focal cerebral or monocular 
function with symptoms lasting less than 24 hours and which is thought to be due 
to inadequate cerebral or ocular blood supply as a result of low blood flow, arterial 
thrombosis or embolism associated with disease of the arteries, heart or blood’ 
(Hankey & Warlow, 1994).  
 
Pathological stroke type: We assessed the pathological stroke type after we 
reviewed the CT or MRI brain scan and classified the type as ischaemic stroke, 
cerebral haemorrhage or subarachnoid haemorrhage (see specific subarachnoid 
haemorrhage definition below). If no scan was available then the stroke type was 
coded as ‘uncertain type.’ 
 
In patients who did not have a CT brain scan, we assigned the pathological stroke 
type based on the patient’s clinical presentation alone. We were more likely to 
diagnose cerebral haemorrhage than ischaemic stroke if the person gave a history 
of severe headache, seizure or loss of consciousness at the onset, as these 
presentations are unusual in ischaemic stroke (Warlow et al., 2001). We 
diagnosed subarachnoid haemorrhage if the patient had a typical presentation of 
sudden very severe headache, associated with neck stiffness and characteristic 
lumbar puncture findings (though we anticipated all patients with subarachnoid 
haemorrhage would have a CT brain scan prior to lumbar puncture). In all cases, 
we have noted when we have used our clinical assessment of pathological 
stroke rather than the far more accurate CT scan diagnosis (above).  
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Subarachnoid haemorrhage: We diagnosed subarachnoid haemorrhage in 
patients who had a characteristic sudden severe headache with a positive CT 
brain scan or cerebrospinal fluid findings to support the diagnosis; or in patients 
who were unable to give a history who had a positive CT brain scan or a normal 
CT brain scan but with supportive cerebrospinal fluid abnormalities (Warlow et al., 
2001). 
 
Ischaemic stroke subtype  
 
We classified ischaemic stroke subtypes according to the Oxfordshire 
Community Stroke Project (OCSP) classification as: total anterior circulation 
infarction, partial anterior circulation infarction, posterior circulation infarction or 
lacunar infarction, using the accepted clinical criteria (Bamford et al., 1991). The 
OCSP classification was based on the clinical assessment and not altered by the 
findings on brain scan, although we did document instances when the clinical 
classification differed from the brain scan findings.  
 
We also used the Trial of Org 10172 in Acute Stroke Treatment trial (TOAST) 
classification to classify the strokes into five causal subtypes 
atherothromboembolic, cardioembolic, small vessel thrombotic (lacunar), other 
determined aetiology and undetermined cause (Adams, Jr. et al., 1993). However, 
instead of classifying those patients with more than one cause as ‘undetermined’ 
we classified them as having ‘multiple causes’ (Goldstein, Jones, Matchar et al, 
2001).  
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The TOAST classification is dependent on detailed investigation of patients and 
even after these diagnostic tests have been performed about 15% of patients 
remain unclassified (Warlow et al., 2001). In our relatively low resource setting, we 
anticipated an even larger proportion of ‘undetermined’ strokes using this 
classification system. We therefore decided to assign our own ‘most likely cause’ 
based on all the clinical assessment, brain imaging findings and available 
investigations.  
 
Ethnicity: We defined someone’s ethnicity based on their self-identified ethnic 
group assigned at time of admission to the hospital. 
 
Risk factors:  
 
Historical risk factors: We used this term to describe risk factors defined on a 
self-reported history from the patient or their carers. 
 
Hypertension:  We defined hypertension as current use of antihypertensive 
medication, a history of having been diagnosed as hypertensive by a doctor or 
nurse prior to the stroke, documented blood pressure of greater than or equal to 
140 mmHg systolic or 90 mmHg diastolic prior to the stroke or more than one 
week following the stroke, or evidence of hypertensive heart disease on ECG (left 
ventricular hypertrophy as assessed using the Sokolow-Lyon index)(Sokolow & 
Lyon, 1949) or echocardiography. 
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Diabetes mellitus: We defined diabetes mellitus as current use of anti-diabetic 
drugs, a history of being diagnosed as diabetic by a doctor or clinic nurse prior to 
the stroke, documented non-fasting blood glucose of greater than 11.1 mmol/L or 
fasting blood glucose of greater than or equal to 7.0 mmol/L (both blood glucose 
values measured on admission).  
 
Peripheral vascular disease (PVD): We defined peripheral vascular disease as 
intermittent calf claudication or absence of both foot pulses or presence of femoral 
bruits or having had peripheral vascular disease surgery.  
 
 
 161 
5.1.3     Data analysis 
 
We entered all questionnaires onto Microsoft Access 2002 SP3 and then analysed 
the data using STATA software (StataCorp, 2001). In some instances we 
calculated confidence intervals using Confidence Interval Analysis software 
(Bryant, 2000) as well as STATA (StataCorp, 2001). We assessed differences in 
patient characteristics, risk factors and investigations, between ethnic groups and 
by stroke pathological type and ischaemic stroke subtype, by χ2 test (for 
categorical variables) or analysis of variance (for continuous variables). We 
compared median values using the Wilcoxon test, and we used logistic regression 
to assess the influence of age on the risk of cerebral haemorrhage. We compared 
differences between all population groups and then between black and white 
patients in keeping with our a priori hypotheses. We considered a level of p<0.05 
as statistically significant. 
 
5.1.4   Ethics 
 
Ethics approval for the study was granted by the University of the Witwatersrand 
Human Ethics Research Committee (M00/03/7). 
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5.2     Results 
 
Five hundred and twenty-four patients were referred to the JHSR. We excluded 92 
patients. Figure 5.1 shows the outline of the study and the reasons why we 
excluded the 92 patients. Very few patients referred had recurrent strokes or 
transient ischaemic attacks (TIA). These findings probably reflect admission 
practices and the pressure on acute medical beds. In other words, people with 
TIAs and recurrent stroke were less likely to be admitted than patients with a new 
(and probably more severe) stroke. 
 
5.2.1 Characteristics of JHSR stroke patients 
 
A total of 432 stroke patients were entered onto the JHSR; including 308 (71%) 
black, 76 (18%) white, 22 (5%) coloured and 26 (6%) Indian / Asian patients. 
Table 5.1 shows the main characteristics of JHSR stroke patients, categorised by 
population group and sex. Although there were slightly more females than males, 
the rounded male to female ratio was 1 for all but the coloured and Indian / Asian 
population groups which were the least represented. The difference may simply 
reflect the small numbers of patients included.  
 
The mean age of stroke patients was 53 years (SD 16) (95% CI, 52 to 55). The 
ages ranged from 18 to 97 years, with a median age of 55 (95% CI, 52 to 56). 
Females were slightly older (mean 54 years) than men (53 years) but this 
difference was not significant (p=0.4). There was a significant difference in mean 
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age between population groups (p<0.001) but when we compared individual 
groups we only found a significant difference in age between whites (who were 
slightly older) and blacks (p<0.001) and whites and Indian / Asians (p=0.04).  
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524 patients with presumed stroke referred to the JHSR team 
 
Black: 364  
White: 98  
Coloured: 28  
Asian / Indian:  34  
 
432 included on the JHSR database 
 
Male:     211 (49%) 
Female:   221 (51%) 
 
Black: 308 Male:153 Female: 155  
White: 76 Male: 40 Female: 36  
Coloured: 22 Male: 7 Female: 15  
Asian / Indian:  26 Male: 11 Female: 15  
30 transient ischaemic attack 
 
16 Black; 10 White; 1 Coloured; 3 Asian / 
Indian 
36 recurrent stroke 
 
21 Black; 7 White; 4 Coloured; 4  
Asian / Indian 
7 insufficient data available / neither 
medical records nor patients found 
 
19 not stroke - diagnoses: 
 
7 HIV associated space occupying lesions 
2 space occupying lesions – likely 
metastatic tumour, 2 epilepsy, 3 subdurals, 
1 HIV associated meningitis, 1 meningitis 
without HIV, 1 vascular dementia, 1 
cerebral hypoxia following toxin ingestion, 
and 1 patient with progressive, fluctuating 
weakness over 2 years – no final diagnosis 
as patient did not return for follow up 
 
Figure 5.1  Study outline: cases included in the Johannesburg Hospital Stroke Register 
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Table 5.1  Characteristics of the stroke patients in the Johannesburg Hospital Stroke 
Register, by population group  
 
 Black White Coloured Indian / Asian Total 
 M F M F M F M F M F 
153 155 40 36 7 15 11 15 211 221 Strokes n  
 
 
(ratio M:F) 1.0 1.0 0.5 0.7 1.0 
Age – mean (95% 
CI)  
51 
(48 to 
53) 
50 
(49 to 
54) 
58 
(53 to 
62) 
66 
(61 to 
71) 
64 
(57 to 
72) 
54 
(41 to 
66) 
55 
(44 to 
66) 
53 
(43 to 
64) 
52 
(50 to 
54) 
54 
(52 to 
56) 
Age – mean (95% 
CI) both sexes 
51 
(49 to 52) 
61 
(58 to 65) 
58 
(49 to 66) 
54 
(47 to 61) 
53 
(52 to 55) 
 p<0.001* 
213 (98%) 57 (95%) 17 (94%) 23 (100%) 310 (98%) 
Independent prior 
to stroke** (% of all 
with available data 
for population 
group) 
n = 315 
p=0.4 
3.5 
(2 to 5) 
2 
(1 to 3) 
2 
(1 to 4) 
2 
(0.5 to 3) 
3 
(2 to 4) 
Mean time to 
presentation 
(days)(95% CI) 
n = 401 p=0.5* 
Median time to 
presentation (days) 
n=401 
1 
(1 to 1) 
1 
(0.5 to 1) 
1 
(0.5 to 2) 
0.4 
(0.25 to 1) 
1 
(1 to 1) 
32 / 285 
(11%) 
14 / 70 
(20%) 
1 / 21 
(5%) 
5 / 25 
(20%) 
53 / 401 
(13%) 
Number who 
presented within 3 
hours / total 
number with time 
to presentation 
data (%)  
n=401 
p=0.1 
63 / 287 
(22%) 
19/ 70 
(27%) 
1 / 21 
(5%) 
9 / 25 
(36%) 
94 / 404 
(23%) 
Number who 
presented within 6 
hours / total 
number with time 
to presentation 
data (%) 
n=401 
p=0.06 
207 
(67%) 
47 
(62%) 
16 
(73%) 
17 
(65%) 
287 
(66%) 
Number scanned 
(% of all strokes in 
population group) 
p=0.8 
121 
(59%) 
29 
(62%) 
4 
(25%) 
13 
(76%) 
167 
(58%) 
Number scanned 
within 24 hours of 
admission (% of 
those scanned) 
p=0.02 
193 
(92%) 
41 
(87%) 
14 
(88%) 
14 
(83%) 
262 
(91%) 
Number scanned 
within 7 days of 
admission (% of 
those scanned) p=0.3 
 
M-male F-female   *  Analysis of variance comparing mean age of population groups and mean time to 
presentation between population groups; ** Independent prior to stroke defined as a modified Rankin score of 
0 to 2 
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We were unable to assess functional independence prior to stroke in all patients 
for the following reasons: in 5 cases the patient died before assessment, in 53 the 
history was not clear e.g. in aphasic patients and patients in whom we could not 
find reliable collateral information, and in a further 58 cases because these data 
were not recorded on our questionnaire. We assessed and recorded the level of 
functioning prior to stroke in 318 patients. The vast majority were independent 
(modified Rankin score of 0 to 2) prior to their stroke (98%) (table 5.1). We did not 
find any significant difference in the level of independence prior to stroke between 
population groups (p=0.4) or between male and female stroke patients (p=0.5).   
 
We were able to assess the time from stroke onset to presentation to the 
emergency service at Johannesburg Hospital (or another hospital in patients who 
were later transferred to Johannesburg Hospital) in 401 patients. The range of 
time to presentation was wide. Although 13 strokes occurred in hospital, the time 
to presentation ranged from 1 hour to 120 days in those in whom the stroke did not 
occur in hospital. Figure 5.2 depicts the spread of times to presentation for each 
population group. Table 5.1 shows the mean time to presentation which was not 
significantly different between population groups (p=0.5) or between males and 
females (p=0.5). The median time from stroke onset to presentation was the same 
(1 day) for all population groups other than the Indian / Asian group in whom the 
median was 10 hours. The lower median in the Indian / Asian group compared to 
other groups may well be a reflection of the small number of strokes in this group.  
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Population group 
 
1.  White 
2.  Black 
3.  Coloured 
4.  Indian / Asian 
Figure 5.2  Distribution of time from stroke onset to presentation (days) by 
population group. Population group: 1 = white; 2 = black; 3= coloured; 
4= Indian / Asian. 
The median time from stroke onset to presentation for white, black, 
coloured and all patients combined (1 day) is indicated with a dashed 
horizontal line. The median was slightly lower for Asian / Indian patients 
(0.4 days) 
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Figure 5.3  Distribution of time from stroke onset to presentation (hours) in those 
patients who presented to Johannesburg Hospital within 48 hours by 
population group. The 3 hour and 6 hour time lines are shown.  
Population group: 1 = white; 2 = black; 3= coloured; 4= Indian / Asian 
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As a number of stroke treatments are only available to patients who present within 
a narrow time-window, we have shown the proportion of patients who presented to 
the hospital within three and six hours of onset (table 5.1) (figure 5.3). Fifty-three 
(13%) of the 401 patients for whom we had accurate time to presentation data, 
presented within three hours of stroke onset. The proportion of patients who 
presented within three hours ranged between 5% in the coloured population (again 
possibly the result of the small number of strokes in this group) and 21% in the 
white population (table 5.1). However, there was no significant difference between 
population groups (p=0.9) or between males and females (p=0.5). The proportion 
of patients who presented within six hours of stroke onset increased to 23% with a 
range from 5% in the coloured population to 36% in the Indian / Asian population. 
There was no significant difference in the proportion who presented within six 
hours of stroke onset between population groups (p=0.06) or males and females 
(p=0.08). 
 
Two hundred and eighty-seven patients (66%) had a CT brain scan. Only three 
patients had an MRI brain scan (<1%) which in all cases followed the CT brain 
scan. No population group (p=0.8) or sex (p=0.05) was more likely to have a CT 
brain scan, although more males (150, 71%) than females (137, 62%) had scans. 
In 167 (58%) of the patients scanned, the CT scan was done within 24 hours of 
presentation to hospital.  Although blacks and whites, the two largest groups, had 
a similar percentage of scans performed within 24 hours, coloureds (25%) and 
Indian / Asians (72%) were at the extremes of likelihood to have a scan within 24 
hours (p=0.02). The difference between males and females scanned within 24 
hours was not significant (males: 89, 53%; females: 78, 47%) (p=0.7). Two-
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hundred and sixty two (91%) of the 287 stroke patients scanned were scanned 
within 7 days of presentation to hospital. There was no significant difference in the 
number of patients scanned within 7 days and after 7 days between population 
groups (p=0.3) or males (137) and females (125) (p=0.6).  
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5.2.2   Pathological stroke types in the JHSR 
 
Table 5.2 presents the proportion of pathological stroke types by population group 
and sex in those patients who had a CT brain scan. About a quarter of the strokes 
were cerebral haemorrhages. Cerebral haemorrhage was far more common in the 
black (27%) compared to the white (15%) and Indian / Asian (12%) population 
groups. The difference in pathological stroke type between all population groups 
(p=0.5) or between males and females (p=0.1) was not statistically significant. 
Surprisingly the difference between the black and white population groups was 
also not significant (p=0.2). Cerebral haemorrhage tends to be more common in 
younger rather than older stroke patients in community-based stroke studies 
(Marini et al., 2001) and we therefore repeated the comparison between white and 
black stroke patients adjusting for age. This did not alter the significance (p=0.62). 
However, when we included only those stroke patients known to be negative for 
HIV the difference was significant both with adjustment for age (p=0.03) and 
without (p=0.03). (See section 5.3.5.4 for further discussion on the impact of HIV 
on pathological stroke type). Ischaemic stroke constituted just under three-
quarters of all strokes and was least common in the black population (68%); while 
subarachnoid haemorrhage (SAH) was not common in any group (6%).    
 
Cerebral haemorrhage may be underestimated in stroke populations if imaging is 
done more than a few days after stroke (Sudlow et al., 1996; Keir, Wardlaw, & 
Warlow, 2002). Signs of cerebral haemorrhage may disappear on CT brain scan 
within 14 days or less if the haemorrhage is small (Dennis et al., 1987; Keir et al., 
2002). We did not have data on how long the CT scan was performed from stroke 
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onset, but we did have data on the time to scan after admission. We recorded the 
time to scan after admission as: less than 24 hours, 24 to 48 hours, 48 to 72 
hours, 3 to 7 days, and more than 7 days. Considering the median time to 
admission was 1 day following the stroke onset, and given the potential 
disappearance of cerebral haemorrhage on CT brain scan with increasing time 
from stroke onset, we analysed the pathological stroke types when the time to 
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Table 5.2   Pathological stroke type in the JHSR by population group and sex (percentage of all scanned patients  
 in the population and sex group shown in brackets)  
 
Black White Coloured 
Indian / 
Asian 
Combined 
 
M F T M F T M F T M F T M F T 
Total number of patients 
scanned 
109 98 207 27 20 47 6 10 16 8 9 17 211 221 287 
Pathological 
Stroke Type: 
               
Cerebral 
Haemorrhage  
35 
(32) 
20 
(20) 
55 
(27) 
6 
(22) 
1 
(5) 
7 
(15) 
1 
(17) 
3 
(30) 
4 
(25) 
1 
(13) 
1 
(11) 
2 
(12) 
43 
(29) 
25 
(18) 
68 
(24) 
Ischaemic stroke  
68 
(62) 
73 
(75) 
141 
(68) 
20 
(74) 
16 
(80) 
36 
(77) 
5 
(83) 
7 
(70) 
12 
(75) 
7 
(88) 
7 
(78) 
14 
(82) 
100 
(67) 
103 
(75) 
203 
(71) 
Subarachnoid haemorrhage  
6 
(6) 
5 
(5) 
11 
(5) 
1 
(4) 
3 
(15) 
4 
(9) 
0 0 0 0 
1 
(11) 
1 
(6) 
7 
(5) 
9 
(7) 
16 
(6) 
 
M- male; F - female; T- total 
We did not find a significant difference in stroke type between population groups (p=0.5) or males and females (p=0.1) 
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Table 5.3   Pathological stroke type in the JHSR by population group, comparing patients who were scanned within 7 
days of presentation to hospital (percentage of all scanned patients in the population group shown in 
brackets)  
 
 Black White Coloured 
Indian / 
Asian 
Combined 
Total number of patients scanned within 7 days 195 43 14 14 266 
Pathological Stroke Type:      
Cerebral 
Haemorrhage n (%) 
54 
(28) 
7 
(16) 
3 
(21) 
2 
(14) 
66 
(25) 
Ischaemic stroke n (%) 
130 
(67) 
32 
(74) 
11 
(79) 
11 
(79) 
184 
(69) 
Subarachnoid haemorrhage n (%) 
11 
(6) 
4 
(9) 
0 
1 
(7) 
16 
(6) 
 
 No significant difference in pathological stroke type between population groups (p=0.5)  
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scan was within 7 days of admission to hospital (table 5.3). There was very little 
difference at all between the proportion of cerebral haemorrhage and other 
pathological stroke types in those patients scanned at any time and those scanned 
within 7 days of admission.  
 
5.2.3  Ischaemic stroke subtypes in the JHSR 
 
Table 5.4 presents the Oxfordshire Community Stroke Project (OCSP) 
classification of ischaemic stroke patients on the JHSR. The table only includes 
the 203 patients with ischaemic stroke confirmed on CT brain scan. The majority 
of these patients (36%) had partial anterior circulation infarcts (PACI) followed in 
frequency by lacunar infarction (LACI) (28%), total anterior circulation infarcts 
(TACI) (25%) and posterior circulation infarcts (POCI) (12%). Although there was 
no statistical difference in the ischaemic stroke subtypes found in the four 
population groups, the black population group had more LACIs (28%) and TACIs 
(28%) than their white counterparts who had 22% and 19% respectively (p=0.4). 
Both these groups had a similar proportion of POCIs (12% and 11%), while the 
white population had more PACIs (47% versus 32%). It is difficult to comment on 
the subtypes in the coloured and Indian / Asian population, as there were so few 
ischaemic strokes in each category.  
 
There was a borderline statistically significant difference between the ischaemic 
stroke subtypes found in males (n=100) and females (n=103) (p=0.044). Women 
were more likely to have LACIs (32% vs 24%) and TACIs (27% vs 22%), and men 
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were more likely to have POCIs (18% vs 6%). A similar proportion had PACIs 
(36% vs 35%).  
 
Table 5.5 shows the OCSP classification applied not only to the stroke patients 
with confirmed ischaemic stroke on CT, but also to those whom we presumed to 
have had an ischaemic stroke. Using these criteria we increased the number of 
eligible patients to 340. Again there was no statistically significant difference in the 
subtypes of ischaemic stroke between the population groups (p=0.98). Indeed in 
this comparison there was very little difference in the proportions of stroke 
subtypes seen in the four population groups, particularly the larger black and white 
groups. The difference between males (n=158) and females (n=182) remained 
(p=0.01). Both sexes now had similar proportions of LACIs (29% females and 30% 
males) and PACIs (36%), but as in the CT brain scan confirmed sample, females 
had far more TACIs (31% vs 20%) and males had more POCIs (13% vs 4%).  
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Table 5.4   Ischaemic stroke subtypes (Oxfordshire Community Stroke Project classification) in patients with ischaemic 
stroke confirmed on CT brain scan by population group (percentage of all scanned strokes in the population 
group)* 
 
 Black White Coloured 
Indian / 
Asian 
Combined 
Total number of ischaemic strokes** 141 36 12 14 203 
Pathological Stroke Type: 
Total Anterior Circulation Infarction (TACI) n (%)* 
39 
(28) 
7 
(19) 
0 
 
4 
(29) 
50 
(25) 
Partial Anterior Circulation Infarction (PACI) n (%) 
45 
(32) 
17 
(47) 
5 
(42) 
5 
(36) 
72 
(36) 
Posterior Circulation Infarction  
(POCI) n (%) 
17 
(12) 
4 
(11) 
2 
(17) 
1 
(7) 
24 
(12) 
Lacunar Infarction 
(LACI) n (%) 
40 
(28) 
8 
(22) 
5 
(42) 
4 
(29) 
57 
(28) 
 
 ** confirmed on CT brain scan 
No significant difference in ischaemic stroke type between population groups (p=0.6)  
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Table 5.5   Ischaemic stroke subtypes (Oxfordshire Community Stroke Project classification) in patients with presumed 
ischaemic stroke (CT confirmed or clinical diagnosis) by population group  
(percentage of all scanned strokes in the population group)* 
 
 Black White Coloured 
Indian / 
Asian 
Combined 
Total number of ischaemic strokes by clinical assessment** 235 65 18 22 340 
Pathological Stroke Type:      
Total Anterior Circulation Infarction (TACI) n (%)* 
62 
(26) 
16 
(25) 
5 
(28) 
5 
(23) 
88 
(26) 
Partial Anterior Circulation Infarction (PACI) n (%)* 
84 
(36) 
23 
(35) 
6 
(33) 
9 
(41) 
122 
(36) 
Posterior Circulation Infarction  
(POCI) n (%)* 
18 
(8) 
8 
(12) 
2 
(11) 
1 
(5) 
29 
(9) 
Lacunar Infarction 
(LACI) n (%)* 
71 
(30) 
18 
(28) 
5 
(28) 
7 
(32) 
101 
(30) 
 
** confirmed on CT brain scan or presumed likely ischaemic 
No significant difference in ischaemic stroke type between population groups (p=0.98) 
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5.2.4   Trial of ORG 10172 in Acute Stroke Therapy (TOAST) trial 
classification of stroke patients in the JHSR 
 
Table 5.6 presents the findings by population group of the TOAST classification 
applied to our patients with CT brain scan confirmed ischaemic strokes. While 
there was no statistical difference between the clinical subtypes of ischaemic 
stroke when we compared all four population groups (section 5.2.3) most likely 
because of the small number of coloured and Asian / Indian patients, we did find a 
significant difference in the aetiopathological subtypes of ischaemic stroke using 
the TOAST classification. As we expected, many (36%) of the 203 eligible patients 
were not sufficiently investigated to allow us to determine the TOAST type and 
were therefore classified as ‘undetermined.’ Cardioembolic, lacunar and ‘other’ 
causes of stroke formed roughly the same proportion (17 to 19%), and a small 
proportion (4%) had atherothrombotic strokes.   
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Table 5.6 TOAST Classification of ischaemic stroke by population group  
  
 Black White Coloured 
Indian / 
Asian 
Combined 
Total number of patients with ischaemic stroke (confirmed with brain 
imaging) n  
141 36 12 14 203 
Atherothrombotic n (%)* 
0 
 
5 
(14) 
2 
(17) 
1 
(7) 
8 
(4) 
Cardioembolic n (%)* 
21 
(15) 
11 
(31) 
2 
(17) 
5 
(36) 
39 
(19) 
Lacunar n (%)* 
25 
(18) 
6 
(17) 
3 
(25) 
2 
(14) 
36 
(18) 
Other cause n (%)* 
24 
(17) 
5 
(14) 
2 
(17) 
3 
(21) 
34 
(17) 
Undetermined n (%)* 
61 
(43) 
6 
(17) 
3 
(25) 
3 
(21) 
73 
(36) 
Multiple possible causes n (%)* 
10 
(7) 
3 
(8) 
0 0 
13 
(6) 
 Significance of difference between groups: p=0.002 
 
* percentage of ischaemic strokes confirmed on CT brain scan 
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We distinguished 13 (6%) patients with multiple causes from the ‘undetermined’ 
group which is often used to categorise patients with more than one cause, to 
distinguish these patients who were investigated from  the majority of the patients 
in the undetermined group who were not. Indeed only one of the patients in the 
undetermined group, a 44-year-old white female, had a complete workup and yet 
we could not find any determinable cause for her stroke.  
 
Using the strict TOAST criteria, we classified far more black patients as 
‘undetermined’ than any of the other population group. None of the black patients 
had an atherothrombotic stroke. Cardioembolic stroke was most frequent in the 
Indian / Asian and white populations. Lacunar stroke was most common in the 
coloured population and roughly equally as common in the white and black 
populations. We found other determined causes in roughly the same proportion of 
blacks, whites and coloureds, but slightly more often in Indian / Asian patients, 
although, as we have mentioned before the small numbers of strokes in the 
coloured and Indian / Asian groups make these comparisons inaccurate.  
 
5.2.5    Causes of ischaemic strokes in the JHSR 
5.2.5.1 Analysis of ischaemic stroke using the ‘most likely cause’ approach 
 
Using the TOAST classification criteria (Adams, Jr. et al., 1993) we were only able 
to assign an aetiopathological classification to 117 (27%) of all stroke patients. We 
therefore used a less rigid approach to assigning cause in an attempt to reduce 
the number of ‘undetermined’ and ‘multiple cause’ strokes. For this analysis we 
assigned patients a ‘most likely cause’ based on the clinical, CT scan and 
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investigation findings. In patients who did not have a CT brain scan, we assigned a 
cause if we thought the pathological stroke type was most likely ischaemic (as in 
table 5.5). In patients with multiple causes, we assigned the most likely primary 
cause.  
 
Using this ‘most likely cause’ approach in the 340 eligible patients we reduced the 
number of undetermined causes to 67 (20%) of presumed ischaemic strokes 
(table 5.7). We could not agree on a primary cause in one patient classified as 
having multiple causes for their stroke. This was a 79-year-old white male who 
presented with a LACI clinically and on CT brain scan. He had a long history of 
hypertension, but also had atrial fibrillation, tight aortic stenosis and ischaemic 
heart disease.  
 
Although the frequency of atherothrombotic stroke increased to 10% of the 340 
patients with ischaemic stroke, it remained much lower in the black patients (6%) 
than the approximately 20% found in the other population groups. Cardioembolic 
stroke accounted for approximately 28% of strokes in whites, coloureds and Indian 
/ Asian patients, and for slightly fewer black patients (24%). Lacunar strokes 
remained about as common in white and black patients (28% and 26%) using the 
‘most likely cause’ approach, but ‘other determined causes’ were more common in 
the black and coloured population (23% and 22%) compared to the white and 
Indian / Asian population. The difference in subtype between population groups 
was significant (p=0.01), but we did not find a significant difference in ‘most likely 
cause’ subtypes between males (n=158) and females (n=182) (p=0.2). 
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Table 5.7 Classification of ischaemic stroke using our ‘most likely cause’ approach in patients with presumed ischaemic 
stroke (CT confirmed or clinical diagnosis)* by population group  
   
 Black White Coloured 
Indian / 
Asian 
Combined 
Total number of patients with ischaemic stroke* n  235 65 18 22 340 
Large vessel atherosclerosis n (%)** 
13 
(6) 
13 
(20) 
4 
(22) 
5 
(23) 
35 
(10) 
Cardioembolic n (%)** 
52 
(21) 
18 
(28) 
5 
(28) 
6 
(27) 
82 
(24) 
Small vessel (lacunar)  (%)** 
60 
(26) 
18 
(28) 
3 
(17) 
4 
(18) 
85 
(25) 
Other cause n (%)** 
57 
(24) 
6 
(9) 
4 
(22) 
3 
(14) 
70 
(21) 
Undetermined n (%)** 
53 
(23) 
9 
(14) 
2 
(11) 
4 
(18) 
67 
(20) 
Multiple possible causes n (%)** 0 
1 
(2) 
0 0 
1 
(<1) 
 Significance of difference between groups: p=0.03 
  
 ** percentage of ischaemic strokes  
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Although we were able to assign more patients to a likely cause using this 
analysis, our findings did not describe whether there were differences in the 
underlying cause for cardioembolic or lacunar strokes, and did not describe the 
‘other causes of stroke’ in the four population groups. The nature and pattern of 
atherosclerotic disease in the patients assigned to the ‘atherothrombotic cause’ is 
also not clear. We will now describe each of these categories of ischaemic stroke 
in detail.  
 
5.2.5.2   Cardioembolic stroke 
 
The proportion of patients with cardioembolic ischaemic stroke was similar in each 
of the population groups (table 5.7). However, the underlying cause of 
cardioembolic strokes differed between the groups (p=0.02). Table 5.8 presents 
the causes of cardioembolic strokes by population group.  
 
Atrial fibrillation and cardiomyopathy together accounted for about two-thirds of 
cardioembolic causes of stroke, while ischaemic heart disease and valvular heart 
disease accounted for about 10% each. Notable differences between populations 
were the large proportion of whites with atrial fibrillation (65%) and ischaemic heart 
disease (30%) in contrast to the other groups. Indeed ischaemic heart disease 
was only found in 2 (4%) black patients with presumed cardioembolic stroke. Half 
of black and a quarter of coloured stroke patients had an underlying 
cardiomyopathy, while this cause was not found in the white and Indian / Asian 
populations. While dilated cardiomyopathy is a well accepted cause for 
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Table 5.8   Cardioembolic strokes in the JHSR  
 
 
 Black White Coloured Indian / Asian Combined 
Total number of patients with cardioembolic stroke  
(CT confirmed or clinical diagnosis)  
52* 20* 4* 5* 81* 
Atrial fibrillation: Total (% of cardioembolic strokes) 15 (29) 13 (65) 1 (25) 2 (40) 31(38) 
- unknown cause 6 7 0 2 15 
- with ischaemic heart disease 1 4 0 0 5 
- with valvular heart disease 2 1 0 0 3 
- with dilated cardiomyopathy 0 1 0 0 1 
- with hypertensive heart disease 6 0 1 0 7 
Ischaemic heart disease: Total (% of cardioembolic strokes) 2 (4) 6 (30) 0 0 8 (10) 
       -    following acute myocardial infarction 1 1 0 0 3 
- IHD with atrial fibrillation 1 4 0 0 5 
- IHD with dyskinetic segment on echocardiography 0 1 0 0 0 
Valvular heart disease: Total (% of cardioembolic strokes) 9 (17) 2 (10) 1 (25) 2 (40) 14 (17) 
- unknown cause 1 0 0 0 1 
- rheumatic valvular disease 6 1 1 2 10 
- associated with dilated cardiomyopathy 2 1 0 0 3 
Cardiomyopathy: Total (% of cardioembolic strokes) 27 (52) 0 1 (25) 0 28 (35) 
- dilated 10 0 1 0 11 
- associated with hypertensive heart disease** 17 0 0 0 17 
Infective endocarditis (% of cardioembolic strokes) 0 1 1 1 3 (4) 
Other (% of cardioembolic strokes) 0 1† 0 0 1(1) 
Unknown** (% of cardioembolic strokes) 0 1 0 0 1 (1) 
 Significance of difference between groups: p=0.02 
  
 
 * NB subtotals and percentages do not add up to combined total as some causes are repeated  
** See text for detail on this category (section 5.2.5.2) 
† This cardioembolic event occurred intra-operatively during aortic valve replacement / aortic aneurysm repair 
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cardioembolic stroke, the role of hypertensive heart disease (HTHD) is 
controversial. Patients were only included in this category if they had evidence  
(clinical or echocardiographic) of heart failure associated with HTHD. However, 6 
black patients and one coloured patient had HTHD and atrial fibrillation. Patients 
did not need to have evidence of heart failure for inclusion in this group. We will 
discuss the controversies regarding the role of hypertensive heart disease in 
causing stroke in section 5.3.4.  
 
Three patients had strokes caused by infective endocarditis, and one had a stroke 
noted immediately following surgery for aortic valve replacement and repair of an 
aortic aneurysm. We included in the ‘unknown’ group a 73-year-old white male 
who presented with a first-ever-in-a-lifetime right PACI. He was a previous smoker 
and currently used alcohol excessively. He gave a history of a recent transient 
ischaemic attack. However, the CT brain scan showed recent cortical infarctions 
involving the left middle cerebral artery territory and left occipital cortex, as well as 
one infarct involving the right cerebellum. He was lost to follow up before 
investigations were completed. Given the multiple territories involved with large 
vessel strokes we felt that a cardiac cause was most likely, but we acknowledge 
that other causes such as aortic atherosclerosis are still possible.  
 
5.2.5.3  Large vessel atherosclerosis in the JHSR patients 
 
Black patients were much less likely to have atherothrombotic / large vessel 
atherosclerotic causes of stroke than the other population groups. None of the 
black patients with CT confirmed ischaemic strokes had atherothrombotic strokes 
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when we used the strict TOAST classification definition. When we used our ‘most 
likely’ cause approach, 13 (6% of 235) black patients had large vessel 
atherosclerotic strokes. Whites, coloureds and Indian / Asian patients had a 
similar, higher, proportion (20 to 23%) using the latter approach. 
 
Few of the 432 stroke patients in the JHSR underwent detailed investigation for 
atherosclerosis. In total 23 patients had carotid Dopplers, 21 angiograms and no 
one had an MR angiogram. It is thus difficult to describe the pattern of 
atherosclerosis in our study population. However, there were a few interesting 
findings which provided some insight into the differences in large vessel 
atherosclerosis between population groups.  
 
Of the 35 patients classified as having atherothrombotic strokes: 3 had carotid 
bruits (2 Indian / Asian and 1 white); 8 had carotid artery stenosis on Doppler (6 
white, 1 coloured and 1 Indian / Asian); and 3 had extracranial atherosclerosis on 
angiogram (2 whites and 1 coloured). Sixteen (5%) of 340 patients with likely 
ischaemic strokes had peripheral artery disease (9 blacks, 2 whites, 3 coloureds 
and 2 Indian / Asians) and 19 (6%) had ischaemic heart disease (6 blacks, 12 
whites, 1 coloured and no Indian / Asian). Therefore, while the black stroke 
population did infrequently have evidence of ischaemic heart disease and 
peripheral vascular disease, none of them had evidence of extracranial 
atherosclerotic disease, although admittedly few patients were adequately 
investigated.  
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5.2.5.4   Lacunar (small vessel) strokes 
 
We found 85 lacunar strokes in 340 patients with presumed ischaemic stroke. 
Table 5.9 outlines the frequency of hypertension, diabetes mellitus and the 
combination in patients with lacunar strokes. We did not find a significant 
difference in the frequency of hypertension (p=0.8) or diabetes (p=0.3) between 
population groups in those who had lacunar strokes. Two white and four black 
patients had no significant risk factors or cause for their lacunar stroke.  
 
5.2.5.5   Other determined causes of ischaemic stroke in the JHSR 
 
Sixty-five of the 340 patients with presumed ischaemic strokes had specific 
conditions which were likely to have caused their stroke. The vast majority 
occurred in black patients (52). Thirty-eight (73%) of the 52 black patients 
classified in this group were HIV positive. In these 38 patients, HIV seropositivity 
was the only identifiable disease in 26 patients. In the remaining 12 patients, HIV 
seropositivity was associated with: carotid artery dissection in 1, internal carotid 
artery occlusion of unknown cause in 2 (with no evidence of atherosclerosis in the 
remainder of the arteries), cerebrospinal fluid features compatible with tuberculous 
meningitis in 2, cryptococcal meningitis in 1, venous stroke during pregnancy in a 
patient with a CD 4 count of 92 x 106/L in 1, elevated CSF protein and 
hypertensive heart disease in 1, elevated CSF protein and a tuberculous pleural 
effusion in 1, pulmonary tuberculosis in 1, and incomplete investigation as a result 
of early death in 2.  
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Table 5.9   Frequency of hypertension and diabetes mellitus in patients 
presenting with lacunar stroke* (n followed by percentage of 
lacunar strokes in brackets) 
 
 Black White Coloured 
Indian / 
Asian 
Combined 
Number of lacunar  strokes* 60 18 3 4 85 
Hypertension without diabetes 
mellitus 
47 (72) 11 (61) 2 (67) 3 (75) 63 (70) 
Diabetes mellitus without 
hypertension 
2 (3) 1 (6) 0 1 (25) 4 (4) 
Both hypertension and diabetes 
mellitus 
7 (11) 4 (22) 1 (33) 0 12 (13) 
Neither hypertension or diabetes 
mellitus 
4 (10) 2 (11) 0 0 6(9) 
 
* diagnosed using combined CT brain and clinical ‘most likely’ diagnosis 
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Of the 6 white patients with an ‘other determined’ cause: 3 had an arterial 
dissection, 1 had temporal arteritis, and 1 was HIV seropositive without any other 
associated illness or abnormal findings. Of the 4 coloured patients in this category: 
1 had a migrainous stroke, 1 had a post-partum cerebral venous thrombosis, 1 
had a middle cerebral artery aneurysm in the appropriate site to explain her stroke, 
perhaps as a result of distal embolisation of thrombus, and 1 patient was HIV 
seropostive with no associated disease. Two Indian / Asian patients had cerebral 
venous thrombosis: one occurred post-partum, and the other had systemic lupus 
arthritis with associated vasculopathy.  
 
5.2.6   Causes of cerebral haemorrhages in the JHSR 
 
Sixty-eight (24%) of the 287 JHSR patients who had a CT brain scan had a 
cerebral haemorrhage. Table 5.10 shows cause of the cerebral haemorrhage for 
each population group. We assigned a cause based on the CT appearance and 
clinical findings e.g. of thrombocytopenia. Hypertension was by far the most likely 
cause for the stroke occurring in 79% of all cerebral haemorrhages and over 80% 
of cerebral haemorrhages in the black population. Thrombocytopenia occurred in a 
patient with leukaemia (platelet count 29 x 109/Ll) and another patient with 
eclampsia who had a platelet count of 67 x 109/L.  A presumptive diagnosis of 
amyloid angiopathy was made in two coloured women one aged 76 and the other 
56 based on CT brain appearance of lobar haemorrhage and the lack of any other 
likely cause (although one had evidence of left ventricular hypertrophy on 
echocardiogram). We accept that this is far from ideal, particularly in the younger 
patient. The ‘other’ category (table 5.10) included a 65-year-old patient who was 
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Table 5.10 Causes of cerebral haemorrhage and subarachnoid haemorrhage by population group (only CT confirmed 
cases of cerebral haemorrhage and subarachnoid included) 
   
 
Black White Coloured 
Indian / 
Asian 
Combined 
Total number of patients with cerebral haemorrhage   55 7 4 2 68 
− Hypertension   45 6 1 2 54 (79)* 
− Aneurysm   2 0 0 0 2 (3)* 
− Amyloid    0 0 2 0 2 (3)* 
− Thrombocytopenia   2 0 0 0 2 (3)* 
− Other   2 1 0 0 3 (4)* 
− Unknown   4 0 1 0 5 (7)* 
 Significance of difference between groups: p<0.001 
Total number of patients with SAH*  11 4 0 1 16 
− Aneurysm  4 3 0 0 7 (44)* 
− Suspected aneurysm   3 1 0 0 4 (25)* 
− Unknown  3 0 0 1 4 (25)* 
− Thrombocytopenia  1 0 0 0 1 (6)* 
 Significance of difference between groups: p=0.3 
 
* percentage of all cerebral haemorrhages or subarachnoid haemorrhages  
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overwarfarinised for deep venous thrombosis, a 67 year old black patient with a 
ruptured mycotic aneurysm and 44 year old black patient with a history of 
hypertension, well controlled at the time of the stroke, who had a cerebral 
haemorrhage following an alcohol binge.  
 
5.2.7   Causes of subarachnoid haemorrhage in the JHSR 
 
We have also outlined the causes of subarachnoid haemorrhage (SAH) in the 
JHSR in table 5.10. Aneurysms diagnosed on angiography accounted for 7 (44%), 
and in a further 4 patients we suspected aneurysms based on the clinical 
presentation and CT brain findings, but angiograms were not available. One SAH 
was associated with thrombocytopenia (platelet count 24 x 109/L) in a patient with 
aplastic anaemia and in 4 cases we could not identify a cause for the SAH. The 
number of patients with SAH was too small for us to comment confidently on any 
differences between population groups.  
 
5.2.8    Risk factors in the JHSR  
 
Table 5.11 shows the frequency of risk factors in the JHSR and compares the 
frequency of risk factors between the four population groups. Hypertension 
(defined as a history of hypertension from the patient or their previous medical 
notes, if the patient was on treatment for hypertension or if there was evidence of 
hypertensive end organ damage) was the most frequent risk factor in our stroke 
patients, present in 73% of the 406 for whom we had sufficient data. 
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Table 5.11  Risk factors in the JHSR by population group (n = number 
assessed) 
Percentage of all patients assessed in each population group 
shown in brackets, unless otherwise stated  
 
 Black White Coloured 
Indian / 
Asian 
Total  
Total number of strokes (n) 308 76 22 26 432  
Age – mean (95% CI) both 
sexes 
51 
(49 to 52) 
61 
(58 to 65) 
58 
(49 to 66) 
54 
(47 to 61) 
53 
(52 to 55) 
*p<0.001 
Male sex 
n=432 
155 
(50) 
40 
(53) 
7 
(32) 
11 
(42) 
211 
(49) 
p=0.3 
Hypertension 
n=406 
214 
(74) 
50 
(69) 
15 
(79) 
17 
(74) 
296 
(73) 
p=0.4 
Mean total cholesterol level at 
time of presentation (95% CI) 
n=174 
4.6 
(4.3 to 4.9) 
5.3 
(4.8 to 5.7) 
5.3 
(3.9 to 6.6) 
5.6 
(4.9 to 6.4) 
4.9 
(4.6 to 5.0) 
p=0.02 
Proportion with total 
cholesterol ≥ 6 mmol/L 
n=174 
14 
(12) 
9 
(22) 
2 
(22) 
5 
(45) 
30 
(17) 
p=0.03 
Cigarette smoking n=350       
- Current 57 (23) 34 (54) 6 (32) 8 (35) 105 (30)  
- Ex 28 (11) 15 (24) 4 (21) 2 (9) 49 (14) p<0.001 
- Never 160 (65) 14 (22) 9 (47) 13 (57) 196 (56)  
Alcohol use n=339       
- Current 63 (27) 14 (23) 2 (3) 1 (4) 80 (24)  
- Ex 16 (7) 7 (12) 1 (5) 2 (9) 26 (8) p=0.14 
- Never 158 (67) 39 (65) 16 (84) 20 (87) 233 (69)  
Diabetes mellitus 
n=378 
42 
(16) 
11 
(16) 
6 
(30) 
6 
(24) 
65 
(17) 
p=0.3 
Previous transient ischaemic 
attack 
n=343 
4 
(1) 
4 
(7) 
1 
(6) 
3 
(14) 
12 
(4) 
p=0.01 
Ischaemic heart disease 
n=256 
8 
(4) 
12 
(25) 
1 
(10) 
0 
21 
(8) 
p<0.001 
Known previous atrial 
fibrillation 
n=424 
10 
(3) 
7 
(10) 
1 
(5) 
2 
(8) 
20 
(5) 
p=0.14 
Peripheral vascular disease 
n=424 
9 
(3) 
4 
(5) 
3 
(14) 
2 
(8) 
18 
(4) 
p=0.2 
Family history of stroke 
n=423 
27 
(9) 
11 
(15) 
6 
(29) 
3 
(12) 
47 
(11) 
p=0.2 
 
*p: significance of difference
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The mean total cholesterol level measured on admission was relatively low (4.9 
mmol/L) and only 17% of the 174 patients with cholesterol results available had a 
total cholesterol level of 6 mmol/L or greater. Current cigarette smoking was 
common (105 of 350), as was current alcohol use (80 of 339). Diabetes mellitus 
(defined as a history of diabetes mellitus, on treatment for diabetes mellitus, or an 
admission random blood glucose of ≥ 11.1 mmol/L) was also common (65 of 378; 
17%). In contrast, known previous atrial fibrillation (20 of 424; 5%) and peripheral 
vascular disease (18 of 424; 4%) were uncommon.  
 
We found a significant difference (p<0.05) in age, mean total cholesterol, the 
proportion with a total cholesterol greater than or equal to 6 mmol/L, frequency of 
cigarette smoking, ischaemic heart disease and prior transient ischaemic attack 
(TIA) between population groups. Comparing the two larger population groups 
represented, black patients were more likely to be younger, have a lower total 
cholesterol (with fewer cholesterol values greater than or equal to 6 mmol/L), and 
never have smoked, than white patients. They were less likely to be current 
smokers, to have reported a prior TIA, or to have ischaemic heart disease. 
However, the low percentage of TIAs may be the result of under-reporting.  
 
Indian / Asian patients were notable in having the highest mean total cholesterol 
level, highest proportion with a total cholesterol level greater than or equal to 6 
mmol/L, and least likely to be current users of alcohol or ever to have used 
alcohol. Coloured patients were most likely to have a history of hypertension, to be 
diabetic, and have PVD and a family history of stroke. The small numbers of 
patients in these groups make these findings unreliable, however, and the 
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absence of ischaemic heart disease in the Indian / Asian patients most likely 
results from this limitation.  
 
In Table 5.12, we have compared risk factors by pathological stroke type (CT brain 
scan confirmed) for ischaemic stroke and cerebral haemorrhage. The only 
significant differences in the frequency of risk factors found in these two 
pathological types were in male sex, hypertension and ischaemic heart disease. 
There was a marginally significant sex difference and males were more likely to 
have cerebral haemorrhages than ischaemic strokes (p=0.046). We found a 
history of hypertension or clinical features of previous hypertension more often in 
patients with cerebral haemorrhage than in ischaemic stroke. We found ischaemic 
heart disease more often in ischaemic stroke than in cerebral haemorrhage. 
Surprisingly, there was no significant difference in total cholesterol levels, diabetes 
mellitus, prior TIA, the frequency of PVD, or known atrial fibrillation between the 
two pathological stroke types. 
 
We found differences in the frequency and proportions of risk factors between 
population groups (table 5.11). To enable us to compare other components of this 
work which focus only on black stroke patients (chapters 3, 4, 6 and 7), and as the 
black population group was the largest population group in the JHSR, we 
compared the risk factors between ischaemic stroke and cerebral haemorrhage in 
black stroke patients (table 5.13). A history of hypertension (or clinical evidence of 
prior hypertension) was the only risk factor that differed significantly between the 
two pathological stroke types in black patients. Ischaemic heart disease was more 
frequently associated with ischaemic stroke than with cerebral haemorrhage (8% 
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Table 5.12  Risk factors in the JHSR by pathological stroke type (only 
ischaemic stroke and cerebral haemorrhage compared)  
 (n = number assessed); Percentage with the risk factor shown in 
brackets unless otherwise stated  
 
 
Cerebral 
Haemorrhage 
Ischaemic Stroke  
Total number of strokes confirmed by CT brain scan 
n=271 
68 203  
Age – mean (SD) (95% CI) both sexes 
53 (13) 
(49 to 56) 
50 (17) 
(47 to 52) 
*p=0.2 
Male sex 
n=271 
43 
(63) 
100 
(49) 
p=0.046 
Hypertension 
n=251 
58 
(88) 
114 
(62) 
p<0.001 
Mean total cholesterol level at time of presentation 
(95% CI) 
n=173 
5.1 
(4.2 to 6) 
4.7 
(4.4 to 5) 
p=0.2 
Proportion with total cholesterol ≥ 6 mmol/L 
n=173 
4 
(19) 
15 
(16) 
p=0.8 
Cigarette smoking 
n=211 
   
- Current 11 (24) 43 (26)  
- Ex 9 (20) 23 (14) p=0.6 
- Never 26 (57) 99 (60)  
Alcohol use 
n=207 
   
- Current 10 (23) 35 (22)  
- Ex 5 (11) 16 (10) p=0.9 
- Never 29 (66) 112 (69)  
Diabetes mellitus 
n=237 
8 
(14) 
30 
(17) 
p=0.6 
Previous transient ischaemic attack 
n=318 
1 
(2) 
9 
(5) 
p=0.3 
Ischaemic heart disease 
n=131 
1 
(2) 
15 
(13) 
p=0.04 
Known previous atrial fibrillation 
n=265 
3 
(5) 
8 
(4) 
p=0.8 
Peripheral vascular disease 
n=365 
2 
(3) 
10 
(5) 
p=0.5 
Family history of stroke  
n=423 
6 
(9) 
28 
(14) 
p=0.4 
  
*p: significance of difference
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Table 5.13  Risk factors in Black stroke patients in the JHSR by pathological 
stroke type (only ischaemic stroke and cerebral haemorrhage 
compared)  
(n = total number assessed for the risk factor; percentage shown 
in brackets unless otherwise stated) 
 
 
Cerebral 
Haemorrhage 
Ischaemic Stroke  
Total number of strokes confirmed by CT brain scan 
n=196 
55 141  
Age – mean (SE) (95% CI) both sexes 
51 (1.7) 
(47 to 54) 
47 (1.4) 
(44 to 50) 
*p=0.1 
Male sex 
n=196 
35 
(64) 
68 
(48) 
p=0.052 
Hypertension 
n=182 
48 
(89) 
77 
(60) 
p=<0.001 
Mean total cholesterol level at time of presentation 
(95% CI) 
n=75 
4.8 
(3.7 to 5.8) 
4.4 
(4.1 to 4.7) 
p=0.3 
Proportion with total cholesterol  
≥ 6 mmol/L 
n=75 
2 
(12) 
7 
(12) 
p=0.97 
Cigarette smoking 
n=150 
   
- Current 7 (19) 22 (20)  
- Ex 7 (19) 14 (12) p=0.6 
- Never 23 (62) 77 (68)  
Alcohol use 
n=147 
   
- Current 10 (29) 27 (24)  
- Ex 4 (11) 9 (8) p=0.7 
- Never 21 (60) 76 (68)  
Diabetes mellitus 
n=167 
5 
(11) 
18 
(15) 
p=0.6 
Previous transient ischaemic attack 
n=192 
1 
(2) 
3 
(2) 
p=0.3 
Ischaemic heart disease 
n=111 
1 
(3) 
6 
(8) 
p=0.4 
Known previous atrial fibrillation 
n=192 
2 
(4) 
3 
(2) 
p=0.5 
Peripheral vascular disease 
n=365 
1 
(2) 
4 
(3) 
p=0.5 
Family history of stroke n=192 
5 
(9) 
15 
(11) 
p=0.6 
  
*p: significance of difference
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compared to 3%) but this difference was not significant. This finding is influenced 
by the low prevalence of IHD in the black population and therefore the small 
numbers in all stroke types.  
5.2.8.1  Socioeconomic status of patients in the JHSR  
 
Socioeconomic status, particularly social deprivation, is said to be associated with 
stroke, specifically stroke mortality and incidence, though the effect on specific 
pathological stroke types and subtypes is not clear (Warlow et al., 2001; Cox, 
McKevitt, Rudd et al, 2006). It has been suggested that the increase in stroke is 
effected via an increase in risk factor prevalence, but this has not been 
investigated sufficiently (Cox et al., 2006).  
 
There were no generally accepted socioeconomic scores for South Africa when 
we first developed the questionnaire for the JHSR. Despite this we included 
several measures that possibly have a bearing on the socioeconomic status of an 
individual living in South Africa (see appendix D). While scoring systems are still 
being developed, one measure based on housing, household commodity index 
(ownership of items such as a telephone, oven, microwave oven) and education 
level is gaining popularity (Professor Paul Rheeder, Professor of Clinical 
Epidemiology, University of Pretoria – personal communication 7 April 
2006)(Westaway & Gumede, 2000). While we did not use the same scoring 
system and did not measure household commodities, we did assess employment 
and housing, as well as marital status. We also asked whether the stroke patient 
was the sole breadwinner for the household. In table 5.14 we compare the 
proportion of each of these measures in the four population groups studied.  
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Table 5.14  Possible socioeconomic measures / factors in stroke patients in 
the JHSR (percentage of those in the population group 
assessed) 
 
Socioeconomic measure 
n=number assessed 
Black White Coloured 
Indian / 
Asian 
Total  
Marital status 
n=314 
      
- Married 126 (58) 25 (45) 8 (49) 16 (73) 175 (56)  
- Single 60 (27) 7 (13) 2 (12) 2 (9) 71 (23) *p<0.001 
- Widowed 28 (13) 14 (25) 6 (35) 4 (18) 52 (17)  
- Divorced 5 (2) 10 (18) 1 (6) 0 (0) 16 (5)  
Sole breadwinner for the household 
n=284 
100 
(57) 
28 
(57) 
7 
(44) 
8 
(40) 
143 
(50) 
p=0.6 
Housing 
n=278 
      
- live in house / flat 131 (69) 47 (89) 13 (93) 18 (90) 209 (75)  
- dormitory / hostel / single 
room 
12 (6) 1 (2) 0 0 13 (5)  
- retirement home 1 (1) 2 (4) 1 (7) 2 (10) 6 (2) p=0.04 
- live with employer 27 (14) 3 (6) 0 0 30 (11)  
- live in serviced shack 13 (7) 0 0 0 13 (5)  
- live in un-serviced shack 7 (4) 0 0 0 7 (3)  
Years of schooling passed 
n=223 
      
- mean (SD) (95% CI) 
8 (3) (7 to 
8) 
11(2) (10 to 
11) 
10 (2) (8 to 
11) 
8 (3) (6 to 
10) 
9 (3) (8 to 
9) 
p<0.001 
- median 8 (8 to 9) 
11 (10 to 
12) 
10 (7 to 12) 9 (6 to 10) 9 (8 to 10) p<0.001** 
- none 8 0 0 1 9  
- less than 7 years 44 2 1 4 51  
- 7 years 19 0 1 2 22  
- less than 12 years 128 26 8 13 175  
- 12 years 26 18 2 2 48  
- any in-service or post-school 
formal training 
53 28 4 7 92  
Employed 
n=314 
      
- unemployed and looking for 
work  
36 (17) 8 (13) 2 (13) 3 (13) 49 (16) p=0.046† 
- any pension 50 (23) 29 (48) 9 (56) 6 (26) 94 (30)  
 
* significance of difference 
* Wilcoxon test: only significant for difference between black and white and Indian / Asian and white;  
† Comparison of employed, unemployed and those on social pension or unemployed by choice 
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About half the stroke patients who were asked whether they considered 
themselves the sole breadwinner for their household said “yes,” and there was no 
significant difference between the population groups for this measure (p=0.6). We 
included social pensioners as ‘bread-winners’ as pensions (state, disability or 
private) are so often the major sources of income in households in South Africa 
(Case, 2001). This figure does appear high, particularly in the black and white 
population groups. In the black population it is feasible because of the young 
mean age of the stroke patients. This possibly results in an increased proportion 
that is economically active. However, it may also be the result of HIV infection 
causing loss of young economically active lives and resulting in more families 
dependening on the elderly. It is more difficult to explain the high proportion of 
sole-breadwinners in the white population group.  
 
There was a significant difference in housing between population groups 
(p=0.004). Far fewer black patients lived in a house or flat (131 of 191 assessed; 
69%) compared to white patients (47 of 53 assessed; 89%) and other population 
groups (table 5.14). Black patients were more likely to live with their employer or in 
a shack than other population groups.   
 
The mean and median number of years of schooling was significantly higher for 
whites than any other population group (table 5.14). This probably reflects the 
apartheid regime’s educational policy which favoured the white population. Current 
employment was more common in black stroke patients, possibly because of their 
younger age than other groups, though this was of borderline significance. Indeed 
when we only assessed patients aged less than 65 years the difference was no 
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longer significant (p=0.6). There was a significant difference in marital status 
between groups with black patients more likely to be single, Indian / Asian patients 
more likely than other groups to be married, coloured to be widowed, and whites 
more likely to be divorced than other groups. This is unlikely to have any role to 
play in stroke risk or even socioeconomic status; though the likelihood of home 
care following stroke seems good for Indian / Asian patients and perhaps black 
patients.  
 
5.2.8.2    Snuff use in the JHSR 
 
Whether snuff (smokeless tobacco) results in an increased risk of stroke or not is 
not clear (Asplund, 2001; Asplund, 2003; Asplund et al., 2003; Henley et al., 
2005). Twenty stroke patients in the JHSR used snuff (18 black, 1 coloured and 1 
Indian / Asian patient), predominantly women (15 women and 5 men) (p=0.04). 
 
5.2.9    Human immunodeficiency virus (HIV) in the JHSR 
 
As mentioned in section 5.0.2 we did not have the resources to carry out additional 
investigations on patients entered onto the JHSR. Our results were dependent on 
the investigations available as part of the routine management of patients in the 
medical wards at Johannesburg Hospital. Although HIV infection is an important 
consideration in medical patients admitted to Johannesburg Hospital, elderly 
patients and particularly older stroke patients are not as likely to be tested for HIV 
as younger patients. This practice is based on the lower prevalence found in older 
population groups (Directorate: Health Systems Research, 2001). Our finding of 
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HIV frequency in the JHSR must therefore be considered to be a minimum 
frequency.  
 
One hundred and seventy-four (40%) of the 432 stroke patients were tested for 
HIV. There was a significant difference in the likelihood of being tested in the four 
population groups assessed (p<0.001): 148 (48%) black, 12 (16%) white, 7 (32%) 
coloured and 7 (26%) Indian / Asian patients. Sixty-five (15%) of the JHSR 
patients tested for HIV were positive: 61 (41%) black patients, 2 (17%) white, and 
2 (29%) coloured patients. None of the Indian / Asian patients tested were 
positive. This difference was not statistically significant (p=0.06) comparing all 
groups, but was significantly different between blacks and whites (p<0.001). There 
was no significant difference between males and females, either in the likelihood 
of having a positive HIV test result (29 males and 36 females, p=0.06) or of being 
tested (p=0.02).  
 
The mean age of patients who tested positive was 38 years (SD 10) (95% CI, 35 
to 40 years) with a range of 18 to 65 years. Of the 65 HIV positive patients, 6 (9%) 
had a cerebral haemorrhage, 1 had a subarachnoid haemorrhage and the 
remainder (58; 89%) had ischaemic strokes. The likelihood of a person being 
tested for HIV was not increased with any particular pathological stroke type 
(p=0.5) or OCSP subtype (p=0.9).  
 
We found no difference in the likelihood of patients with HIV having a particular 
OCSP ischaemic stroke subtype (p=0.6). Of the 58 patients with ischaemic stroke 
who tested positive for HIV, 14 (24%) had total anterior circulation infarcts (TACI), 
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25 (43%) had partial anterior circulation infarcts (PACI), 1 (2%) had a posterior 
circulation infarct (POCI) and 18 (31%) had lacunar infarct (LACI).  
 
There was, however, an increased likelihood for black patients of certain 
aetiological stroke types to be tested for HIV (p=<0.001). Using our ‘’most likely 
cause’’ classification, not surprisingly strokes in the ‘’other’’ ischaemic stroke 
category were most likely to be tested (51 of 112 ischaemic stroke tested; 51%), 
but then patients were more likely to be allocated to this category if they were HIV 
positive and had no other cause for their stroke. However, black patients with 
atherothrombotic strokes were least likely to be tested (3 of 112 ischaemic stroke 
tested; 3%). 
 
Twenty-two HIV positive patients had their CD4 count measured. The mean count 
was 218 (SD 268)(95% CI, 99 to 336) with a range of 2 to 1047. Twenty of these 
were measured in black stroke patients, and one each in a white and coloured 
individual. The investigation of HIV positive stroke patients was not extensive 
enough for us to comment on the likely causes of stroke in these patients. 
 
5.2.9.1    HIV in young stroke patients 
 
Young stroke patients are often considered separately because they are less likely 
to have stroke caused by atherosclerotic disease or complex small vessel disease 
than patients over the age of 60 years (Warlow et al., 2001). In South Africa as 
elsewhere, HIV is more prevalent in young people than in the older population, 
probably because of its sexual transmission and early deaths in people not using 
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antiretroviral therapy. For this reason it is worth considering the impact of HIV 
infection in young patients. The definition of young varies from study to study. 
Usually patients up to the age of somewhere between 30 and 50 years of age are 
considered young. We will consider all patients less than 50 years of age to be 
young patients to allow us to compare our findings with those of the Durban Stroke 
Data Bank (Hoffmann, 2000). 
 
There were 171 young stroke patients in the JHSR: 139 black, 15 white, 8 
coloured and 9 Indian / Asian. HIV infection was significantly different across 
population groups (p=0.04). Young black stroke patients had the highest frequency 
with HIV infection in 49 of 94 tested patients (52%). Coloured patients followed 
with 2 of 6 tested infected (33%) and then whites with 1 of 6 tested (17%). None of 
the 5 Indian / Asian patients tested were positive. As the numbers are so small in 
all but the young black population we will only discuss HIV infection in young black 
stroke patients in more detail.  
 
The difference in the frequency of HIV infection between young male and female 
stroke patients was not significant with 21 of 47 tested males positive for HIV 
(45%) and 28 of 47 tested females positive (60%) (p=0.2). Mean age of the HIV 
positive young black patients was 35 years (SD 7; 95% CI 33 to 37) with a range 
of 22 to 49 years. One young black male gave a history of substance misuse 
(cannabis) but we did not test him for HIV infection.  
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5.2.10   Syphilis in the JHSR 
 
We did not systematically test for syphilis in our patients. Indeed, we only tested 
for syphilis in 78 patients: 59 black, 9 white, 6 coloured and 4 Indian / Asian 
patients. Syphilis serology (VDRL) was positive in 9 patients (6 males and 3 
females) all of whom were black. Of those 9, we tested 6 patients for HIV infection 
and found one patient positive. One patient with a positive VDRL had a cerebral 
haemorrhage and the rest had ischaemic strokes. The ischaemic strokes were: 
cardioembolic (total anterior circulation infarct) in 1, lacunar in 4, associated with 
HIV in 1 (partial anterior circulation infarct) and undetermined in 2 patients (total 
anterior circulation infarct in one and partial anterior circulation infarct in the other).   
 
Only two of the patients with a positive VDRL result had CSF results available. In 
both the CSF was abnormal. In the first patient, a 58 year old white female who did 
not have an HIV test, the CSF protein was raised at 1,02 without any other 
abnormality, but syphilis FTA antibodies were not present thereby excluding a 
diagnosis of neurosyphilis (Timmermans et al., 2004). 
  
The other patient, a 35-year-old HIV negative male with a cerebral haemorrhage 
had an active CSF with 1 polymorphonuclear cell, 25 lymphocytes, 25 
erythrocytes, glucose of 3.5 mmol/L and a raised protein of 0.73 g/L. The India ink 
test and cryptococcal antigen were negative, the adenosine deaminase (ADA) 
level was normal, and the CSF VDRL was negative. He was previously well and 
did not have any symptoms of meningitis prior to the stroke. While it is possible to 
have neurosyphilis in the presence of a negative CSF VDRL (Timmermans et al., 
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2004), this is unlikely and so we cannot confidently diagnose neurosyphilis in 
either of these two patients.  
 
5.2.11    Stroke severity and related disability 
5.2.11.1 Stroke severity 
 
We used the National Institutes of Health stroke score (NIHSS) as well as the 
Scandanavian Stroke Score (SSS) to determine stroke severity. Table 5.15 
presents our findings categorised by population group. We did not find any 
significant difference in the mean or median scores between population groups or 
male and female sex. The mean and median scores for all groups and using both 
scoring systems suggested that the strokes overall were of moderate severity 
(comparison with other populations will be discussed in section 5.3.6.1).  
 
5.2.11.2  Barthel Index and modified Rankin score 
 
We assessed the Barthel Index and modified Rankin score at the time we first 
assessed the patient, i.e. within one to two days of admission. Table 5.15 shows 
the proportion of patients who scored below a Barthel Index (BI) of 20, 15 and 10 
to compare the proportions of patients across population groups who had varying 
levels of functional difficulty. We also compared the proportion of each population 
group with a modified Rankin score (mRs) of 0 to 2 representing those who were 
independent, and a score of 3 to 5 representing those stroke patients who were 
not independent. We found no significant difference between population groups 
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Table 5.15  Severity of stroke and stroke related functional impairment and 
disability in the JHSR, by population group (percentage of 
population group assessed) 
 
 
 
 
 
 
Scale / Impairment 
n = total number assessed 
in JHSR 
Black White Coloured 
Indian / 
Asian 
Total 
Significance 
of 
difference 
NIH stroke scale       
- Mean (SD) 12(9) 12(10) 12(11) 12(9) 12(10) 0.9 
- Median (95%) CI) 
10  
(8 to 12) 
7  
(5 to 12) 
7  
(3 to 17) 
9  
(5 to 15) 
10  
(8 to 11) 
0.4* 
Scandinavian SS       
- Mean (SD) 29 (20) 30 (22) 30 (23) 36 (19) 30 (21) 0.5 
- Median (95% CI) 
30  
(26 to 36) 
33  
(20 to 47) 
30  
(10 to 52) 
43  
(25 to 50) 
31  
(26 to 36) 
0.5* 
Barthel Index* <20 n=432 
259 
(84) 
56 
(74) 
16 
(73) 
22 
(85) 
353 
(82) 
p=0.1 
Barthel Index <15 
n=432 
214 
(69) 
45 
(59) 
12 
(55) 
19 
(73) 
290 
(67) 
p=0.2 
Barthel Index <10 
n=432 
174 
(55) 
42 
(57) 
11 
(50) 
14 
(46) 
241 
(56) 
p=0.9 
Barthel Index median 
(95% CI) 
n=432 
7 
(6 to 9) 
7 
(4 to 17) 
10 
(2 to 18) 
9 
(4 to 14) 
7 
(6 to 9) 
 
mRankin scale 0-2 
n=416 
100 
(34) 
30 
(41) 
7 
(33) 
9 
(35) 
146 
(35) 
MRankin scale 3-5 
196 
(66) 
43 
(59) 
14 
(67) 
17 
(35) 
270 
(65) 
p=0.7 
 
* for black / white population comparison but no significant difference in the median between any 
two population groups 
NIH: National Institute of Health; SS: stroke scale 
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(p=0.1) or males and females (p=0.4) in the proportion of people who scored 
below 20 on the BI. However, when we compared black and white stroke patients 
alone, we found a significant difference (p=0.03). White stroke patients were more 
likely than black stroke patients to have retained normal functioning and 
independence i.e. to have a score of 20 on the BI. There was no significant 
difference when we compared the proportion of patients with moderate and severe 
or severe loss of functioning and increasing dependence (scores below 15 and 10 
on the BI) between the four population groups, black and white patients alone 
(p=0.09 and 0.9 respectively), or sexes (p=0.08 and 0.3 respectively).  
 
We were able to assess the modified Rankin score in 416 of 432 patients. This 
figure is lower than the BI assessment probably because it requires a more 
subjective assessment of the patient’s level of independence. As such, we could 
not assess the modified Rankins score retrospectively in patients who had died or 
left the hospital before we examined them. Although a larger proportion of white 
patients (30 of 73 white patients assessed; 41%) were independent than the 
approximately 35% found in other population groups, this difference was not 
statistically significant (p=0.7) (table 5.15). We did not find any statistically 
significant difference when we did a direct comparison between whites and blacks 
(p=0.2) or between males and females (p=0.4).  
 
Thus, using both the Barthel Index, which includes a measure of disability and 
dependence in activities of daily living (Warlow et al., 2001), and the modified 
Rankin score, which does not just measure handicap but rather dependency and 
change in lifestyle (Warlow et al., 2001), we found no statistical difference between 
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patients in the four population groups other than in the proportion of whites and 
blacks with a normal BI. However, there we did find a non-significant increase in 
the proportion of white patients who were fully independent and functional 
compared to other population groups. 
 
5.2.11.3    Other measures of impairment 
We assessed the neurological findings as well as urinary incontinence (Appendix 
D) for the calculation of the Barthel Index, NIHSS and Scandinavian Stroke Scale, 
and to ensure that stroke patients were thoroughly assessed. We did not find a 
significant difference in any of these measures between population groups.  
 
5.2.12   Stroke related complications in the JHSR 
 
Pneumonia was the commonest complication in our stroke patients. It occurred in  
22 patients, 17 black, 2 white, and 2 coloured, although this difference was not 
significant (p=0.5). This was followed in frequency by early post-stroke seizures 
which occurred in 21 patients (19 black, 1 white, and 1 coloured patient) (p=0.3). 
Other complications included: post-stroke depression which occurred in 6 patients 
(1 white, 5 black), painful shoulder syndrome in 5 (3 black, 1 coloured and 1 Indian 
/ Asian), urinary tract infection in 1 black patient, deep venous thrombosis in 1 
white patient, and surprisingly myocardial infarction in 1 black patient in whom the 
myocardial infarction occurred following his admission for stroke. In the latter 
patient it is possible that he embolised to the heart and the brain.  
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Five patients had recurrent strokes while in hospital: 3 black, 1 coloured and 1 
Indian / Asian patient (p=0.1).  
 
Thirty-five patients died in hospital following their stroke: 23 black, 9 white, 1 
coloured and 2 Indian / Asian patients (p=0.2). Twenty males and 15 females died 
(p=0.4).The pathological stroke types in those patients who had a CT brain scan 
prior to death were: ischaemic stroke 14, cerebral haemorrhage 13, and 
subarachanoid 2. The NIH stroke score was ≥ 14 (severe) for 33 of the 35 patients 
who died (p<0.001). In two it was ≤ 5 (mild) on admission. One, a 64-year-old 
white male with a partial anterior circulation infarct died from aspiration, and the 
other a 35-year-old HIV positive black male died of unknown causes. No autopsies 
were done on patients in the JHSR who died, but the following were noted as 
cause of death: 2 metabolic (diabetes and renal failure), 1 aspiration, 1 pulmonary 
embolus, 1 pulmonary infection, 26 irreversible coma following stroke or 
progressive raised intracranial pressure following the stroke, and in 4 the cause of 
death was not known.  
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5.3      Discussion 
 
In this section we will initially summarise the key findings of the JHSR and then go 
on to compare our findings with other stroke registers in South Africa, recent 
stroke registers from the rest of sub-Saharan Africa, and with populations in the 
rest of the world. The latter will focus on comparing our black stroke patients with 
Africans living in the United States of America and in the United Kingdom and on 
briefly comparing the findings in white patients with other typical high-income white 
populations.  
 
5.3.1   Summary of the JHSR findings 
 
The JHSR included 432 first-ever-in-a-lifetime stroke patients admitted to the 
urban Johannesburg Hospital over 23 months. The ethnic profile of patients (71% 
black, 18% white, 5% coloured and 6% Indian / Asian) mirrored the demographic 
profile of South Africa as a whole, although we had twice as many white and 
Indian / Asian patients and about half as many coloured in the register (Lehohla, 
2005). However, this profile closely mirrors the population group mix found in the 
city of Johannesburg. In 2000 the population of Johannesburg consisted of: 72% 
black, 17% white, 7% coloured and 4% Indian / Asian inhabitants (City of 
Johannesburg Local Government, 2001). We found a sex ratio of 1:1.  
 
Although we have compared all four population groups in the results section, the 
small number of patients in both the coloured and Indian / Asian groups makes the 
findings somewhat imprecise. Therefore, we will focus on the findings in the black 
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and white stroke patients and any differences between these two groups in the 
discussion section.  
 
5.3.1.1  Key findings of the JHSR 
 
Characteristics of stroke patients 
 
• We found that the mean age of black stroke patients was 10 years younger 
than the mean for white stroke patients 
• 98% of patients were independent prior to their stroke with no significant 
difference between population groups 
• 13 strokes occurred in hospital 
• The mean time from stroke onset to presentation was long (3 days) with a 
wide range of 1 hour to 120 days, but the median was the same (1 day) for 
both white and black patients as well as the register as a whole 
• 23% of stroke patients presented to hospital within 6 hours of the onset of 
their stroke and the difference between black (22%) and white (27%) 
patients was not significant 
• 287 patients (66%) had a CT brain scan; 58% within 24 hours of 
presentation and 91% within 7 days of presentation to hospital. There was 
no significant difference between population groups or sex in the CT scan 
rate or time to scan 
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Pathological stroke type and ischaemic stroke subtype 
 
• 24% of scanned patients had a cerebral haemorrhage. More black (27%) 
than white patients (15%) had cerebral haemorrhage (p=0.2) 
• Ischaemic stroke occurred in 71% of patients and subarachnoid 
haemorrhage in 6%; again without a significant difference between 
population groups 
• The majority of ischaemic strokes were partial anterior circulation events 
(PACI) (36%), followed by total anterior circulation events (TACI) (25%), 
lacunar infarcts (LACI) (28%) and posterior circulation infarcts (POCI) 
(12%) 
• Black and white stroke patients had almost the same proportion of POCIs 
(12% vs 11%), but black patients had more LACIs (28% vs 22%) and 
TACIs (28% vs 19%) than white patients 
• We found a difference in ischaemic stroke subtypes between men and 
women (p=0.01). Women had more TACIs (31% vs 20%), and men had 
more POCIs (13% vs 4%) 
 
Cause of stroke 
 
• The TOAST classification did not perform well in our population and 36% of 
patients who had undergone brain imaging (43% of black patients) were 
classified as being of “undertermined” cause 
• There was a statistically significant difference in the TOAST categories 
between population groups. Atherothrombosis caused 14% of strokes in 
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white patients, but none of the strokes in black patients. Cardioembolic 
stroke occurred twice as often in white patients, lacunar stroke occurred in 
a similar number of white and black patients, and other determined causes 
of stroke occurred slightly more often in black patients (17% vs 14% of 
whites) 
• Using our ‘most likely cause’ approach in ischaemic strokes: 
o Very few (6%) black stroke patients had atherothrombotic strokes, 
and none of these patients had evidence of extracranial carotid 
artery disease 
o Cardioembolic stroke occurred in about a quarter of strokes in all 
population groups, but the underlying cause for the cardioembolic 
event differed. Atrial fibrillation and ischaemic heart disease 
occurred commonly in white stroke patients. In contrast ischaemic 
heart disease was rare in black stroke patients, but cardiomyopathy 
was common. Dilated cardiomyopathy accounted for about a third 
and hypertensive heart disease for two-thirds of the 
cardiomyopathies in black patients. In black patients atrial fibrillation 
was caused by hypertensive and valvular heart disease and rarely if 
ever by ischaemic heart disease. Rheumatic valvular disease 
accounted for about 10% of all cardioembolic stroke 
o Hypertension and diabetes accounted for 90 - 100% of lacunar 
strokes in all population groups 
• HIV infection was found in 17% of presumed ischaemic strokes and 15% 
of all strokes, although we cannot comment on the mechanism of stroke in 
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most patients. 80% of HIV infected patients were black. HIV infection did 
not result in an increase in any particular stroke subtype 
• None of our patients had a confirmed diagnosis of neurosyphilis, although 
we admit that this may well reflect inadequate investigation for syphilis 
rather than a low prevalence of positive syphilis serology and neurosyphilis 
• Hypertension was the single most important likely cause of cerebral 
haemorrhage (around 80%) in all patients. Amyloid was rare, though again 
this may reflect an inadequate level of investigation for the condition 
•  The majority of subarachnoid haemorrhages were the result of cerebral 
artery aneurysm 
 
Risk factors 
 
• Hypertension was the commonest risk factor in all population groups and 
was found in just under three-quarters of patients. Although black patients 
had a history of hypertension more often than white patients, the difference 
was not significant 
• Cholesterol levels were significantly lower in black patients compared to 
all other groups 
• Twice as many white patients were current cigarette smokers as black 
patients 
• Diabetes mellitus occurred in a similar proportion of black and white 
stroke patients 
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• Peripheral vascular disease occurred about as often in black and white 
stroke patients, but ischaemic heart disease occurred about five times 
more often in white than in black patients 
• Previous TIA was uncommon in all population groups but rare in black 
patients 
• In terms of socioeconomic measures between population groups; whites 
had received more years of schooling, black patients were less likely than 
other groups to live in a house or flat and more likely to live with their 
employer or in a shack 
 
Stroke severity and the impact of stroke on the stroke survivor 
 
• Stroke severity and the resulting impact on patients level of functioning, 
as well as stroke related impairments and complications were 
remarkably similar between population groups 
 
Comparison of population groups 
 
Thus, black stroke patients compared to white stroke patients: were younger, had 
lower cholesterol levels, were less likely to smoke cigarettes, had less 
atherosclerosis in the extracranial carotid and coronary arteries, but were more 
likely to have strokes associated with HIV. While the proportions of pathological 
stroke types and subtypes, and even aetiopathological categories did not differ 
enormously between the two groups other than in atherothrombosis, the 
underlying cause of cardioembolic stroke and other specific causes of stroke did 
 217 
differ. The nature of stroke in whites was dominated by atherosclerotic disease 
and in blacks by hypertension and infectious disease, particularly HIV.  
 
Apart from the differences in the nature of stroke between black and white stroke 
patients, the characteristics of stroke patients including time to presentation, 
severity of stroke and impact on level of functioning, did not differ significantly 
between population groups.  
 
5.3.2    Limitations of the JHSR 
 
There are several limitations of the JHSR which fall into four main categories. 
Firstly the limited number of stroke patients in the coloured and Indian / Asian 
population groups result in wide, but probably insignificant, variations in findings. 
As a result, we are not able to draw conclusions from our findings in these two 
groups with any confidence. We decided against combining these groups or even 
comparing patients in the black population and other population groups because 
we do not know if the nature of stroke is comparable across these groups. 
Therefore, we have limited many of our comparisons to the two larger groups i.e. 
white and black patients.  
 
The second major limitation results from our lack of funding to investigate all 
patients in detail, as well as the limited resources available for all forms of imaging 
at Johannesburg Hospital at the time of the register. The enormous burden on the 
hospital also forces very rapid turnover of patients and many patients are 
discharged early and asked to return for further investigation as outpatients. In our 
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experience this seldom happens in stroke patients. As a result we have a relatively 
low CT scan rate, and the investigation of the cause of strokes was not as detailed 
as we would have liked. This influences our ability to comment accurately on the 
cause of stroke in some patients, particularly those with HIV. It also influences our 
ability to comment on the influence of diseases such as syphilis in our population. 
A further limitation related to resource limitations relates to the register running on 
two occasions between July and December. There is some evidence to support a 
seasonal variation in stroke incidence (Rothwell, Wroe, Slattery et al, 1996; 
Connor, 2002), and ideally studies of stroke, particularly incidence studies, should 
include full years of ascertainment (Sudlow et al., 1996). 
 
Thirdly, the high service load placed on our clinicians meant that we could not 
follow up all stroke patients to the day of discharge. Our in-hospital case fatality 
assessment is therefore likely to be very inaccurate and we do not have 
assessments at the time of discharge.  
 
Finally, the study was hospital-based and took place in a hospital with severe 
pressure on acute medical beds. Hospital-based bias as well as admission bias 
may have influenced the characteristics of stroke patients in the JHSR, although 
the hospital did not have an official stroke admission policy. The younger age of 
both white and black stroke patients may be the result of admission bias, though 
the difference in mean age between the two groups is not. Rather the age 
difference is likely a reflection of a younger black population (demographic 
factors), possibly a higher stroke incidence in young age groups in the black 
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population, and perhaps the impact of HIV infection (these are explored further 
later).  
 
It is extremely difficult to know whether more young white patients tended to seek 
private medical care, therefore avoiding admission to the Johannesburg Hospital. 
Given the surprisingly low age of our white stroke patients compared to white 
populations elsewhere in the world, this is not likely to have been a major source 
of bias. The high proportion of patients who were previously independent may well 
reflect admission bias. It may also reflect a high stroke case fatality rate, but it is 
difficult to know if this is relevant given the lack of stroke case fatality data for the 
population. 
 
Despite these limitations, however, we feel that our case ascertainment was 
excellent over the 23 months, that we assessed patients in detail as often as was 
possible (allowing for those patients who were discharged or died before we could 
see them), and that we have provided useful information comparing stroke across 
a representative population of South Africa in an urban setting, during the HIV era. 
This is the first study in Sub-Saharan Africa to do this. 
  
We will now compare our findings first with other stroke registers from South 
Africa, and then with other populations in the world.  
 
 220 
5.3.3   Comparison of JHSR with other South African stroke registers 
 
Three stroke registers have investigated stroke in South Africa previously 
(Rosman, 1986; Joubert, 1991; Hoffmann, 2001). The Kalafong (Rosman, 1986) 
and Medunsa (Joubert, 1991) studies included predominantly urban and semi-
urban black patients, while the urban-based Durban Stroke Data Bank (DSDB) 
included all population groups (Hoffmann, 2001). Although both the DSDB and our 
JHSR included all population groups and were urban-based, there are a number of 
differences between the JHSR and the DSDB. The DSDB included consecutive 
stroke patients referred to a single neurologist in private practice, although he did 
include some stroke patients seen at the state King Edward Hospital in Durban. 
The DSDB therefore predominantly included higher socioeconomic patients who 
had medical insurance. This influenced the population group profile of the 1000 
patients in the DSDB: 781 (78%) white, 103 (10%) Indian, 100 (10% black – all 
young patients), 14 mixed race / coloured (1%), 1 Asian patient and 1 patient of 
uncertain ethnicity. All patients underwent extensive investigation according to a 
defined protocol. The JHSR on the other hand included indigent patients, better 
reflected the population group profile of South Africa, but did not investigate 
patients to nearly the same extent. It is therefore difficult to compare our findings in 
black patients with those of the DSDB other than for young patients, and the best 
comparison is probably between white and Indian / Asian patients in the two 
studies. Unfortunately, the published data from the DSDB seldom provides 
population specific information for older stroke patients.  
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5.3.3.1   Comparison of black patients in South African stroke registers 
 
Table 5.16 compares the nature of stroke in black patients in the JHSR, with that 
in the Kalafong and Medunsa studies. It is important to note that the original 
publication of the Kalafong study (n=116) did not include all the data used for 
comparison (Rosman, 1986). The complete data set is available in the original 
dissertation and we have used this when necessary for comparison (Rosman, 
1989). There are several publications related to the Medunsa study (Joubert, 
1991) and the number of patients included varies from publication to publication 
(Joubert et al., 1989; Joubert, Lemmer, Fourie et al, 1990; Joubert, Pilloy, Van 
Reenen et al, 1990; Joubert et al., 2000). We have noted when we have compared 
our findings with data from secondary or later publications.  
 
5.3.3.1.1  Comparison of black patients in South African stroke registers – 
age and sex 
 
Our patients were younger than those included in the Medunsa study (table 5.16). 
This may be the play of chance but it is surprising that our study conducted twenty 
years after the Medunsa study in a similar population has found a lower age. If the 
health transition was influencing age, even over this short period, one might 
expect a similar or slightly older mean age. The lower mean age in black patients 
in our study may be the result of an increased prevalence of HIV in our population, 
which is more likely to have an effect on young patients.   
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Table 5.16   Comparison of findings in the black population group in the 
JHSR with previous stroke registers in black stroke patients 
from South Africa (only first-ever-in-a-lifetime strokes 
compared) 
 
 JHSR (n=342) Kalafong (n=116)* Medunsa (n=304) 
Age    
- males (mean years) 51 n/a 55 
- females (mean years) 51 n/a 62 
Sex ratio (M:F) 1:1 1:1 1:1.2 
Employed at time of stroke n (%) 110 (32) 97 (37)* 
Only percentage available 
(29) 
Proportion with 10 or more years of 
schooling (%) 
59 (48) 
(total assessed n=223) 
7 (7) 
(total assessed n=101) 
n/a 
Brain scan rate n (%) 207 (67) 92 (79) 250 (82) 
Pathological stroke type (only CT confirmed cases): 
- Cerebral haemorrhage (%) 55 (27) 38 (33)** 65 (26) 
- Ischaemic stroke (%) 141 (68) 77 (66)** 178 (71) 
- Subarachnoid haemorrhage 
(%) 
11 (5) Excluded from study 7 (3) 
- Unspecified (%) 0 1 (1)** 0 
Ischaemic stroke subtype (all strokes included not only those with brain imaging): 
- Small vessel disease (% 
of all stroke) 
- 86 (20) - 24 (21) - 4 (1) 
- Cardioembolic (% of all 
stroke) 
- 82 (19) - 16 (14)† - 47 (16) 
Cause of cardioembolic stroke (percentage of all stroke): 
Atrial fibrillation: total 15 (4) 14 (7)* 5 (5) ‡ 
- unknown cause 6 n/a 1 
- with ischaemic heart disease 1 n/a 0 
- with rheumatic valvular heart 
disease 
2 n/a 2 
- with dilated cardiomyopathy 0 n/a 0 
- with hypertensive heart 
disease 
6 n/a 1 
- with non-obstructive 
hypertrophic cardiomyopathy 
0 n/a 1 
Ischaemic heart disease 4 (<1) 0 * 7(7)‡ 
Cardiomyopathy: total 27 (6) 5 (2)* 7 (7)‡ 
- dilated cardiomyopathy 10 n/a 3 
- associated with hypertensive 
heart disease 
17 n/a 4 
Rheumatic valvular heart disease 6 (1) 27 (13)* 16 (16)‡ 
Infective endocarditis 0 5 (2) 5 (2) 
Hypertensive heart disease without 
cardiac failure (this is not an 
accepted cause of cardioembolic 
events – see section 5.2.5) 
17 (4) n/a 20 (20) ‡ 
 
* n=212 for complete register findings reported in dissertation (Rosman, 1989) 
**all patients not only patients with CT brain scan  
† embolic causes not separated into cardioembolic and artery to artery emboli; total number of embolic strokes used here  
‡ separate publication of 102 consecutive stroke patients who had more extensive cardiac investigation (see section 
2.3.1.6) (Joubert et al., 1989) n/a: data not available 
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The mean age of the 61 HIV positive black stroke patients in the JHSR was 38 
years (SD 10; 95% CI 35 to 40) compared to the mean age of 54 years (SD 15, 
95% CI 52 to 56) in HIV negative black stroke patients.  
 
All three studies in table 5.16 found a similar proportion of males and females and 
a sex ratio of about one. A similar proportion of patients were employed in the 
three studies (range 29 to 37%), but far more had 10 or more years of education in 
the JHSR (48%) than in the Kalafong study (7%). We cannot exclude the 
possibility that variations in admission bias in the three studies resulted in these 
differences.  
 
5.3.3.1.2  Comparison of black patients in South African stroke registers –      
pathological stroke types and ischaemic stroke subtypes 
 
The scan rate was lower in our study than in the Kalafong or Medunsa studies for 
the reasons we have discussed in section 5.3.2. Despite this limitation the 
proportions of pathological stroke types was remarkably similar in the three studies 
shown in table 5.16. Cerebral haemorrhage occurred in 26% in the Medunsa 
study, 33% in the Kalafong study and 27% in the JHSR. Ischaemic stroke also 
occurred in a very similar proportion of patients (68 to 71%) in the three studies, 
while subarachnoid haemorrhage occurred in 3% in the Medunsa study and 5% in 
the JHSR. Subarachnoid haemorrhage was not assessed in the Kalafong study. 
The high proportion of cerebral haemorrhage in these three studies is typical of 
hospital-based stroke studies in Africa (section 2.4.1.2) and may be the influence 
of the health transition but equally may simply reflect a hospital-based stroke study 
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bias because cerebral haemorrhages are more dramatic in presentation and more 
likely to result in admission than small ischaemic strokes (Bamford et al., 1986; 
Dennis et al., 1994).  
 
We found almost exactly the same proportion of lacunar (small vessel) ischaemic 
strokes as were found in the Kalafong study (table 5.16). This suggests that the 
low frequency of lacunar stroke in the Medunsa study (1%) is likely the result of 
lacunar strokes not being admitted to hospital, or of the different definition of and 
criteria for the diagnosis of lacunar stroke used in the Medunsa study (section 
2.3.1.7).  
 
We found roughly the same proportion of cardioembolic stroke in our study and 
the two previous South African studies in black patients (14 to 19%) (table 5.16). 
The underlying cause of the cardioembolic stroke was also similar in the three 
studes. Atrial fibrillation accounted for 4% of strokes in the JHSR and 5 to 7% of 
strokes in the other two studies. It was only associated with ischaemic heart 
disease (IHD) in one patient in the JHSR and not associated with IHD in the other 
two studies. As in the Medunsa study, atrial fibrillation in the remainder of patients 
with a known cause was caused by rheumatic valvular heart disease and 
hypertensive heart disease.  
 
Ischaemic heart disease was found in 7 (7) of 102 patients investigated in detail 
for a cardiac cause in the Medunsa study (Joubert et al., 1989), in 4 (<1%) of 342 
black patients in the JHSR and in none of the patients in the Kalafong study. The 
patients in the Medunsa study were diagnosed with ischaemic heart disease on 
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the basis of ECG evidence of old myocardial infarction in 4 patients, 
echocardiogram (hypokinetic segment) changes alone in 2 and in the final patient 
solely on the basis of ischaemic T wave changes on the ECG. None of the 
patients had symptoms of IHD. We diagnosed IHD in our four patients based on 
ECG changes of previous myocardial infarction in two patients, one of whom gave 
a history of supportive symptoms, and acute ischaemic changes on history and 
ECG in two patients. Thus, the slightly lower frequency in our series compared to 
the Medunsa study may be the result of less intensive cardiac investigation in the 
JHSR or our requirement of definite ECG changes or clear symptoms with 
supportive evidence on ECG for diagnosing IHD, or both.   
 
Cardiomyopathy (both dilated and secondary to hypertensive heart disease with 
myopathic ventricles i.e. secondary systolic failure) was present in similar 
proportions in our study (6%) and the Medunsa study (7%), and in a somewhat 
smaller proportion (2%) in the Kalafong study. We found much less rheumatic 
valvular heart disease than the other two studies though. In the Kalafong study 
rheumatic valvular heart disease occurred in 13% of stroke patients and in the 
Medunsa study it occurred in 16%. In the JHSR we only found it in 6 patients (1%). 
This may reflect the anecdotal decrease in the prevalence of rheumatic fever in 
the urban South African black population (Essop et al., 2005) but we cannot be 
sure of this without community-based evidence of a decreasing prevalence of the 
disease.  
 
We did not find any cases of infective endocarditis in black stroke patients in the 
JHSR, although we did find three cases in other population groups (table 5.8). 
 226 
While this too may reflect a decline in rheumatic heart disease the number of 
patients with infective endocarditis in both the Kalafong and Medunsa study is so 
small that it may simply be the play of chance that we did not find any patients.  
 
Hypertensive heart disease although listed in table 5.16 is not an accepted source 
of cardiac emboli, particularly in the absence of heart failure. We will discuss this 
further in section 5.3.4.  
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5.3.3.1.3  Comparison of black patients in South African stroke registers – 
risk factors 
 
We found hypertension (70%) in a similar proportion to that found in the Kalafong 
study (74%), but in substantially more than in the Medunsa study (42%) (table 
5.17). It is not clear how hypertension was defined in the Medunsa study, but our 
definition (section 5.1.2.1) was similar to that used in the Kalafong study in which 
the diagnosis of hypertension was based on previous treatment for hypertension 
or confirmation in the hospital records of hypertension, or on the basis of end-
organ hypertensive damage. However, the limits of blood pressure differed 
between our study and the Kalafong study. We diagnosed hypertension if the 
systolic blood pressure was greater than or equal to 140 mmHg, or a diastolic 
blood pressure of greater than or equal to 90 mmHg, whereas the respective 
figures used in the Kalafong study were 160 mmHg and 95 mmHg. The lower 
prevalence in the Medunsa study may reflect a lower frequency of hypertension in 
their stroke patients or different criteria for the diagnosis. As the Kalafong study 
was performed at a similar time and in a population very close geographically to 
the Medunsa population, the latter is more likely.  
 
The mean cholesterol level in the JHSR and Kalafong study were remarkably 
similar and the 0.2 mmol/L difference between the two means is unlikely to 
represent a real difference between the two populations. Mean cholesterol levels 
were lower in the 14 HIV positive black patients for whom we had cholesterol 
levels: 3.7 mmol/L (SD 1; 95% CI 3.2 to 4.3) compared to the 4.7 mmol/L (SD 1, 
95% CI 4.1 to 5.2) in the 20 HIV negative black patients for whom we had 
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Table 5.17  Comparison of risk factors in the black population group in the 
JHSR with previous stroke registers of black stroke patients 
from South Africa (only first-ever-in-a-lifetime strokes 
compared) 
 
 JHSR (n=342) Kalafong (n=116)* Medunsa (n=304) 
Risk factors: 
Hypertension (%) 214 of 291 assessed (74) ** (70) ** (42) 
Cholesterol (mean) mmol/L 
n=113 
mean=4.6 
n=128 
mean 4.8 
n/a 
Diabetes (%) 
42 of 264 assessed 
(16) 
22 of 211 assessed 
(10) 
n/a 
Current cigarette smokers (%) 
57 of 245 
(23) 
32 of 115 
(28) 
** (28) 
Current alcohol use (%) 63 of 237 (27) 43 of 119 (36) n/a 
Peripheral vascular disease (%) 
9 of 303 
(3) 
n=n/a (15) 3 (1) 
Previous TIA (%) 
4 of 303 
(1) 
n=n/a 
(7) 
5 of 267 
(2) 
Other: 
HIV (%) 61 of 148 (41) Not tested Not tested 
Syphilis – positive serology only (%) 9 of 59 (15) 41 of 147 (28) n/a 
 
* n=212 for complete register findings reported in dissertation (Rosman, 1989) 
** only percentage available 
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cholesterol levels. However, this difference may be the result of other factors such 
as the younger mean age of HIV positive patients.  
 
Diabetes mellitus was slightly more common in the JHSR than in the Kalafong 
study. Our definitions were similar. We diagnosed diabetes if the patient had a 
prior diagnosis or was on treatment for diabetes but differed in the requirements 
for blood glucose levels. The definition of diabetes in the Kalafong study required a 
fasting glucose of greater than 7.8 mmol/L, or a two-hour value of greater than or 
equal to 11.1 mmol/L following a glucose tolerance test. We required a random 
blood glucose of over 11.1 mmol/L or a fasting blood glucose of greater than or 
equal to 7.0 mol/L. This may account for our increased frequency of diabetes 
mellitus, but we cannot exclude the possibility that the prevalence of diabetes 
mellitus is increasing in South Africa in the black population, as it is elsewhere in 
sub-Saharan Africa (Unwin, Setel, Rashid et al, 2001; Aspray & Unwin, 2001; 
Walker et al., 2002).  
 
Cigarette smoking was slightly less frequent in our patients (23%) compared to the 
Kalafong patients (28%). The difference is small but it may reflect the decreasing 
prevalence of cigarette smoking in adults that has occurred in South Africa 
following tighter government legislation against cigarette advertising and smoking 
in public places and associated increased cigarette prices (van Walbeek, 2002). 
Current use of alcohol was also lower in our patients (27%) than in the Kalafong 
patients (36%). However, the current use of alcohol in our black patients in the 
JHSR was similar to the prevalence of current alcohol use in South Africa found in 
1998 in the Demographic and Health Survey (DHSA). The prevalence of current 
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alcohol use in urban black males in the DHSA was 44% and in urban black 
females it was 13% (Parry, Pluddemann, Steyn et al, 2005). The frequency of 
current alcohol use in JHSR black males was 41% and in black females it was 
significantly lower at 12% (p<0.001).  
 
Peripheral vascular disease (PVD) was far more common (15%) in the Kalafong 
study than in our study (3%) or the Medunsa study (1%) (table 5.17). The 
diagnosis of peripheral vascular disease in the Kalafong study included 
‘diminished’ as well as absent pulses in the dorsalis pedis or femoral pulses 
(Rosman, 1989). Our definition was different and required a history of intermittent 
calf claudication, both foot pulses absent or the presence of femoral bruits. This 
may explain the discrepancy between the two studies. The definition of PVD in the 
Medunsa study is not clear (Joubert, 1991).  
 
A history of previous transient ischaemic attack (TIA) was present in 1% of our 
black stroke patients, in a similar 2% of the Medunsa study patients and in slightly 
more (7%) of the Kalafong patients. This difference may be related to the accuracy 
of our histories of previous TIA compared to those in the Kalafong study or to the 
interpretation of symptoms, or may simply be the play of chance as the numbers 
are small in all three studies compared in table 5.17. 
 
As discussed in section 5.2.8.1 socioeconomic status is difficult to assess in South 
Africa and we used a few surrogate measures (table 5.16) in an attempt to assess 
and compare socioeconomic status between population groups. We certainly 
cannot readily compare our findings with any study done outside South Africa. 
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However, we can compare the same measures with other South African studies. 
The Kalafong study assessed employment and level of education (Rosman, 1989). 
One hundred and fifteen (63%) of the 212 patients were not economically active 
compared to 103 (48%) of the 213 black stroke patients assessed in the JHSR. 
Unfortunately we cannot compare the proportion of patients who were unemployed 
and actively looking for work (17% in the JHSR) with those who were unemployed 
by choice e.g. students, unemployed partners living at home, between the two 
studies because these data are not available for the Kalafong study. Ninety-one 
(90%) of 101 patients received 8 or less years of schooling in Kalafong. In the 
JHSR the median years at school was 8 years. Based on these measures it would 
appear as though our stroke patients are better off than those in the Kalafong 
study. This may represent an element of economic improvement since the end of 
the apartheid regime, but it may also reflect a difference in case mix, or in the case 
of unemployment a difference in the definitions used. We cannot compare the 
mean age of our patients with the Kalafong study, as the data are not available for 
the latter. Perhaps our black stroke patients were younger, possibly the result of 
HIV infection (section 5.2.6.4) and so more likely to be employed. However, this 
does not explain the higher proportion of patients that had more than 8 years of 
schooling in our study. This may be geographically determined i.e. people in the 
greater Johannesburg area are more likely to have received more schooling than 
in areas away from the main economic centre of the country.  
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5.3.3.1.4  Comparison of black patients in South African stroke registers – 
HIV and syphilis 
 
Human immunodeficiency virus was far less of a problem in the mid-1980s in 
South Africa than it was by the late 1990s. Indeed in sexually transmitted disease 
clinics in Johannesburg in 1988, HIV seropositivity was found in less than 2% of 
males and females (Martin, Schoub, Padayachee et al, 1990). So, it is not 
surprising that the Kalafong and Medunsa studies did not include any assessment 
of their patients’ HIV status. Thus, we cannot compare our findings with other 
South African stroke studies that included black patients of all ages.  
 
The Durban Stroke Data Bank (DSDB) assessed HIV status in young (less than 50 
years of age) black patients.  They found 20 of 100 (20%) young black stroke 
patients to be HIV positive, however the prevalence of HIV infection in pregnant 
black females at the time was 31%. They therefore considered their prevalence of 
HIV positive stroke patients to reflect the background population prevalence. We 
found HIV infection in 49 of 94 tested young black patients (52%) a frequency 
much higher than the prevalence of HIV infection in young people in Gauteng 
Province around that time. The prevalence of HIV infection in women attending 
antenatal clinics in Gauteng Province in 1996 was 16% (Swanevelder, Kustner, & 
van Middelkoop, 1998). This rapidly rose to around 30% by 2001 with the highest 
prevalence found in the 25 to 29 year old age group of women attending antenatal 
clinics, who had a prevalence of 31% (95% CI, 30 -33%) (Directorate: Health 
Systems Research, 2001). Even if we had found that all the young black stroke 
patients who were not tested for HIV were negative, the proportion of HIV infected 
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patients would still have been higher than the population prevalence (49 of 139; 
35%).  This possibly supports recent studies that suggest that HIV infection is an 
independent risk factor for stroke (Cole et al., 2004; Patel et al., 2005).  
 
5.3.3.2   Comparison of white patients in South African stroke series 
 
The Durban Stroke Data Bank (DSDB) is the only stroke register that prospectively 
assessed consecutive white patients admitted to a hospital in South Africa 
(Hoffmann, 1998). The DSDB included 781 (78% of 1000 patients) with a mean 
age of 61 years (SD 14). The mean age of the 76 white patients in the JHSR was 
the same as that in the DSDB (JHSR: 61 years SD 15). This is surprisingly low 
compared to studies in white patients from western (usually high-income) 
populations (Rothwell et al., 2004) and probably reflects admission and referral 
bias. Unfortunately neither the publications related to the DSDB (Hoffmann, 2000; 
Hoffmann et al., 2000a; Hoffmann, 2001), nor the dissertation associated 
(Hoffmann, 1998) with the DSDB, provide data that are comparable with the JHSR 
by population group, with the exception of  the findings in young stroke patients 
(Hoffmann, 2000). We only included 15 white patients under the age of 50 years in 
the JHSR, so direct comparison with the 260 young white patients in the DSDB is 
not likely to be accurate or informative.  
 
Other series of stroke patients have included selected patient populations referred 
to the Johannesburg Hospital TIA Clinic and have dealt with important 
management problems such as the role of carotid endarterectomy, rather than 
defining the nature of stroke patients in detail (Levien, Fritz, & Lithgow-Jolly, 1984; 
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Fritz, Voll, & Levien, 1985; Fritz & Levien, 1988). Others have studied patients with 
transient ischaemic attack, an exclusion criteria for entry into the JHSR 
(Giovannoni & Fritz, 1993). One study from the Johannesburg Hospital TIA Clinic 
compared the proportions of TIA and minor stroke patients who had diabetes 
mellitus as a risk factor (Fritz, Bilchik, & Levien, 1987). In this study 28 (20%) of 
the 137 patients with minor stroke referred to the clinic had diabetes mellitus. This 
was higher than the 11 (16%) of 69 white patients in the JHSR, but this difference 
may be explained by the referral pattern to the clinic or, given the small numbers in 
the JHSR, by the play of chance.  
 
5.3.4    Hypertensive heart disease and stroke in the JHSR 
 
We diagnosed hypertensive heart disease without any clinical or echocardiogram 
evidence of heart failure in 17 patients (4% of all stroke patients) on the basis of 
isolated left ventricular hypertrophy on echocardiogram, although 2 patients had 
diastolic dysfunction without systolic dysfunction. Three patients had cerebral 
haemorrhages. In two of these, both black patients, the cerebral haemorrhage was 
the result of hypertension, but in the third, a coloured patient, we considered 
amyloid angiopathy more likely.  
 
Fourteen patients with ischaemic stroke had hypertensive heart disease, 9 black, 3 
white, 1 coloured and 1 Indian / Asian patient. We considered the cause of the 
stroke in these patients to be: lacunar on the basis of hypertension in 6, 
cardioembolic in 2 (1 with atrial fibrillation and the other who was described in 
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section 5.2.5.2 had an ‘unknown’ cardiac source), atherosclerotic in 4, arterial 
dissection in 1 and complicated migraine in 1.  
 
Hypertensive heart disease (HTHD) is the term given to the structural and 
resulting functional damage which occurs in the heart secondary to prolonged 
hypertension. A full discussion of HTHD is beyond the scope of this work, but the 
role of HTHD in stroke is worth consideration. HTHD may be associated with 
systolic or diastolic dysfunction, concomitant or related ischaemic heart disease, 
increased arrhythmias, sudden death and in extreme cases overt heart failure (Lip 
et al., 2000; Ramakrishnan, Kothari, & Bahl, 2003), which in some cases results 
from an end-stage dilated cardiomyopathy (Iriarte, Olea, Sagastagoitia et al, 
1995).  
 
HTHD has been associated with increased stroke risk for all stroke (ischaemic and 
cerebral haemorrhage) (Verdecchia, Porcellati, Reboldi et al, 2001) but particularly 
ischaemic stroke in case control studies (Di Tullio, Zwas, Sacco et al, 2003). It is 
not at all clear whether this is simply because of an association with hypertension 
and other risk factors, or whether HTHD itself predisposes to cardioembolic stroke. 
The latter is possible if there is associated atrial fibrillation as there was in seven of 
our patients, or if the patient develops systolic failure and particularly a dilated 
cardiomyopathy with left ventricular mural thrombus. We included seventeen 
(black) patients with evidence of left ventricular hypertrophy in our cardioembolic 
stroke group because they had echocardiographic evidence of systolic heart 
failure as well as symptoms of heart failure. We accept this is controversial as 
hypertrophic cardiomyopathy is seldom if ever associated with embolic events 
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(Warlow et al., 2001), but we feel that cardioembolic events are more likely in the 
presence of systolic heart failure. HTHD is particularly common in black stroke 
patients (table 5.8) and the mechanism for cardioembolic stroke (if there is one) 
requires further study.  
 
5.3.5  Comparison of stroke in black and white patients in the JHSR with 
other studies from Sub-Saharan Africa and the rest of the world 
 
We have compared the black and white population groups in the JHSR with stroke 
patients in prospective stroke registers of consecutive stroke admissions to 
hospital from other regions in Sub-Saharan Africa (Zimbabwe and 
Gambia)(Matenga et al., 1986). The Zimbabwean study used brain imaging, but 
the two studies from the Gambia did not have access to brain scanning. We also 
compared our findings to those in African-Americans in the Northern Manhattan 
Stroke Study (NMSS) (Sacco et al., 1998) or where comparisons were not 
possible with the NMSS then with the Greater Cincinnati / Northern Kentucky 
Stroke Study (GCNKSS) (Broderick et al., 1998). Finally we compared our findings 
to those from two community-based studies in Oxfordshire, United Kingdom, the 
recent OXVASC study (Rothwell et al., 2004), and when we had insufficient data 
for comparison from this study, from the earlier Oxfordshire Community Stroke 
Project (OCSP) (Bamford et al., 1991).  
 
5.3.5.1   Comparison of pathological stroke type and ischaemic stroke    
subtype 
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Table 5.18 compares the pathological stroke types and ischaemic stroke subtypes 
in black and white patients from the JHSR, who had had brain imaging, in patients 
from Zimbabwe, the Gambia, African-American patients and community-based 
stroke patients from the United Kingdom.   
 
Although there are two stroke studies from the Royal Victoria Hospital in the 
Gambia (Walker et al., 2003; Garbusinski, van der Sande, Bartholome et al, 2005), 
we have only used one (Garbusinski et al., 2005) for comparison in table 5.18, as 
the other (Walker et al., 2003) did not distinguish between pathological stroke 
types. Pathological stroke type in JHSR black patients was very similar to that 
found in Zimbabwe in a sub-study of 93 patients, all of whom had had CT brain 
scans (Matenga et al., 1986). This is in keeping with the similar proportions of 
pathological stroke types found in other South African stroke registers (table 5.16). 
Cerebral haemorrhage was far more frequent in the study from the Gambia 
(Garbusinski et al., 2005). However, this study did not have brain imaging 
available and used the Siriraj Stroke Score to assess pathological stroke type. 
This score has not been validated for use in Sub-Saharan Africa and it is possible 
that it overestimated cerebral haemorrhage (see chapter 6 for further discussion 
on the Siriraj Stroke Score).  
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Table 5.18  Comparison of pathological stroke type and ischaemic stroke subtype found in black and white patients in the JHSR, 
with African-American stroke patients in the NMSS and with the community-based OXVASC / OCSP studies 
(all figures are number of participants with percentages in brackets)  
 
 
OXVASC - Oxford Vascular Study ; NMSS – Northern Manhattan Stroke Study 
* only CT brain scan confirmed cases included for pathological stroke type 
** Data for the NMSS are only for African-Americans. The NMSS did not classify stroke cases using the OCSP classification and only lacunar strokes overlap the with the classification used. 
† Siriraj score used to diagnose pathological stroke type into cerebral haemorrhage, ischaemic stroke or undetermined 
 
JHSR – black stroke 
patients* 
n=207 
Zimbabwe* 
n=93 
(Matenga, 1986) 
Gambia† 
n=138 
(Garbusinski, 2005) 
NMSS** (1993 - 1996)  
(n=148) 
(Sacco, 1998) 
JHSR – white stroke 
patients* 
n=47 
OXVASC (n=262 ) 
(Rothwell, 2004) 
Pathological stroke type: 
       
Cerebral haemorrhage 55 (27) 29 (31) 63 (46) 21 (15) 7 (15) 17 (7 ) 
Ischaemic stroke 141 (68) 62 (67) 42 (30) 120 (81) 36 (77) 223 (85) 
Subarachnoid haemorrhage 11 (3) 2 (2) Not assessed 6 (4) 4 (9) 16 (6) 
Unsure 0 0 17 (24) 0 (0) 0 6 (2) 
       
 
JHSR n=235 
(clinical assessment 
of ischaemic stroke) 
Zimbabwe* 
n=93 
Gambia† 
n=105 (all 
pathological stroke 
types) 
NMSS* (1993 - 1997) 
n=155 
(White, et al, 2005) 
JHSR n=65 
(clinical assessment 
of ischaemic stroke) 
OCSP
 
n=543 
(Bamford, 1991) 
OCSP classification of ischaemic 
stroke subtype:   
       
Total anterior circulation syndrome 62 (26) n/a 46 (35) - 16 (25) 92 (17) 
Partial anterior circulation syndrome 84 (36) n/a 35 (27) - 23 (35) 185 (34) 
Lacunar syndrome 71 (30) n/a 18 (14) 33 (21) 18 (28) 137 (25) 
Posterior circulation syndrome 18 (8) n/a 6 (5) - 8 (12) 129 (24) 
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Our white JHSR patients had more than double the number of cerebral 
haemorrhages compared to patients in the OXVASC study from the UK (Rothwell 
et al., 2004). This may well be the influence of hospital bias resulting in more 
patients with cerebral haemorrhage and fewer with mild ischaemic stroke admitted 
to hospital. Interestingly, African-Americans had a pathological stroke type profile 
very similar to the white patients in the JHSR. Although the NMSS attempted to 
include community-based strokes it is not considered a truly community-based 
stroke study (Feigin et al., 2003b). The higher frequency of cerebral haemorrhage 
in our white stroke patients compared to that in the OXVASC study may reflect a 
slight hospital-based bias, when compared to the OXVASC study that was truly 
community-based. However, if one considers that the percentage of cerebral 
haemorrhage in our black patients was almost double that found in NMSS, then 
perhaps the NMSS findings support the view that African-Americans represent a 
population that has progressed through the health transition (Gillum, 1996a) 
(section 1.6 and table 1.1). In contrast black South African and Zimbabwean 
stroke patients are at a point much earlier in the transition. It is probably unwise to 
interpret the high proportion of cerebral haemorrhage in the Gambian stroke 
patients as a sign of them being at an even earlier stage of the transition, because 
of the potential for overestimation of cerebral haemorrhage in that study.  
 
Only four of the studies in table 5.18 used the OCSP classification. It is a clinical 
classification and so less likely to be influenced by the lack of brain imaging in the 
Gambia, although the inclusion of some cerebral haemorrhages in the patient 
group assessed may have caused an increase in the number of total and partial 
anterior circulation events and a decrease in milder lacunar strokes. There were 
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more total anterior circulation infarcts in the Gambia study than in any other study, 
and the smallest number of lacunar infarcts. This suggests that this study included 
more severe strokes and fewer mild ischaemic strokes. An even larger proportion 
of total anterior circulation syndrome strokes (51%) were found in another study of 
106 patients from the Gambia undertaken 10 years previously (Walker et al., 
2003). 
 
In a similar vein, there were far more total anterior circulation infarcts in the JHSR 
white patients compared to the OCSP patients, likely at least in part the result of 
hospital-based study bias. The proportion of partial anterior circulation infarcts and 
lacunar infarcts were very similar between the two groups, but the proportion of 
posterior circulation events (POCIs) in the JHSR patients was about half that in the 
OXVASC patients. This may reflect a true difference in proportions of POCIs in the 
community, a difference in likelihood of diagnosing POCIs i.e. a different 
diagnostic approach, or perhaps there was some reason why POCIs, which 
sometimes have unusual presentations, did not present to Johannesburg Hospital. 
However, even in the group of patients with CT brain scan confirmed infarction, 
there were only 4 POCIs (11%) in the white population group and 24 (12%) if we 
included all population groups. 
 
Interestingly, the white and black JHSR patients compared most closely with one 
another rather than any other study population. However, as discussed in section 
5.2.5.2., the underlying causes for the clinical subtypes differed. Hypertension was 
more frequent in JHSR black patients, yet lacunar stroke was only slightly more 
common in black than in white patients. Of course it has recently been shown that 
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hypertension is equally associated with lacunar stroke and other ischaemic stroke 
subtypes (Landau & Nassief, 2005; Jackson & Sudlow, 2005b), and previous 
studies using risk factor based classifications have probably overestimated the 
association of hypertension (and diabetes mellitus) and lacunar infarction.  
 
5.3.5.2   Comparison of TOAST classification subtypes 
 
Both the NMSS and GCNKSS classified ischaemic according to the TOAST 
classification, but only the GCNKSS has provided the number of patients in each 
category. In 362 ischaemic strokes in black patients in the GCNKSS, 
cardioembolic stroke occurred in 54 (15%), a similar finding to the 21 of 141 (15%) 
black patients in the JHSR. In white patients in the GCNKSS, cardioembolic stroke 
occurred in 344 of 1594 (22%) ischaemic stroke patients. Our white patients also 
had a larger proportion (11 of 36; 31%) than our black patients (21 of 141; 15%), 
although the numbers were so small that this finding may be inaccurate. The 
similarity in proportion of cardioembolic stroke in JHSR black patients and those in 
the GCNKSS is striking. However, the underlying cause of the cardiac embolus 
may differ as it did between our white and black patients. We do not have 
sufficient data from the GCNKSS to assess this possibility.  
 
Small vessel disease occurred in 64 (18%) black patients in the GCNKSS and in 
25 (18%) of our black patients. Again there is a clear similarity, given the need for 
brain imaging and the strict criteria for the TOAST classification. In JHSR white 
patients small vessel disease accounted for 6 (17%) stroke patients, and in the 
GCNKSS for 244 (15%), again a fairly similar finding. One possible explanation for 
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this similarity across all four groups is that small vessel disease is equally common 
in all groups despite the very high levels of hypertension in JHSR black patients. 
Of course, we could classify fewer than half our patients using the TOAST 
classification and it is likely that the OCSP classification which shows a high 
proportion of lacunar infarcts, is more accurate.  
 
Large-vessel atherosclerotic disease occurred in a similar proportion of white 
patients in the two studies: 194 (12%) in the GCNKSS and 5 (14%) in the JHSR. 
However, the findings in black patients were quite different: 37 (10%) in the 
GCNKSS, and nil in the JHSR. This may again reflect a difference in stage of the 
health transition between South African black stroke patients and African-
American stroke patients, with more atherosclerotic disease in the African-
American patients as shown in autopsy studies previously (compare section 
2.3.3).  
 
Other identified causes of stroke were found in 11 (3%) blacks and 37 (2%) whites 
in the GCNKSS, and in 24 (17%) blacks and 5 (14%) whites in the JHSR. The 
much higher proportion of other causes in the JHSR may reflect the younger 
population in our study compared to both whites and blacks in the GCNKSS. The 
mean age of black patients in the JHSR was 51 years (SD 16) and of white 
patients 61 years (SD 15), compared to blacks in the GCNKSS who had a mean 
age of 68 years (SD 15) and whites who had a mean age of 73 years (SD 14).  
 
We had enormous difficulty in classifying a large proportion of patients using the 
TOAST classification: 61 (43%) black patients and 6 (17%) white patients. Yet it 
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appears as though this is a common problem. In the GCNKSS 196 (54%) black 
and 775 (49%) white patients were unclassified. The proportion of undetermined 
strokes in our series would increase if we included the 130 patients who did not 
have a CT brain scan to 162 (53%) blacks and 35 (46%) whites. However, the 
imaging rate for the GCNKSS is likely to be 100% (not stated in the manuscript) 
(Schneider et al., 2004) and so the large proportion of undetermined cause in all 
groups represents a shortcoming of the TOAST classification which has been 
noted previously (Warlow et al., 2001). 
 
In summary, there was great similarity in the proportion of cardioembolic and small 
vessel strokes between the JHSR black population and the GCNKSS black 
population using the TOAST classification, although the underlying mechanism of 
cardiac embolism may differ. However, the JHSR black patients had no large 
vessel atherosclerotic strokes and more ‘other determined’ causes, reflecting a 
younger population in earlier transition than the African-American population. The 
JHSR white patients had a similar proportion of large-vessel atherosclerotic and 
small vessel strokes to the GCNKSS white patients, more cardioembolic and other 
determined causes. The latter likely reflects the 12 year difference in mean age 
between the two populations.  
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5.3.5.3    Comparison of risk factors 
 
Table 5.19 compares various accepted risk factors for stroke as well as the 
frequency of HIV and syphilis infection found in the JHSR black and white 
population groups, with findings from stroke registers in Zimbabwe (Matenga et al., 
1986), Gambia (Garbusinski et al., 2005), the United States of America (African-
American patients only) (Kissela, Broderick, Woo et al, 2001), the United Kingdom 
(patients of African descent only) (Lawrence, Coshall, Dundas et al, 2001) and the 
mostly white OXVASC study (Rothwell et al., 2004). All studies prospectively 
included first-ever-in-a-lifetime strokes and brain imaging except the study from 
the Gambia in which 12% of patients had recurrent stroke and none had brain 
imaging (Garbusinski et al., 2005). Other recent stroke studies from Sub-Saharan 
Africa were excluded because they ascertained stroke cases retrospectively 
(Zabsonre, Yameogo, Millogo et al, 1997; Talabi, 2003; Ogunrin, Unuigbe, Eregie 
et al, 2004; Osalusi, Ogun, Ojini et al, 2004; Ogun, Ojini, Ogungbo et al, 2005; 
Zenebe, Alemayehu, & Asmera, 2005a). Where appropriate we have included the 
prevalence of risk factors in the general South African population from the 
Demographic and Health Survey (Medical Research Council, 1998).  
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Table 5.19   Comparison of the risk factors found in black and white patients in the JHSR, with African-American stroke patients in 
the GCNKSS and with the community-based OXVASC study (all figures refer to the number of participants and 
percentages of the total number assessed for that risk factor group are shown in brackets)  
 
JHSR – Johannesburg Hospital Stroke Register; OXVASC - Oxford Vascular Study ; GCNKSS – Greater Cincinnati / Northern Kentucky Stroke Study; SLSR – South London 
Stroke Register;  *  n will vary for each risk factor in study; ** not all first-ever-in-a-lifetime strokes – 18 (12)% recurrent stroke; † See text for definition of hypertension in each 
study; n/a not available 
 
 
 
 
JHSR – Black 
stroke patients 
n=308* 
Zimbabwe 
n=93 
(Matenga, 1986) 
Gambia** 
n=148 
(Garbusinski, 
2005) 
GCNKSS  (n=705) 
(Kissela, 2004) 
SLSR - 
Black stroke patients 
n=204 
(Lawrence, 2001) 
JHSR – White 
stroke patients 
n=76* 
OXVASC (n=262 ) 
(Rothwell, 2004) 
Risk factor: 
       
Age – mean (SD) 51 (16) 52 (n/a) n/a n/a 63 (15) 61 (15) 74 (12) 
Sex ratio (M:F) 1:1 1:1.7 1:1 n/a 1:1.2 1:1 1:1 
Hypertension (%)† 214 (74) 49 (53) 71 (65) 456 (65) 134 (66) 50 (69) 118 (46) 
Cholesterol – mean (95% CI) mmol/L 4.6 (4.2 to 5.0) n/a n/a n/a n/a 5.4 (4.9 to 5.8) 5.4 (5.3 to 5.5) 
Diabetes mellitus (%) 42 (16) (3) 7 (5) 212 (30) 60 (29) 11 (16) 25 (10) 
Atrial fibrillation (%) 10 (3) n/a 6 (4) 51 (7) n/a 7 (10) 44 (17) 
Current cigarette smoking (%) 57 (23) (14) n/a 195 (28) 47 (23) 34 (54) 47 (18) 
Peripheral vascular disease 9 (3) n/a n/a n/a n/a 4 (5) 22 (9) 
Previous myocardial infarction 0 n/a n/a n/a n/a 3 (4) 33 (13) 
Previous TIA 4 (1) n/a n/a n/a n/a 4 (7) 41 (16) 
Other:        
HIV seropositive (%) 61 of 148 (41) n/a n/a n/a n/a 2 of 12 (17%) n/a 
Syphilis serology positive (%) 9 of 59 (15) 10 of 62 (16) n/a n/a n/a 0 of 9 (0%) n/a 
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Black patients in the JHSR were young with a mean age of 51 years, similar to the 
mean age of 52 years found in the Zimbabwean study (table 5.19), but much 
younger (median age 51 years) than stroke patients in the Gambia (median age 
64 years). In the South of London study, the mean age of black patients was 
closer to the mean of 61 years in our JHSR white patients than to our black 
patients. Patients in the community-based OXVASC study were noticeably older 
than any hospital-based population. This may reflect an older population, but may 
also at least in part reflect the possibility that institutionalised elderly patients or 
elderly patients with good home care are not readily admitted to hospital (Sudlow 
et al., 1996).  
 
The sex ratio of males to females was about 1 in the JHSR for both population 
groups compared in table 5.19 and for the study population as a whole. It was also 
1 in the Gambia and OXVASC but there were slightly more females in the 
Zimbabwean and South London studies. Without community-based studies in the 
latter two areas, it is difficult to comment on whether this reflects case mix or a true 
increase of females with stroke in the population. 
 
Hypertension was found most often in our black stroke population (74%), closely 
followed by our white population (69%). African-Americans (65%), Africans living 
in London (66%), and Africans from the Gambia also had a high frequency of 
hypertension. We defined hypertension as the current use of antihypertensive 
medication, a history of having been diagnosed as hypertensive by a doctor or 
nurse prior to the stroke, a documented blood pressure of greater than or equal to 
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140 mmHg systolic or 90 mmHg diastolic prior to the stroke or more than one 
week following the stroke, or evidence of hypertensive heart disease on ECG or 
echocardiography. In the Greater Cincinnati / Northern Kentucky Stroke Study 
(GCNKSS) hypertension was diagnosed on review of the patient’s medical notes 
but the exact definition used is not clear. The definition is also not clear from the 
South London study. In the Gambia hypertension was diagnosed if patients were 
on treatment for hypertension on admission, or if their blood pressure was >140 
mmHg systolic and / or > 90 mmHg diastolic twice, more than one week after the 
stroke onset. It is possible that we were more likely to diagnose hypertension than 
investigators in the other three studies, though the difference in definition 
particularly in the Gambian study must only have accounted for a small proportion 
of patients.  
 
Hypertension was least common in stroke patients in the OXVASC study (46%) 
when we defined it as a blood pressure of ≥ 150 mmHg systolic or ≥ 85mmHg 
diastolic using the data provided. Blood pressures were the most recent blood 
pressure reading prior to stroke taken from the general practitioner’s notes 
(Rothwell et al., 2004). Again, differences in the definition of hypertension may 
account for some but not all of the inter-study differences in the proportion of 
patients with hypertension. It is likely that hypertension is more common in our 
stroke population than in others compared in table 5.19. 
 
Cholesterol levels were only available for stroke patients in the JHSR and the 
OXVASC study in table 5.19. The mean cholesterol levels of JHSR whites and the 
OXVASC population were the same (5.4 mmol/L) and much higher than the mean 
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level (4.6 mmol/L) found in black stroke patients. In the THUSA study from the 
North-Western province of South Africa, cholesterol levels were measured in a 
community sample of 1854 people over the age of 15 years. Mean total 
cholesterol in black South Africans living in an urban area were found to be 4.0 
mmol/L (95% CI, 4.5 to 5.0) in 171 HIV negative individuals and 3.85 mmol/L (95% 
CI 3.6 to 4.0) in 50 HIV positive individuals (Oosthuizen, Vorster, Kruger et al, 
2002). When we analysed mean cholesterol levels in our black stroke patients with 
and without HIV we found a mean of  4.7 mmol/L (95% CI 4.1 to 5.2) in HIV 
negative patients and a mean of 3.7 mmol/L (95% CI 3.2 to 4.3) in HIV positive 
individuals. One hypothesis may be that in HIV negative individuals elevated 
cholesterol levels carry an increased level of risk for stroke or vascular disease in 
general, but in HIV positive individuals the risk of stroke is independent of 
accepted vascular risk factors. Of course, HIV positive patients in our study were 
younger than HIV negative patients and we did not systematically test everyone 
for HIV. It is possible that clinicians were more likely to test younger patients, who 
may have lower cholesterol levels, for HIV than to test older patients who may 
have higher cholesterol levels. 
 
Diabetes mellitus was present about half as frequently in our black and white 
stroke patients as in African-American patients and African stroke patients living in 
London, and it was slightly more common than in OXVASC. Blood glucose was 
not measured in the Gambian study and so the lower proportion with diabetes 
mellitus may be an under-representation. However, diabetes mellitus certainly 
increases as populations progress through the health transition, and African-
Americans have a disproportionately high prevalence of diabetes mellitus (Egede 
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& Dagogo-Jack, 2005; Graham, Leath, Payne et al, 2006). In the South London 
Stroke Register, black stroke patients had almost three times the frequency of 
diabetes mellitus as their white counterparts (Lawrence et al., 2001). So the 
progression in the proportion of patients with diabetes from the Gambia (5%), 
through South African patients in the JHSR (16%) to African-American and 
African-UK patients may represent a transitional change.  
 
Atrial fibrillation was far more common (17%) in the OXVASC population than in 
any other stroke population in table 5.19, though we found the next highest 
proportion JHSR white patients (10%). While atrial fibrillation was far less common 
in black patients in the JHSR (3%) and in the Gambia (4%), it was slightly more 
common in African-American stroke patients (10%). Atrial fibrillation in JHSR black 
patients is seldom if ever caused by ischaemic heart disease which is not common 
in this population group, but rather by hypertensive heart disease, valvular or 
cardiomyopathic disease (table 5.8). It is possible that the frequency of atrial 
fibrillation increases as the prevalence of ischaemic heart disease increases in the 
population, resulting in the progressive increase in the frequency of atrial 
fibrillation from Africans to Africans living outside Africa and then Caucasians. 
Equally, however, the low frequency of atrial fibrillation in our black stroke patients 
and even our white stroke patients compared to those in the OXVASC study, may 
be because they were younger.  
 
In the JHSR stroke patients a history of current smoking was found in 48 (31%) 
black males and significantly fewer (9 of 155, 7%) black females (p<0.001). In 
white JHSR patients smoking occurred in higher proportions of males (68%) and 
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females (41%) (p=0.09). In both this was higher than the national prevalence of 
39% of 500 males and 27% of 600 females (Steyn, Bradshaw, Norman et al, 
2002) in the community  over the age of 15 years. Indeed smoking in white JHSR 
stroke patients was more common than in any other stroke population, while 
current smoking was least common in the OXVASC study. This finding of 
increased current smoking in white stroke patients compared to black stroke 
patients was found in the South London Stroke Register (whites 31%; blacks 23%) 
but not in the GCNKSS study in the USA (whites 19%, blacks 28%). One has to be 
cautious comparing these studies as cigarette smoking decreases with increasing 
age, and both our white and black stroke patients were younger than other 
populations. Thus, current smoking is currently less frequent in our black stroke 
patients. Smoking should not increase if new government anti-smoking policies 
work (van Walbeek, 2002).  
 
It is not clear whether snuff (smokeless tobacco) is a risk factor for stroke, and 
there are conflicting results of two case-control studies in the literature (Asplund et 
al., 2003; Henley et al., 2005). The situation is further confused by the fact that 
some snuffers chew the tobacco (the predominant method in Sweden) (Asplund et 
al., 2003) and others (the predominant method in South Africa) (Steyn et al., 2002) 
sniff or inhale the tobacco nasally.  Of the almost 14 000 people over the age of 15 
years in the South African Demographic and Health Survey (SADHS), 1% of 
males and 10% of females used snuff. However, snuff use was very limited in all 
but the black population where 1% of males and 13% of females used snuff (Steyn 
et al., 2002). Snuff use gradually increased with age in black females in the 
SADHS ranging from 3% of 15 to 24 year olds to 29% of over 65 year-olds. Our 
 251 
finding that 18 (12%) of 155 females stroke patients used snuff is probably in 
keeping with the general population prevalence, though of course a large 
prospective case-control study is needed to assess the relationship between snuff 
and stroke in our population. 
 
Peripheral vascular disease and ischaemic heart disease are both markers of 
large vessel, extracranial atherosclerosis. Although myocardial infarction was 
more common in the OXVASC study and white JHSR patients than in JHSR black 
patients, the proportion of patients with peripheral vascular disease did not differ 
markedly between groups though we are likely to have overestimated it compared 
to the OXVASC study. In the OXVASC study baseline peripheral vascular disease 
was diagnosed on the basis of symptoms (good history of claudication) or a 
confirmed (by medical records) history of a diagnoisis of chronic / acute on chronic 
arterial disease in the legs, irrespective of whether treated and now symptomatic 
(e.g. previous critical ischaemia, amputation, angioplasty, bypass surgery). 
OXVASC did not include asymptomatic previously undiagnosed disease, such as 
absent pulses or femoral bruits (personal communication Professor Peter 
Rothwell, Professor of Neurology, University Department of Clinical Neurology, 
Radcliffe Infirmary, Oxford, United Kingdom), but we did include these patients.  
 
There are no community-based surveys of peripheral vascular disease in urban 
South Africans, though there is one small survey of ankle-brachial pressure 
indices in rural South Africans which found the prevalence of sub-clinical 
peripheral vascular disease to be similar to that found in high-income populations 
(Fowkes, Thorogood, Connor et al, 2006). Ischaemic heart disease in general was 
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more prevalent in the South London Stroke Register black patients (14%) than in 
black JHSR patients (6%), but less common than in white JHSR patients (27%). 
Extracranial artery atherosclerosis increases as a population moves through the 
health transition (section 1.6). It is not surprising, therefore that IHD increases in 
frequency from South African black patients to Africans living outside Africa and 
white populations. Whether peripheral vascular disease increases before IHD in 
low and middle-income stroke populations requires further investigation.  
 
A history of prior transient ischaemic attack (TIA) was seldom found in black JHSR 
patients (1%) and only found about half as often in white JHSR patients (7%) as in 
the OXVASC population (16%). This may reflect a real difference in the likelihood 
of prior TIAs, perhaps reflecting the prevalence of extracranial carotid artery 
disease in part, but it is more likely we did not identify previous TIAs that 
accurately on history. The much higher proportion of patients in the Kalafong study 
with previous TIAs suggests that this is possible (Rosman, 1989).  
 
5.3.5.4   HIV infection in stroke patients 
 
Two of twelve (17%) white JHSR patients tested positive for HIV, though HIV 
testing was done so infrequently in white JHSR patients that the pre-test 
probability of a positive test was probably high in those tested (table 5.19). A much 
higher proportion of black patients were HIV positive (40%), and while only 48% of 
patients were tested, this proportion probably more accurately reflects the true 
prevalence of HIV infection in our black patients than our findings in white JHSR 
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patients. The population prevalence of HIV infection was discussed in section 
5.3.3.1.4. 
 
None of the other studies in table 5.19 assessed HIV infection in their stroke 
patients. However, a recent study from Malawi included 100 consecutive adult 
patients with a stroke-like presentation i.e. a sudden onset of focal neurological 
deficit which had been present for less than 7 days (Kumwenda et al., 2005). All 
patients were antiretroviral therapy naïve (as were all patients on the JHSR). 
Ninety-two patients received a CT brain scan with and without contrast within one 
week of admission. They then compared the presence of non-stroke lesions, any 
differences in pathological stroke type, and outcome in HIV positive and negative 
patients. To compare their findings to the JHSR we have assessed our experience 
with non-stroke lesions from the original 524 patients referred to the JHSR, and 
compared HIV positive and negative stroke and non-stroke black patients in the 
JHSR with those in the study from Malawi (table 5.20). Three HIV positive and 4 
HIV negative patients were excluded from the JHSR because of ring enhancing 
lesions noted on CT brain scan, and two HIV negative patients because of 
subdural haematoma noted on CT brain scan. We did not therefore find, as the 
Queen Elizabeth Central Hospital (QECH) study did, that HIV positive patients 
were more likely to present with stroke-like presentation than HIV negative 
patients. In both studies there was a slight increase in the number of females who 
were HIV positive compared to males, yet in the HIV negative group males 
predominated. The mean age of HIV positive black patients was lower than HIV 
negative patients, though this difference was less marked in the JHSR than in the 
QECH study. The mean age of the patients excluded from the JHSR is distinctly 
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different between the HIV positive group who were younger and the HIV negative 
group who were older. It is possible that there is a difference in the underlying 
aetiology of the ring-enhancing lesions between the young HIV positive and older 
HIV negative patients, with more infective causes in the young patients and more 
neoplastic / metastatic lesions in the older patients, but this requires further 
investigation.  
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Table 5.20  Comparison of stroke and non-stroke lesions in the black 
population group referred to the JHSR and to QECH in Malawi 
(Kumwenda, 2005), by HIV status 
 
 JHSR QECH 
 
HIV  
positive 
HIV 
negative 
HIV 
positive 
HIV 
negative 
Total number  157 98 
Male  28 60 19 30 
Female  36 33 28 21 
Mean age (SD) in years** 38 (10) 48 (15) 38 (13) 59 (17) 
Mean age of excluded patients (SD) 32 (8) 60 (14) n/a n/a 
Stroke (CT confirmed)  
(% of all strokes scanned): 
n=117 n=81 
Cerebral haemorrhage (%) 5 (10) 23 (34) 1 (3) 15 (32) 
Ischaemic stroke* (%) 43 (88) 41 (60) 33 (97) 32 (68) 
Subarachnoid haemorrhage (%) 1 (2) 4 (6) n/a n/a 
Other lesion: 3 6 7 2 
- brain tumour 0 0 1 0 
- subdural 0 2 0 1 
- white matter disease (not PML) 0 0 0 1 
- PML 0 0 2 0 
- ring enhancing lesion 3 4 4 0 
 
JHSR: Johannesburg Hospital Stroke Register;  
QECH: Queen Elizabeth Central Hospital, Blantyre, Malawi; 
 * includes CT normal stroke;  
** mean age for JHSR is only for those patients with confirmed stroke 
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Table 5.21  Comparison of risk factors in HIV-positive and HIV-negative 
black stroke patients in the JHSR (percentage in brackets unless 
otherwise stated) 
 
 HIV positive HIV negative 
Significance of 
difference 
Risk factor:    
Mean age (SD) years 
n=148 
38 (10) 48 (15) p<0.001 
Hypertension  
n=134* 
25 (49) 62 (75) p=0.002 
Diabetes   
n=125* 
1 (2) 10 (14) p=0.03 
Cholesterol – mean (95% CI)  
n=64* 
3.7 (3.2 to 4.3) 4.7 (4.1 to 5.2) p=0.02 
Current cigarette smoking  
n=110* 
14 (29) 18 (29) p=0.4 
Current alcohol use  
n=109* 
17 (35) 15 (25) p=0.5 
Atrial fibrillation   
n=145* 
0 2 (2) p=0.2 
Cardiomyopathy 
n=148 
5 (6) 7 (8) p=0.8 
 
JHSR: Johannesburg Hospital Stroke Register;  
*n refers to total number of patients with HIV status and risk factor assessed 
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We found a similar influence of HIV status on pathological stroke type diagnosed 
on CT brain scan as was found in the QECH study (Kumwenda et al., 2005)(table 
5.20). In HIV negative patients, cerebral haemorrhage accounted for about 30% of 
strokes in both the JHSR and the QECH study, a similar finding to most hospital-
based stroke series from Sub-Saharan Africa (tables 5.16 and 5.18). In HIV 
positive patients, however, haemorrhage is not common (10% in the JHSR and 
3%) in the QECH study. We found this difference to be statistically significant 
(p=0.005). 
 
HIV may cause a dilated cardiomyopathy (Magula & Mayosi, 2003) and so cause 
embolic stroke. We did not find any significant difference in the frequency of atrial 
fibrillation in HIV positive black stroke patients (table 5.21) or in cardiomyopathy 
although the small numbers of patients make this assessment inaccurate. Of the 
148 patients tested for HIV infection, 5 HIV positive patients had a cardiomyopathy 
and 7 patients without HIV infection had a cardiomyopathy (p=0.8).  
  
The QECH study did not find a significant difference in risk factors between HIV 
positive and negative patients, although not surprisingly it found an increase in 
stroke risk factor prevalence in people over the age of 40 years. We found 
significantly less hypertension, diabetes mellitus, as well as lower mean 
cholesterol in HIV positive patients, but no difference in current cigarette smoking, 
alcohol use, or atrial fibrillation between the two groups (table 5.21).  
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Although we did not find the same preponderance of space-occupying lesions in 
HIV positive patients presenting with a stroke-like onset, as was found in the 
QECH study (Kumwenda et al., 2005), we did find space occupying lesions 
mimicking stroke. It is possible that the clinicians who assessed patients before 
referring them to us excluded some patients with space occupying lesions.  
 
The rest of our findings are very similar to those found by the QECH study. In 
summary HIV positive stroke patients are younger, less likely to have cerebral 
haemorrhage than ischaemic stroke, have a lower cholesterol level, and are less 
likely to have hypertension and diabetes than HIV negative patients. In a setting 
with a high prevalence of HIV, when a patient presents with clinical features of a 
stroke, it is probably prudent to assess their HIV status. If found to be HIV positive, 
patients should have a brain scan if possible and a lumbar puncture to exclude 
infective or other HIV related causes of the stroke (Connor et al., 2000; Mochan et 
al., 2003; Kumwenda et al., 2005).  
 
5.3.5.5  Syphilis infection in stroke patients 
 
Most studies from SSA and outside SSA have not provided data on syphilis 
serology in stroke patients (table 5.19). Syphilis was positive in almost the same 
proportion of stroke patients in the stroke study from Zimbabwe as in black 
patients in the JHSR (16% versus 15%), though syphilis serology was only 
assessed in 62 of 93 patients in Zimbabwe and in 59 of 308 patients in the JHSR. 
The mean age of patients with positive blood serology for syphilis in the JHSR was 
52 years (SD 13) (range 30 to 70). In the JHSR none of the patients tested were 
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found to have neurosyphilis (although again investigation was incomplete in 
almost all patients), and in the Zimbabwean study, 8 patients were found to have 
neurosyphilis. The prevalence of syphilis infection in South Africa appears to be 
declining, and in 2001 2.7% of women attending antenatal clinics in Gauteng 
province had the infection, with the highest prevalence in the 20 to 34 year-old age 
group (Directorate: Health Systems Research, 2001). Despite this decline the 
association between HIV infection and syphilis infection is well documented (Lynn 
et al., 2004) and the search for neurosyphilis should be more detailed than in the 
JHSR.  
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5.3.6        Stroke severity, impairment and related disability 
5.3.6.1     Stroke severity 
 
Stroke severity as measured on the Scandinavian Stroke Scale (SSS) 
(Scandinavian Stroke Study Group, 1985) and the National Institutes of Health 
Stroke Scale (NIHSS) (National Institute of Neurological Disorders and Stroke, 
2005) was not significantly different in any population group (table 5.14). It was not 
possible to compare the severity of acute stroke in our patients with other studies 
in South Africa because, although the Durban Stroke Data Bank assessed acute 
stroke, they used the Canadian Neurological Scale (Hoffmann, 1998).  
 
Prospective hospital-based studies from the rest of Sub-Saharan Africa have also 
not used the NIHSS or SSS frequently. However, the recent study from the 
Gambia (Garbusinski et al., 2005) (tables 5.18 and 5.19) did assess initial stroke 
severity using a modified NIHSS. The modification (mNIHSS) consisted of two 
substitutions: “what is the season” and “who is the head of your compound” 
replaced asking a patient his/her age and the current month (Garbusinski et al., 
2005).  We did not modify the NIHSS in the JHSR. Most patients (no exact data 
provided) in study from the Gambia were admitted within 48 hours, so possibly 
slightly later than in the JHSR where the median time to admission was 1 day 
(table 5.1). In the study from the Gambia, 18 (12%) of the 148 patients were 
admitted with a recurrent stroke, while all patients in the JHSR had first-ever-in-a-
lifetime stroke.  
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The Gambian study assessed the mean mNIHSS in 146 patients on admission 
and found it to be 16 (SD 7) (higher figures correspond to higher severity). They 
did not provide a median value for the scale. In the JHSR the mean NIHSS score 
at our first assessment was 12 (SD 10) in the 431 patients assessed. The mean in 
black stroke patients was 12 (SD 9). Strokes appear to be more severe in the 
Gambia study than in the JHSR, perhaps in keeping with the greater proportion of 
total anterior circulation syndrome strokes and cerebral haemorrhages (as 
assessed by the Siriraj Score) in the Gambian study compared to the JHSR (table 
5.18).  
 
Very few publications gave separate data on the NIHSS at time of admission for 
African-Americans (Sheinart, Tuhrim, Horowitz et al, 1998; Rundek, Mast, 
Hartmann et al, 2000) and we could not find any studies that assessed the SSS in 
African populations. One study, which included 958 patients with first ischaemic 
stroke, 30% African Americans, 51% Hispanics and 19% whites Americans, from 
the Northern Manhattan Stroke Study group, did assess the NIHSS though data 
were not provided separately for each population group (Rundek et al., 2000). The 
NIHSS score was categorised as: mild (NIHSS ≤ 5), moderate (NIHSS 6 to 13), 
and severe (NIHSS ≥ 14). We categorised our ischaemic stroke patients (n= 339, 
all population groups included) similarly, and compared the two studies (Northern 
Manhattan Study / JHSR). We found fewer mild (56% / 39%) and moderate (35% / 
26%), and more severe (9% / 35%) strokes in the JHSR than was found in the 
NMSS.  
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We could not find studies including African-Americans or Africans living in Africa, 
or in countries outside Sub-Saharan Africa that used the Scandinavian Stroke 
Scale. We have therefore compared our findings to the Copenhagen stroke study 
which used the Scandinavian Stroke Scale (Jorgensen, Nakayama, Raaschou et 
al, 1995). In contrast to the NIHSS the SSS scores decrease with  increasing 
severity and patients are usually categorised as: very severe (0 to 14 points), 
severe (15 to 29 points), moderate (30 to 44 points), and mild (45 to 58 points) 
(Jorgensen et al., 1995; Reith, Jorgensen, Nakayama et al, 1997). We compared 
our patients to those in the Copenhagen Stroke Study, but excluded all 
subarachnoid haemorrhages for the comparison (included n=416), as the 
Copenhagen study did not include this pathological stroke type. The Copenhagen 
study included 1197 patients and 82% had a CT brain scan. Comparing the two 
studies we found the following proportions of patients in each category of the SSS 
(Copenhagen Stroke Study / JHSR): very severe (19% / 31%), severe (14% / 
17%), moderate (26% / 17%), and mild (41% / 35%). Thus, we found far more 
severe strokes and fewer mild strokes in the JHSR than were found in the 
Copenhagen Stroke Study (Jorgensen et al., 1995). Strokes presenting to hospital 
may be more severe in urban Johannesburg than in high-income regions. 
 
Of course, this does not suggest that stroke is more severe in the urban South 
African community, because the likelihood of someone presenting to hospital, or 
being admitted once they present to the emergency service, is probably very 
different in Johannesburg compared to the many high-income regions. Indeed, 
with the pressure of HIV infected medical patients on local health services and 
resulting long waiting times for assessment, people are likely to avoid presenting 
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to the emergency services and once there doctors are only likely to admit more 
severe patients. To assess stroke severity in the community, we need a 
community-based incidence study.  
 
5.3.6.2     Stroke related acute impairment and disability 
 
Independence following stroke, whether assessed using the Barthel Index (BI) or 
the modified Rankin score was not significantly different between population 
groups, although slightly more white than black patients were fully independent (BI 
score of 20) (table 5.15). Disability was also not significantly different between 
groups.  
 
It is not possible to compare functional impairment in the JHSR with other hospital-
based stroke studies from South Africa. The Kalafong study (Rosman, 1989) did 
not assess the Barthel Index or modified Rankin score, and it is not clear from 
published results whether these scores were assessed in the Medunsa study 
(Joubert et al., 1989; Joubert, 1991; Joubert et al., 2000). Both scores were 
assessed in the Durban Stroke Data Bank (Hoffmann, 1998), but the results were 
not reported in sufficient detail to allow us to compare our findings. The DSDB did 
not report the results of the Barthel Index in black patients because they found it 
difficult to assess functions such as combing hair and bathing, wheelchair skills, 
and stair use. We did not find an enormous difference between the assessment of 
the Barthel Index in black stroke patients and other population groups.  
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In the study from the Gambia, a modified Barthel Index was used (Garbusinski et 
al., 2005), but this was assessed at discharge and we assessed the BI in our 
patients on admission. It is therefore not appropriate to compare the two 
assessments. Similarly, the BI was assessed one week following stroke onset in 
the South London Stroke Register, and it is therefore not appropriate to compare 
our patients with theirs. 
 
5.3.6.3   Stroke related complications, recurrent stroke in hospital and death 
 
Our follow-up of stroke patients until discharge was not complete for logistical 
reasons. The high service load, frequent transfer of patients around the hospital 
because of the ongoing bed shortage, and high turnover of patients admitted and 
discharged, made it almost impossible to follow up patients effectively or note 
complications accurately. We regard the frequency of complications in the JHSR 
as a minimum likely value. Our findings of recurrent stroke in hospital and death 
are likely to be more accurate because the medical units invariably drew our 
attention to patients who suffered recurrent stroke or died. We did not follow up 
patients following their discharge and did not establish the 30-day case fatality.  
 
Despite these limitations, major complications in the Durban Stroke Data Bank 
(DSDB) occurred with a very similar frequency to those in the JHSR. In the DSDB 
and JHSR specific post-stroke complications occurred in the following proportion 
respectively (n=1000 for the DSDB / n=432 for the JHSR): pneumonia in 23 / 22 
(2% / 5%), seizures in 53 / 21 (5% in both), depression in 44 / 6 (4% / 1%), 
recurrent stroke in 30 / 11 (3% / 3%), and death in 53 / 35 (5% / 8%). We did not 
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distinguish between onset seizures (occurring in the first 24 hours following stroke) 
and post stroke seizures (occurring after a stable deficit is present) (Burn et al., 
1997).  
 
The DSDB placed a focus on the impact of stroke on higher cortical function and 
so not surprisingly found behavioural abnormality in 166 (17%) of patients. We did 
not assess higher function at all. In the trial period leading up to the development 
of the JHSR (data not included in the JHSR), we attempted to modify the 
Hodkinson Abbreviated Mental Test (Hodkinson, 1972) (10 items) to suit South 
African patients, by replacing the address to be repeated with a local 
Johannesburg address, and the question ‘present monarch’ with ‘previous 
president.’ Despite this adaptation, we found the test very unreliable in our local 
population and decided against using any cognitive score in the JHSR. 
 
Post-stroke lung infections occurred more frequently (18%), and epilepsy less 
frequently (2%) in the 148 patients in the Gambian stroke study (Garbusinski et al., 
2005) than in the JHSR. Death occurred far more frequently during hospitalisation 
(61 of 148 patients; 41%) than in our study, most likely in keeping with the high 
proportion of severe strokes in the Gambian study. Our lack of long term follow up 
of patients prevented comparison with data from the second study from the 
Gambia undertaken in 1990, which provided 4 years of community follow up 
(Walker, 1963). 
 
Post stroke epilepsy occurred in 48 (7%; 95% CI 6 to 9) of 675 stroke patients in 
the community-based Oxfordshire Community Stroke Project (OCSP) compared to 
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our similar finding of 21 of 432 (5%; 95% CI 3 to 7) (Burn et al., 1997). We also 
found an increased proportion with total anterior circulation infarcts (28%) 
compared to other OCSP ischaemic stroke subtypes (4 with partial anterior 
circulation events and 1 with a lacunar infarct) (p=0.004).  
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5.3.7  Evidence of the health transition based on the JHSR 
 
Our comparison of the nature of stroke in black JHSR patients, white JHSR stroke 
patients and African-American stroke patients supports the notion of a health 
transition taking place in black South Africans. As we discussed in chapter 1 
(section 1.6) (table 1.1), it is postulated that the nature of stroke should change 
with a population’s transition from stroke initially caused predominantly by 
cardioembolic events resulting from cardiomyopathy and rheumatic heart disease, 
to stroke associated with hypertension and hypertensive heart disease and a high 
proportion of cerebral haemorrhage; and finally the emergence of atherosclerotic 
stroke and ischaemic heart disease.  
 
We found a high proportion of cerebral haemorrhage (almost all hypertension 
related) and hypertension related small vessel disease in black stroke patients. 
While the ischaemic stroke subtypes were remarkably similar between our black 
and white stroke patients, the underlying cause of large artery strokes differed. 
Cardioembolic strokes were seldom if ever caused by ischaemic heart disease 
(IHD), though we found IHD in a small number of black stroke patients. Instead the 
major causes of cardioembolic stroke were cardiomyopathies, often caused by 
end-stage hypertensive heart disease, rheumatic valvular heart disease and atrial 
fibrillation unrelated to IHD.  
 
Although we found the emergence of symptomatic IHD in black stroke patients, 
and a similar frequency of peripheral vascular disease, we did not find significant 
atherosclerosis of the extracranial carotid arteries in black patients. Hypertension 
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was the major risk factor in black stroke patients, cholesterol levels were low and 
cigarette smoking was less frequent than in white stroke patients. Diabetes 
mellitus was about as common in black and white stroke patients. The mean age 
of black stroke patients (excluding HIV positive patients) was significantly younger 
than white stroke patients and African-Americans.  
 
This profile of risk factors, pathological stroke types, ischaemic stroke subtypes 
and causes of stroke is, we think, in keeping with a population in transition. Black 
stroke patients are probably in stage 2 of the postulated transition (table 1.1), but 
there are distinct features compatible with stage 3 i.e. the emergence of IHD, the 
presence of peripheral vascular disease and a similar frequency of diabetes 
mellitus to that found in white stroke patients. However, compared to African-
American stroke patients and African’s with stroke living in London, South African 
urban black stroke patients have strokes at a younger age, have more cerebral 
haemorrhage, more small vessel disease, and are more frequently hypertensive. 
They have less diabetes mellitus and ischaemic heart disease, but a similar 
proportion smoke cigarettes. If African-Americans (and other African populations 
living permanently in high-income regions) represent the final stages of the African 
vascular transition, then South African black stroke patients are in a much earlier 
stage of the transition. We anticipate a change in stroke types, subtypes and 
vascular risk factors over future decades as our population advances towards this 
final stage, unless effective primary prevention in the population alters this course. 
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5.4    Conclusion 
 
In an urban stroke hospitalised population that was representative of the diverse 
population of South Africa, we found distinct differences in the nature of stroke in 
different population groups, particularly between blacks and whites. Black stroke 
patients were younger, had lower cholesterol levels, were less likely to smoke 
cigarettes, had features of lower socioeconomic status, had less atherosclerosis in 
the extracranial carotid arteries and coronary arteries and had distinctly different 
causes of cardioembolic strokes, compared to white stroke patients. In black 
stroke patients cardioembolic stroke was caused by cardiomyopathy, atrial 
fibrillation and rheumatic valvular disease. The most important underlying 
mechanism of cardioembolic events was not ischaemic heart disease as in the 
whites, but hypertension and hypertensive heart disease. The exact mechanism 
causing stroke in hypertensive heart disease, and the cardioembolic risk at various 
stages of hypertensive heart disease, require further investigation. 
 
When we compared the nature of stroke in South African black patients with that in 
African Americans, in Africans living in high-income regions, and in white stroke 
populations, we found distinct differences that suggest that black stroke patients 
are in an earlier stage of the vascular health transition. However, they are 
developing stroke types, subtypes and the associated risk factor profile compatible 
with later stages of the transition. 
 
We found HIV infection predominantly in black stroke patients. This subgroup was 
younger and had fewer traditional risk factors than HIV negative stroke patients 
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had. Although cerebral haemorrhage occurred less frequently in HIV positive 
stroke patients, ischaemic stroke subtypes occurred about as often as in HIV 
negative stroke patients. We cannot comment on the likely underlying cause of the 
stroke in these patients, however.  
 
Despite the difference we found in the nature of stroke between population groups 
in the JHSR, the other characteristics of stroke patients in the various groups were 
very similar. In particular, the time taken to presentation, stroke severity, clinical 
impairment, complications arising from stroke, and the impact of stroke on the 
individual’s level of functioning and independence did not differ markedly between 
population groups.  
 
Our findings suggest that there is still time to improve primary prevention in the 
black South African population to prevent an otherwise inevitable increase in 
atherosclerosis related stroke and heart disease. Hypertension is currently the 
single most important risk factor for, and underlying cause of stroke in the South 
African population. Simply lowering the population’s blood pressure would likely 
decrease stroke incidence significantly. HIV infection has clearly altered the profile 
and nature of stroke, particularly in black South Africans, and more research is 
needed to clarify the underlying cause and risk of stroke related to HIV infection.  
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5.4.1  What this study adds to the literature 
 
The JHSR is the first stroke register that is reasonably representative of the whole 
South African population and therefore able to compare the nature of stroke in the 
various populations (though this is most accurate for the larger black and white 
populations). It is also the first stroke register in Sub-Saharan Africa to provide a 
direct comparison between population groups. The comparison of the nature of 
stroke in black and white stroke patients, in particular the differences in 
cardioembolic stroke and emergence of ischaemic heart disease, provide 
evidence for a vascular health transition occurring in the South African black 
population. The JHSR is also the first stroke register in Sub-Saharan Africa to 
show the impact of HIV on the nature of stroke across the full age spectrum of 
black South African stroke patients. Finally, it is the first Sub-Saharan African 
stroke register to highlight the impact of hypertensive heart disease on the cause 
of stroke in black patients.  
 
 
 
 
 
 
 
 
 
 
 272 
CHAPTER 6 VALIDATION OF THE ALLEN (GUY’S HOSPITAL) 
AND SIRIRAJ STROKE SCORES IN URBAN SOUTH 
AFRICAN BLACK STROKE PATIENTS  
 
6.0    Introduction 
 
The assessment of pathological stroke type (cerebral haemorrhage, ischaemic 
stroke and subarachnoid haemorrhage) is essential for understanding the nature 
of stroke in a population, and for comparing the nature of stroke across 
populations. We have described the nature of urban hospital-based strokes in the 
Johannesburg Hospital Stroke Register (JHSR) in chapter 5, and in chapter 7 we 
will describe the nature of strokes presenting to the rural Tintswalo Hospital. 
 
Ideally, a CT or MRI brain scan is necessary to distinguish pathological stroke 
type, but unfortunately Tintswalo Hospital did not have a scanner. The nearest CT 
scanner available for patients admitted to Tintswalo Hospital was 300 km away 
(about 4 hours drive). With scarce resources and very often only one ambulance 
servicing the entire hospital and region, few if any stroke patients ever have a 
brain scan. Indeed, CT and MRI scanners are not readily available throughout 
Sub-Saharan Africa, and few stroke patients are scanned (El Khamlichi, 2001; 
Bower & Zenebe, 2005). In hospitals without access to CT or MRI scanners, 
clinicians attempt to assess pathological stroke type at the bedside. 
  
However, previous studies in high-income populations have shown that the 
bedside assessment of pathological stroke type by clinicians is inaccurate (von 
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Arbin, Britton, de Faire et al, 1981; Allen, 1983). Prior to the widespread availability 
of CT scanners in high-income regions of the world, clinical scores were 
developed in an attempt to improve the clinician’s bedside assessment of 
pathological stroke type. Some of these, such as the Siriraj Stroke Score, have 
been used in Sub-Saharan Africa to distinguish pathological stroke type in 
epidemiological studies e.g. in one study from the Gambia (discussed in chapter 5) 
(Garbusinski et al., 2005).  
 
However, none of these stroke scores have been developed or prospectively 
validated for use in Sub-Saharan Africa. Indeed, many of the scores rely on 
measures of atherosclerosis to distinguish pathological stroke type. Thus, while 
they may perform relatively well in stroke populations with a high prevalence of 
atherosclerosis, it is not at all certain how well they perform in the Sub-Saharan 
African black stroke population which has a low prevalence of atherosclerosis.  
 
We decided to prospectively validate two of the most frequently used stroke 
scores, the Siriraj Score and the Allen (Guy’s Hospital) score, in the South African 
black population using the Johannesburg Hospital Stroke Register in the hope that 
we could use one or the other in the Tintswalo Hospital Stroke Register (chapter 
7). Although several scores have been developed (Hatano, 1976b; Allen, 1983; 
Poungvarin, Viriyavejakul, & Komontri, 1991; Besson, Robert, Hommel et al, 1995; 
Talavera, Wacher, Laredo et al, 2000), we chose the Siriraj Stroke Score (SSS) 
(Poungvarin et al., 1991) and the Allen (Guy’s Hospital) Stroke score (hereafter 
referred to as the Guy’s Hospital Stroke Score or GHSS) (Allen, 1983), because 
they required the least ancillary testing and investigation, and were the simplest to 
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use in our low resourced setting. The SSS only requires a clinical history and 
examination, and the GHSS only requires a chest x-ray and ECG in addition to a 
clinical history and examination. 
 
During the second period of the 23 months that we ascertained stroke patients for 
the JHSR (chapter 5), we also decided to evaluate the stroke team members’ 
ability to assess the pathological stroke type based on a patient’s clinical 
presentation. We did not specifically instruct to use specific criteria in the hope that 
their assessment would be as generalisable as possible to doctors elsewhere. We 
added instructions to the team members to assign each patient a pathological 
stroke type prior to finding out the CT scan result (Appendix D), and assured them 
that we would not assess the accuracy of any individual clinician. We therefore 
have limited data to compare the stroke team clinicians’ assessment of 
pathological stroke type, compared to the assessment using the two scoring 
systems, and the CT scan “gold-standard” result.  
 
We assessed the accuracy of the scores in black patients with first-ever-in-a-
lifetime stroke (the JHSR patients described in chapter 5), and in black patients 
with recurrent stroke separately. We included recurrent stroke, as have other 
studies (Hawkins, Bonita, Broad et al, 1995), because the diagnosis of 
pathological stroke type is not only important for epidemiological studies assessing 
first-ever strokes, but also in the management of all stroke patients in settings 
where a CT or MRI scan is not available. 
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The literature related to clinical assessment of pathological stroke type as well as 
to the performance of the SSS and GHSS in other populations will be outlined and 
compared to our findings in the discussion (section 6.3).  
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6.0.1   Aim of the study 
 
Our aim was to assess the accuracy of the Siriraj Stroke Score (SSS) and the 
Guy’s Hospital Stroke Score (GHSS) in distinguishing between intracranial 
haemorrhage (see section 6.1.3 for the definition and reason we used this 
assessment) and ischaemic stroke in both first-ever-in-a-lifetime and all (recurrent 
and first-ever-in-a-lifetime) black stroke patients in the Johannesburg Hospital 
Stroke Register (JHSR). A secondary aim was to assess whether the scores were 
more accurate than our stroke team clinicians were in diagnosing cerebral 
haemorrhage. 
 
6.1   Methods 
6.1.1   Setting and population, and methods used in the JHSR 
 
We described the population, setting and methods for the JHSR in section 5.1. In 
the JHSR we only included patients with first-ever-in-a-lifetime stroke, however we 
also assessed the Siriraj and Guy’s Hospital Stroke Scores in black patients who 
presented with recurrent stroke. We considered a stroke recurrent if the patient 
had a sudden onset of a new focal neurological deficit at least 28 days following 
their initial stroke.   
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6.1.2   Assessment of Siriraj and Guy’s Hospital Score  
 
The stroke team clinician documented all the information required for assessing 
the SSS and GHSS as part of the JHSR questionnaire (Appendix D), but they did 
not calculate the scores. Instead, the variables were combined on the stroke 
questionnaire in a format similar to that used on the Department of Clinical 
Neuroscience, University of Edinburgh, online prediction model website (Perry, 
1998). From the 1st August 2001 till 31st December 2002 (the second time period 
of case ascertainment for the JHSR), the clinicians also documented what they 
thought the likely pathological stroke type was and whether this assessment was 
made without knowledge of the brain imaging result.  
 
The stroke team clinicians included neurology registrars (predominantly), medical 
registrars rotating through neurology, and psychiatry registrars rotating through 
neurology. I was the only consultant neurologist assessing the JHSR patients. 
Apart from the patients I assessed on my own, I often re-examined those stroke 
patients who the registrars had initially examined. However, we only analysed the 
assessment of pathological stroke type made by the first stroke team clinician to 
see the patient.  
 
Stroke patients were entered into this sub-study if they were black South Africans, 
had sufficient data available to calculate the SSS and GHSS, and had had a CT 
brain scan within 15 days of admission (to exclude the misdiagnosis of possible 
resolving haemorrhage – see section 5.2.2).  
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6.1.3   Data analysis 
 
We calculated both the SSS and GHSS using the technique provided in the 
original descriptions (Allen, 1983; Poungvarin et al., 1991), and used the same 
cut-off points for diagnosing intracranial haemorrhage and ischaemic stroke 
(infarction) used in these publications (Appendix F). From a clinical perspective it 
is useful to distinguish all sources of intracranial haemorrhage (subarachnoid 
haemorrhage and cerebral haemorrhage) and we followed previous studies that 
have validated the SSS and GHSS and combined subarachnoid haemorrhage and 
cerebral haemorrhage as ‘intracranial haemorrhage’ for the purposes of analysis 
(Sandercock, Allen, Corston et al, 1985; Hawkins et al., 1995).  
 
We calculated the scores using STATA (StataCorp, 2001), and analysed the 
distribution of the scores using SSC-stat (Statistical Services Centre, 2004). We 
compared the population with and without CT brain scans using a χ2 test for 
homogeneity using STATA. We calculated the sensitivity, specificity, positive 
predictive values, likelihood ratios and kappa scores (comparing each score and 
the clinicians with the CT scan result), as well as confidence intervals with 
Confidence Interval Analysis software (Bryant, 2000) using the ‘uncertain’ results 
i.e. the results that did not yield a definite answer of haemorrhage or infarction in 
the analysis (see section 6.3 for discussion of the effect of including or excluding 
‘uncertain’ results in the calculation). We only used the clinicians’ evaluation of 
pathological stroke type if they were not aware of the brain scan result at the time 
of the assessment.  
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We analysed the sensitivity, specificity, positive predictive value and kappa scores 
separately for first-ever-in-a-lifetime strokes and all strokes. The remainder of the 
analyses included all strokes.  
 
6.1.4    Ethics  
 
The assessment of the SSS and GHSS was an integral part of the original 
methodology of the JHSR and we requested and were granted ethics approval as 
part of the JHSR: University of the Witwatersrand Human Ethics Research 
Committee (M00/03/7). 
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6.2   Results 
 
The JHSR included 432 first-ever-in-a-lifetime stroke patients. Of these 308 were 
black stroke patients. Two-hundred and seven (67%) of these patients had a CT 
brain scan within 15 days of admission and sufficient information available for 
calculation of the Siriraj and Guy’s Hospital scores. One hundred and twenty-one 
scans (59%) were done within 24 hours. A further 15 black patients presented with 
recurrent stroke, had a scan within 15 days of onset and complete score data. 
Sixty-six (32%) first-ever stroke patients and 70 (32%) of all stroke patients 
(including recurrent strokes) had an intracranial haemorrhage (59 cerebral 
haemorrhages and 11 subarachnoid haemorrhages).  
 
We described the demographic details of first-ever black stroke patients in chapter 
5. There were 9 male and 6 female recurrent stroke patients with a mean age of 
51 years (SD 16; 95% CI 42 to 60; range 28 to 74). The mean age of the recurrent 
stroke and first-ever stroke patients was the same. 
 
6.2.1    Stroke score findings 
 
Figure 6.1 shows the distribution of scores in each pathological stroke type 
(ischaemic stroke and combined intracranial haemorrhages) using the Siriraj 
Stroke Score (SSS), and figure 6.2 shows the equivalent distribution of the scores 
using the Guy’s Hospital Stroke Score (GHSS).   
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Figure 6.1 Distribution of diagnostic scores for the Siriraj Stroke Score  
 
The dotted horizontal lines refer to the cutoff level at which the score predicted the 
pathological stroke type with around 90% certainty (see Appendix F) 
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Figure 6.2   Distribution of diagnostic scores for the Guy’s Hospital Stroke 
Score 
 
The dotted horizontal lines refer to the cutoff level at which the score predicted the 
pathological stroke type with around 90% certainty (see Appendix F) 
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Each figure demonstrates the threshold values above and below which there was 
about 90% certainty of the stroke type diagnosis (see Appendix F) in the original 
validation studies for each score (Allen, 1983; Poungvarin et al., 1991). Between 
these thresholds, the scores return an uncertain result.  
 
Applying the optimum threshold values described in Appendix F, the SSS 
produced an uncertain result in 44 (20%) and the GHSS in 65 (29%) of 222 stroke 
patients. The SSS score diagnosed intracranial haemorrhage in 60 (27%) and the 
GHSS in 31 (14%) stroke patients. The scores diagnosed ischaemic stroke in 118 
(53%) and 126 (57%) of the stroke patients respectively. The SSS identified 
intracranial haemorrhage reasonably well with a score over 5, but did not 
accurately identify ischaemic stroke at any cut-off point. The GHSS diagnosed 
ischaemic stroke reasonably well below a score of 10 but did not identify 
intracranial haemorrhage well. However, using these new cut-off points the scores 
would only identify pathological stroke type in very few patients, for example 57 
(81%) of the intracranial haemorrhages would not be scored as such with the SSS 
and 135 (89%) of the true infarcts with the GHSS. 
 
We assessed whether the population studied in the validation of the SSS and 
GHSS, which therefore had CT brain scans, differed from the population that did 
not have CT brain scans in terms of score diagnosis or pathological stroke type. 
Sixty-nine black stroke patients had complete SSS and GHSS scores but did not 
have a CT brain scan. A smaller proportion of patients without a CT scan had 
intracranial bleeds according to the SSS and GHSS than those that did not have a 
scan (15% versus 29% for the SSS; and 4% versus 14% for the GHSS), possibly 
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because intracranial haemorrhage has a more dramatic presentation than 
ischaemic stroke or may have an atypical stroke presentation and so patients with 
cerebral haemorrhage were more likely to have a CT brain scan. When we 
compared the results of the scores for definite intracranial haemorrhage, definite 
ischaemic stroke and uncertain results across the two populations, we did not find 
a significant difference (p=0.07 for the SSS and p=0.06 for the GHSS). Thus, 
patients with and without a CT brain scan did not differ significantly in terms of 
score result.  
 
Clinicians from the stroke team assessed stroke type in 199 consecutive black 
stroke patients. We excluded their assessment in 80 patients, who did not have a 
CT brain scan and in a further 43 because they admitted to having some idea of 
the CT brain scan result prior to assessing the pathological stroke type. Despite 
making every attempt to blind themselves to the CT scan result, and reminders on 
the questionnaire (appendix D), stroke team clinicians were often inadvertently 
informed of the scan result by the referring physician, the patient or some other 
source, prior to making their own assessment. The clinicians finally assessed the 
pathological stroke type in 76 black stroke patients who also had a CT brain scan 
available. They assessed the pathological stroke type as ischaemic stroke in 52 
(68%) patients, intracranial haemorrhage in 16 (21%), and ‘uncertain’ in 8 patients 
who had an ischaemic stroke on CT scan. They diagnosed two patients who had 
subarachnoid haemorrhage on CT brain scan with secondary ischaemic stroke, as 
having had cerebral haemorrhages, though for the purposes of the following 
analysis we combined cerebral haemorrhage and subarachnoid haemorrhage as 
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‘intracranial haemorrhage.’ The clinicians accurately assessed the pathological 
stroke type in 56 (74%) of the 76 patients.  
 
Table 6.1 shows the sensitivity, specificity, positive predictive value, likelihood 
ratios and kappa score for the SSS, the GHSS and the clinicians’ assessment of 
intracranial haemorrhage in all (first-ever-in-a-lifetime and recurrent) stroke 
patients. 
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Table 6.1  Comparison of the Siriraj Stroke Score, Guy’s Hospital Stroke 
Score and clinician assessment of intracranial haemorrhage with 
CT brain scan diagnosis of intracranial haemorrhage in all* 
stroke patients (Note: an uncertain result was included as an 
incorrect assessment in the analysis of the Siriraj Stroke Score 
and Guy’s Hospital Stroke Score) 
 
 CT scan result  
 
Diagnosis ICH Not ICH Total 
Siriraj Stroke Score ICH (score >1) 42 18 60 
 Not ICH (score ≤1) 28 134 162 
 Total 70 152 222 
     
Guy’s Hospital Score ICH (score >24) 24 7 31 
 Not ICH (score ≤ 24) 46 145 191 
 Total 70 152 222 
     
Clinicians Assessment ICH 12 4 16 
 Not ICH 8 52 60 
 Total 20 56 76 
 
 
     Results (95% CI) 
 Siriraj Stroke Score 
Guy’s Hospital Stroke 
Score 
Clinician assessment 
Sensitivity 0.60 (0.48 to 0.71) 0.34 (0.24 to 0.46) 0.60 (0.39 to 0.78) 
Specificity 0.88 (0.82 to 0.92) 0.95 (0.90 to 0.98) 0.93 (0.83 to 0.97) 
Positive predictive value 0.70 (0.58 to 0.80) 0.77 (0.60 to 0.89) 0.75 (0.51 to 0.90) 
Likelihood ratio:    
- for a positive score 5.1 (3.2 to 8.1) 7.5 (3.4 to 16.5) 8.4 (3.0 to 23) 
- for a negative score 0.5 (0.3 to 0.6) 0.7 (0.6 to 0.8) 0.4 (0.3 to 0.7) 
Kappa statistic 0.5 (0.4 to 0.6) 0.4 (0.2 to 0.5) 0.6 (0.3 to 0.8) 
 
* All stroke patients = first-ever-in-a-lifetime and recurrent stroke patients 
ICH – intracranial haemorrhage 
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Table 6.2  Comparison of the Siriraj Stroke Score, Guy’s Hospital Stroke 
Score and clinician assessment of intracranial haemorrhage with 
CT brain scan diagnosis of intracranial haemorrhage in first-ever-
in-a-lifetime stroke patients (Note: an uncertain result was 
included as an incorrect assessment in the analysis of the Siriraj 
Stroke Score and Guy’s Hospital Stroke Score) 
 
 CT scan result  
 
Diagnosis ICH Not ICH Total 
Siriraj Stroke Score ICH (score >1) 42 17 59 
 Not ICH (score ≤1) 24 124 148 
 Total 66 141 207 
     
Guy’s Hospital Score ICH (score >24) 23 5 28 
 Not ICH (score ≤ 24) 43 136 179 
 Total 66 141 207 
     
Clinicians Assessment ICH 11 4 15 
 Not ICH 7 49 56 
 Total 18 53 71 
 
 
 Results (95% CI) 
 Siriraj Stroke Score 
Guy’s Hospital  Stroke 
Score 
Clinician assessment 
Sensitivity 0.64 (0.52 to 0.74) 0.35 (0.25 to 0.47) 0.61 (0.39 to 0.80) 
Specificity 0.88 (0.82 to 0.92) 0.97 (0.92 to 0.99) 0.93 (0.82 to 0.97) 
Positive predictive value 0.71 (0.59 to 0.81) 0.82 (0.64 to 0.92) 0.73 (0.48 to 0.89) 
Likelihood ratio:    
- for a positive score 5.3 (3.3 to 8.5) 9.8 (3.9 to 24.7) 8.1 (2.9 to 22.3) 
- for a negative score 0.4 (0.3 to 0.6) 0.7 (0.6 to 0.8) 0.4 (0.2 to 0.8) 
Kappa statistic 0.5 (0.4 to 0.7) 0.4 (0.2 to 0.5) 0.6 (0.3 to 0.8) 
 
ICH – intracranial haemorrhage 
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Table 6.2 provides the same analyses but only in black patients with first-ever-in-
a-lifetime stroke. The findings were not markedly different when applied to first-
ever-in-a-lifetime stroke patients or all stroke patients. The GHSS had a slightly 
better sensitivity (probability of a positive test in people with the disease), 
specificity (probability of a negative result in people without the disease) and 
positive predictive value (probability of the person having the disease when the 
test is positive) when only first-ever strokes were assessed, although this did not 
change the ranking of the scores. The likelihood ratio for a positive score using the 
GHSS was better when only first-ever strokes were considered, but the Kappa 
statistic was the same for both all stroke and first-ever stroke patients.  
 
In general, the SSS had about the same sensitivity for detecting intracranial 
haemorrhage as the clinicians, and both had a higher sensitivity than the GHSS. 
The GHSS was, however, more specific than the SSS or clinicians, and had the 
highest positive predictive value. The likelihood ratio incorporates both the 
sensitivity and specificity of the test and provides a direct estimate of how much a 
positive test will change the odds of having a disease or in this case an intracranial 
haemorrhage (Sackett, Haynes, Guyatt et al, 1991; Altman, Machin, Bryant et al, 
2000; Simon, 2006). The likelihood ratio for a positive score tells one how much 
the odds of the disease increase when a score (for intracranial haemorrhage in 
this case) is positive, and the likelihood ratio for a negative score tells one how 
much the odds of the disease decrease with a negative score. Both the GHSS and 
the clinicians had a higher likelihood ratio with a positive diagnosis of intracranial 
haemorrhage than the SSS, and the GHSS performed best in the patients with 
first-ever stroke.  
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We used the Kappa statistic, which in this case is a measure of agreement 
between the scores and the CT findings, or clinician assessment and the CT 
findings. The Kappa statistic assesses agreement beyond the level of agreement 
expected by chance alone (Altman et al., 2000). Using this statistic, the GHSS had 
fair agreement, the SSS moderate and the clinicians good agreement with the CT 
result (0.0 to 0.2: slight agreement; 0.2 to 0.4: fair agreement; 0.4 to 0.6: moderate 
agreement; 0.6 to 0.8: good / substantial agreement; 0.8 to 1.0: almost perfect 
agreement) (Sackett et al., 1991; Simon, 2006).  
 
Thus, the SSS and clinicians were more likely to detect intracranial haemorrhage 
and had moderate to good agreement with the CT findings, but if the GHSS gave 
a definite diagnosis of intracranial haemorrhage the odds of patient indeed having 
intracranial haemorrhage were higher than with the SSS or clinician assessment. 
 
Table 6.3 (all stroke) and 6.4 (first-ever-in-a-lifetime stroke) show the same 
analyses of sensitivity, specificity, positive predictive value, likelihood ratio and 
Kappa statistic for the SSS, GHSS and clinician assessment of ischaemic stroke. 
The findings in all stroke and first-ever-in-a-lifetime stroke patients were almost 
identical for the diagnosis of ischaemic stroke. The SSS and GHSS were equally 
sensitive, but the SSS was more specific than the GHSS in the diagnosis of 
ischaemic stroke, when compared to the CT brain scan diagnosis. Clinicians were 
more likely to detect ischaemic stroke than the scores, but less specific. 
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Table 6.3  Comparison of the Siriraj Stroke Score, Guy’s Hospital Stroke 
Score and clinician assessment of ischaemic stroke with CT 
brain scan diagnosis of ischaemic stroke in all* stroke patients 
(Note: an uncertain result was included as an incorrect 
assessment in the analysis of the Siriraj Stroke Score and Guy’s 
Hospital Stroke Score) 
 
 CT scan result  
 
Diagnosis IS Not IS Total 
Siriraj Stroke Score IS (score < -1) 107 11 118 
 Not IS (score ≥ -1) 45 59 104 
 Total 152 70 222 
     
Allen (Guy’s Hospital) Score IS (score < 4) 108 18 126 
 Not IS (score ≥ 4) 44 52 96 
 Total 152 70 222 
     
Clinicians Assessment IS 44 8 52 
 Not IS 12 12 24 
 Total 56 20 76 
 
 
 
  Results (95% CI)  
 Siriraj Stroke Score 
Allen (Guy’s Hospital 
Score) 
Clinician assessment 
Sensitivity 0.70 (0.63 to 0.77) 0.71 (0.63 to 0.78) 0.79 (0.66 to 0.87) 
Specificity 0.84 (0.74 to 0.91) 0.74 (0.63 to 0.83) 0.60 (0.39 to 0.78) 
Positive predictive value 0.91 (0.84 to 0.95) 0.86 (0.79 to 0.91) 0.85 (0.73 to 0.92) 
Likelihood ratio:    
- for a positive score 4.5 (2.6 to 7.8) 2.8 (1.8 to 4.2) 2.0 (1.1 to 3.4) 
- for a negative score 0.4 (0.3 to 0.5) 0.4 (0.3 to 0.5) 0.4 (0.2 to 0.7) 
Kappa statistic 0.5 (0.4 to 0.6) 0.4 (0.3 to 0.5) 0.4 (0.1 to 0.6) 
 
* All stroke patients = first-ever-in-a-lifetime and recurrent stroke patients 
IS – ischaemic stroke 
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Table 6.4  Comparison of the Siriraj Stroke Score, Guy’s Hospital Stroke Score 
and clinician assessment of ischaemic stroke with CT brain scan 
diagnosis of ischaemic stroke in first-ever-in-a-lifetime stroke 
patients (Note: an uncertain result was included as an incorrect 
assessment in the analysis of the Siriraj Stroke Score and Guy’s 
Hospital Stroke Score) 
 
 CT scan result  
 
Diagnosis IS Not IS Total 
Siriraj Stroke Score IS (score < -1) 99 10 109 
 Not IS (score ≥ -1) 42 56 98 
 Total 141 66 207 
     
Allen (Guys Hospital) Score IS (score < 4) 100 17 117 
 Not IS (score ≥ 4) 41 49 90 
 Total 141 66 207 
     
Clinicians Assessment IS 42 7 49 
 Not IS 11 11 22 
 Total 53 18 71 
 
 Results (95% CI) 
 Siriraj Stroke Score 
Allen (Guy’s Hospital 
Score) 
Clinician assessment 
Sensitivity 0.70 (0.62 to 0.71) 0.71 (0.63 to 0.78) 0.79 (0.67 to 0.88) 
Specificity 0.85 (0.74 to 0.92) 0.74 (0.63 to 0.83) 0.61 (0.39 to 0.80) 
Positive predictive value 0.91 (0.84 to 0.95) 0.86 (0.78 to 0.91) 0.86 (0.73 to 0.93) 
Likelihood ratio:    
- for a positive score 4.6 (2.6 to 8.3) 2.8 (1.8 to 4.2) 2.0 (1.1 to 3.7) 
- for a negative score 0.4 (0.3 to 0.5) 0.4 (0.3 to 0.5) 0.3 (0.2 to 0.7) 
Kappa statistic 0.5 (0.4 to 0.6) 0.4 (0.3 to 0.5) 0.4 (0.1 to 0.6) 
 
IS – ischaemic stroke 
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The positive predictive value was similar for clinicians and the two scores, but the 
likelihood ratio of a positive score was almost double for the SSS compared to 
both the GHSS and clinicians. The Kappa statistic showed that the measure of 
agreement between the scores and the clinicians, and a definite CT scan 
diagnosis of ischaemic stroke, was moderate at best.  
 
Thus, although there was not a great deal of difference between the accuracy in 
diagnosing ischaemic stroke using the SSS, the GHSS and clinician assessment, 
the SSS performed slightly better. The scores and clinician assessment were more 
sensitive in the diagnosis of ischaemic stroke than intracranial haemorrhage, but 
less specific. Agreement above that expected by chance (the Kappa statistic) with 
CT brain scan findings of pathological stroke type, was moderate for both scores 
and the clinician assessment.  
 
While scores used in epidemiological studies should be accurate in diagnosing 
both intracranial haemorrhage and ischaemic stroke, in the day-to-day 
management of stroke patients in a setting without a CT scanner, a score’s ability 
to identify patients with haemorrhage, who might be harmed by the use of 
antiplatelet agents or in certain circumstances antithrombotic agents, is very 
important. Thus, a good screening score with a high sensitivity for diagnosing 
intracranial haemorrhage would be useful clinically, particularly if it added to the 
clinician assessment. The SSS, although it did not perform particularly well, was 
the more sensitive of the two scoring systems in detecting intracranial 
haemorrhage. Given that the SSS only requires a history and examination, it is  
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more likely to be used in low resource settings like rural South Africa, and is 
therefore the more promising of the two scores.  
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6.3    Discussion 
 
We found that the Siriraj Stroke Score (SSS) and the Guy’s Hospital Stroke Score 
(GHSS) did not perform particularly well in diagnosing the pathological stroke type 
in black South African stroke patients. The SSS performed marginally better than 
the GHSS and had a much higher sensitivity for detecting intracranial 
haemorrhages. Neither score offered much advantage over our stroke team 
clinicans’ assessments of pathological stroke type.  
 
This study is the first prospective study of scores used to distinguish pathological 
stroke type in Sub-Saharan African stroke patients. There have, however, been 
retrospective assessments of the Siriraj Score and WHO score from elsewhere in 
Sub-Saharan Africa (Ogun, Oluwole, Oluremi et al, 2001; Ogun, Oluwole, Fatade 
et al, 2002; Zenebe, Asmera, & Alemayehu, 2005b). We have compared our 
findings with those found in Nigeria (Ogun et al., 2001; Ogun et al., 2002) and 
Ethiopia (Zenebe et al., 2005b), and in other regions of the world in tables 6.5 and 
6.6. We separated prospective and retrospective studies, as incomplete records 
so often affect the latter. We also noted when studies included and excluded 
‘uncertain’ results from their calculations. Both sensitivity and specificity may be 
increased by excluding ‘uncertain’ results. For example in our evaluation of the 
SSS, if we had excluded the ‘uncertain’ results, we would have increased the 
sensitivity for diagnosing intracranial haemorrhage from 0.60 to 0.79, although the 
specificity decreased marginally from 0.88 to 0.86 and the positive predictive value 
was unchanged. As a high sensitivity for detection of intracranial haemorrhage is 
essential in the clinical setting, and ‘uncertain’ results are part of the routine use of 
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a score, inclusion of the ‘uncertain’ results provides the more accurate assessment 
of the score. 
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Table 6.5  Performance of the Siriraj Stroke Score and Guy’s Hospital Stroke Score in 
diagnosing intracranial haemorrhage compared to gold standard (brain imaging or 
autopsy) in different populations 
 
Study 
Study 
size* 
Design Sensitivity Specificity PPV 
Uncertain scores included / 
excluded 
Siriraj Stroke Score 
Diagnosis of intracranial haemorrhage 
Africa 
JHSR 
(South Africa) 
222 prospective 0.60 0.88 0.70 included 
Nigeria 
(Ogun et al) 
96 retrospective 0.50 0.63 0.55 included 
Ethiopia 
(Zenebe et al) 
41 retrospective 0.48 0.75 0.67 
included (re-calculated from 
data provided) 
Rest of the world 
Thailand (Poungvarin et al) 165 prospective 0.89 0.93 0.97 excluded 
Italy 
(Celani et al) 
193 prospective 0.61 0.94 0.63 excluded 
India 
(Badam et al) 
134 prospective 0.79 0.71 - N/A 
India 
(Kochar et al) 
159 prospective 0.85 0.73 0.71 N/A 
Pakistan 
(Shah et al) 
100 prospective 0.73 0.90 0.83 N/A 
Hong Kong, China 
(Hui et al) 
253 prospective 0.91 0.90 0.69 N/A 
Malaysia 
(Kan et al) 
160 prospective 0.50 0.91 0.66 included 
USA 
(Akpunonu et al) 
254 retrospective 0.36 - 0.77 excluded 
New Zealand (Hawkins et al) 485 retrospective 0.48 0.85 0.59 included 
United Kingdom (Weir et al) 482 retrospective 0.67 0.71 0.22 N/A 
Guy’s Hospital Stroke Score 
Diagnosis of intracranial haemorrhage 
Africa 
JHSR 
(South Africa) 
222 prospective 0.34 0.95 0.77 included 
Rest of the world 
Italy 
(Celani et al) 
187 prospective 0.38 0.98 0.71 excluded 
Taiwan 
(Huang et al) 
180 prospective 0.67 1.00 1.00 excluded 
India 
(Badam et al) 
134 prospective 0.81 0.76 - N/A 
India 
(Kochar et al) 
147 prospective 0.60 0.91 0.82 N/A 
New Zealand 
(Hawkins et al) 
472 retrospective 0.31 0.95 0.73 included 
United Kingdom 
(Sandercock et al)† 
228 retrospective 0.78 0.81 0.95 N/A 
United Kingdom (Weir et al) 322 retrospective 0.79 0.66 0.21 N/A 
 
JHSR – Johannesburg Hospital Stroke Register; *Study size refers to the number of cases used in the analysis and not the total 
number of stroke cases; †Figures refer to the results for the Oxfordshire Community Stroke Project assessment of the score; 
PPV – positive predictive value; N/A – not available 
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Table 6.6  Performance of the Siriraj Stroke Score and Guy’s Hospital Stroke Score in 
diagnosing ischaemic stroke compared to gold standard (brain imaging or 
autopsy) in different populations 
 
Study 
Study 
size* 
Design Sensitivity Specificity PPV 
Comment on handling of 
cases with uncertain scores 
Siriraj Stroke Score 
Diagnosis of ischaemic stroke 
Africa 
JHSR 
(South Africa) 
222 prospective 0.70 0.84 0.91 included 
Nigeria 
(Ogun et al) 
96 retrospective 0.58 0.55 0.63 
included for sensitivity, 
excluded for specificity and 
PPV 
Ethiopia 
(Zenebe) 
41 retrospective 0.40 0.86 0.73 
included (re-calculated from 
data provided) 
Rest of the world 
Thailand 
(Poungvarin et al) 
165 prospective 0.93 0.89 0.76 excluded 
Pakistan 
(Shah et al) 
100 prospective 0.71 0.85 0.87 N/A 
India 
(Kochar et al) 
159 prospective 0.73 0.85 0.85 N/A 
Hong Kong, China 
(Hui et al) 
253 prospective 0.78 0.80 0.93 N/A 
Malaysia 
(Kan et al) 
160 prospective 0.70 0.64 0.85 included 
New Zealand 
(Hawkins et al) 
485 retrospective 0.61 0.74 0.84 included 
USA 
(Akpunonu et al) 
254 retrospective 0.90 - 0.61 excluded 
Allen (Guy’s Hospital) Score 
Diagnosis of ischaemic stroke 
Africa 
JHSR 
(South Africa) 
222 prospective 0.71 0.74 0.86 included 
Rest of the world 
India 
(Kochar et al) 
147 prospective 0.91 0.60 0.77 N/A 
New Zealand 
(Hawkins et al) 
472 retrospective 0.78 0.70 0.86 included 
United Kingdom 
(Sandercock et al) 
228 retrospective 0.78 0.81 0.95 N/A 
 
JHSR – Johannesburg Hospital Stroke Register; *Study size refers to the number of cases used in the analysis and not the total 
number of stroke cases; †Figures refer to the results for the Oxfordshire Community Stroke Project assessment of the score; 
PPV – positive predictive value; N/A – not available 
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6.3.1  Comparison of our SSS and GHSS findings with other studies – 
intracranial haemorrhage 
 
We found a higher sensitivity, specificity and positive predictive value for the SSS 
in detecting intracranial haemorrhage than was found in the two retrospective 
assessments of the score in Nigeria and Ethiopia. This was in spite of their higher 
proportions of intracranial haemorrhage (59% in Ethiopia and 47% in Nigeria) 
(Ogun et al., 2002; Zenebe et al., 2005b), compared to the 70 intracranial 
haemorrhages in our 222 (32%) stroke patients. This probably reflects patient 
selection or case mix and the limitations of a retrospective study design rather 
than a true difference in the performance of the SSS in other black populations in 
Sub-Saharan Africa. Our findings are well within the range of findings in 
populations with a varying prevalence of cerebral haemorrhage (table 6.5). The 
most appropriate study for comparison with our study is from Malaysia (Kan, Lee, 
Low et al, 2000). It too was a prospective study of 160 patients which included 
‘uncertain’ results in the analyses. We found the SSS had a slightly higher 
sensitivity for detecting intracranial haemorrhage than in the Malaysian study (0.60 
versus 0.50), but the specificity and positive predictive values were similar in the 
two studies.  
 
Not surprisingly, the SSS did not fare nearly as well in our study as it did in the 
original validation study (Poungvarin et al., 1991), though only one study from 
Hong Kong (Hui, Wu, Tang et al, 2002) has ever replicated the promise of the 
original study. It has been suggested that the SSS has failed to impress in high-
income white populations because it was developed in Thailand in a population 
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with a high prevalence of cerebral haemorrhage (Hawkins et al., 1995). However, 
the score did not do much better in our population despite a high prevalence of 
cerebral haemorrhage. The SSS, despite performing better than the GHSS, needs 
further refinement and adaptation to meet our population needs.  
 
Although the GHSS has shown a high specificity in the diagnosis of intracranial 
haemorrhage and a fairly good positive predictive value, the sensitivity has been 
more variable (table 6.5). Together with studies from Italy (Celani, Righetti, 
Migliacci et al, 1994) and New Zealand (Hawkins et al., 1995) we found the lowest 
sensitivity (0.31 to 0.38) for detecting intracranial haemorrhage using the GHSS. 
Again it has been suggested that the GHSS was developed with relatively young 
stroke patients (under the age of 76 years), and therefore in a population with a 
higher prevalence of intracranial haemorrhage (Hawkins et al., 1995), yet the 
score failed to perform well in our very young stroke population.  
 
6.3.2  Comparison of our SSS and GHSS findings with other studies – 
ischaemic stroke 
 
The SSS performed better in our study than in the two retrospective studies from 
Nigeria and Ethiopia (table 6.6). We found the same sensitivity for diagnosing 
ischaemic stroke as was found in Malaysia in a study that also included ‘uncertain’ 
cases in the analyses (Kan et al., 2000). Our findings for sensitivity, specificity and 
positive predictive value are remarkably consistent with those found in prospective 
studies from Pakistan, India and Hong Kong (Kochar, Joshi, Agarwal et al, 2000; 
Hui et al., 2002; Shah, Salih, Saeed et al, 2003).  
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The GHSS performed better at diagnosing ischaemic stroke than intracranial 
haemorrhage in our study, yet this was still poor compared to the GHSS 
performance in other studies (table 6.6). The GHSS score places far more 
emphasis on measures of atherosclerosis than the SSS does. It is possible that it 
performs better in populations in which atherosclerosis is an important cause of 
ischaemic stroke, rather than in populations such as ours where atherosclerotic 
diseases such as ischaemic heart disease, extracranial carotid artery disease and 
symptomatic peripheral vascular disease are uncommon.  
 
6.3.3  The accuracy of bedside clinical diagnosis of pathological stroke type 
 
Previous studies have shown that the bedside assessment of pathological stroke 
type by clinicians is not accurate (von Arbin et al., 1981; Allen, 1983; Allen, 1984). 
In Stockholm (von Arbin et al., 1981), clinicians made an accurate bedside 
diagnosis in 69% of 206 stroke cases, a very similar finding to our clinicians who 
accurately diagnosed 56 (74%) of 76 stroke patients. Clinicians at Guy’s Hospital 
were less accurate than the Guy’s Hospital Stroke Score, but still diagnosed stroke 
type accurately in 84% of patients (detailed number of patients not available). In a 
recent study from Ethiopia, stroke type was accurately diagnosed in 37 (76%) of 
49 stroke patients, far more often than by the SSS which only managed to 
accurately make the diagnosis in 18 (44%) of 41 patients (Zenebe et al., 2005a).  
 
Thus, our clinicians performed about as well as other clinicians have around the 
world. However, clinicians in our study as in the other three studies were working 
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in major centres. In our study, neurologists or trainees in neurology assessed the 
majority of patients. Possibly clinicians without neurology training would not 
perform as well. This would limit the generalisation of our findings to hospitals and 
clinics in remote areas of South Africa, and it is in these settings that the stroke 
score may still have a role.  
 
6.3.4   Limitations of this study 
 
Apart from the difficulty with generalisation of our clinician assessments, this study 
has several further limitations. The number of patients assessed by clinicians was 
very small resulting in wide confidence intervals around our assessments of their 
accuracy in diagnosing stroke type. We added the clinician assessment about half-
way through the study and were unable to assess many patients because the 
clinicians already knew the results of the CT brain scan. In any future studies, we 
would have to put a great deal of effort into alerting colleagues in the medical 
department to the need for withholding the pathological stroke type information.  
 
Although we did not find a significant difference between the score results in those 
patients who had a CT brain scan and those that did not have a CT scan, our low 
scan rate may have influenced our findings. The ideal validation study would have 
an almost 100% scan rate, preferably in a community-based study in order to 
assess the stroke score in stroke patients with a wide range of severity, and to 
assess the score’s potential performance in epidemiological studies.  
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We did not assess whether the intracranial haemorrhages missed were indeed 
clinically relevant. It is possible that many of the haemorrhages missed were small 
and from a management perspective in rural South Africa this might not be too 
important. The 800 patients with cerebral haemorrhages in the International Stroke 
Trial who were given aspirin did not show evidence of net hazard (Chen, 
Sandercock, Pan et al, 2000), and it would not be of great concern should a score 
miss this type of small cerebral haemorrhage, as long as it accurately detected 
larger haemorrhages.  
 
We have not evaluated the sequential use of the two scores, nor what factors in 
the scores are most predictive of intracranial haemorrhage. This analysis and the 
further validation in a new population would be important in devising a stroke score 
that performs well in the local South African black population. 
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6.4    Conclusion 
 
We agree with others who have suggested that stroke scores are not sufficiently 
accurate to replace CT brain imaging in either epidemiological studies or clinical 
management (Weir, Murray, Adams et al, 1994; Hawkins et al., 1995; Kan et al., 
2000; Badam, Solao, Pai et al, 2003). The scores were only accurate when we 
used new cut-off points that resulted in a diagnosis of uncertain stroke type in the 
vast majority. Therefore, one could only possibly consider using the scores, as 
was done in the Oxfordshire Community Stroke Project, to supplement CT scan 
results. 
 
Unfortunately, stroke incidence is likely to increase across Sub-Saharan Africa, a 
region with very limited access to CT or MRI scanners, and stroke scores may yet 
have a clinical role here. For great parts of Sub-Saharan Africa, thrombolytics and 
even anticoagulation for the few that need it, are not feasible therapeutic options 
given the limited access to imaging and laboratory facilities. However, a score that 
excluded significant cerebral haemorrhage would encourage doctors and nurses in 
remote areas to initate aspirin therapy. Only one of the 103 prevalent stroke 
patients in the SASPI study (chapter 3 and 4) were taking aspirin, and early 
initiation of aspirin in hospital may increase the number of patients who continue it 
as secondary prevention. We need further studies to adapt these scores for use in 
our population.  
 
In the following chapter, we present the findings of the Tintswalo Hospital Stroke 
Register, a rural register established in a hospital without easy access to CT brain 
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scanning. We used the same methodology to calculate the SSS and GHSS in the 
Tintswalo Hospital Stroke Register as we used in the JHSR. Despite the poor 
performance of the SSS and GHSS, we will report the assessment of pathological 
stroke types using the stroke scores as well as using our clinical assessment. 
 
6.4.1  What this study adds to the literature 
 
This study provides the first prospective, and largest, validation study of stroke 
scores designed to distinguish pathological stroke type in Sub-Saharan Africa, and 
is the only stroke score validation study from South Africa. Apart from being 
prospective, our study also had a higher CT scan rate than the Nigerian and 
Ethiopian studies in tables 6.5 and 6.6, and is the first to assess the performance 
of the Guy’s Hospital Stroke Score in Sub-Saharan Africa. Furthermore, this study 
provides the only prospective assessment of the accuracy of clinician bedside 
diagnosis of pathological stroke type in Sub-Saharan Africa. 
 
 
 
 305 
CHAPTER 7 THE TINTSWALO HOSPITAL STROKE REGISTER 
(THSR) – RURAL STROKE 
 
 
7.0   Introduction 
 
Most stroke case series and all previous prospective stroke registers from Sub-
Saharan Africa (SSA) have been urban based (chapter 2), and included urban or a 
mixture of both urban and rural stroke patients (Kwasa et al., 1990; Walker et al., 
2003; Garbusinski et al., 2005). Several studies have found a higher prevalence of 
vascular risk factors in urban than in rural populations in SSA (Edwards, Unwin, 
Mugusi et al; Aspray, Mugusi, Rashid et al; van Rooyen, Kruger, Huisman et al, 
2000; Kruger, Venter, & Vorster, 2001; Vorster, 2002; Oosthuizen et al., 2002), 
most likely the result of urbanisation of the population. The increase in vascular 
risk drives the emergence of vascular disease in populations undergoing health 
transition (chapter 1). As discussed in section 1.6, the nature of stroke is likely to 
change during a population’s transition. It is probable, though not well 
documented, that the nature of stroke differs between rural and urban populations 
as it does between high and low income regions of the world (chapter 1 and 2).  
 
We established a rural stroke register, based at Tintswalo Hospital, to compare the 
nature of rural stroke with urban stroke in blacks (Johannesburg Hospital Stroke 
Register). Furthermore, although we had assessed the prevalence and nature of 
prevalent stroke cases in the Bohlabela region (chapters 3 and 4), it is likely that 
our assessment of pathological stroke type, ischaemic stroke subtype, and 
underlying cause in the prevalent cases was influenced by the sometimes lengthy 
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time delay between stroke onset and our assessment of the stroke survivors. The 
Tinswalo Hospital Stroke Register (THSR) provided the opportunity to assess 
acute stroke patients in the same rural population and to document their pattern of 
presentation to hospitals in this under-resourced area, where simply getting to 
hospital provides a major challenge to most patients.  
 
7.0.1 Aim of the THSR 
 
Our aim was to assess the profile of stroke patients admitted to Tintswalo Hospital, 
including their demographic characteristics, pathological stroke type as far as 
possible, ischaemic stroke subtype, risk factors, cause, severity, and in-hospital 
outcome, and to compare this with black stroke patients in the Johannesburg 
Hospital Stroke Register (JHSR).  
 
7.1  Methods of the THSR 
 
7.1.1 Population and setting 
 
Tintswalo Hospital is a 400 bed hospital, based in Acornhoek in the Bohlabela 
region of Limpopo Province, in the north-east of South Africa (Acornhoek is shown 
on the map in figure 3.1). The population served is almost exclusively black South 
African. Although the region is considered rural (Tollman, Mkhabela, & Pienaar, 
1993; Tollman, Herbst, Garenne et al, 1999), some parts of the region are 
probably semi-urban. Tintswalo Hospital is one of the three hospitals that provide 
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secondary level care to people living in the Agincourt Health and Population Unit 
demographic surveillance site, where we assessed the prevalence of rural stroke 
(chapter 3). Although the hospital has 400 beds, a large proportion are for 
psychiatric patients, as the hospital is the regional psychiatric referral hospital. 
Most doctors are either interns (house officers) or doing their community-service, 
and the number of doctors varies from year to year. There were between four and 
eight permanent doctors at the time we ran the THSR, with a couple of general 
practitioners in the area providing emergency cover from time to time.  
 
Tintswalo Hospital, and the Bohlabela region, did not have access to a CT scanner 
at the time of the THSR. Indeed the province only had one CT scanner servicing 
patients without medical insurance, based in the provincial capital, Polokwane, 
some 300 km away. The hospital only had access to three ambulances, but in our 
experience, only one was operational at any given time. X-ray facilities were 
limited and although basic chest x-rays were theoretically available, we were only 
able to obtain them erratically if at all during the THSR. The medical wards had an 
electrocardiograph machine, but this too seldom functioned. The hospital 
laboratory provided a limited and erratic service but about halfway through the 
register, as part of the SASPI study, we received funding to courier blood samples 
to the University of the Witwatersrand Contract Lab Services.  
 
7.1.2 Case ascertainment and assessment 
 
The Tintswalo Hospital Stroke Register (THSR) included all consecutive cases of 
stroke admitted to Tintswalo Hospital, or which occurred while in hospital, over 20 
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months during two periods: from 1st June 2001 till 31st December 2001 and from 
1st April 2002 till 30th June 2003. Initially a nurse trainer from the primary health 
care nursing group based at Tintswalo Hospital ascertained stroke cases. During 
the second longer period, we had a trained senior nurse dedicated to the THSR. 
The THSR nurse ascertained cases on a daily basis from the casualty (emergency 
room) register, the hospital admission book, the medical wards and by checking 
the death register. All the hospital doctors met every morning to hand over the 
patients admitted overnight and to discuss clinical ‘problem cases.’ The THSR 
nurse used this opportunity to ask the doctors whether they had admitted any 
patients with stroke or transient ischaemic attack, or if any in-patients had had a 
stroke or transient ischaemic attack. We assessed patients with transient 
ischaemic attack (TIA) but did not include them on the register, as so often 
patients assumed to have had a TIA turn out to have had a stroke.  
 
Once the THSR nurse had located a potential stroke patient, she informed the 
patient or their carers (if the patient could not communicate), about the THSR. She 
provided them with an information sheet in Shangaan (the most frequently spoken 
local language), and asked for verbal consent to assess them. She also asked for 
consent to take blood (from the 1st July 2002 when we had funding for blood 
investigations to be sent to Johannesburg), and for me to assess the patient with 
her on my approximately weekly to fortnightly visits to the hospital. She obtained 
consent for HIV testing separately, and if the patient agreed she counselled the 
patient prior to venesecting them. (Figures 7.1 and 7.2 show scenes of Tintswalo 
Hospital and the staff who ran the THSR).  
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Figure 7.1  Tintswalo Hospital male surgical (above) and female medical ward 
(below) 
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Figure 7.2  Entrance and outpatient waiting area – Tintswalo Hospital (above); 
below (left to right) Myles Connor, Andrina Sambo (THSR nurse) and 
Bulelwa Ngoma SASPI research fellow and co-ordinator 
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I assessed all possible patients in detail when I visited the hospital, i.e. unless the 
patient had died, or rarely been discharged prior to my visit. I also reviewed each 
questionnaire in detail before entering the patient’s data onto the THSR database. 
 
Unlike in the JHSR where we excluded patients who had had a stroke more than 6 
months prior to admission, patients were included in the register if the stroke was 
the main reason for seeking medical assistance. We took this approach because 
we wanted to obtain a full picture of the health seeking behaviour of rural stroke 
patients.  
 
We assessed and documented the patients’ demographic details, history and 
examination findings, as well as the results of investigations on the THSR 
questionnaire (Appendix G), which was adapted from the basic questionnaire used 
for the JHSR and stroke prevalence study. The methodology of the JHSR and 
THSR therefore overlapped in the following areas of assessment: socioeconomic 
indicators, symptoms at stroke onset, known stroke risk factors (based on the 
history from the patient and their carers), medication use, assessment of functional 
state both at the time of our assessment and prior to the stroke, findings of the 
neurological, cardiac, vascular and general medical examination, stroke severity 
(National Institutes of Neurological Disorders and Stroke Scale and Scandinavian 
Stroke Scale), modified Rankin score and Barthel score (see section 5.1.2 for 
more detail). We also documented any complications arising from the stroke and 
any in-hospital deaths in the THSR.  
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We used the same definitions of stroke, first-ever-in-a-lifetime stroke, and transient 
ischaemic attack as we used in the JHSR (section 5.1.2.1). However, in view of 
the lack of CT brain scanning, we assessed pathological stroke type (cerebral 
haemorrhage or ischaemic stroke) based on our clinical judgement and the Siriraj 
and Guy’s Hospital stroke scores (chapter 6). We were more likely to diagnose 
cerebral haemorrhage if the patient presented with sudden onset of neck stiffness, 
severe headache, and seizures, accompanied by new focal neurological signs and 
symptoms. We diagnosed subarachnoid haemorrhage based on the characteristic 
sudden severe headache without new focal neurological signs. We considered 
appropriate cerebrospinal fluid abnormalities and neck stiffness supportive of the 
diagnosis.  
 
We assessed ischaemic stroke subtypes using the Oxfordshire Community Stroke 
Project (OCSP) classification, and used the Trial of Org 101 in Acute Stroke 
Treatment (TOAST) classification as in the JHSR (section 5.1.2.1). However, in 
the absence of CT brain imaging we did not anticipate that the TOAST 
classification would be helpful, and as in the JHSR we also assigned a ‘most likely’ 
cause to all first-ever-in-a-lifetime stroke patients, based on their history, risk 
factors, examination findings and investigations.  
 
The risk factors assessed and the definitions we used for: diabetes mellitus, 
cigarette smoking, alcohol use, ischaemic heart disease, peripheral vascular 
disease, first-ever-in-a-lifetime stroke, transient ischaemic attack, ethnicity, and 
historical risk factors were the same as those used in the JHSR (see section 
5.1.2). We used the same definition for hypertension as we used in the JHSR, but 
 313 
we did not have access to echocardiography for the diagnosis of left ventricular 
hypertrophy. Therefore, we diagnosed hypertensive heart disease on the basis of 
a history of hypertension, marked clinical evidence of left ventricular hypertrophy, 
ECG findings of left ventricular hypertrophy or a blood pressure of greater than or 
equal to 140 mmHg systolic or 90 mmHg diastolic if this was recorded prior to the 
stroke or more than one week following the stroke. We seldom had access to 
ECGs for the diagnosis of atrial fibrillation, so unlike in the JHSR where our 
definition of atrial fibrillation included ECG evidence of atrial fibrillation, in the 
THSR, we accepted the clinical finding of an irregularly irregular heart rate without 
a better explanation, as atrial fibrillation. We considered recurrent stroke to be a 
stroke (new focal neurological signs in a different territory to the index stroke) that 
occurred following our index stroke, and prior stroke to be a history of stroke prior 
to the current admission. We assessed patients with prior stroke in detail, but did 
not include them in the analysis and results of the first-ever-in-a-lifetime stroke 
cases.  
 
Blood investigations requested included: full blood count, erythrocyte 
sedimentation rate, urea and electrolytes, blood glucose (random), serum total and 
high denity lipid (HDL) cholesterol (random), syphilis serology and if the patient 
had given consent, HIV serology (ELISA). Cerebrospinal fluid was sent for routine 
testing when appropriate.  
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7.1.3 Data analysis 
 
We entered all questionnaires onto Microsoft Access 2002 SP3 and analysed the 
data using STATA software (StataCorp, 2001) using exactly the same 
methodology as used in the JHSR (section 5.1.3). We used Confidence Interval 
Analysis software (Bryant, 2000)  and STATA to assess confidence intervals.  
 
7.1.4 Ethics approval 
 
 
 The University of the Witwatersrand Human Ethics Research Committee provided 
us with approval for the Tintswalo Hospital Stroke Register as an extension to the 
approval for the Johannesburg Hospital Stroke Register (M00/03/7) (March 2001 
full meeting) (Appendix H). 
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7.2 Results 
7.2.1 Characteristics of the THSR stroke patients 
 
One hundred and seventy-two patients with presumed stroke were referred to the 
THSR team over a 20-month period. We diagnosed 138 patients with first-ever-in-
a-lifetime stroke. Figure 7.3 shows the reasons why we excluded 34 patients. 
Three patients with a history of prior stroke were dead on arrival at the hospital, 
and 11 patients did not have a stroke. Twenty patients had a history of prior 
stroke, and now presented with new focal neurological signs rather than simply 
deterioration in their old symptoms. We assessed these patients but did not 
include them in our analyses of the 138 first-ever-in-a-lifetime stroke patients. 
None of the patients had a transient ischaemic attack.  
 
All the stroke patients were black South Africans from the local Bohlabela area. 
Table 7.1 shows the main characteristics of the stroke patients by sex. We found 
that females predominated, with a male to female ratio of 1:1.7. We could assess 
age in 133 of 138 patients. In five patients, we could not assess age because the 
patient and their relatives did not know their age and they did not have any official 
record of their age. The mean age was 64 years with a wide range of 19 to 94 
years and a median age of 68 years (95% CI, 65 to 71 years). We did not find a 
significant difference in the mean (p=0.8) or median (p=0.7) age of males and 
females. All but one of the 129 patients we could assess for prior independence, 
were independent (modified Rankin score of 0 to 2) prior to the stroke. 
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172 patients with presumed stroke 
referred to the THSR team 
 138 first-ever-in-a-lifetime stroke 
 
Male:     51 (37%) 
Female:   87 (63%) 
 
0 transient ischaemic attack 
 
20 with a clear history of prior stroke 
 
3 patients with previous stroke, dead on 
arrival at the hospital, insufficient 
information to decide on cause of death 
 
11 not stroke - diagnoses: 
 
1 pneumonia, 2 poorly controlled diabetes 
mellitus, 1 tuberculous meningitis, 1 cardiac 
failure and severe infection, 1 previous 
stroke and now hypoglycaemia, 1 delirium 
 
Figure 7.3  Study outline: cases included in the Tintswalo Hospital Stroke 
Register 
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Table 7.1  Characteristics of the stroke patients in the Tintswalo Hospital 
Stroke Register, by sex (n is the number of patients with sufficient 
data to assess the characteristic; number with characteristic / total 
number assessed shown where relevant) 
 
 Male Female Total  
Strokes n 51 (37%) 87 (63) 138 
(ratio M:F) 1:1.7  
 
Age years – mean (SD) (95% CI) 
(range)  
n=133 
65 (14) (61 to 69) 
(range 25 to 94) 
64 (18) (60 to 68) 
(range 19 to 93) 
64 (17) (61 to 67) 
(range 19 to 94) 
*p=0.8** 
Independent prior to stroke** (%) 
n=129 
47 / 47 (100) 81 / 82 (99) 128 / 129 (99) p=0.9 
Mean time to presentation (days)(95% 
CI) 
n=120 ‡ 
2 (1 to 3 days) 11 (1 to 22) 8 (1 to 15) p<0.001 
Median time to presentation (days) 
(95% CI) 
n=120 ‡ 
0.5 (8 hours to 1 day) 1 day (1 to 1) 1 (1 to 1) p=0.06† 
Number who presented within 3 hours 
/ total number with time to presentation 
data (%) 
n=125 
10 / 46 (22) 15 / 79 (19) 25 / 125 (20) p=0.6 
Number who presented within 6 hours 
/ total number with time to presentation 
data (%) 
n=125 
23 / 46 (50) 26 / 79 (33) 49 / 125 (39) p=0.7 
Number scanned (%)  
n=138 
3 / 51(6) 6 / 87 (7) 9 / 138 (7) p=0.8 
 
*   p: significance of difference 
**  Analysis of variance comparing mean age and mean time to presentation by sex; ** Independent prior to 
stroke defined as a modified Rankin score of 0 to 2; ‡ excluding 5 patients who had strokes in hospital; † 
Wilcoxon test for comparison of medians 
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Five patients had a stroke in hospital. When we excluded these five patients, the 
mean time to presentation was long (8 days), but this was heavily influenced by 
the wide range of time to presentation (2 hours to 365 days). The median time to 
presentation was thus much shorter (1 day). Although there was a significant 
difference between the mean time to presentation for males (2 days) and females 
(11 days), the median time was not significantly different. The range of time to 
presentation for males was 2 hours to 21 days, and for females was 2 hours to 
365 days. Three female patients presented more than three months following their 
stroke; two within 4 months and one a year after their stroke. All three patients had 
attended traditional healers for assistance prior to seeking help from allopathic 
health care. Twenty-five (20%) of patients presented within 3 hours of stroke 
onset, and 49 patients (39%) within 6 hours of stroke onset. Neither of these 
figures was significantly different for males and females. 
 
The Tintswalo Hospital doctors referred nine patients (7%) to the provincial capital, 
Polokwane, for a CT brain scan. Although both males and females were as likely 
to have a CT brain scan (p=0.8), the mean (47years, SD 19; 95% CI 33 to 62) and 
median (42 years; 95% CI 30 to 72) age for those nine patients was lower than for 
the stroke population as a whole (p=0.06). All nine patients had their brain scans 
done within 7 days of admission to Tintswalo Hospital.  
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7.2.2    Pathological stroke types in the THSR 
 
Of the nine patients who had a CT brain scan, the pathological stroke type was 
cerebral haemorrhage in three patients and ischaemic stroke in six patients. In the 
remaining patients, we assessed pathological stroke type using our clinical 
judgement and the Siriraj Stroke Score (SSS). We also attempted to assess the 
Guy’s Hospital Stroke Score (GHSS), but failed in the majority of patients. 
Accurate assessment of the GHSS requires a chest x-ray and electrocardiogram 
(ECG) to assess cardiomegaly and atrial fibrillation respectively (Allen, 1983) 
(appendix F). Given the difficulties with access to both at Tintswalo Hospital, only 
36 patients had a chest x-ray and 32 patients had an ECG. As such, we could only 
reliably assess the GHSS in the 32 patients who had both a chest x-ray and an 
ECG, and have therefore not considered the GHSS findings further.  
 
Table 7.2 compares pathological stroke types using our assessment and the SSS 
in males and females. No stroke patient presented with subarachnoid 
haemorrhage during the time we ran the THSR and so for simplicity we coded any 
SSS diagnosis of ‘intracranial haemorrhage’ as cerebral haemorrhage. The SSS 
did not perform very well in the THSR. While the SSS produced an uncertain 
diagnosis in 20% of the JHSR stroke patients assessed, in the THSR it provided 
an ‘uncertain’ diagnosis in 35 (37%) of the 128 patients with sufficient data 
available for assessment.  
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Table 7.2  Comparison of pathological stroke types (cerebral haemorrhage 
and ischaemic stroke)* in the Tintswalo Hospital Stroke Register 
as assessed by clinician and the Siriraj Stroke Score, by sex 
(percentage in brackets) 
 
 Clinician assessment Siriraj Stroke Score 
Pathological stroke type: Male Female Total Male Female Total 
Total number of stroke 
patients assessed 
51 87 138 47 81 128 
Cerebral haemorrhage* 16 (31) 16 (18) 32 (23) 16 (34) 23 (28) 39 (31) 
Ischaemic stroke 32 (63) 66 (76) 98 (71) 16 (34) 38 (47) 54 (42) 
Uncertain 3 (6) 5 (6) 8 (6) 15 (32) 20 (25) 35 (37) 
Significance of difference 
between sexes 
p=0.5 p=0.4 
Significance of difference between 
our assessment and SSS 
 
p=0.2 
 
 
* The SSS does not distinguish between subarachnoid haemorrhage and cerebral haemorrhage 
(chapter 6). However as none of the THSR patients had a subarachnoid haemorrhage-like 
presentation, we coded all ‘intracranial haemorrhage’ as cerebral haemorrhage  
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The large number of ‘uncertain’ diagnoses rendered the SSS almost useless in the 
THSR. When we excluded patients with an ‘uncertain’ score, 42% of patients had 
a cerebral haemorrhage and 58% had an ischaemic stroke. In males, the 
proportion with cerebral haemorrhage increased to 50% when we excluded the 
‘uncertain’ scores, in comparison to 33% if we excluded ‘uncertain’ scores from the 
clinician assessment (table 7.2). When we compared the SSS diagnosis of 
pathological stroke type with the CT findings in the nine patients who had CT brain 
scans, one patient with a cerebral haemorrhage had an ‘uncertain’ SSS result, the 
SSS score correctly diagnosed two patients with ischaemic stroke and one patient 
with cerebral haemorrhage. In the remaining 5 patients, the SSS diagnosis was 
wrong in 3 and in 2 the score had not been completed, presumably because the 
patient already had a CT brain scan diagnosis. We could not compare clinician 
diagnoses with CT brain findings as the clinician assessments already 
incorporated the CT findings. 
 
 Despite the high proportion of ‘uncertain’ and cerebral haemorrhage results found 
using the SSS, we did not find a significant difference between the clinician and 
SSS diagnoses (p=0.4). There was no statistical difference in the proportions of 
pathological stroke type found in males and females with either method of 
diagnosing pathological stroke type (table 7.2), although males we thought had 
more cerebral haemorrhages than females, particularly in our clinician 
assessment.  
 
In summary, we found cerebral haemorrhage occurred in somewhere between a 
quarter and a third of stroke patients, and was more common in males than in 
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females though this difference was not significant statistically. We did not find any 
subarachnoid haemorrhages during the study, despite our careful case 
ascertainment and the generally higher awareness of stroke that occurred at 
Tintswalo Hospital as a result of the THSR. However, we acknowledge that 
without a CT scan diagnosis our assessment of pathological stroke type using 
both clinician and Siriraj Stroke Score diagnosis was inaccurate.  
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7.2.2.1   Ischaemic stroke subtypes in the THSR 
 
Table 7.3 presents the Oxfordshire Community Stroke Project (OCSP) 
classification of ischaemic stroke patients as assessed by both clinician diagnosis 
and the Siriraj Stroke Score. Both assessments found a high proportion (36 to 
37%) of the more severe total anterior circulation ischaemic strokes. About a third 
were partial anterior circulation strokes, a quarter were lacunar strokes and a small 
number (2 to 4%) were posterior circulation strokes. Lacunar strokes were less 
common in males than in females (table 7.3) and total anterior circulation strokes 
more common. Thus, males were more likely to have a severe stroke at 
presentation, although the difference in OCSP types between males and females 
was not statistically significant. Posterior circulation strokes were uncommon.  
 
7.2.2.2   The cause of ischaemic strokes in the THSR 
 
Not surprisingly, the Trial of ORG 10172 in Acute Stroke Therapy (TOAST) trial 
classification was not at all useful in the THSR. Using the TOAST classification we 
classified all but one of the ischaemic stroke patients as having strokes of 
‘undetermined cause’, because of the lack of investigation available at Tintswalo 
Hospital. This one patient, a 30-year-old woman with a total anterior circulation 
infarct confirmed on CT brain scan, had severe post-partum cardiomyopathy with 
intraventricular thrombus visible on echocardiogram.  
 
 324
 
 
 
Table 7.3   Ischaemic stroke subtypes (Oxfordshire Community Stroke Project classification) in patients with presumed 
ischaemic stroke (using clinical assessment or SSS) by sex (percentage in brackets) 
 
Clinical assessment Siriraj Stroke Score 
 
Males Females Total Males Females Total 
Total number of ischaemic strokes  32 66 98 16 38 54 
Total number of patients assessed using OCSP 30 64 94 15 36 51 
Pathological Stroke Type:   
Total Anterior Circulation Infarction (TACI)  (%) 14 (47) 20 (31) 34 (36) 9 (60) 10 (28) 19 (37) 
Partial Anterior Circulation Infarction (PACI)  (%) 10 (33) 26 (41) 36 (38) 3 (20) 13 (36) 16 (31) 
Posterior Circulation Infarction (POCI)  (%) 1 (3) 3 (5) 4 (4) 0 1 (3) 1 (2) 
Lacunar Infarction (LACI)  (%) 5 (17) 15 (23) 20 (21) 3 (20) 12 (33) 15 (29) 
Significance of difference between males and females p=0.5 p=0.2 
 
OCSP: Oxfordshire Community Stroke Project classification 
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Table 7.4 compares the possible cause of ischaemic stroke in the THSR using our 
‘most likely diagnosis’ approach in males and females, and using our clinician 
diagnosis of ischaemic stroke. We were unable to make a diagnosis in 40 (41%) of 
the 98 patients with presumed ischaemic stroke. Cardioembolic stroke and lacunar 
stroke were the commonest assigned causes, with cardioembolic strokes 
accounting for just over a quarter and lacunar strokes for just under a quarter of all 
ischaemic strokes. Large vessel atherosclerosis almost never occurred.  
 
We did not have carotid Doppler or angiography available, which made the 
accurate diagnosis of large vessel atherosclerosis almost impossible. However, 
given the absolute lack of ischaemic heart disease and relative lack of peripheral 
vascular disease (see section 7.2.9 below for further discussion) it is unlikely that 
we have grossly underestimated extracranial carotid atherosclerosis. We 
diagnosed large vessel atherosclerosis in one patient, a 94-year-old male who had 
an ischaemic stroke without any obvious cause other than a carotid bruit on the 
appropriate side.  
 
The 22 small vessel lacunar strokes we diagnosed were associated with 
hypertension in 16 (73%) patients, diabetes mellitus in 1 (5%) patient, and both 
hypertension and diabetes mellitus in 4 (18%) patients. The remaining patient had 
neither hypertension nor diabetes mellitus and we did not find any other potential 
cause for their lacunar infarct. 
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Table 7.4 Cause of ischaemic stroke using our ‘most likely cause’ approach in patients with presumed ischaemic  
 stroke (clinician assessment)* by sex (percentages in brackets) 
   
 Male Female Total 
 
Total number of patients with presumed ischaemic stroke*  32 66 98 
Large vessel atherosclerosis (%) 1 (3) 0 1 (1) 
Cardioembolic  (%) 8 (25) 19 (29) 27(28) 
Small vessel (lacunar) (%) 7 (22) 15 (23) 22(23) 
Other cause (%) 2 (6) 6 (9) 8 (8) 
Undetermined (%) 14 (44) 26 (39) 40 (41) 
Significance of  
difference 
 
p=0.7 
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The ‘other cause’ category of ischaemic strokes included one presumed arterial 
dissection in a patient with epilepsy since childhood, who had not suffered a head 
injury, and four patients who had HIV infection. However, in one of these four HIV 
infected patients, a 33-year-old woman, the stroke occurred immediately post-
partum and the HIV infection may have been unrelated to her stroke. We were 
unable to establish an exact cause of the stroke in the HIV infected patients.  
 
7.2.2.3  Cardioembolic stroke in the THSR 
 
We diagnosed 28 (29%) of the 98 ischaemic stroke patients as potentially 
cardioembolic in aetiology. Table 7.5 shows the likely underlying cause of the 
cardioembolic strokes in these patients. None of the patients had any signs or 
symptoms to suggest ischaemic heart disease, though few had ECGs. Atrial 
fibrillation, accounted for almost half of the cardioembolic strokes (13 patients). We 
thought that the atrial fibrillation had been caused by rheumatic valvular heart 
disease in three patients, dilated cardiomyopathy in three patients, hypertensive 
heart disease in 3 patients, and in the remaining 4 patients we could not find an 
underlying cause.  
 
 328 
 
 
 
Table 7.5   Cardioembolic strokes in the THSR 
 
 Male Female Total 
Total number of patients with cardioembolic stroke (CT confirmed or clinical 
diagnosis) 
8 19 27 
Atrial fibrillation: Total (% of cardioembolic strokes) 3 (38) 10 (53) 13 (48) 
- unknown cause 2 2 4 
- with ischaemic heart disease 0 0 0 
- with valvular heart disease 0 3 3 
- with dilated cardiomyopathy 0 3 3 
- with hypertensive heart disease 1 2 3 
Ischaemic heart disease: Total (% of cardioembolic strokes) 0 0 0 
Valvular heart disease: Total (% of cardioembolic strokes) 2 (25) 6 (32) 8 (30) 
- unknown cause 0 0 0 
- rheumatic valvular disease 0 4 4 
- associated with dilated cardiomyopathy 2 2 4 
Cardiomyopathy: Total (% of cardioembolic strokes) 5 (63) 7 (37) 12 (44) 
- dilated 4 7 11 
- associated with hypertensive heart disease** 1 0 1 
Infective endocarditis (% of cardioembolic strokes) 0 0 0 
Significance of difference between sexes p=0.4 
  
 
 
 * NB subtotals and percentages do not add up to combined total as some causes are repeated  
** See chapter 5 text for detail on this category (section 5.2.5.2) 
 329 
Twelve patients had a cardiomyopathy. In eleven patients, this was a dilated 
cardiomyopathy and in one, we suspected end-stage hypertensive 
cardiomyopathy. Only one patient (discussed in at the beginning of section 7.2.4) 
had an echocardiogram which confirmed a post-partum dilated cardiomyopathy 
with intraventricular thrombus. None of the patients had infective endocarditis. 
Eight patients had valvular heart disease, which we thought was the result of 
rheumatic heart disease in at least half the patients. We could not be sure whether 
the four patients we diagnosed with dilated cardiomyopathy were originally 
rheumatic in origin or not.  
 
In summary, cardioembolic stroke in the THSR was almost always the result of 
atrial fibrillation, dilated cardiomyopathy and rheumatic heart disease. Ischaemic 
heart disease or at least symptomatic ischaemic heart disease did not occur in our 
patients. Our findings are limited by the lack of ECGs and echocardiograms and 
further detailed investigation would be needed to diagnose the underlying cause of 
cardioembolic ischaemic stroke in rural stroke patients.  
 
7.2.3  Hypertensive heart disease in the THSR 
 
We discussed the controversy surrounding the role of hypertensive heart disease 
in stroke in section 5.3.4. In the JHSR we diagnosed hypertensive heart disease in 
patients with isolated left ventricular hypertrophy (i.e. in the absence of cardiac 
failure or any other cardiac abnormality) seen on echocardiograms. Unfortunately, 
only one patient in the THSR had an echocardiogram. The diagnosis of 
hypertensive heart disease requires post-mortem, echocardiographic, MRI or ECG 
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evidence for left ventricular hypertrophy (Lip et al., 2000). Given the frequency of 
hypertension in our rural stroke population (see section 7.2.9) it is likely that there 
is a high prevalence of hypertensive heart disease, and we found clinical evidence 
of marked left ventricular hypertrophy in 45 (33%) of our 138 stroke patients. Ten 
of these 45 patients had an ECG, and 7 patients had features of left ventricular 
hypertrophy (Lip et al., 2000). Considering we only managed to obtain ECGs on 
32 stroke patients, it is likely that we missed many cases of hypertensive heart 
disease.  
 
7.2.4 Causes of cerebral haemorrhage in the THSR 
 
Thirty-two of the 138 stroke patients had a presumed cerebral haemorrhage 
according to our clinician assessment. None had cerebral angiograms and only 
three had CT brain scans. We thought that the cerebral haemorrhage was caused 
by hypertension in two of the patients with a CT brain scan, and by a low platelet 
count (66 x 109/l) in a 73-year-old HIV negative female. Twenty-five of the 
remaining patients who did not have a CT brain scan had hypertension, and in five 
patients, we could not find any likely cause for the cerebral haemorrhage. None of 
the patients with cerebral haemorrhage had positive HIV serology or appeared to 
have HIV on clinical examination.  
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7.2.5 HIV infection in the THSR 
 
Testing for HIV infection in South Africa is fraught with difficulty. Given the lack of 
therapy available at the time of the THSR and the potential social stigma of a 
positive diagnosis, we were very cautious about requesting informed consent for 
HIV testing from our stroke patients. At the same time the THSR was running, we 
were conducting a survey of vascular risk factors in people over the age of 35 
years in the Agincourt Health and Population Unit field site. We had to abandon 
our attempt to perform anonymous unlinked HIV testing as so many people 
refused HIV testing and then withdrew consent for other blood investigations 
(Thorogood et al., 2005). We also had great difficulty obtaining consent for HIV 
testing from stroke patients. Of the 47 patients who consented to our register 
blood investigations, only 14 consented to HIV testing. Five (36%) of the 14 were 
positive. A further patient had previously documented HIV infection. In three 
patients, we did not have HIV serology, but their clinical findings were highly 
suggestive of HIV infection. Thus, HIV infection was either definitely present or 
likely to be present in nine (6%) of all our stroke patients. While this is almost 
certainly an underestimation of the true HIV prevalence in our patients, the 
prevalence of HIV infection in Limpopo Province at that time was one of the two 
lowest recorded in the country (15% of antenatal clinic attendees) (Directorate: 
Health Systems Research, 2001).  
 
The mean age of HIV infected stroke patients was 38 (SD 19; 95% CI, 23 to 53) 
with a median age of 33 years (95% CI, 23 to 65) (range 20 to 72 years). Of the 
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nine patients who had definite or suspected HIV infection, eight were females and 
one was male.  
 
7.2.6 Syphilis in the THSR 
 
We tested 49 of the 138 stroke patients for syphilis using a rapid plasma reagin 
(RPR) screening test. This test is 100% sensitive and 98% specific during 
secondary syphilis, but less sensitive (98% and 73% respectively) during primary 
and latent phases of the disease (Larsen, Steiner, & Rudolph, 1995). Only one 
patient (1% of all stroke patients and 2% of those tested) had a positive RPR. This 
was a 71-year-old female who presented with a total anterior circulation presumed 
ischaemic stroke. We thought that the cause of the stroke was likely to be 
cardioembolic, caused by atrial fibrillation and a dilated cardiomyopathy rather 
than related to her positive syphilis serology. She did not have any clinical 
evidence of aortic regurgitation to suggest aortic root disease caused by syphilis, 
and we did not examine her cerebrospinal fluid. About 2% of woman between 45 
and 49 years of age attending antenatal clinics in South Africa were positive for 
syphilis in 2000, and 4% of antenatal clinic attendees in Limpopo Province had a 
positive RPR in 2000 (Directorate: Health Systems Research, 2001).  
 
Doctors at Tintswalo Hospital had requested syphilis serology on eight of the 49 
patients tested for syphilis, including the one positive patient before we started our 
THSR blood investigations. We tested 41 of the 47 patients with blood sent to 
Johannesburg for syphilis. None of these patients was positive. Frustratingly, 
although we should have tested all 47 patients, six were not tested because of 
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logistical errors such as laboratory error, difficulty with venesection resulting in 
insufficient blood arriving at the laboratory, and broken specimens during the 
courier process. We gained a great deal of experience in getting blood specimens 
couriered safely from rural Limpopo Province to Johannesburg and then tested 
during the running of the THSR and SASPI.  
 
7.2.7 Risk factors for stroke in the THSR 
 
Table 7.6 compares the frequency of stroke risk factors in males and females by 
clinician assigned pathological stroke type. None of the risk factors shown was 
significantly more frequent in presumed cerebral haemorrhage than in presumed 
ischaemic stroke. The mean age of the population as previously noted was 64 
(95% CI, 61 to 67) years, and the median slightly higher at 68 (95%CI, 65 to 71) 
years, with a range of 19 to 94 years. Only 51 (37%) of the stroke patients were 
male. There were slightly more females than males in the general population. The 
Agincourt Health and Population Unit is representative of the local population, and 
in this population 47% of people were male (figure 3.1). In 1995, 44% of the 
population over the age of 35 years were male. Therefore, there must be some 
reason why males were less likely to be admitted to hospital. One factor might be 
the high labour migration out of the area to the larger towns for most of the year. 
Although both males and females were involved in labour migration, far more 
males (60%) than females (14%) in the 30 to 49 year old age group were absent 
from the area for a great deal of the year (Tollman et al., 1999).   
 334 
 
Table 7.6  Risk factors in the THSR by sex and clinician assessed 
pathological stroke type (n = number assessed) (percentage in 
brackets unless otherwise stated) 
 
 
Cerebral 
haemorrhage 
Ischaemic stroke   
 M F M F All strokes* 
Total number of strokes n 16 16 32 66 138 
 
Age – mean (95% CI) 
n=133 
65 (58 to 
73) 
71 (65 to 
78) 
66 (61 to 
70) 
62 (57 to 
67) 
64 (61 to 67) **p=0.06 
Age – median (95% CI) 
n=133 
65 (57 to 
76) 
73 (65 to 
81) 
67 (60 to 
73) 
68 (63 to 
72) 
68 (65 to 71) p=0.2 
Male sex (% of stroke type) 
n=138 
16 (50) 16 (50) 32 (33) 66 (67) 51 (37) p=0.08 
Hypertension (%) 
n=136 
14 (88) 11 (69) 23 (72) 41 (62) 95 (70) p=0.07 
Mean total cholesterol level 
mmol/L (95% CI) 
n=44 
4.9 (3.8 to 
6.0) 
4.8 (1.6 to 
8) 
4.3 (3.0 to 
5.6) 
4.7 (4.2 to 
5.1) 
4.7 (4.4 to 5.0) p=0.5 
Cigarette smoking n=123       
- Current 1 (7) 0 4 (14) 0 6 (5)  
- Ex 2 (14) 0 6 (21) 0 8 (7) p=0.96 
- Never 11 (79) 15 (100) 19 (66) 59 (100) 109 (89)  
Alcohol use n=124      
 
 
- Current 5 (36) 2 (13) 7 (24) 4 (7) 19 (15)  
- Ex 0 1 7 (24) 4 (7) 14 (11) p=0.2 
- Never 9 64) 12 (80) 15 (52) 52 (87) 91 (73)  
Diabetes mellitus 
n=138 
5 (31) 3 (19) 8 (25) 6 (9) 24 (17) p=0.2 
Previous transient 
ischaemic attack 
n=133 
0 0 2 (7) 4 (6) 6 (5) p=0.4 
Ischaemic heart disease 
n=133 
0 0 0 0 0  
Known previous atrial 
fibrillation 
n=136 
1 (6) 0 0 1 (2) 2 (2) 
 
p=0.4 
 
Peripheral vascular disease 
n=134 
0 2 (13) 3 (10) 0 5 (4) p=0.7 
Family history of stroke 
n=133 
1 (6) 0 0 3 (5) 4 (3) p=0.9 
 
*   All strokes includes strokes of ‘uncertain’ pathological stroke type 
**  Significance of difference between stroke types
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If these people were to have symptoms of a stroke, it is highly likely that they 
would present to the health service close to their employment rather than to 
Tintswalo Hospital. This may also explain the slightly older mean age of males (65 
years) compared to females (64 years) (table 7.1). It remains possible, however, 
that other as yet unrecognised factors contributed to the low proportion of males in 
the THRS.  
 
Hypertension was the commonest modifiable risk factor in the THSR. We did not 
find a significant difference between the frequency of hypertension in males and 
females (p=0.5). The frequency of hypertension in stroke patients was much 
higher than in the local community over the age of 35 years where we found 43% 
of people over the age of 35 years were hypertensive (Thorogood et al., 2005).  
 
We diagnosed diabetes mellitus in 24 (17%) stroke patients. Significantly more 
males (14) were diabetic than females (10) (p=0.02). The prevalence of diabetes 
mellitus in our stroke patients (17%) was much higher than the 3% found in the 
local population over the age of 35 years (Thorogood et al., 2005), though we 
suspect this finding may be an underestimate because of difficulty getting 
specimens to the laboratory rapidly. The mean blood glucose within 72 hours of 
admission in stroke patients was 8.9 mmol/L (SD 5.5; 95% CI 7.5 to 10.4; range 
2.5 to 31) and the median was 7 mmol/L (95% CI, 6.2 to 8.2). In contrast, the 
mean random blood glucose in 262 people over the age of 35 years in the 
community was 5.3 mmol/L.  
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We found a mean non-fasting total cholesterol taken within the first three days of 
admission of 4.7 mmol/L (95% CI, 4.4 to 5.0) in stroke patients, compared to the 
mean of 4.28 mmol/L in males and 4.53 mmol/L in females found in the same 
survey of risk factors previously mentioned in those aged over the age of 35 years 
(Thorogood et al., 2005). We did not find a significant difference in the mean 
random total cholesterol level in males and females (p=0.9).  
 
Cigarette smoking was not common and none of the female stroke patients was a 
current smoker or had ever smoked cigarettes. Only 3% of males were current 
smokers. This was much lower than the percentage of the general population over 
the age of 35 years in the area who were current daily smokers (13% of females 
and 32% of males) (Thorogood et al., 2005). This finding is surprising and 
suggests perhaps, that we did not obtain an accurate smoking history from our 
stroke patients.  
 
Significantly more males (13 of 45; 29%) drank alcohol than females (6 of 79; 8%) 
(p=0.002), but this mirrored the survey mentioned in the Agincourt population 
where 8% of females were current drinkers and 43% of males. In contrast, females 
used snuff more often than males (25 of 78 females; 32% and only 3 of 40 males; 
8%). In the community 36% of females used snuff and 4% of males. Thus, the use 
of alcohol and snuff was similar in our stroke patients to that found in the general 
adult population (Thorogood et al., 2005). We did not find a family history of stroke 
in first-degree relatives in many patients (4 of 133 asked; 3%). 
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A history of previous transient ischaemic attack was uncommon and only occurred 
in presumed ischaemic stroke patients. A history of atrial fibrillation too was rare (2 
patients), though on examination 17 of 138 (12%) stroke patients had atrial 
fibrillation. We found peripheral vascular disease in 5 patients, but we did not find 
any patients with ischaemic heart disease. Four patients had a carotid bruit, two of 
these patients had ischaemic strokes (1 lacunar and one large vessel), one had a 
presumed cerebral haemorrhage and in one, we could not assign a pathological 
stroke type. Thus, we did not find much evidence of large artery extracranial 
atherosclerosis in the Tintswalo Hospital Stroke Register patients.  
 
7.2.8   Socioeconomic measures in the THSR patients 
 
We discussed the association of socioeconomic measures and stroke risk, as well 
as the lack of an accepted measure of socioeconomic status in South Africa in 
section 5.2.8.1. We assessed the same socioeconomic measures in the THSR as 
we assessed in the JHSR. Two measures were significantly different between 
males and females, marital status and sole-breadwinner status. Males were more 
likely to be currently married than females who were far more likely to be widowed 
than men. This may simply reflect the fact that women live longer than men (World 
Health Organisation, 2006). A larger proportion of male (25 of 41; 61%) than 
female (25 of 76; 33%) stroke patients considered themselves as sole 
breadwinners for the household they lived in.  
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Table 7.7  Possible socioeconomic measures / factors in stroke patients in the 
THSR (total number of patients assessed in bold with percentage of 
those assessed in brackets) 
 
Socioeconomic measure 
n=number assessed 
Male Female Total 
Significance of 
difference 
Marital status 
n=117 
41 76 117 
- married 35 19 54 (46) 
- single 3 14 17 (15) 
- widowed 2 41 43 (37) 
- divorced 1 2 3 (3) 
p<0.001 
Sole breadwinner for the household 
n=104 
25 25 50 (48) p=0.01 
Housing 
n=115 
41 74 115 
- live in house / flat 40 69 109 (95) 
- dormitory / hostel / single room                          0 0 0 
- retirement home 0 0 0 
- live with employer 0 1 1 
- live in serviced shack 1 1 2 
- live in un-serviced shack 0 3 3 
p=0.5 
Years of schooling passed 
n=109 
38 71 109  
- mean (SD) (95% CI) 4 (1)  (3 to 5) 3 (0.5)  (2 to 4) 3 (0.5)  (2 to 4) p=0.2 
- median (95% CI) 4 (0to 6) 0 (0 to 2) 0 (0 to 4) p=0.2 
- none 17 41 58 (53) 
- less than 7 years 29 57 86 (79) 
- less than 12 years 36 69 105 (96) 
- 12 years 2 2 4 (4) 
- any in-service or post-school 
formal training 
2 1 3 (3) 
p=0.7 
Employment assessed 
n=120 
42 78 120 
- unemployed and looking for work 1 9 10 (8) 
- any pension 28 50 78 (65) 
p=0.1 
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Almost all males and females said they lived in a house or flat (table 7.7). This is 
difficult to interpret knowing the low-resourced area surrounding Tintswalo 
Hospital. Perhaps stroke patients who are able to get to hospital tend to be of a 
higher socioeconomic status, or more likely the interpretation of ‘house’ by stroke 
patients and their families included informal dwellings that many, especially urban 
dwellers, might consider shacks.  
 
The mean and median years of schooling were very low for both males and 
females. Seventy-nine percent of stroke patients had less than 7 years of 
schooling and only 4% had passed 12 years of schooling (table 7.7). Only ten 
(8%) stroke patients considered themselves ‘unemployed and looking for work.’ 
This likely reflects the age of the THSR stroke patients, as 78 (65%) patients were 
receiving some form of pension (social / disability).  
 
In summary, the THSR stroke population had a very low level of education. The 
majority were receiving a state pension and almost half supported their household 
financially.  
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7.2.9  Stroke severity and related disability in the THSR 
7.2.9.1 Stroke severity 
 
We assessed stroke severity in the THSR using the same two measures, the 
National Institutes of Health Stroke Scale (National Institute of Neurological 
Disorders and Stroke, 2005) and the Scandanavian Stroke Scale (Scandinavian 
Stroke Study Group, 1985), used in the Johannesburg Hospital Stroke Register 
(JHSR)(section 5.2.11.1). In table 7.8 we compare stroke severity in males and 
females in the THSR.  
 
We did not find any significant difference in the severity of stroke between sexes. 
The mean and median scores were almost identical in the two groups (mean score 
of 16 in both sexes, median of 15 in females, 16 in males). The NIHSS score was 
categorised as: mild (NIHSS ≤ 5), moderate (NIHSS 6 to 13), and severe (NIHSS 
≥ 14).  
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Table 7.8 Severity of stroke and proportion of stroke survivors with various 
measures of disability in the THSR, by sex (percentage of males, 
females or total patients assessed in brackets unless otherwise stated) 
 
 
 
 
 
Scale / Impairment 
n = total number assessed 
Males Females Total 
Significance of 
difference 
NIH stroke scale 48 82 130  
- Mean (SD) 16 (9) (13 to 18) 16 (8) (14 to 17) 16 (8) (14 to 17) p=0.95 
- Median (95%) CI) 16 (12 to 19) 15 (13 to 18) 15 (13 to 18) p=0.9 
Scandinavian SS 46 84 130  
- Mean (SD) 23 (17) (18 to 28) 23 (16) (20 to 27) 23 (16) (20 to 26) p=0.97 
- Median (95% CI) 20 (15 to 26) 19 (16 to 25) 20 (17 to 23) p=0.95 
Barthel Index  <20  
n=134 
49 (100) 80 (94) 129 (96) p=0.8 
Barthel Index <15 
n=134 
45 (92) 66 (78) 122 (91) p=0.9 
Barthel Index <10 
n=134 
40 (82) 66 (78) 106 (79) p=0.5 
Barthel Index median (95% CI) 
n=134 
3 (1 to 5) 2 (1 to 3) 2 (1 to 4) p=0.4 
mRankin scale 0-2 
n=135 
6 (12) 10 (12) 16 (12) 
MRankin scale 3-5 44 (88) 75 (88) 119 (88) 
p=0.4 
 
NIH: National Institute of Health; SSS: Scandinavian Stroke Scale 
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7.2.9.2   The Barthel and modified Rankin scores in the THSR 
 
We discussed the use of the Barthel Index (BI) and modified Rankin scores in 
stroke patients in section 5.2.11.2, and presented the findings from the THSR in 
the same format (table 7.8). Only 5 of the 134 patients in whom we were able to 
assess the Barthel Index had a score of 20, i.e. no functional impairment. The 
majority of patients were severely functionally impaired, 79% (106 of 134) scored 
below 10 and the median score was very low (2). We did not find any difference in 
BI score between males and females.  
 
We considered stroke patients independent if they had a modified Rankin score of 
between 0 and 2. Only 16 of 135 patients assessed (12%) were independent when 
we assessed them. There was no difference in the proportion of males and 
females who were independent (table 7.8). 
 
7.2.10   Stroke related complications in the THSR 
 
Pneumonia and post-stroke seizures were the commonest in-hospital 
complications in the THSR stroke patients. Pneumonia occurred in 9 patients (3 
males and 6 females), and seizures in 9 (5 males and 4 females). Other 
complications included painful shoulder syndrome in three patients and bedsores 
in two patients. None of the patients developed symptoms of depression or deep 
venous thrombosis, though the frequencies of these and the other complications 
were probably underestimates given the limited potential for investigation and 
inadequate staffing levels at the hospital.  
 343 
 
Two patients, both female, had a recurrent stroke during their in-hospital stay. 
Twenty-five of the 138 stroke patients died in-hospital. Males died significantly 
more frequently (15) than females (10) (p=0.008). It is not clear why males died 
more often. We did not find a significant difference in the mean (male: 21; female 
25; p=0.2) or median (male 23; female 23.5; p=0.5) NIHSS score, or mean (male 
68; female 65; p=0.8) and median (male 70; female 72; p=0.9) age in males and 
females who died, using analysis of covariance (ANOVA) to compare the means 
and the Wilcoxon ranksum test to compare the medians. Although none of the 
patients underwent autopsy, the cause of death in the 25 patients was assessed 
as: directly related to severe stroke with raised intracranial pressure in 11, 
infection (pneumonia, infected bed sores, tuberculosis) in 5, renal and liver failure 
in 1 patient, hypokalaemia (potassium of 2 mmol/l in one patient) and in 7 the 
cause of death was unknown. The hypokalaemia mentioned in one patient who 
died, a 71 year old female with a total anterior circulation infarction likely caused 
by dilated cardiomyopathy and atrial fibrillation, was not noted until the THSR 
blood investigations were performed in Johannesburg. Unfortunately, she had died 
by the time this result was available. 
 
7.2.11     Length of hospital stay for stroke patients in THSR 
 
We had accurate data on the length of hospital stay in 66 patients. The mean 
duration of hospitalisation was 8 days (95% CI, 7 to 9 days) with a median stay of 
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7 days (95% CI, 6 to 9 days). We did not find any difference in the mean or 
median duration of stay for males and females (p=0.8 and 0.4 respectively).  
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7.3 Discussion 
7.3.0 Outline of the discussion  
 
In this section we will outline the key findings of the THSR and discuss the 
limitations of the study. We will then discuss the findings generally and briefly 
compare the findings with black JHSR stroke patients and patients from the 
Gambia. In chapter 8 we will compare the nature of stroke in the prevalent stroke 
cases (chapter 3 and 4) and the nature of stroke patients at Johannesburg and 
Tintswalo Hospitals. Thus, to prevent too much repetition we will keep the 
discussion and comparison with other work brief.  
 
7.3.1   Summary of the THSR findings 
 
The THSR included 138 patients with first-ever-in-a-lifetime stroke admitted to the 
rural Tintswalo Hospital over 20 months. All patients were black Shangaan 
speaking South Africans from the local Bohlabelo region.  
 
7.3.1.1 Key findings of the THSR 
 
Characteristics of stroke patients 
 
• More females were admitted with stroke than males (ratio M:F 1:1.7) 
 346 
• The stroke patients were elderly with a mean age of 64 years and median 
age of 68 years 
• 99% of patients were independent prior to the stroke 
• 5 patients had a stroke in hospital 
• The mean time to presentation was very long (8 days) with a wide range of 
2 hours to 365 days, but the median time to presentation was much shorter 
(1 day) 
• 20% of patients presented within 3 hours of stroke onset, and 39% within 6 
hours of stroke onset 
• Only 7% of patients had a CT brain scan and these patients were 
significantly younger than the patients who did not have a brain scan 
 
Pathological stroke type and ischaemic stroke subtype 
• The Guy’s Hospital Stroke Score required a chest x-ray and ECG and these 
were so seldom available that it could not be used in the THSR to 
differentiate pathological stroke type 
• The Siriraj Stroke Score (SSS) performed poorly with 37% of patients 
diagnosed as ‘uncertain’ pathological stroke type, and a very poor 
correlation with the CT brain scan findings in the nine patients who had a 
scan 
• Using our clinical assessment of pathological stroke type, about a quarter of 
patients were thought to have had a cerebral haemorrhage, none a 
subarachnoid haemorrhage, and three-quarters an ischaemic stroke 
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• We found about the same proportion of total anterior circulation (36%) and 
partial anterior circulation (38) ischaemic strokes, with slightly fewer lacunar 
infarcts (21%) and a small number of posterior circulation infarcts (2%) 
• We did not find a statistically significant difference in pathological stroke 
type or ischaemic stroke subtype between males and females 
 
Cause of stroke 
 
• We found the TOAST classification impossible to use in this low-resource 
setting, as all but one ischaemic stroke patient were classified as 
‘undetermined’ because of inadequate investigation 
• Using our ‘most likely diagnosis’ approach, we still remained with an 
‘undetermined’ cause in 41% of ‘ischaemic stroke’ patients, but in the 
remainder we found 28% to be cardioembolic, 23% to be caused by small 
vessel disease which was mainly the result of hypertension, and only 1 
patient to likely have large vessel atherosclerotic disease 
• Cardioembolic ‘ischaemic’ strokes were caused by atrial fibrillation, dilated 
cardiomyopathy and rheumatic valvular heart disease and we did not find 
any evidence of ischaemic heart disease in our ‘ischaemic’ stroke patients 
• The commonest cause of ‘cerebral haemorrhage’ was hypertension (84%), 
but we did not adequately investigate patients to exclude vascular 
malformations or aneurysms 
• Other determined causes of ’ischaemic’ stroke included: arterial dissection 
and possible HIV related stroke in 6% of our stroke patients, though this is 
likely to be an underestimate as we only received consent from 14 patients 
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for HIV testing. The mean age of HIV infected stroke patients was much 
lower than the general stroke population (38 years; median 33 years), and 
HIV infected patients were predominantly female (8 female, 1 male) 
• Only one stroke patient had positive syphilis serology, and none had 
evidence of neurosyphilis, although we did not actively exclude 
neurosyphilis in this patient and only tested syphilis blood serology in 36% 
of patients 
 
Risk factors 
 
• Hypertension was the commonest modifiable stroke risk factor in male and 
female stroke patients, found in 70% of all stroke patients 
• Cholesterol levels were low with a mean of 4.7mmol/L 
• We found diabetes mellitus in 17% of stroke patients, and significantly more 
males than females were diabetic (p=0.02) 
• We found that cigarette smoking was uncommon and less frequent than in 
the local community, raising the possibility that we did not obtain an 
accurate history of cigarette smoking from our patients 
• More males were current users of alcohol than females, and more females 
used snuff than males, in both cases this reflected the pattern of use in the 
local community 
• Peripheral vascular disease was uncommon and ischaemic heart disease 
did not occur in our patients 
• Previous TIA was uncommon 
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• Socioeconomic measures revealed that stroke patients had a low level of 
education, the majority were receiving a state pension and almost half 
supported their household financially 
 
Stroke severity and the impact of stroke on the stroke survivor 
 
• Strokes included in the THSR were severe, and over 80% were dependent 
and had significant loss of function at the time of our assessment 
• The nature of impairments reflected the high proportion of severe total 
anterior circulation and partial anterior circulation strokes with cortical 
involvement 
• Impairments and complications were similar in males and females, but 
more males died in hospital than females despite being of similar age and 
stroke severity 
• In hospital case fatality was 18% 
 
 350 
7.3.2  Limitations of the THSR 
 
We aimed to establish the profile of stroke patients and nature of stroke in an 
under-resourced rural hospital. However, the lack of resources was limiting and we 
did not have sufficient research funding to adequately supplement the 
investigation of stroke patients. As a result we depended on our clinical 
assessment of pathological stroke type and cause of stroke, both of which were 
unlikely to be very accurate (see chapter 6 for clinician pathological stroke type 
assessment). We had planned to supplement our assessment of pathological 
stroke type with the Siriraj and Guy’s Hospital Stroke Scores, but neither of these 
proved practical.  
 
Even when we were able to supplement the blood investigations, very few patients 
gave consent for HIV testing, so limiting our assessment of the frequency of this 
prevalent condition. Lack of echocardiography limited our ability to assess the 
proportion of patients with hypertensive heart disease, a condition we found to be 
very prevalent in black stroke patients in the Johannesburg Hospital Stroke 
Register.  
 
Despite these limitations, we were able to ascertain stroke patients admitted to 
Tintswalo Hospital over 20 months accurately and to assess the vast majority in 
detail clinically. We have therefore provided useful demographic and clinical data 
on the nature of stroke in a rural South African population. This is the first study in 
Sub-Saharan Africa to do this.  
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7.3.3  Comparison of the THSR stroke patients with black stroke patients 
from urban South Africa and from the Gambia 
 
Tables 7.9 and 7.10 compare the main characteristics of stroke patients, 
pathological stroke types, Oxfordshire Community Stroke Project stroke subtypes, 
risk factors and measures of impairment, in stroke patients in the Tintswalo 
Hospital Stroke Register (THSR), black patients in the Johannesburg Hospital 
Stroke Register (JHSR), and stroke patients in two studies from the same hospital 
in the Gambia ten years apart (Walker et al., 2003; Garbusinski et al., 2005). The 
Gambian studies included first-ever-in-a-lifetime and recurrent stroke patients 
whereas the THSR and JHSR only included first-ever-in-a-lifetime stroke patients. 
Note that all comparisons made below are with black stroke patients from the 
JHSR unless otherwise stated. 
 
Patients in the THSR were on average more than 10 years older than patients in 
the JHSR and more than five years older than patients in the Gambia. Females 
predominated in the THSR, whereas males and females were equally represented 
in the JHSR and the 2000 / 2001 study from the Gambia. Males predominated in 
the other study from the Gambia performed in 1990. As discussed in section 
2.4.4.1 earlier stroke studies form Sub-Saharan Africa often found a male 
predominance, while later studies found little difference between sexes. This may 
be age related, as incidence studies in high-income populations have found a 
higher proportion of males than females in younger age groups and a similar 
proportion of males and females in older age groups.   
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Table 7.9 Comparison of stroke patients in the Tintswalo Hospital Stroke Register, black 
patients in the Johannesburg Hospital Stroke Register, and stroke patients in 
two stroke studies from the same hospital in the Gambia (2000/1* and 1990**) 
(Garbusinski et al, 2005; Walker et al, 2003) 
 
 
 
THSR  
(n=138) 
JHSR  
(n=308) 
Gambia, 1990  
(n=106) 
Gambia, 2000/1  
(n=148) 
Age     
- Mean (SD) 64 (17) 51 (16) 58 (16) n/a 
- Median (95% CI) 68 (65 to 71) 51 (49 to 55) 60 n/a 
Sex ratio (M:F) 1:1.7 1:1 1.9:1 1:1 
Economically active (contribute to 
family income) 
n (%) 
106 (77) 117 (55)† n/a n=? (53) 
Brain scan rate (%) 7% 67% 0 0 
Mean time to presentation (days) 
(95% CI) 
8 (1 to 15) 3.5 (2 to 5) 
n/a but mean of 
29 hours for 80 
admitted within 7 
days 
n/a 
Median time to presentation 
(days) 
1 ( to 1) 1 (1 to 1) 
8 hours for 
sample above 
n/a 
Proportion who presented within 
3 hours (%) 
25 (20)† 32 (11)† n/a n/a 
NIHSS mean (SD) 16 (8) 12 (9) n/a 12 (6) 
NIHSS median 15 (13 to 18) 10 (8 to 12) n/a n/a 
Barthel Index <10 (%) 106 (79)† 174 (55) n/a n/a 
Barthel Index median (95% CI) 2 (1 to 4)† 7 (6 to 9) n/a n/a 
Pathological stroke type: 
 
n=138 
 
n=138 
SSS 
n=207 
CT scan 
n=307 
SSS 
n=106 
n=138 
SSS 
Cerebral haemorrhage n (%) 32 (23) 39 (31) 55 (27) 71 (23) n/a 63 (46) 
Ischaemic stroke n (%) 98 (71) 54 (42) 141 (68) 171 (56) n/a 42 (30) 
Subarachnoid haemorrhage n (%) 0 0 11 (3) n/a n/a not assessed 
Uncertain n (%) 8 (6) 35 (37) 0 65 (21) n/a 17 (24) 
OCSP stroke subtype 
n=98 
IS 
stroke 
n=131‡ 
all stroke 
n=235 
IS 
stroke 
n=308 
all stroke 
n=106 
all strokes 
n=130 
all stroke 
Total anterior circulation 
syndrome 
34 (36) 60 (46) 
62 
(26) 
92 (30) 54 (51) 46 (35) 
Partial anterior circulation 
syndrome 
36 (38) 41 (31) 
84 
(36) 
105 (34) 33 (31) 35 (27) 
Lacunar syndrome 20 (21) 23 (18) 
71 
(30) 
76 (25) 19 (18) 18 (14) 
Posterior circulation syndrome 4 (4) 7 (5) 18 (8) 21 (7) 0 6 (5) 
Undetermined 0 0 0 
14 (5) all 
CH / SAH 
0 25 (19) 
 
THSR: Tintswalo Hospital Stroke Register, JHSR: Johannesburg Hospital Stroke Register; NIH: National Institute of Health; 
SSS: using the Siriraj Stroke Score; † percentage of patients assessed ‡ all pathological stroke types assessed; CH: 
cerebral haemorrhage; SAH: subarachnoid haemorrhage; IS: ischaemic stroke
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As discussed in 7.2.8 our finding of a significant female predominance in the 
THSR may be the result of a higher proportion of females in the local adult 
population and the result of labour migration which involves more males than 
females.  
 
The older age of our patients suggests that stroke occurs less frequently in the 
young rural population of South Africa than in the young urban population. While 
this may be true and may even be the result of the rural population being at an 
earlier stage of the health transition, it is also likely that other factors such as 
labour migration, which results in many young patients working in urban areas for 
much of the week or even the year play a part. These young patients are more 
likely to present to the health service closer to their employment, and while in our 
experience many return home to the area, they are less likely to seek acute 
medical care in Bohlabelo.  
 
Although the proportion of economically active stroke patients (defined as 
‘contributing to the family income’) was higher in THSR than in the JHSR or in the 
Gambia, this is likely the result of a high proportion of THSR patients receiving 
state pensions. State pensions are an important source of income for families in 
the area (Case, 2001). Only 28 (20%) of the THSR patients were employed, 
compared to 110 (36%) of the black patients on the JHSR. This is probably the 
result of an older and therefore unemployed population in the THSR as well as 
higher unemployment in the rural areas around Tintswalo Hospital (Kahn, Tollman, 
Thorogood et al, 2005).  
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The mean time to presentation (8 days) for patients in the THSR was much longer 
than the mean of 3.5 days for patients in the JHSR.This was the result of a few 
patients who took months to present to hospital. The median time to presentation 
was the same in both registers, and the proportion of patients who presented 
within three hours, a time limit that influences management decisions such as the 
use of thrombolysis, was higher at Tintswalo Hospital than Johanneburg Hospital. 
It is difficult to compare our THSR and JHSR findings with the studies from the 
Gambia as the time to presentation is only reported for subgroups of the Gambian 
patients (Walker et al., 2003; Garbusinski et al., 2005).  
 
The severity of stroke patients as measured using the mean and median NIH 
stroke scale (NIHSS) was higher in the THSR than the JHSR (table 7.9). Stroke 
severity in patients in the one Gambian study that reported NIH stroke scale 
findings was the same as in black JHSR patients. The median Barthel Index (BI) 
was lower (functioning worse) in THSR than JHSR, and the proportion of patients 
with a BI score less than 10 (severely functionally impaired) was higher in THSR 
than JHSR stroke patients, in keeping with the NIHSS finding that THSR strokes 
were more severe than JHSR strokes. This is also in keeping with the higher 
proportion of total anterior circulation syndrome strokes, lower proportion of 
lacunar syndrome strokes, and higher proportion of patients with a decreased level 
of consciousness in the THSR than in the JHSR and 2000 / 2001 Gambian study 
(tables 7.9 and 7.10).  
 
There was a marked skew towards major stroke (as measured by NIHSS and 
mRS) in the THSR. This likely reflects hospital referral bias i.e. few people with 
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mild stroke present to hospital, and perhaps admission bias. It is likely that in a low 
resource area like Bohlabela there are many obstacles to hospital admission, such 
as the availability of transport and financial resources to pay for transport (SASPI 
Project Team, 2004). The elderly in Bohlabela also play an enormous role in 
supporting households by caring for children, particularly in the HIV era when 
many households have lost members in the 20 to 45 year old age group because 
of the disease. Thus, it is likely that people ignore minor stroke symptoms and only 
symptoms which result in a significant loss of function force people to hospital. No 
doubt, there is also a far higher awareness of stroke and stroke symptoms in 
Johannesburg than in Bohlabela, among health care workers and the public.  
 
Pathological stroke type is difficult to assess in regions without access to brain 
imaging. One Gambian study used the Siriraj Stroke Score (SSS) to assess 
pathological stroke type (Garbusinski et al., 2005). Although the SSS performed 
relatively well in black JHSR stroke patients, with a moderately good sensitivity, 
specificity, likelihood ratio and Kappa statistic (chapter 6), it did not perform well in 
the THSR resulting in an ‘uncertain’ diagnosis in 37% of stroke patients as well as 
correlating poorly against the few available CT scan findings. The proportion of 
patients who had an ‘uncertain’ Siriraj Stroke Score was much lower in the JHSR 
(21%) and the Gambian study (24%). The SSS uses level of consciousness, 
vomiting and headache within two hours of stroke onset, diastolic blood pressure 
(multiplied by 0.1) and markers of atherosclerosis (diabetes history, peripheral 
artery disease, and angina) to derive a score (appendix F). Given the high 
proportion with a decreased level of consciousness (65%) in the THSH, a typical 
THSR patient might score 2.5 for level of consiousness, nil for vomiting and 
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headache, 9 for diastolic blood pressure (the mean and median diastolic blood 
pressure in both the THSR and JHSR was 90mmHg), and nil for atheroma 
markers. After subtracting the constant of -12, the result would be an uncertain 
score of -0.5. Although far more analysis and investigation are required to assess 
why the SSS does not perform well in rural patients, and to improve the SSS 
performance in all South African patients, it is likely that in patients with severe 
ischaemic stroke but without headache and vomiting associated, the score will 
return an ‘uncertain’ score. Given the low level of atherosclerosis in black South 
Africans, the score is likely to be driven by blood pressure (high blood pressure 
increasing a diagnosis of cerebral haemorrhage), and vomiting and headache after 
stroke. Given the high likelihood of elevated diastolic blood pressure in Sub-
Saharan African populations, the score is likely to overestimate cerebral 
haemorrhage and underestimate ischaemic stroke. 
 
In table 7.9 we compared the Gambian study with our CT based diagnosis of 
stroke type in the JHSR and clinician based assessment of stroke type in the 
THSR, as well as the SSS assessment of pathological stroke type in both our 
South African studies. Firstly comparing our clinician diagnosis in the THSR and 
the CT based diagnosis in the JHSR, both studies had similar proportions of 
ischaemic stroke (about 70%). There were slightly more cerebral haemorrhages in 
the JHSR (27% versus 23%). The proportion of ischaemic stroke was much lower 
when we used the SSS assessment, possibly for the reasons outlined above. In 
the Gambia, 46% of strokes were cerebral haemorrhages and only 30% ischaemic 
strokes. While it is tempting to implicate the health transition to explain a higher 
proportion of cerebral haemorrhage in the Gambia (indicative of the early phase of 
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the transition – chapter 1) than in South Africa, it is as likely that the high 
proportion of cerebral haemorrhages is the result of the SSS methodology. 
Community-based stroke incidence studies with early imaging are needed to 
clarify the pathological stroke types found in the Sub-Saharan African community. 
Hospital-based study bias and inaccuracies in clinical and stroke score diagnosis 
prevent an accurate assessment based on current data.  
 
The two Gambian stroke studies applied the OCSP stroke classification to all 
strokes, not just ischaemic strokes. To compare our findings with these studies we 
have compared our assessment of stroke subtypes when applied to all strokes as 
well as ischaemic strokes (table 7.9). Posterior circulation syndrome strokes 
accounted for a similar proportion in all studies. Lacunar strokes were more 
frequent in the JHSR, whether applied to all or just ischaemic strokes (25% to 
30%), than in the THSR or either of the two Gambian studies. Partial anterior 
circulation strokes accounted for somewhere between 27% and 38% of patients 
and were more frequent when applied to ischaemic strokes than to all strokes. 
This finding and the finding of a higher proportion of total anterior circulation 
strokes in ‘all stroke’ analyses than in ischaemic strokes, is probably the result of 
the inclusion of cerebral haemorrhages in the data. Cerebral haemorrhages are 
often more dramatic and severe in their presentation and more likely to be 
classified as partial or total anterior circulation events (Anderson, Taylor, Hankey 
et al, 1994). The lower proportion of lacunar strokes and higher proportion of total 
anterior circulation strokes in the THSR compared to the JHSR is probably the 
result of fewer mild strokes admitted in the THSR than in the JHSR as discussed 
previously.  
 358 
 
 359 
7.3.4 Comparison of the THSR stroke patients with black stroke patients 
from urban South Africa and from the Gambia – risk factors and in-
hospital deaths 
 
In table 7.10 we compare the prevalence of risk factors found in the above studies. 
Unfortunately, the frequencies of most of the risk factors were not reported in the 
studies from the Gambia.  
 
Hypertension was the commonest risk factor for stroke in both the THSR and the 
JHSR, present in similar proportions of stroke patients (70% to 74%). Only about 
half the patients in the Gambian study were hypertensive (48%). In the Gambian 
study hypertension was diagnosed when patients were on treatment for 
hypertension on admission, or when their blood pressure was greater than 140 
mmHg or 90 mmHg diastolic more than one week after the stroke onset 
(Garbusinski et al., 2005). Our definition included a history of hypertension, or 
documented evidence of a blood pressure of more than 140 / 90 mmHg and 
evidence of left ventricular hypertrophy (clinically or on ECG in the THSR and on 
ECG or echocardiography in the JHSR). Thus, our wider-ranging definition may 
have increased the number of patients we diagnosed with hypertension. However, 
based on a history of hypertension alone we would have diagnosed hypertension 
in 51% of THSR stroke patients and 58% of JHSR black stroke patients. Given the 
high proportion of undiagnosed and untreated hypertensive patients in South 
Africa (Steyn, Gaziano, Bradshaw et al, 2001) and the inaccuracy of diagnosing 
hypertension in the acute stroke patient (Warlow et al., 2001), we consider it 
important to broaden the definition of hypertension as we have done. 
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Table 7.10 Comparison of risk factors, prevalence of previous stroke and in-hospital death 
in the Tintswalo Hospital Stroke Register, black patients in the Johannesburg 
Hospital Stroke Register, and stroke patients in two stroke studies from the 
same hospital in the Gambia (2000/1* and 1990**)(Garbusinski et al, 2005; 
Walker et al, 2003) (percentage in brackets unless otherwise stated) 
 
 
 
 
 
 
 THSR (n=138) JHSR (n=308) 
Gambia, 1990 
(n=106) 
Gambia, 2000/1 
(n=148) 
Risk factors:     
- Hypertension n (%) 95 / 136 (70) 214 (74) n/a 71 (48) 
- Diabetes n (%) 24 / 138 (17) 42 (16) n/a 7 (5) 
- Mean total cholesterol mmol/l 
(95% CI) 
4.7 (4.4 to 5.0) 4.6 (4.3 to 4.9) n/a n/a 
- Ischaemic heart disease n (%) 0 8 (4) n/a n/a 
- Atrial fibrillation 15 (11) 20 (7) n/a 6 (4) 
- Current cigarette smoking 5 (5) 57 (23) n/a 48 (32) 
- Current alcohol use 19 (15) 63 (27) n/a n/a 
- Peripheral vascular disease 5 (4) 9 (3) n/a n/a 
- Previous transient ischaemic 
attack 
6 (5) 4 (1) n/a n/a 
- Carotid bruit 4 (3) 1 (<1) n/a n/a 
History of a previous stroke 
(NB n for THSR =172   ) 
23 (13) 
36 / 524 (7%) n/a by 
population group 
10 (9) 18 (12) 
Death during initial admission 25 (18) 23 (8) 
25 (19) of patients 
who presented 
within 7 days 
61 (41) 
 
THSR: Tintswalo Hospital Stroke Register, JHSR: Johannesburg Hospital Stroke Register NIH: National Institute of Health; 
SSS: Scandinavian Stroke Scale † percentage of patients assessed ‡ all pathological stroke types assessed 
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Diabetes was about as prevalent in THSR and JHSR stroke patients, but about a 
third as common in the Gambia (table 7.10). As discussed in section 5.3.5.3 
diabetes mellitus increases in populations undergoing health transition. However, 
we cannot ignore the possibility that the lower prevalence in the Gambian study 
occurred because the diagnosis in these patients did not include the measurement 
of blood glucose. 
 
The mean total cholesterol levels in THSR and JHSR patients were almost 
identical. This is interesting as one might expect that urban stroke patients would 
have higher blood total cholesterol than rural patients. As discussed in section 
7.2.8 total cholesterol levels were lower (4.3 mmol/L in males and 4.5 mmol/L in 
females) in the local Bohlabela community and perhaps the higher level in THSR 
stroke patients simply reflects a high-risk group of people. Cholesterol levels were 
still much lower than has been found in populations with a high prevalence of large 
artery atherosclerosis (section 5.3.3.1.3). 
 
In keeping with our finding that large artery atherosclerosis (ischaemic heart 
disease, peripheral vascular disease and carotid bruits as a marker of extracranial 
carotid artery disease) was uncommon in JHSR black patients, we did not find any 
patients with ischaemic heart disease in the THSR. We found a low prevalence of 
peripheral vascular disease and found carotid bruits infrequently (table 7.10). 
Previous transient ischaemic attack occurred slightly more frequently in the THSR 
patients than in the JHSR. Secondary prevention of stroke is poor in the Bohlabela 
region (Thorogood, Connor, Lewando-Hundt et al, 2004) and it is possible that 
detection and management of transient ischaemic attack is equally poor. Obtaining 
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accurate histories of a previous cerebral ischaemic event is not easy at Tintswalo 
Hospital. People are often not specific about weakness or sensory symptoms as 
we found in the SASPI stroke prevalence study (chapter 3 and 4)(Hundt et al., 
2004). Although we were very cautious about recording a previous transient 
ischaemic attack, it is possible that we overestimated the frequency. History of 
previous stroke was a similar problem, but a history of prolonged focal 
neurological deficit was easier to establish than a history of transient deficit. 
Roughly a similar proportion of people with previous strokes were referred to the 
THSR and JHSR as were included in the Gambian studies, although we did not 
include these patients in our analyses. 
 
Atrial fibrillation was slightly more common in the THSR than in the JHSR. This 
may be because cardiac disease is not well managed in Bohlabela, because more 
severe stroke patients tended to be admitted and cardioembolic strokes are often 
severe, because THSR patients were older than patients in the JHSR, or a 
combination of these factors. Current cigarette smoking and alcohol use were far 
less frequent in the THSR patients than in either JHSR or in the case of cigarette 
smoking, in the Gambia. This may reflect the older population admitted with 
stroke, or may suggest that we did not obtain accurate histories of cigarette 
smoking and alcohol use.  
 
Far more stroke patients died during their initial admission in the THSR than in the 
JHSR (18% versus 8%). This may be the result of strokes being more severe in 
the THSR, and possibly explains why a similar proportion of the 1990 Gambian 
study patients died during hospital admission. The 2000 / 2001 Gambian study, 
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however, found a much higher in-hospital case fatality (41%) despite less severe 
stroke patients than in the THSR. Management differences or some other factors 
related to case mix differences not detected by the NIH Stroke Scale may account 
for this difference.  
 
7.3.5 Comparison of cardioembolic stroke in the JHSR and THSR 
 
In table 7.11 we compare the causes of cardioembolic stroke in the THSR and in 
black stroke patients in the JHSR. Cardioembolic stroke accounted for 27 of 98 
(28%) of the ischaemic strokes in the THSR and a similar proportion, 53 of 235 
(23%) of ischaemic strokes, in the JHSR. Atrial fibrillation, valvular heart disease 
and dilated cardiomyopathy were more common in the THSR than in the JHSR.  
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Table 7.11   Comparison of cardioembolic stroke in the THSR and black 
stroke patients in the JHSR 
 
 
 THSR JHSR 
Total number of patients with cardioembolic stroke  27 52 
Atrial fibrillation: Total (% of cardioembolic strokes) 13 (48) 15 (29) 
- unknown cause 4 6 
- with ischaemic heart disease 0 1 
- with valvular heart disease 3 2 
- with dilated cardiomyopathy 3 0 
- with hypertensive heart disease 3 6 
Ischaemic heart disease: Total (% of cardioembolic strokes) 0 2 (4) 
Valvular heart disease: Total (% of cardioembolic strokes) 8 (30) 9 (17) 
- unknown cause 0 1 
- rheumatic valvular disease 4 6 
- associated with dilated cardiomyopathy 4 2 
Cardiomyopathy: Total (% of cardioembolic strokes) 12 (44) 27 (52) 
- dilated 11 10 
- associated with hypertensive heart disease** 1 17 
Infective endocarditis (% of cardioembolic strokes) 0 0 
 
  THSR: Tintswalo Hospital Stroke Register, JHSR: Johannesburg Hospital Stroke Register  
* NB subtotals and percentages do not add up to combined total as some causes are repeated  
** See chapter 5 text for detail on this category (section 5.2.5.2) 
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Ischaemic heart disease though not common did occur in the JHSR, but did not 
occur at all in the THSR. No patient in either register had infective endocarditis.  
 
The lower proportion of patients with hypertensive cardiomyopathy in the THSR, 
while possibly the result of less hypertensive heart disease in the community, is far 
more likely the result of the unavailability of echocardiography in the THSR. It is 
unlikely that we would have missed a cardiomyopathy, but it is quite possible that 
we would have diagnosed a patient with end-stage hypertensive heart disease in 
cardiac failure as having dilated cardiomyopathy (see section 5.2.5.2 for further 
discussion on hypertensive heart disease).  
 
Thirteen patients (48% of cardioembolic stroke patients) had atrial fibrillation in the 
THSR. None of these patients had ischaemic heart disease and the cause of the 
atrial fibrillation was roughly equally distributed between valvular heart disease, 
dilated cardiomyopathy, hypertensive heart disease and atrial fibrillation of 
unknown cause. Possibly atrial fibrillation is common in Bohlabela because care of 
cardiac patients is poor. There are no specialist physicians and no cardiologists in 
the area and people are seldom referred to specialist centres because of limited 
resources. Follow up care for cardiac patients and specialist cardiac medication is 
not readily available in the area (National Department of Health (South Africa), 
2003).  
 
Valvular heart disease was more common in the THSR. This may reflect a higher 
prevalence of rheumatic heart disease and associated valvular disease in the rural 
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areas of South Africa, but this is simply speculation. A community-based study of 
rheumatic heart disease and indeed of all heart disease in South Africa is needed.  
 
Thus, cardioembolic stroke is common in rural and urban South Africa, and the 
causes are very similar. We will, with due caution, highlight the possible role of the 
health transition in the subtle differences in causes of cardioembolic stroke in 
chapter 8. 
 
7.3.6 Comparison of HIV and syphilis infection in the THSR and the JHSR 
 
We tested very few (14) of the THSR stroke patients for HIV infection as most of 
the 47 patients who had blood investigations refused testing. We had similar 
experience in the SASPI risk factor survey in adults over 35 years of age 
conducted at the same time as the THSR (Thorogood et al., 2005). This possibly 
occurred because patients were concerned about a positive diagnosis with the 
associated social stigma, particularly at a time when antiretroviral therapy was not 
available (Sidley, 2001).  
 
We found that 5 stroke patients were HIV positive in the THSR i.e. 36% of the 14 
tested and 6% of all stroke patients. In contrast in the JHSR 61 of 148 black stroke 
patients tested for HIV were positive (41% of those tested and 20% of all black 
stroke patients). While the proportion of the patients tested who were positive is 
similar in the two registers, the findings from the THSR are unlikely to be accurate 
given the small number of patients tested, and all we can assume is that a 
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minimum of 6% of all stroke patients at Tintswalo Hospital were HIV positive at the 
time of the register. 
 
 We tested far more patients for syphilis (49 of 138; 36%) and only found one 
patient with the infection (2%). In the JHSR we tested 59 of 308 (19%) black 
patients and found 15% had the infection. It is likely that syphilis is not as 
prevalent in the rural South African elderly population as in the younger urban 
population of Johannesburg. In 2000 in Gauteng Province the prevalence of 
syphilis in antenatal clinic attendees was about 10% compared to the Limpopo 
Province prevalence of 4% (Directorate: Health Systems Research, 2001) and the 
prevalence decreased with age in all populations. Syphilis was far less common in 
our study than in other stroke studies that have assessed syphilis serology in Sub-
Saharan Africa (section 5.3.5.5). 
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7.4 Conclusion 
 
We found distinct differences between rural and urban South African hospital-
based stroke patients. Patients admitted to the rural Tintswalo Hospital were older, 
more likely to be pensioners and to be female than in Johannesburg. Rural stroke 
patients had more severe strokes than in the urban stroke register and were more 
functionally impaired. The majority of patients took the same time to get to hospital 
as in Johannesburg. Pathological stroke types were not markedly different in the 
two sites as far as we could tell, but there were more large artery and fewer 
lacunar ischaemic strokes in rural patients than urban patients. This suggests that 
rural stroke patients were less likely to present to hospital than urban stroke 
patients.  
 
Other than cigarette smoking and current alcohol use which were more common in 
urban stroke patients (possibly because patients were younger), the risk factors in 
rural stroke patients were remarkably similar to those in urban patients, including 
their cholesterol levels. Large artery atherosclerotic disease was about as 
common in rural and urban stroke patients but ischaemic heart disease did not 
occur. Cardiac causes of stroke were similar in rural and urban stroke patients, 
though rheumatic valvular heart disease was more common in rural stroke than 
urban patients.  
 
HIV and syphilis infection were not common in rural stroke patients, possibly 
reflecting a lower community prevalence of HIV especially in the elderly. However, 
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we were not able to investigate enough patients for these conditions to be 
confident about this conclusion.  
 
Hypertension was the most significant risk factor in rural and urban stroke patients, 
and is in our opinion the most important target for both primary and secondary 
prevention. More stroke patients died in the rural than the urban stroke register. 
This may well be the result of case mix differences i.e. rural hospital-based stroke 
patients had more severe strokes. However, seen together with the need for risk 
factor reduction and the need to detect and manage milder strokes in the 
community, what we really need is increased stroke awareness amongst both the 
general public and health care workers in the region, and a better package of care 
including improved acute and chronic management. 
 
The nature of stroke in rural South Africa was similar to that found in two recent 
stroke studies from an urban referral hospital in the Gambia. Our rural stroke 
patients were older and had more severe strokes, likely the result of limited 
financial and household resources in the community discouraging hospital 
admission. Hypertension and diabetes mellitus appeared to be more common in 
rural South African patients, but this difference may in be the result of 
methodological differences between the Gambian studies and ours.  
 
The lack of access to CT or MRI brain imaging in the Tintswalo Hospital Stroke 
Register and the Gambian stroke studies made it difficult to compare pathological 
stroke types. We found that the Siriraj Stroke Score did not perform as well in the 
rural stroke register as it did in the urban register. More than a third of patients did 
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not have a pathological stroke type assigned using the score, and the score 
appeared to underestimate ischaemic stroke and yet miss CT documented 
cerebral haemorrhages. The Siriraj Stroke Score may have underestimated 
ischaemic stroke in other studies from Sub-Saharan Africa including the Gambian 
stroke study. We could not use the Guy’s Hospital Stroke Score in our study 
because it required ECGs and chest x-rays which were seldom available in our 
low-resourced rural hospital. We do not feel that either of these scores in their 
current form is useful to distinguish pathological stroke type in Sub-Saharan 
African populations. 
 
Hospital-based studies present a biased view of stroke in any community, but 
when comparing our rural and urban stroke studies it appears that this bias is 
greatest in the rural population. To understand stroke in rural South African and 
indeed in Sub-Saharan Africa more clearly, we need community-based stroke 
incidence studies with good case ascertainment and early brain imaging.  
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7.4.1 What this study adds to the literature 
 
This is the first prospective rural stroke register from South Africa and the first 
prospective stroke register from Sub-Saharan Africa to focus entirely on rural 
stroke patients. The overlap in timing and design between the rural THSR and 
urban JHSR gives us the opportunity to compare the nature of rural and urban 
stroke patients in the same country during the same period, and provides insight 
into the influence of urbanisation on the nature of stroke. This study is also useful 
from the health service perspective as it highlights deficiencies in our rural stroke 
care at present. Only severe stroke patients appear to be admitted to hospital, and 
it is likely that milder stroke patients in the community are missed, together with 
the opportunity to prevent them from having a subsequent major stroke. This study 
has also highlighted the inadequacies of both the clinical and stroke score 
assessment of stroke patients, and the need for brain imaging in epidemiological 
studies in Sub-Saharan Africa.  
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CHAPTER 8   IS THERE EVIDENCE OF A HEALTH TRANSITION 
IN SOUTH AFRICA?  
 
8.0  Introduction 
 
In section 1.6 we described the postulated influence of the health and 
demographic transition on disease (Omran, 1971; Yusuf et al., 2001). For ease of 
reference we have repeated a table summarising the stages of the health 
transition (table 8.1). In summary, populations undergoing economic development 
undergo a gradual shift from infectious, perinatal and poverty related disease to 
non-communicable disease. Vascular risk factors emerge in a population in 
transition, with hypertension the predominant risk factor initially. Gradually 
diabetes mellitus and later elevated cholesterol levels add to the vascular risk 
factors as does increasing cigarette use. During the phase dominated by 
hypertension, stroke is the major vascular disease. Then later as the population 
moves into stage 3 of the transition (table 8.1), ischaemic heart disease takes the 
lead. During the transition, stroke is not only thought to increase in incidence but 
the nature of stroke also changes (Bonita, 2001). Pathological stroke type changes 
with an initial increase in the proportion of cerebral haemorrhage due to 
hypertension in stage 2, to a gradual decline in cerebral haemorrhage in stage 3 
and 4. Other causes of cerebral haemorrhage such as amyloid angiopathy are 
likely to increase in the later stages of the transition.  
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Table 8.1  Stages of the health transition based on the original theory devised by Omran (adapted from Howson et al., 
1998; Bonita, 2001; Omran, 1971 and Yusuf, 2001) 
 
Stage of Transition 
Percentage of all deaths caused 
by cardiac and vascular disease 
Predominant cardiac and vascular 
diseases 
Predominant nature of stroke Likely regional examples 
Age of pestilence and famine 5-10 
Rheumatic heart disease, infections, 
and nutritional cardiomyopathies 
Cardioembolic 
Sub-Saharan Africa, rural India, and 
South America 
Age of receding pandemics 10-35 
7As above, plus hypertension, 
hypertensive heart disease; stroke 
more common than ischaemic heart 
disease. High rheumatic heart 
disease to atherosclerotic heart 
disease ratio 
As above, plus haemorrhagic stroke 
due to hypertension. Stroke occurring 
at relatively young age. Emergence 
of atherothrombotic stroke 
China 
Age of degenerative and man-
made diseases 
35-55 
Ischaemic heart disease at relatively 
young ages. Heart disease more 
common than stroke. Very low 
rheumatic heart disease to 
atherosclerotic heart disease ratio 
Proportion of strokes due to 
haemorrhage decreases and 
atherothrombotic stroke increases 
Urban India, former socialist 
economies 
Age of delayed degenerative 
diseases 
<50 
Stroke and ischaemic heart disease 
at older ages 
Atherothrombotic stroke; 
cardioembolic stroke often secondary 
to effects of ischaemic heart disease 
(atrial fibrillation, mural thrombi, 
cardiomyopathy) 
Western Europe, North America, 
Australia, New Zealand 
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The cause of ischaemic stroke is also thought to change from an initial 
predominance of cardioembolic strokes, with cardiac disease the result of 
rheumatic heart disease, infectious and nutritional cardiomyopathies, to a 
predominance of atherothrombotic disease (table 8.1) (Bonita, 2001). The cause 
of cardioembolic stroke too changes as ischaemic heart disease emerges in the 
population. Ischaemic heart disease results in atrial fibrillation, mural thrombi and 
ischaemic cardiomyopathy.  
 
Early in the transition when hypertension is very prevalent, stroke tends to occur at 
a younger age than in later stages. However, the theory of the health transition, 
particularly as applied to stroke, is merely a framework. There are virtually no 
studies from Sub-Saharan Africa to support the theory, show changes in the 
nature of stroke occurring in a population, or that have assessed the impact of the 
HIV epidemic on the transition of vascular disease, as the continent develops 
economically.  
 
Gillum has suggested that the health or epidemiologic transition in people of Sub-
Saharan African origin is better explained in six stages spanning pre-colonial 
populations living in Africa to rural, inner city poor, and affluent urban African-
American populations (Gillum, 1996a) (table 8.2). We described these phases in 
section 1.6. Figure 8.1 depicts the influence of salt intake, fat consumption and 
cigarette smoking on the prevalence of hypertension and atherosclerotic disease 
(Cappuccio, 2004) with reference to Gillum’s six postulated stages of the health 
transition.  
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Table 8.2  Gillum’s adapted stages of the health / epidemiologic transition among person’s of Sub-Saharan African origin 
(Gillum, 1996) 
 
Cardiovascular Disease 
 
Stage 
 
Example 
population 
 
Acculturation 
 
Urbanisation 
 
Affluence 
 
Saturated fat 
intake 
 
Salt intake 
 
Smoking 
Hypertensive Atherosclerotic 
1 pre-colonial SSA 0 0 0 + + 0 0 0 
2 
modern urban 
SSA + ++ + ++ ++ + ++ 0 
3 
modern blacks 
living in the West 
Indies 
++ ++ ++ ++ +++ ++ ++++ + 
4 
rural African-
Americans +++ + ++ +++ ++++ +++ ++++ ++ 
5 
inner city, poor 
African-
Americans 
+++ ++++ +++ ++++ ++++ ++++ ++++ ++++ 
6 
Affluent urban 
African-
Americans 
++++ ++++ ++++ +++ +++ +++ ++ +++ 
 
SSA: Sub-Saharan Africa 
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Figure 8.1 Gillum’s stages of the epidemiological or health transition in populations 
of Sub-Saharan African origin (from Cappuccio, 2004) 
 
Key to Gillum’s stages: 
Stage 1: Pre-colonial Africa and remaining traditional African populations 
Stage 2: Modern urban Sub-Saharan Africans 
Stage 3: Modern black populations of the West Indies 
Stage 4: Rural African-Americans 
Stage 5: Poor inner city African-Americans 
Stage 6: Affluent urban African-Americans  
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To explore the health transition further, as it applies to SSA and in particular South 
Africa, we will in this chapter compare the pathological stroke types, ischaemic 
stroke subtypes, risk factors for stroke and where possible causes of 
cardioembolic stroke in our prevalent stroke, and rural and urban hospital-based 
stroke patients. We will focus on comparing black and white stroke patients from 
the JHSR as the small number of stroke patients in other population groups 
renders our findings inaccurate.  
 
We acknowledge that our assessment of pathological stroke type was limited in 
the prevalent stroke cases because patients did not have a brain scan and we 
assessed them a long time after their stroke. In the Tintswalo Hospital Stroke 
Register (THSR) our assessment of pathological stroke type was also limited 
because patients were not scanned.  Despite this, we feel that the comparison will 
provide some useful insight into the impact, if any, of the health transition on the 
nature of stroke in South Africa. 
 
We will compare study populations in terms of: age, pathological stroke type, 
ischaemic stroke subtype, major causes of stroke, and when available causes of 
cardioembolic stroke, prevalence of hypertension, diabetes mellitus, total 
cholesterol levels, and cigarette smoking. Finally, we will review the influence, if 
any, of HIV infection on the health transition in our studies.  
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8.1 Comparison of studies  
 
In table 8.3 we compare the age, stroke risk factors, pathological stroke types, 
ischaemic stroke subtypes and cause of cardioembolic strokes in black and white 
urban stroke patients in the JHSR (chapter 5), black patients in the rural THSR 
(chapter 7) and in prevalent black stroke patients (chapters 3 and 4). The case mix 
of patients in these studies is likely to have influenced our findings. Prevalence 
studies tend to exclude more severe stroke patients who are likely to die soon 
after their stroke. This probably accounts for the large proportion of small vessel / 
lacunar strokes and small proportion of large vessel strokes. Hospital-based 
patients are more likely to have severe strokes. Although black and white patients 
in the JHSR had strokes of similar severity (chapter 5), rural THSR patients had 
more severe strokes and were older (chapter 7). This may account for some of the 
differences seen in table 8.3 such as the large proportion of total anterior 
circulation ischaemic strokes.  
 
The comparison of our studies is fraught with hospital-bias and the shortcomings 
of stroke prevalence studies. Only community-based incidence studies with early 
CT scanning (as we originally proposed but could not fund) would be able to 
assess the situation adequately. 
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Table 8.3    Comparison of the nature of stroke in the black and white population group in 
the Johannesburg Hospital Stroke Register with prevalent stroke patients and 
patients from the Tintswalo Hospital Stroke Register (n for each assessment 
shown with percentages in brackets unless otherwise stated) 
 
JHSR 
 
Black White 
THSR 
SASPI 
Prevalence study 
Number 308 76 138 103 
Mean age (SD) years 51 (16) 61 (15) 64 (17) 61 (17) 
Pathological stroke type                                           207* 47* 138 103 
- Cerebral haemorrhage  55 (27) 7 (15) 32 (23) 31 (30) 
- Ischaemic stroke  141 (68) 36 (77) 98 (71) 63 (61) 
- Subarachnoid haemorrhage  11 (5) 4 (9) 0 0 
- Unspecified  0 0 8 (6) 9 (9) 
OCSP ischaemic stroke subtype  141 36 98 63 
- Total anterior circulation infarct 39 (28) 7 (19) 34 (36) 4 (6) 
- Partial anterior circulation infarct 45 (32) 17 (47) 36 (38) 22 (35) 
- Lacunar infarct 17 (12) 4 (11) 20 (21) 30 (48) 
- Posterior circulation infarct 40 (28) 8 (22) 4 (4) 7 (11) 
Ischaemic stroke subtype  235** 65** 98 63 
- Small vessel disease (% of all stroke) 60 (26) 18 (28) 11 (23) 30 (48) 
- Cardioembolic (% of all stroke) 53 (23) 18 (28) 27 (28) 5 (8) 
- Atherothrombotic stroke 13 (6) 13 (20) 1 (1) 0 
Cause of cardioembolic stroke 
(percentage of cardioembolic stroke)  
53** 20** 27 5 
Atrial fibrillation: total 15 (28) 13 (65) 13 (48) 1 (20) 
- unknown cause 6 7 4 1 
- with ischaemic heart disease 1 4 0 0 
- with rheumatic valvular heart disease 2 1 3 0 
- with dilated cardiomyopathy 0 1 3 0 
- with hypertensive heart disease 6 0 3 0 
Ischaemic heart disease 3 (6) 6 (30) 0 0 
Cardiomyopathy: total 27 (51) 0 12 (44) 2 (40) 
- dilated cardiomyopathy 10 0 11 2 
- associated with hypertensive heart 
disease 
17 0 1 0 
Rheumatic valvular heart disease 6 (11) 1 (5) 4 (15)† 2 (40) 
Infective endocarditis 0 1 0 0 
Risk factors ( n / total assessed)     
Hypertension  214/306 (74) 50/74 (69) 95/136 (70) 73 / 103 (71) 
Diabetes mellitus  42/264 (16) 11/74 (15) 24/138 (17) 12 / 103 (12) 
Total cholesterol mean (95% CI) 4.6 (4.3 to 4.9) 5.3 (4.8 to 5.7) 4.7 (4.4 to 5.0) n/a 
Current cigarette smoking  57/ 245 (23) 34/63 (54) 6/123 (5) 9 / 103 (9) 
 
*patients with brain imaging; ** all ischaemic stroke not only those with CT included  OCSP: Oxfordshire Community Stroke 
Project  
† this is likely to be an underestimate given the lack of echocardiography and may be as high as 8 (30%) ‡ history or ECG 
evidence 
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8.1.1 Comparison of age 
 
Patients from Bohlabela (THSR and prevalent strokes) were older than black 
patients in the JHSR and about as old as white patients. While people develop 
stroke at a younger age as they progress through the early phases of the 
transition, and it is tempting to suggest that the JHSR stroke patients were 
younger because they were further along the transition, this is unlikely to be true. 
We are very likely to have missed young stroke patients in the prevalence and 
THSR studies because of labour migration and hospital-bias.  
 
8.1.2 Comparison of pathological stroke type and ischaemic stroke subtype 
 
In the JHSR 30% of black patients had cerebral haemorrhages, far more than we 
found in white JHSR stroke patients (15%). Our finding in white stroke patients 
was similar to the 12% found in 997 white stroke patients in the South London 
Stroke Register (Lawrence et al., 2001). The assessment of pathological stroke 
type in the THSR was probably too inaccurate for comparison here.  
 
The proportion of stroke caused by cerebral haemorrhage is thought to increase in 
the early phases of the health transition (original Omran stage 1 to 2) and then 
decrease later in the transition (stage 3 to 4) (table 8.1). Therefore, the JHSR 
findings support the notion that urban black stroke patients are at an earlier phase 
of the health transition than white stroke patients in South Africa and the United 
Kingdom. 
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We did not find any patients in rural South Africa with subarachnoid haemorrhage, 
although the numbers of patients with subarachnoid haemorrhage were small in 
the JHSR and it is possible that we missed patients in the prevalence study of 
stroke survivors. Subarachnoid haemorrhage is not usually considered in the 
theory of the health transition which is probably sensible since typical vascular risk 
factors do not influence the incidence of subarachnoid haemorrhage as they do 
cerebral haemorrhage and ischaemic stroke (Warlow et al., 2001).  
 
While ischaemic stroke subtypes differed between the studies, this was as likely to 
be the result of case mix differences as discussed above, as anything to do with 
the health transition. In the JHSR stroke severity was very similar in black and 
white stroke patients as was the proportion of large artery, small vessel and 
cardioembolic strokes (table 8.3).  
 
However, we did find significant differences between the causes of cardioembolic 
strokes in the four groups (table 8.3). In white stroke patients, atrial fibrillation and 
ischaemic heart disease accounted for 95% of cardioembolic strokes. In urban 
black stroke patients, atrial fibrillation, cardiomyopathy and rheumatic valvular 
heart disease caused 96% of cardioembolic strokes. Ischaemic heart disease 
occurred but was uncommon. None of the rural stroke patients, whether hospital 
or community based, had cardioembolic strokes associated with ischaemic heart 
disease, but rheumatic heart disease was relatively common. 
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Thus, the rheumatic heart disease to ischaemic heart disease ratio (table 8.1) was 
very high in rural stroke patients and low in urban white stroke patients. Though 
uncommon, ischaemic heart disease did occur and decreased this ratio in urban 
black stroke patients.  
 
8.1.3 Comparison of risk factors 
 
The prevalence of hypertension and diabetes mellitus was similar across all four 
groups (table 8.3). The mean total cholesterol levels were no different in urban and 
rural black stroke patients, and both values were lower than in white stroke 
patients. However, current cigarette smoking was commonest in urban white 
stroke patients despite them being older, less common in urban black stroke 
patients and uncommon in rural black patients. Cigarrette smoking may have been 
more common in urban black patients because they were younger than rural black 
patients. This risk factor profile suggests that black stroke patients are at an earlier 
phase of the health transition than urban white patients (figure 8.1 and table 8.2).  
 
8.1.4 Comparison with African-American stroke patients 
 
Gillum suggests that African-Americans are representative of the final stages of 
the health transition in populations of Sub-Saharan African origin. In African-
American stroke studies such as the Northern Manhattan Stroke Study and 
Greater Cincinnati / Kentucky Stroke Study (GCNKSS) hypertension was found in 
65 to 68% of stroke patients, diabetes mellitus in 33%, and current cigarette 
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smoking in 26% (Woo, Gebel, Miller et al, 1999; White et al., 2005) as previously 
discussed in chapter 5. Cerebral haemorrhage accounted for 15% of strokes in the 
GCNKSS, a similar proportion to our white stroke patients. Unfortunately we could 
not find data from these studies on the causes of cardioembolic stroke to compare 
with our patients, other than atrial fibrillation which was more common in African-
Americans (10% of all stroke) than in our urban black patients (3% of all patients) 
(section 5.3.5.3), though the African-American patients were much older. 
However, ischaemic heart disease is as common or almost as common in African 
populations living in America or the United Kingdom and far more common than in 
black Sub-Saharan African populations (Lawrence et al., 2001; Ferdinand, 2006).  
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8.2 Discussion 
 
There is evidence from our hospital-based stroke studies and community-based 
stroke prevalence study to give some support to the theory of the health transition. 
As vascular risk factors increased with urbanisation in our black stroke patients, so 
ischaemic heart disease emerged and the ratio of rheumatic valvular heart disease 
to ischaemic heart disease decreased. In comparison with urban white South 
Africans and African-Americans who represent the final stages of the health 
transition, black South Africans probably have more cerebral haemorrhages and 
less atherosclerosis.  
 
Rural South African stroke patients appear to be emerging from stage 1 into stage 
2 of the original health transition proposed by Omran (table 8.1). Urban South 
African stroke patients are firmly in stage 2. When we apply Gillum’s suggested six 
stage adaptation of the transition (table 8.2), it is more difficult to differentiate 
between our rural and urban stroke patients. Gillum stage 2 best describes our 
rural stroke patients, yet hypertension is at least as common in our rural stroke 
patients as it is in African-Americans. Atherosclerotic disease emerges in Gillum 
stage 3, which probably best describes the features exhibited by our urban stroke 
population. Gillum suggests that black populations of the West Indies are typical of 
stage 3. Urban black South African stroke patients may represent the vanguard or 
so called ‘early-adopter’ population (Yusuf et al., 2001) within Sub-Saharan Africa.  
 
Gillum’s suggested stages do not adequately describe our rural stroke patients. 
Furthermore, it is likely (as shown in autopsy studies investigating atherosclerosis 
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in chapter 2, section 2.3.3) that asymptomatic atherosclerosis emerges before 
symptomatic atherosclerotic disease in populations undergoing transition. We 
therefore suggest an adaptation of Gillum’s six-staged transition for use in Sub-
Saharan Africans (table 8.4).  
 
Black Sub-Saharan Africans are currently at most at stage 3a of the modified 
Gillum classification (table 8.4). Their advance through the transition will depend 
on whether adequate preventative strategies are set in place to reduce vascular 
risk factors and subsequent vascular disease. If these measures fail or are not set 
in place then inevitably they will advance through the transition to an epidemic of 
stroke and ischaemic heart disease.  
 
As we discussed in chapter 5, HIV-infected stroke patients were younger and less 
likely to have traditional vascular risk factors. However, our study was too small to 
investigate differences in the cause of stroke adequately. In section 5.3.5.4 we 
discussed our finding of similar frequencies of atrial fibrillation and cardiomyopathy 
in HIV positive and negative stroke patients. It is likely, that HIV positive stroke 
patients form a distinct group and will not follow the described transition unless 
they are treated. Antiretroviral therapy is associated with a marked elevation in 
blood lipids and the full impact of this on vascular disease in treated HIV infected 
patients will only become clear in time (Sekhar, Jahoor, Pownall et al, 2004). 
Meanwhile, the elderly in Sub-Saharan Africa, who are at highest risk of stroke, 
maintain households that have lost younger adults to HIV infection. 
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It is essential that these people and those who avoid HIV infection are not lost to 
an impending epidemic of vascular disease. 
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Table 8.4   Adaptation of Gillum’s stages of health / epidemiologic transition for use in Sub-Saharan Africa 
 
 
The degree to which each factor or disease is present in each stage is shown, with 0 denoting virtually absent and ++++ denoting present at the highest reported level 
SSA: Sub-Saharan Africa    *symptomatic here refers to symptomatic ischaemic heart disease or symptomatic extracranial carotid artery disease; ** early adopter populations within SSA  
Vascular Disease  
 
Stage 
African 
populations 
outside of 
SSA 
 
SSA population 
 
 
Affluence 
 
Saturated fat 
intake 
 
Salt intake 
 
 
Smoking Hypertensive Atherosclerosis 
        Asymptomatic Symptomatic* 
1 
pre-colonial 
SSA 
traditional SSA 
populations 
0 + + 0 0 0 0 
2a - rural SSA + ++ ++ + ++ 0/+ 0 
2b - 
rural / semi-urban 
SSA ** 
+ ++ +++ + ++++ + 0 
3a - 
urban 
SSA 
++ ++ +++ ++ ++++ +/++ 0/+ 
3b 
modern blacks 
living in the 
West Indies 
++ ++ +++ ++ ++++ ++ + 
4 
rural African-
Americans 
++ +++ ++++ +++ ++++ ++ ++ 
5 
inner city, poor 
African-
Americans 
+++ ++++ ++++ ++++ ++++ ++++ ++++ 
6 
affluent urban 
African-
Americans 
 
The future, pending 
preventative 
strategies 
++++ +++ +++ +++ ++ +++ +++ 
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CHAPTER 9   CONCLUSIONS 
 
Using an urban and a rural hospital-based stroke register, and the first community-
based South African stroke prevalence study, we found that: 
 
- the prevalence of stroke in rural South Africa is about half that found in 
high-income countries and twice that found in rural Tanzania, but the 
prevalence of disabling stroke is already at least as high as that found in 
high-income countries; 
- there is evidence that both urban and rural black South Africans are well 
into the health transition and that this transition is impacting on the nature of 
stroke in black stroke patients in South Africa; 
- the cause of cardioembolic stroke, in particular the rheumatic valvular heart 
disease to ischaemic heart disease ratio, provides a useful marker of the 
evolution of the health transition in our population; 
- HIV infection alters the nature of stroke and the profile of patients who 
suffer a stroke; 
- Guy’s Hospital and Siriraj Stroke Scores require further adaptation and 
refinement for use in black South African stroke patients. At present they 
are not helpful in clinical or epidemiological studies; and 
- there is a dire need for community-based stroke incidence studies with 
complete case ascertainment, early brain imaging and detailed investigation 
of incident stroke cases, to clarify the nature of stroke, the role of the health 
transition in Sub-Saharan Africa, and the role of HIV infection in stroke. 
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Thus, from our findings it appears as though there is already a heavy burden of 
stroke in rural and urban South Africa. Comparing our rural and urban stroke 
populations, we found evidence to suggest that the South African black population 
is advancing into the early stages of the health transition. If stroke risk factors 
continue to increase as predicted by the health transition, then we can anticipate 
an increasing burden of stroke as well as increasing ischaemic heart and 
peripheral artery disease in the future. This vascular disease epidemic will place a 
further burden on our population, which already carries a large burden of infectious 
disease, specifically HIV infection, perinatal disease and trauma. To prevent this 
inevitable progression of vascular disease, we need to reduce whole population 
risk and identify and treat high-risk individuals. We also need to adjust our health 
service which is accustomed to providing acute medical care particularly for 
infections and trauma, to deal better with the management of chronic disease.  
 
However, we need further research to fully understand the burden and nature of 
stroke in both South Africa, and the rest of Sub-Saharan Africa. Only high-quality 
community-based stroke incidence studies that adhere to ‘ideal’ incidence study 
criteria will provide accurate answers. We have shown the difficulties that arise in 
interpreting data from hospital-based stroke studies in rural and urban areas, and 
the failure of stroke scores designed to assess pathological stroke types. Until we 
have community-based studies with brain imaging we will never know the precise 
burden and nature of stroke, the effect of the health transition, the influence of HIV 
on stroke or the optimal approach to preventing a stroke epidemic in our 
population.  
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By comparing not only rural and urban stroke in South Africa, but also our findings 
compared to the limited data available from the rest of Sub-Saharan Africa, we 
have shown that stroke is not homogenous across the continent. Community-
based incidence studies, while expensive, should be conducted in different 
populations across Sub-Saharan Africa, perhaps in well-defined populations that 
form part of established demographic surveillance sites.  
 
Stroke, the forerunner of vascular disease in populations in transition, has been 
underestimated, poorly researched and poorly managed in Sub-Saharan Africa for 
decades. The difficulties that researchers experience in the region are often used 
as an excuse not to fund high quality research. It is now clear from this study, and 
many others, that stroke is increasing across the continent. We, the clinicians and 
researchers, together with research funders, face the challenge of accurately 
documenting the burden and nature of stroke, of providing adequate and 
appropriate stroke prevention, and care when prevention fails.  
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APPENDIX A: SEARCH CRITERIA FOR THE SYSTEMATIC 
REVIEW (CHAPTER 2) 
Comprehensive textword and MeSH-based search criteria for EMBASE designed 
to retrieve articles with data on stroke in Sub-Saharan Africa. We used a similar, 
appropriately adapted search strategy to retrieve articles from MEDLINE. 
 
1. exp cerebrovascular disease/ 
2. stroke$.tw. 
3. cerebrovascular$.tw. 
4. (cerebral or cerebellar or brainstem or vertebrobasilar).tw. 
5. (infarct$ or isch?emi$ or thrombo$ or emboli$).tw.  
6. 4 and 5 
7. carotid$.tw. 
8. (cerebral or intracerebral or intracranial or parenchymal or brain or 
intraventricular or brainstem or cerebellar or infratentorial or supratentorial 
or subarachnoid).tw. 
9. (haemorrhage or hemorrhage or haematoma or hematoma or bleeding or 
aneurysm).tw. 
10. 8 and 9 
11. transient isch?emic attack$.tw. 
12. exp aphasia/ 
13. dysphasia/ 
14. hemianopia/ 
15. hemiplegia/ 
16. hemiparesis/ 
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17. (aphasi$ or dysphasi$ or hemianop$ or hemipleg$ or hemipar$ or 
migraine$).tw. 
18. exp carotid artery surgery/ 
19. 1 or 2 or 3 or 6 or 7 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 
20. negro/ 
21. ethnic group/ 
22. race/ 
23. ethnic difference/ 
24. “ethnic and racial groups”/ 
25. “ethnic or racial aspects”/ 
26. ethnology/ 
27. (black$ or negro$ or African?).tw. 
28. africa/ 
29. exp africa south of the sahara/ 
30. developing country/ 
31. underdeveloped country/ 
32. africa.tw. 
33. sub?saharan.tw. 
34. (“Ethiopia” or “Ghana” or “Kenya” or “Mozambique” or “Nigeria” or “Senegal” 
or “South Africa” or “Sudan” or “United Republic of Cameroon” or “Zaire” or 
“Zambia” or “Zimbabwe”).cp. 
35. 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 
33 or 34 
36. 19 and 35  
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 Doctor completing the form: 
 
 Date of visit:  . .2002 
 
 Name:   
 
 
 Agincourt DSS ID Number:          
 
 Village and Household Number:        
 
 Village Name: 
 
 Date of Census Screening Visit: . .2002 
 
 Individual: Alive     Deceased   ………. Date of Death: . .2002 
 
 Sex:                                               Male       Female  
 
 Refugee:                                       Yes        No  
 
 Age:                                                years 
 
 Is this an estimate:                      Yes               No  
 
 Date of Birth:                                . .  
 
 Census Questions:                      ‘Yes’ to weakness    ‘Yes’ to stroke  
 
 Date of onset of the symptoms (first event): . .   
 
 
 Age at time of first event:  
 
 
 
 
 
 
 
 
South African Stroke Prevention Initiative – Prevalence Study 
  
 
 Office use                   Prevalent Patient number:                                Form complete 
 
 
 
APPENDIX B  PREVALENCE STUDY QUESTIONNAIRE 
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 History: 
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 Possibly a stroke or TIA?  
 
o Yes  - continue with form / interview 
 
o No    - complete the examination to document as far as possible the likely 
cause of weakness or reason for ‘yes’ answer; and skip the rest of the form 
 
Specific questions on history (if more than one stroke or TIA then questions refer to the 
first event): 
 Symptoms present on waking? 
• Yes         No  
 Blood pressure ever checked prior to the stroke? 
• Yes           No  
o  Within the 3 months prior to stroke / TIA? 
o  Between 3 and 12 months prior 
o  More than a year before the stroke 
 Ever told that they have high blood pressure before the stroke / TIA? 
• Yes              No  
 On treatment for high blood pressure at the time of the stroke? 
• Yes               No  
 After the stroke / TIA were they on antihypertensive treatment at any time? 
• Yes               No  
 
 
      Activities of Daily Living (ADL): 
 
 Was the patient independent prior to admission?        Yes    No    Unknown  
 Rankin modified before this event? *               0    1     2    3   4    5   
 
 
* Modified Rankin score 
 
0  =  no symptoms. 
1  =  minor symptoms which do not interfere with lifestyle. 
2  =  some restriction to lifestyle, but look after themselves. 
3  =  significant restriction to llifestyle, preventing total independence. 
4  =  severe handicap preventing independent existence but 
      not requiring constant attention. 
5  =  severe handicap, totally dependent, requiring attention night and day. 
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 Hypertension                     YES           NO          UNKNOWN  
 Diabetes: YES  NO   UNKNOWN  
 Periph. vasc. disease: YES  NO   UNKNOWN  
 Atrial fibrillation: YES  NO   UNKNOWN  
 Hyperlipidaemia:  YES  NO  UNKNOWN  
 Coagulopathy:     YES  NO  UNKNOWN  
 Collagen vasc. disease: YES  NO   UNKNOWN  
 Migraine with aura: YES  NO  UNKNOWN  
 Pregnancy:  YES  NO   UNKNOWN  
 Trauma:  YES  NO   UNKNOWN  
 Previous TIA:  YES  NO  UNKNOWN  
 Previous Stroke:    YES  NO  UNKNOWN  
 Oral contraception:  YES  NO  UNKNOWN  
 Family history: YES  NO  UNKNOWN  
 
 Any symptoms of angina?      YES     NO     IMPOSSIBLE TO ASSESS   
 
 
 Substance abuse:    YES   NO  
DAGGA   MANDRAX    OTHER:        
 
 Smoking:      NEVER     EX-SMOKER (> 1 YEAR)        
CURRENT SMOKER   
      
NUMBER SMOKED PER DAY     
 
 Snuff (current):  YES   NO  
 
 Alcohol:    NEVER / HARDLY EVER   EX-DRINKER (> 1 YEAR)     DRINKS  
 
AMOUNT OF ALCOHOL PER DAY *   g  
• (100 ml wine (1 glass) or 30 ml spirits (1 tot) or 250 ml beer all = 10 g alcohol) 
 
 
 
 
 
 
 
 
 
 
 
 
 
RISK FACTORS  
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General Examination 
      
 Irregular pulse:    Yes   No  
 Is this Atrial Fibrillation clinically?  Yes   No         Not sure  
 BP at first assessment (supine, average of 3 readings ): 
1.   /      2.   /   3.   /  
     AVERAGE:       /    
 Evidence of hypertensive end organ damage?      YES  NO  
CARDIAC   FUNDI   RENAL (RENAL DYSFUNCTION)  
 
 Carotid bruits:        RIGHT   LEFT   
 
 Clinical heart failure:  
(i.e.: signs of LVF/RVF, not just on treatment)  YES   NO  
 
 Clinical valvular heart disease:  
(not a simple low murmur < 2/6)     YES   NO  
 
 Peripheral vascular disease:  
(both foot pulses absent or femoral bruits)     YES   NO  
 
 Cardiac disease:       YES   NO  
 
ISCHAEMIC            VALVULAR      ATRIAL FIBRILLATION       
CARDIOMYOPTHY          HYPERTENSIVE HEART DISEASE WITHOUT CARDIOMYOPATHY   
 
 Other arteriopathy:       
 
NEUROLOGIC DEFICIT: 
 
 Indicate whether the following signs and symptoms are present: 
 
 
   Coma:       Yes   No  
    
   Decreased LOC:      Yes   No  
 
   Motor weakness:     Yes   No  
  
   Sensory deficit:      Yes   No  
 
   Cerebellar signs:      Yes   No  
 
   Dysphasia:       Yes   No  
 
   Dysphagia:       Yes   No  
 
   Other cortical signs:     Yes   No  
   (apraxia, visual deficit, cortical sensory) 
 
   Urinary incontinence:      Yes   No  
 
   Can lift arm against gravity:    Yes   No     
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Modified Rankin Score 
 
 Circle your choice of score from the following list of options: 
DESCRIPTION: SCORE: 
No symptoms 0 
Minor symptoms which do not interfere with lifestyle 1 
Some restriction to lifestyle, but look after themselves 2 
Significant restriction to lifestyle, preventing total independence 3 
Severe handicap preventing independent existence but not requiring constant attention 4 
Severe handicap, totally dependent, requiring attention night and day 5 
 
 
 
Barthel Score 
 
 Circle one score for each of the categories: 
CATEGORY: 
DESCRIPTION: 
SCOR
Bowels Incontinent or needs enemas 0 
 Occasional  incontinence (< once per week) 1 
 Continent 2 
Bladder Incontinent/unable to manage catheter 0 
 Occasional accident ( < once per day) 1 
 Continent 2 
Grooming Needs help with shaving, washing, hair or teeth 0 
 Independent 1 
Toilet use Dependent 0 
 Needs some help  1 
 Independent on, off dressing and cleaning 2 
Feeding Dependent 0 
 Needs some help (e.g. with cutting, spreading) 1 
 Independent if food provided within reach 2 
Transfer (e.g. bed 
or chair) 
Unable and no sitting balance 0 
 Needs major help 1 
 Needs minor help 2 
 Independent 3 
Mobility Unable 0 
 Wheelchair independent indoors 1 
 Walks with help or supervision 2 
 Independent (but may use aid) 3 
Dressing Dependent 0 
 Needs some help 1 
 Independent including fasteners 2 
Stairs Unable 0 
 Needs some help or supervision 1 
 Independent up and down 2 
Bathing Dependent 0 
 Independent in bath or shower 1 
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NIH Scale 
 
 Circle one score for each of the categories: 
CATEGORY: DESCRIPTION SCORE 
Conscious level Awake 0 
 Drowsy, somnolent 1 
 Stupor (rousable to correct localization of painful stimulus) 2 
 No reaction or extensor or flexor spastic response 3 
Response to questions (month, age) Both answers correct 0 
 One answer correct 1 
 Both answers wrong or no response 2 
Eye movement Normal 0 
 Partial gaze palsy 1 
 Complete gaze palsy (also to oculocephalic  maneuver)                                                                   2 
Facial palsy Normal 0 
 Slight 1 
 Moderate 2 
 Complete 3 
Limb ataxia (affected side) Normal 0 
 One limb ataxic 1 
 Both limbs ataxic 2 
Neglect Normal 0 
 Partial neglect (inattention) on side 1 
 Complete hemi-neglect (several sensory modalities) 2 
Aphasia Normal 0 
 
Mild dysphasia (word finding difficulty, paraphasia, 
grammatical errors) 
1 
 Motor (Broca) or sensory (Wernickle) aphasia or variants 2 
 Complete aphasia, muteness 3 
Attempted Posture (affected lower limb) Unremarkable (5s) 0 
 Droops 1 
 Lower limb flops (5s) 2 
 Postural attempt impossible 3 
Reaction to Verbal Order 
(open or shut eyes, hand grip) 
Both correct 0 
 One correct 1 
 No reaction or incorrect action 2 
Visual fields Full 0 
 Incomplete hemianopia 1 
 Complete hemianopia 2 
Attempted posture (affected arm) Unremarkable (10s) 0 
 Pronation 1 
 90° posture fails <10s, rapid droop 2 
 Postural attempt fails 3 
Sensation Normal 0 
 Hypesthesia 1 
 Anaesthesia 2 
Dysarthria Normal 0 
 Dysarthric but easily understood 1 
 Severe dysarthria, barely intelligible 2 
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Scandinavian Stroke scale 
 
 Circle one score for each of the categories: 
CATEGORY: DESCRIPTION: SCORE: 
Consciousness Fully conscious  6 
 Somnolent, can be awaked to full conscience 4 
 Reacts to verbal command, but is not fully conscious 2 
Eye movement No gaze palsy 4 
 Gaze palsy present 2 
 Conjugate eye deviation 0 
Arm motor, power * Raises arm with normal strength 6 
 Raises arm with reduced strength 5 
 Raises arm with flexion in elbow 4 
 Can move, but not against gravity 2 
 Paralysis 0 
Hand motor, power * Normal strength 6 
 Reduced strength in full range 4 
 Some movement, fingertips do not reach palm 2 
 Paralysis 0 
Leg motor power * Normal strength 6 
 Raises straight leg with reduced strength 5 
 Raises leg with flexion of knee 4 
 Can move, but not against gravity 2 
 Paralysis 0 
Orientation Correct for time, place and person 6 
 2 of these 4 
 1 of these 2 
 Completely disorientated 0 
Speech No aphasia 10 
 Limited vocabulary or incoherent speech 6 
 More than yes/no, but not longer sentences 3 
 Only yes/no or less 0 
Facial palsy None/dubious 2 
 Present 0 
Gait Walks 5 in without aids 12 
 Walks with aids 9 
 Walks with help of another person 6 
 Sits without support 3 
 Bedridden/wheelchair 0 
 
• Motor power is assessed only on the affected side 
 
Glasgow Coma Scale 
 
 Circle one score for each of the categories: 
CATEGORY: DESCRIPTION: SCORE: 
Eye opening None E1 
 To painful stimulus E2 
 To command/voices E3 
 Spontaneously with blinking E4 
Motor response None M1 
 Arm extension to painful stimulus M2 
 Arm flexion to painful stimulus M3 
 Arm withdraws from painful stimulus M4 
 Hand localizes painful stimulus M5 
 Obeys commands M6 
Verbal response None V1 
 Sounds but no recognizable words V2 
 Inappropriate words/expletives  V3 
 Confused speech V4 
 Normal  V5 
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Other relevant findings on examination:  
      YES   NO  
 
 
 
 
 
 
CLINICAL OPINION OF LIKELY PATHOLOGICAL STROKE TYPE : 
 
HAEMORRHAGE     INFARCT     SAH     NOT SURE  
 
Answer known on history e.g. patient told that it was a haemorrhage on CT scan: YES   NO  
 
 
LOCALISATION AND SUBTYPE OF STROKE OR TIA (Clinically – include all information known about 
deficit at time of event and current findings to localize and subtype) 
 
COMPLETE ANTERIOR CIRCULATION (TACS/I)    
 
 Select one  PARTIAL ANTERIOR (PACS/I)       
 
POSTERIOR CIRCULATION (POCS/I)      
 
 LACUNAR (LACS/I)        
 
MEDICATION  (names only - no dosages necessary) 
 
 At time of assessment  
 
 
  
 
 
  
 
 
  
 
Complications since event that are likely directly related to the stroke:  
PAINFUL SHOULDER SYNDROME        
RECURRENT STROKE     
PNEUMONIA           
DVT        
 Select all relevant boxes:           MYOCARDIAL INFARCT          
SEIZURES      
DEPRESSION         
BEDSORES      
PROGRESSING STROKE (SYMPTOMS  
AND SIGNS EVOLVE OVER HOURS)    
OTHER       
 
 
 
 
 
Specify: 
 Home carer needed?   YES   NO  
 Home carer available   YES  NO  
Is the patient’s partner the carer?  YES  NO  
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Specify: 
 
 
    Aspirin: 
 Should Aspirin be prescribed?   YES  NO  
 Was Aspirin prescribed?   YES  NO   
 
FINAL DIAGNOSIS (insert a number from the codes) 
o Stroke   
 
o TIA        
 
o Other    
 
If other then what?  
 
 
 First-ever-in-a-lifetime stroke:  YES   NO   UNABLE TO ASSESS  
DEFINITE   PROBABLE    POSSIBLE  
    
 Was there more than one stroke or TIA? 
o Yes    No   
 
 How many?    
 
 Date of most recent event: . .   
 
 Did the patient seek assistance from health care providers / healers following the stroke? 
 
o Yes   No       
 
o  Clinic 
 
o  Hospital:  Tintswalo    Mapulaneng   Matikwane  Other…..  
 
o  Traditional Healer 
 
o  ZCC or other Church group 
 
 Which health service attended first?  Hospital/clinic    Traditional healer   Church 
 
 
 Do you have any reason to believe that the patient may have retroviral disease? 
 
 Yes     No  
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> > > > > > > > > > DO NOT LOOK AT THE CT SCAN BEFORE COMPLETING THIS FORM < < < < < < < < < < 
 
  
 
 
NOTES:  
Each individual question is marked  ‘ > ’  
Some responses require expansion most often facilitated by shading. Illustrated in the following example: 
  Is it the weekend?  YES   NO  
              What day is it?  SATURDAY  SUNDAY  
Here, the second question only needs to be considered if the response to the first question is ‘YES’ 
 
 
 
 Doctor completing this form:  
 
 Patient hospital number:      
 Ward:       
 Date of birth:      .  . 19    
 Age:       
 Contact telephone number:   
   (friend / relative)   
 Sex:       MALE        FEMALE  
 Ethnic group:    WHITE        BLACK  COLOURED   INDIAN-ASIAN 
 
 Date of stroke:      .  . 20   
 Date of admission:     .  . 20  
 Date of assessment by stroke team:  .  . 20   
 
 Time between onset of stroke  
 and hospital medical attention:   HOURS  DAYS 
 
HISTORY OF EVENT 
 Symptoms present on waking:    YES  NO  UNKNOWN   
 Headache within 2 hours of onset:   YES  NO  UNKNOWN  
 Vomited since symptom onset:    YES  NO  UNKNOWN  
 Loss of consciousness at onset:    YES  NO  UNKNOWN  
 Drowsiness since symptom onset:   YES  NO  UNKNOWN  
 Seizure since symptom onset:    YES  NO  UNKNOWN  
 If symptoms have resolved by the time of  
 examination, how long were they present?   HOURS  DAYS 
 
Office use    Form completed       Register number  
APPENDIX D JOHANNESBURG HOSPITAL STROKE REGISTER 
QUESTIONNAIRE 
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ADL (Activities of Daily Living) 
 Was the patient independent prior to admission?     YES  NO  UNKNOWN  
 Rankin modified before this event? *               0         1          2      3    4          5   
 
* Modified Rankin score 
 
0  =  no symptoms. 
1  =  minor symptoms which do not interfere with lifestyle. 
2  =  some restriction to lifestyle, but look after themselves. 
3  =  significant restriction to llifestyle, preventing total independence. 
4  =  severe handicap preventing independent existence but 
      not requiring constant attention. 
5  =  severe handicap, totally dependent, requiring attention night and day. 
 
 
 
RISK FACTORS  
 Hypertension: YES  NO      UNKNOWN  
 Diabetes: YES  NO   UNKNOWN  
 Periph. vasc. disease: YES  NO   UNKNOWN  
 Atrial fibrillation: YES  NO   UNKNOWN  
 Hyperlipidaemia:  YES  NO  UNKNOWN  
 Recent infection: YES  NO  UNKNOWN  
 Coagulopathy:     YES  NO  UNKNOWN  
 Collagen vasc. disease: YES  NO   UNKNOWN  
 Migraine with aura: YES  NO  UNKNOWN  
 Pregnancy:  YES  NO   UNKNOWN  
 Trauma:  YES  NO   UNKNOWN  
 Previous TIA:  YES  NO  UNKNOWN  
 Previous Stroke:    YES  NO  UNKNOWN  
 Oral contraception:  YES  NO  UNKNOWN  
 Family history:  YES  NO  UNKNOWN  
 
 Substance abuse:    YES   NO  
DAGGA   MANDRAX    OTHER:        
 
 Smoking:       NEVER     EX-SMOKER (> 1 YEAR)      
 CURRENT SMOKER   
      
NUMBER SMOKED PER DAY     
 
 Snuff (current):  YES   NO  
 
 Alcohol:     NEVER / HARDLY EVER   EX-DRINKER (> 1 YEAR)     DRINKS  
 
AMOUNT OF ALCOHOL PER DAY *   g  
* (100 ml wine (1 glass) or 30 ml spirits (1 tot) or 250 ml beer all = 10 g alcohol) 
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HANDEDNESS 
 Select one  LEFT HANDED   RIGHT HANDED    UNKNOWN  
 
SOCIO-ECONOMIC 
 Marital Status:      MARRIED/COMMON LAW *        SINGLE       WIDOWED      DIVORCED 
 
   * (includes partners where living together)  
                            
 Sole Bread Winner: YES        NO   
       NUMBER OF FINANCIAL DEPENDENTS INCLUDING PARTNER 
 
 
 
Housing:    OLD-AGE RETIREMENT FACILITY    
   HOUSE/FLAT           
SERVICED SHACK (TOILET PLUS TAP)  
 Select one  UNSERVICED SHACK      
     DORMITORY/HOSTEL/SINGLE ROOM   
     ACCOMMODATION WITH EMPLOYER  
E.G. DOMESTIC WORKER     
      
     OTHER:     
 
 NUMBER OF PEOPLE LIVING IN DWELLING:   
 (if living with employer do not include employers family/house) 
 
 NUMBER OF ROOMS USED FOR SLEEPING  
 IN THE DWELLING:        
 (if living with employer do not include employers family/house) 
 
Education:      
 YEARS OF SCHOOLING PASSED:      
 YEARS OF TERTIARY EDUCATION PASSED:   
 
Employment:   
 Select one 
              Employed                   Unemployed 
   
  PROFESSIONAL/MANAGERIAL   LOOKING FOR WORK 
 MIDDLE MANAGEMENT                UNEMPLOYED BY CHOICE E.G.  HOMEMAKER 
 MANUAL FORMAN/SKILLED ARTISAN            FULL-TIME STUDENT 
 FARMER – LARGE FARM                                  SOCIAL PENSIONER – ON DISABILITY GRANT   
 SUBSISTENCE FARMER    OR OLD AGE PENSIONER       
 CLERICAL/SEMI-SKILLED       
 UNSKILLED/ INFORMAL SECTOR TRADER                                              
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GENERAL EXAMINATION      
 Irregular pulse:   YES  NO  
 
 BP at first assessment (supine, average of 3 readings ): 
1.   /       2.   /    3.   / 
 
     AVERAGE:       /    
 Evidence of hypertensive end organ damage?      YES  NO  
CARDIAC   FUNDI   RENAL (RENAL DYSFUNCTION)  
 
 Carotid bruits:         RIGHT    LEFT   
 
 Clinical heart failure:  
(i.e.: signs of LVF/RVF, not just on treatment)  YES   NO  
 
 Clinical valvular heart disease:  
(not a simple low murmur < 2/6)      YES   NO  
 
 Peripheral vascular disease:  
(both foot pulses absent or femoral bruits)     YES   NO  
 
 Cardiac disease:        YES   NO  
 
ISCHAEMIC            VALVULAR      ATRIAL FIBRILLATION       
CARDIOMYOPTHY          HYPERTENSIVE HEART DISEASE WITHOUT CARDIOMYOPATHY   
 
 Other arteriopathy:       
 
 
NEUROLOGIC DEFICIT: 
 
 Indicate whether the following signs and symptoms are present: 
 
Coma:      YES   NO  
 Decreased LOC:     YES   NO  
Motor weakness:     YES   NO  
Sensory deficit:     YES   NO  
Cerebellar signs:     YES   NO  
Dysphasia:      YES   NO  
Dysphagia:      YES   NO  
Other cortical signs:     YES   NO  
(apraxia, visual deficit, cortical sensory)    
Urinary incontinence:    YES   NO  
Can lift arm against gravity:   YES   NO  
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Glasgow Coma Scale 
 
 Circle one score for each of the categories: 
CATEGORY: DESCRIPTION: SCORE: 
Eye opening None E1 
 To painful stimulus E2 
 To command/voices E3 
 Spontaneously with blinking E4 
Motor response None M1 
 Arm extension to painful stimulus M2 
 Arm flexion to painful stimulus M3 
 Arm withdraws from painful stimulus M4 
 Hand localizes painful stimulus M5 
 Obeys commands M6 
Verbal response None V1 
 Sounds but no recognizable words V2 
 Inappropriate words/expletives  V3 
 Confused speech V4 
 Normal  V5 
 
Barthel Score 
 
 Circle one score for each of the categories: 
CATEGORY: 
DESCRIPTION: 
SCOR
Bowels Incontinent or needs enemas 0 
 Occasional  incontinence (< once per week) 1 
 Continent 2 
Bladder Incontinent/unable to manage catheter 0 
 Occasional accident ( < once per day) 1 
 Continent 2 
Grooming Needs help with shaving, washing, hair or teeth 0 
 Independent 1 
Toilet use Dependent 0 
 Needs some help  1 
 Independent on, off dressing and cleaning 2 
Feeding Dependent 0 
 Needs some help (e.g. with cutting, spreading) 1 
 Independent if food provided within reach 2 
Transfer (e.g. bed 
or chair) 
Unable and no sitting balance 0 
 Needs major help 1 
 Needs minor help 2 
 Independent 3 
Mobility Unable 0 
 Wheelchair independent indoors 1 
 Walks with help or supervision 2 
 Independent (but may use aid) 3 
Dressing Dependent 0 
 Needs some help 1 
 Independent including fasteners 2 
Stairs Unable 0 
 Needs some help or supervision 1 
 Independent up and down 2 
Bathing Dependent 0 
 Independent in bath or shower 1 
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Modified Rankin Score 
 
 Circle your choice of score from the following list of options: 
DESCRIPTION: SCORE: 
No symptoms 0 
Minor symptoms which do not interfere with lifestyle 1 
Some restriction to lifestyle, but look after themselves 2 
Significant restriction to lifestyle, preventing total independence 3 
Severe handicap preventing independent existence but not requiring constant attention 4 
Severe handicap, totally dependent, requiring attention night and day 5 
 
NIH Scale 
 
 Circle one score for each of the categories: 
CATEGORY: DESCRIPTION SCORE 
Conscious level Awake 0 
 Drowsy, somnolent 1 
 Stupor (rousable to correct localization of painful stimulus) 2 
 No reaction or extensor or flexor spastic response 3 
Response to questions (month, age) Both answers correct 0 
 One answer correct 1 
 Both answers wrong or no response 2 
Eye movement Normal 0 
 Partial gaze palsy 1 
 Complete gaze palsy (also to oculocephalic  maneuver)                                                                   2 
Facial palsy Normal 0 
 Slight 1 
 Moderate 2 
 Complete 3 
Limb ataxia (affected side) Normal 0 
 One limb ataxic 1 
 Both limbs ataxic 2 
Neglect Normal 0 
 Partial neglect (inattention) on side 1 
 Complete hemi-neglect (several sensory modalities) 2 
Aphasia Normal 0 
 
Mild dysphasia (word finding difficulty, paraphasia, 
grammatical errors) 
1 
 Motor (Broca) or sensory (Wernickle) aphasia or variants 2 
 Complete aphasia, muteness 3 
Attempted Posture (affected lower limb) Unremarkable (5s) 0 
 Droops 1 
 Lower limb flops (5s) 2 
 Postural attempt impossible 3 
Reaction to Verbal Order 
(open or shut eyes, hand grip) 
Both correct 0 
 One correct 1 
 No reaction or incorrect action 2 
Visual fields Full 0 
 Incomplete hemianopia 1 
 Complete hemianopia 2 
Attempted posture (affected arm) Unremarkable (10s) 0 
 Pronation 1 
 90° posture fails <10s, rapid droop 2 
 Postural attempt fails 3 
Sensation Normal 0 
 Hypesthesia 1 
 Anaesthesia 2 
Dysarthria Normal 0 
 Dysarthric but easily understood 1 
 Severe dysarthria, barely intelligible 2 
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Scandinavian Stroke scale 
 
 Circle one score for each of the categories: 
CATEGORY: DESCRIPTION: SCORE: 
Consciousness Fully conscious  6 
 Somnolent, can be awaked to full conscience 4 
 Reacts to verbal command, but is not fully conscious 2 
Eye movement No gaze palsy 4 
 Gaze palsy present 2 
 Conjugate eye deviation 0 
Arm motor, power * Raises arm with normal strength 6 
 Raises arm with reduced strength 5 
 Raises arm with flexion in elbow 4 
 Can move, but not against gravity 2 
 Paralysis 0 
Hand motor, power * Normal strength 6 
 Reduced strength in full range 4 
 Some movement, fingertips do not reach palm 2 
 Paralysis 0 
Leg motor power * Normal strength 6 
 Raises straight leg with reduced strength 5 
 Raises leg with flexion of knee 4 
 Can move, but not against gravity 2 
 Paralysis 0 
Orientation Correct for time, place and person 6 
 2 of these 4 
 1 of these 2 
 Completely disorientated 0 
Speech No aphasia 10 
 Limited vocabulary or incoherent speech 6 
 More than yes/no, but not longer sentences 3 
 Only yes/no or less 0 
Facial palsy None/dubious 2 
 Present 0 
Gait Walks 5 in without aids 12 
 Walks with aids 9 
 Walks with help of another person 6 
 Sits without support 3 
 Bedridden/wheelchair 0 
 
* Motor power is assessed only on the affected side 
 
 
LOCALISATION OF STROKE OR TIA:  Clinically - before CT seen  
 
 
COMPLETE ANTERIOR CIRCULATION (TACS/I)   
 
 Select one  PARTIAL ANTERIOR (PACS/I)   
 
POSTERIOR CIRCULATION (POCS/I)  
 
LACUNAR (LACS/I)  
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FROM THE CHARTS OR RECORDS 
 
 Pyrexial      YES  NO  
(anytime since admission) 
 BP on admission:      /  
  (cas or admission ward)   
 BP 24 hours after admission:      /   
 BP on discharge:        /    
 
 
MEDICATION  (names only - no dosages necessary) 
 
 On admission:  
 
 
  
 
 
  
 
 
  
 
 At time of assessment by stroke team:  
 
 
  
 
 
  
 
 
  
 
 
ECG      
 
 ECG:  NOT DONE   NORMAL    ABNORMAL   
 
             ATRIAL FIBRILLATION/FLUTTER  LVH  
   
 Select all abnormalities:   ST/T WAVE CHANGE    ACUTE MI 
   
   OLD MI     
 LBBB/RBBB/LEFT AXIS  
   OTHER      
 
Specify 
if other:  
 
 
RADIOLOGY 
 
 Chest x-ray: NOT DONE   NORMAL    ABNORMAL       
 
LUNG   CARDIAC  
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> > > > > > > > > > > PLEASE FILL THIS IN BEFORE LOOKING AT THE CT SCAN < < < < < < < < < < < 
 
 
 
 
 What stroke type do you suspect the patient has had? 
 
HAEMORRHAGE     INFARCT     SAH      CAN’T SAY  
 
 
 Do you already know the findings of the CT scan?    YES   NO   
 
ALLEN AND SIRIRAJ SCORES  
 
Onset: 
LOSS OF CONSCIOUSNESS   
HEADACHE WITHIN 2 HOURS   
VOMITING      
NECK STIFFNESS     
Level of Consciousness: 
ALERT       
DROWSY       
UNCONSCIOUS     
 Select/complete  Plantar Response: 
all relevant boxes: BOTH FLEXOR/SINGLE EXTENSOR  
      BOTH EXTENSOR     
 Diastolic BP 24 hours after admission:   mm Hg 
Atherama Markers: 
ANGINA       
CLAUDICATION     
DIABETES HISTORY     
History of hypertension present:  YES  NO  
Previous event TIA or Stroke:  YES  NO  
Heart disease: 
AORTIC OR MITRAL MURMUR    ATRIAL FIBRILLATION  
  
CARDIOMEGALY (CHEST X-RAY)   MI WITHIN 6 MONTHS  
  
CARDIAC FAILURE     
 CARDIOMYOPTHY    
 
END ALLEN AND SIRIRAJ SCORES 
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CT scan - head   
 
 CT scan:   DONE   NOT DONE         
 
How many CT scans were done?   1   2   > 2  
Was contrast used?   YES  NO  
CT scan done: 0 – 24 HOURS   24 – 48 HOURS   48 - 72 HOURS   
    3 – 7 DAYS        > 7 DAYS  
 
CT scan:  NORMAL    ABNORMAL  
 
 
Specify:  
 
Cerebral angiogram   
 
 Angiogram:   NOT DONE   NORMAL    ABNORMAL       
 
Specify: 
 
 
MRI - head   
 
 MRI:    NOT DONE   NORMAL    ABNORMAL       
 
 
Specify: 
 
 
MRA - head    
 
 MRA:    NOT DONE   NORMAL    ABNORMAL       
 
Specify:  
 
 
SPECT     
 
 Spect:   NOT DONE   NORMAL    ABNORMAL       
 
Specify:  
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Carotid duplex Dopplers  
 
 Dopplers:   NOT DONE   NORMAL    ABNORMAL       
 
Specify:  
 
 
 % OCCLUSION LEFT        % OCCLUSION RIGHT        
Dissection      YES  NO  
 
Transcranial Dopplers   
 
 Dopplers:   NOT DONE   NORMAL    ABNORMAL       
 
Specify:  
 
 
Cardiac Echo    
 Echo:   NOT DONE   NORMAL    ABNORMAL  
 
Transthoracic:  INTRACAVITY CLOT    DYSKINETIC SEGMENT  VALVULAR 
LESION    
RIGHT TO LEFT SHUNT   LV HYPERTROPHY  
 
Transoesophageal: INTRA-CAVITY CLOT    DYSKINETIC SEGMENT   R to L SHUNT
   
VALVULAR LESION    LV HYPERTROPHY    AORTIC 
PLAQUE   
 
Other: 
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OTHER RELEVANT INVESTIGATIONS 
Bloods & CSF                   X                         X 
FBC Normal   Abnormal     Hb  WCC  
       Plts.    
 
Blood 
glucose (on 
admission) 
Normal   Abnormal      mmol/l   
 
ESR Not done  Done     mm/hour   
 
Urea/Creat-
inine/ Elecs. 
Normal   Abnormal     Na  K+  
       Urea  Creat.  
 
HIV Not done   Negative   Positive  CD4 count    
 
VDRL Not done   Negative  Positive      
 
INR/PTT  Not done   Normal   Abnormal  INR  PTT  
 
 
Hypercoag-
ulation screen 
Not done   Negative   Positive  Specify    
 
Collagen 
screen 
Not done   Negative   Positive  Specify    
 
Lipids – 
non fasting 
Not done   Normal   Abnormal  Cholesterol  mmol/l  
 
Lipids – 
fasting  
Not done   Normal   Abnormal  Cholesterol  Tg  
       HDL  LDL  
 
CSF Not done   Normal   Abnormal   Specify    
 
 
TREATMENT 
Antiplatelet agents:  
ASPIRIN          
 Select all relevant boxes:  ASPIRIN + DIPYRIDAMOLE      
TICLOPIDINE           
CLOPIDOGREL      
Anticoagulation:       
 Heparin:     YES  NO     
PROPHYLACTIC DOSE    FULL DOSE     IV   
 SC   
 
 Warfarin:     YES  NO  
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 Oxygen:     YES  NO  
 Antibiotics:     YES  NO   
 Anti-pyretics:    YES  NO  
 Insulin:     YES  NO  
 Surgery:     YES  NO   
 
Specify:  
 
 Thrombolysis:     YES   NO  
 
Thrombolytic agent ::          
 
Total dose: 
      
   
Route of administration:   INTRAVENOUS    INTRA-ARTERIAL  
       Time interval (stroke onset to infusion) :   HOURS  DAYS 
 
Complications:   
SYMPTOMATIC INTRACEREBRAL HAEMORRHAGE:    
 Select all relevant boxes:  ASYMPTOMATIC INTRACEREBRAL HAEMORRHAGE:  
EXTRACRANIAL HAEMORRHAGE:    
  
OTHER:        
  
 
Specify:  
 
 
 
 Neuroprotective agents:  YES   NO  
 
Agent:        
 
 
 
 Steroids prescribed (for stroke): YES  NO  
 
 Mannitol:    YES  NO  
 
 IV fluids:  
Up at time of assessment ?   YES  NO  
IV fluids contain glucose?   YES  NO  
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 Anti-hypertensives: 
Patient on anti-hypertensives prior to admission?  YES  NO  UNKNOWN  
Anti-hypersensitives continued during admission?    YES  NO  
 
Is there evidence to suggest that the patient is a known hypertensive (history, end-organ damage, old 
notes)?          YES  NO 
 UNKNOWN  
 
 Patient hypertensive on admission?       YES  NO  UNKNOWN  
 
Anti-hypertensives given within the first week?     YES  NO  
 
ANTI-HYPERTENSIVES GIVEN OTHER THAN B BLOCKER, DIURETICS, ICCB, ACE INHIBITOR: 
 
 
 Anti-hypertensives started after 1
st
 week?    YES  NO  UNKNOWN  
 
 Patient on anti-hypertensives at discharge?  YES  NO  UNKNOWN  
 
 
ASSESSMENT OF PROFESSIONALS ALLIED TO MEDICINE: 
 
Physiotherapy     
Within 24 Hours    YES  NO  
Speech therapy     
Within 24 hours    YES  NO   
Occupational therapy   
 Select all relevant boxes:  Within 24 hours    YES  NO    
Community liaison   
Within 24 hours    YES  NO    
Social worker    
Within 24 hours  YES  NO  
Dietician     
Within 24 hours    YES  NO    
Psychologist    
 Within 24 hours    YES  NO  
 
ASSESSMENT:          
 
Stroke Type: (only complete if CT scan available) 
          TIA  HAEMORRHAGE  
 Select one:  ISCHAEMIC INFARCT  UNCERTAIN (NO CT)  
SAH   RETINAL ARTERY OCCLUSION  
MULTI-INFARCT PICTURE  
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Complications:  
PAINFUL SHOULDER SYNDROME        
RECURRENT STROKE     
PNEUMONIA           
DVT        
 Select all relevant boxes:  MYOCARDIAL INFARCT         
SEIZURES      
DEPRESSION         
BEDSORES      
PROGRESSING STROKE (SYMPTOMS  
AND SIGNS EVOLVE OVER HOURS)   
OTHER       
 
Specify: 
 
 
Aetiology of ischaemic stroke: 
 Large vessel atherothromboembolic:   PROBABLE     POSSIBLE  
 Cardioembolic:         PROBABLE     POSSIBLE  
 Small vessel (lacunar):     PROBABLE     POSSIBLE  
 Acute ischaemic stroke of other aetiology:  YES  NO  
 
Specify:  
 
 
 Acute ischaemic stroke of unknown cause:  
(incomplete workup)          YES 
 NO  
 
 Acute ischemic stroke of unknown cause:  
(no probable aetiology despite complete workup)      YES  NO  
 
 Acute ischaemic stroke of unknown aetiology:  
(more than one likely aetiology and a single likely aetiology cannot be determined)  YES  NO  
  
 
Specify: 
 
 
 
 Aetiology of intracerebral haemorrhage: 
 
 
 
 
 Aetiology of SAH: 
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 > > > > > > > COMPLETE BELOW ONLY IF YOU KNOW THE DETAILS OF THE FULL ADMISSION < < < < < < 
< 
 
 
Duration of Hospitalisation: 
ADMISSION WARD      ………… DAYS  
 Select all appropriate boxes:  MEDICAL WARD         ………… DAYS  
STROKE UNIT           ………… DAYS  
OTHER WARD     ………… DAYS  
 
                    TOTAL   ……………..………  DAYS  
 Death:     YES  NO  
 
 Cause:  
 
 Discharge: 
 Discharge to:  HOME CARE          REHABILITATION CENTER    OTHER  
  
Specify: 
 
 
 Home carer available  YES  NO  
Partner?    YES  NO  
 
Specify: 
 
 
 Should Aspirin be prescribed?   YES  NO  
 Was Aspirin prescribed?    YES  NO  
 
 
> > > > > > > > > > > > > > > > > > > DO NOT COMPLETE THIS SECTION < < < < < < < < < < < < < < < < < < < < 
 
 
  
 Patient of interest?  YES  NO  
 
Reason: 
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 Final diagnosis:  STROKE  
     TIA   
   RAO   
     OTHER    (Include events within the last 6 months 
only.  
 Multiple diagnoses may be coded) 
  
 Reason: 
 
 
 First-ever-in-a-lifetime stoke:   YES  NO  UNABLE TO ASSESS  
DEFINITE   PROBABLE    POSSIBLE  
 
 
                                                   
 
 
 
 
 
 
 
 
 
 
Use the following codes: 
 
Code 1 = possible (not for RAO) 
Code 2 = probable (not for RAO) 
Code 3 = definite 
Code 9 = not applicable 
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SUMMARY OF ASSESSMENT BY STROKE TEAM 
Thank you for referring your patient to the Stroke Team! 
 
 
 
 
 
 Date seen:  .  . 20  Patient hospital number:     
 
  HISTORY (key features that make this a vascular event, or not): 
 
 
 
 
 
EXAMINATION:  
 Cortical signs present: YES  NO  
A/Dysphasia   Parietal lobe signs  
Other  
   Specify: 
 
 
 Cranial nerves involved:  YES   NO  
       List: 
 
 
 Motor signs:  YES   NO  
 
LEFT    RIGHT    BILATERAL  
ARM    LEG  
 
 Sensory signs:  YES   NO  
 
LEFT    RIGHT    BILATERAL  
ARM    LEG  
 
 Cerebellar signs:  YES    NO  
 
LEFT    RIGHT   BILATERAL   AXIAL  
 
 Other key features: 
 
 
ASSESSMENT: 
 
 TIA         STROKE         INFARCTION         HAEMORRHAGE             SAH  NOT SURE  
 FIRST EVER IN A LIFETIME            RECURRENT  
 ANTERIOR CIRCULATION:   YES   NO   
 PARTIAL ANTERIOR CIRCULATION:  YES   NO  
 LACUNAR    YES   NO      
 TOTAL ANTERIOR CIRCULATION:    YES   NO  
 POSTERIOR CIRCULATION:   YES   NO  
 
SUGGESTION/S: 
 
 Further investigation/s:  
 
 Treatment: 
 
 Referral:  
 
 
 
 SIGN:  
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APPENDIX F.   THE SIRIRAJ STROKE SCORE AND GUY’S  
      HOSPITAL STROKE SCORE 
 
The scores are derived by assigning a value to various clinical features as indicated. A 
constant is then added to the sum of these indicators and the final value determines 
whether the patient has an ischaemic stroke, intracranial haemorrhage or falls into an 
‘uncertain’ area according to cut-off points determined by the original validation studies 
(Allen, 1983; Poungvarin et al., 1991). These cut-off or threshold points for infarction 
(ischaemic stroke) or intracranial haemorrhage were validated at 90% certainty for the 
diagnosis. The threshold points are given below: 
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Calculation of the Siriraj Stroke Score 
 
1. Consciousness:  
a. Alert = 0 
b. Drowsy or stupor = 2.5 
c. Coma or semicoma = 5 
2. Vomiting: 
a. No=0 
b. Yes=2 
3. Headache (within 2 hours of stroke onset): 
a. No=0 
b. Yes=2 
4. Diastolic blood pressure (in mmHg): diastolic BP multiplied by 0.1 
5. Atheroma markers (history of diabetes mellitus, intermittent claudication, or 
angina):  
a. None=0 
b. One or more= -3 
6. Constant: -12 
 
Threshold / cut-off points for the Siriraj Score:  
 
> 1:  Haemorrhage; -1 to +1: Uncertain; < - 1: Infarction 
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Calculation of the Allen (Guy’s Hospital) Stroke Score 
 
1. Apoplectic onset (loss of consciousness, headache within 2 hours, 
vomiting, neck stiffness): 
a. One or none of these=0 
b. Two or more=+21.9 
2. Level of consciousness (24 hours after admission):  
a. Alert=0 
b. Drowsy=+7.3 
c. Unconscious=+14.6 
3. Plantar responses: 
a. Both flexor or single extensor=0 
b. Both extensor=+7.1 
4. Diastolic blood pressure (24 hours after admission, in mmHg): diastolic 
BP multiplied by 0.17 
5. Atheroma markers (angina, claudication, diabetes history): 
a. None=0 
b. One or more= -3.7 
6. History of hypertension: 
a. Not present=0 
b. Present= -4.1 
7. Previous event (transient ischaemic attack or stroke): 
a. None=0 
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b. Any number of events= -6.7 
8. Heart disease: 
a. None=0 
b. Aortic or mitral murmur= -4.3 
c. Cardiac failure= -4.3 
d. Cardiomyopathy= -4.3 
e. Atrial fibrillation= -4.3 
f. Cardiomegaly (from x-ray) = -4.3 
g. Myocardial infarct (within 6 months) = -4.3 
9. Constant= -12.6 
 
Threshold / cut-off points for the Allen Score: 
 
> 24: Haemorrhage; 4 – 24: Uncertain; < 4: Infarction 
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APPENDIX G: TINTSWALO HOSPITAL STROKE REGISTER QUESTIONNAIRE 
 
UNIVERSITY OF THE WITWATERSRAND STROKE DATABASE – TINTSWALO HOSPITAL 
 
> > > > > > > > > > DO NOT LOOK AT THE CT SCAN BEFORE COMPLETING THIS FORM < < < < < < < < < < 
 
  
 
 
NOTES:  
Each individual question is marked  ‘ > ’  
Some responses require expansion most often facilitated by shading. Illustrated in the following example: 
  Is it the weekend?  YES   NO  
              What day is it?  SATURDAY  SUNDAY  
Here, the second question only needs to be considered if the response to the first question is ‘YES’ 
 
 
 
 Doctor completing this form:  
 
 Patient hospital number:       
 Ward:      MALE        FEMALE       OTHER  
 Date of birth:      .  . 19    
 Age:       
 Contact telephone number:   
   (friend / relative)   
 Sex:       MALE        FEMALE  
 Ethnic group:    WHITE        BLACK  COLOURED   INDIAN-ASIAN  
 Date of stroke:      .  . 20   
 Date of admission:     .  . 20  
 Date of assessment by stroke team:  .  . 20   
 
 Time between onset of stroke  
 and hospital medical attention:   HOURS  DAYS 
 
HISTORY OF EVENT 
 Symptoms present on waking:    YES  NO  UNKNOWN   
 Headache within 2 hours of onset:   YES  NO  UNKNOWN  
 Vomited since symptom onset:    YES  NO  UNKNOWN  
 Loss of consciousness at onset:    YES  NO  UNKNOWN  
 Drowsiness since symptom onset:   YES  NO  UNKNOWN  
 Seizure since symptom onset:    YES  NO  UNKNOWN  
 If symptoms have resolved by the time of  
 examination, how long were they present?   HOURS  DAYS 
 
Office use    Form completed       Register number  
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ADL (Activities of Daily Living) 
 Was the patient independent prior to admission?     YES  NO  UNKNOWN  
 Rankin modified before this event? *               0         1          2      3    4          5   
* Modified Rankin score 
 
0  =  no symptoms. 
1  =  minor symptoms which do not interfere with lifestyle. 
2  =  some restriction to lifestyle, but look after themselves. 
3  =  significant restriction to llifestyle, preventing total independence. 
4  =  severe handicap preventing independent existence but 
      not requiring constant attention. 
5  =  severe handicap, totally dependent, requiring attention night and day. 
 
 
 
RISK FACTORS  
 Hypertension: YES  NO      UNKNOWN  
 Diabetes: YES  NO   UNKNOWN  
 Periph. vasc. disease: YES  NO   UNKNOWN  
 Atrial fibrillation: YES  NO   UNKNOWN  
 Hyperlipidaemia:  YES  NO  UNKNOWN  
 Recent infection: YES  NO  UNKNOWN  
 Coagulopathy:     YES  NO  UNKNOWN  
 Collagen vasc. disease: YES  NO   UNKNOWN  
 Migraine with aura: YES  NO  UNKNOWN  
 Pregnancy:  YES  NO   UNKNOWN  
 Trauma:  YES  NO   UNKNOWN  
 Previous TIA:  YES  NO  UNKNOWN  
 Previous Stroke:    YES  NO  UNKNOWN  
 Oral contraception:  YES  NO  UNKNOWN  
 Family history:  YES  NO  UNKNOWN  
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 Substance abuse:    YES   NO  
DAGGA   MANDRAX    OTHER:        
 
 Smoking:       NEVER     EX-SMOKER (> 1 YEAR)      
 CURRENT SMOKER   
      
NUMBER SMOKED PER DAY     
 
 Snuff (current):  YES   NO  
 
 Alcohol:     NEVER / HARDLY EVER   EX-DRINKER (> 1 YEAR)     DRINKS  
 
AMOUNT OF ALCOHOL PER DAY *   g  
* (100 ml wine (1 glass) or 30 ml spirits (1 tot) or 250 ml beer all = 10 g alcohol) 
 
 
HANDEDNESS 
 Select one  LEFT HANDED   RIGHT HANDED    UNKNOWN  
 
SOCIO-ECONOMIC 
 Marital Status:      MARRIED/COMMON LAW *        SINGLE       WIDOWED      DIVORCED 
 
   * (includes partners where living together)  
                            
 Sole Bread Winner: YES        NO   
       NUMBER OF FINANCIAL DEPENDENTS INCLUDING PARTNER 
 
 
 
Housing:    OLD-AGE RETIREMENT FACILITY    
   HOUSE/FLAT           
SERVICED SHACK (TOILET PLUS TAP)  
 Select one  UNSERVICED SHACK      
     DORMITORY/HOSTEL/SINGLE ROOM   
     ACCOMMODATION WITH EMPLOYER  
E.G. DOMESTIC WORKER     
      
     OTHER:     
 
 NUMBER OF PEOPLE LIVING IN DWELLING:   
 (if living with employer do not include employers family/house) 
 
 NUMBER OF ROOMS USED FOR SLEEPING  
 IN THE DWELLING:        
 (if living with employer do not include employers family/house) 
 
Education:      
 YEARS OF SCHOOLING PASSED:      
 YEARS OF TERTIARY EDUCATION PASSED:   
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Employment:   
 Select one 
              Employed                   Unemployed 
   
  PROFESSIONAL/MANAGERIAL      LOOKING FOR WORK 
 MIDDLE MANAGEMENT    UNEMPLOYED BY CHOICE E.G.                                   
HOMEMAKER 
 MANUAL FORMAN/SKILLED ARTISAN      FULL-TIME STUDENT 
 FARMER – LARGE FARM   SOCIAL PENSIONER – ON DISABILITY GRANT   
 SUBSISTENCE FARMER    OR OLD AGE PENSIONER       
 CLERICAL/SEMI-SKILLED       
 UNSKILLED/ INFORMAL SECTOR TRADER                                              
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GENERAL EXAMINATION      
 Irregular pulse:   YES  NO  
 
 BP at first assessment (supine, average of 3 readings ): 
1.   /       2.   /    3.   / 
 
     AVERAGE:       /    
 Evidence of hypertensive end organ damage?      YES  NO  
CARDIAC   FUNDI   RENAL (RENAL DYSFUNCTION)  
 
 Carotid bruits:         RIGHT    LEFT   
 
 Clinical heart failure:  
(i.e.: signs of LVF/RVF, not just on treatment)  YES   NO  
 
 Clinical valvular heart disease:  
(not a simple low murmur < 2/6)      YES   NO  
 
 Peripheral vascular disease:  
(both foot pulses absent or femoral bruits)     YES   NO  
 
 Cardiac disease:        YES   NO  
 
ISCHAEMIC            VALVULAR      ATRIAL FIBRILLATION       
CARDIOMYOPTHY          HYPERTENSIVE HEART DISEASE WITHOUT CARDIOMYOPATHY   
 
 Other arteriopathy:       
 
 
NEUROLOGIC DEFICIT: 
 
 Indicate whether the following signs and symptoms are present: 
 
Coma:      YES   NO  
 Decreased LOC:     YES   NO  
Motor weakness:     YES   NO  
Sensory deficit:     YES   NO  
Cerebellar signs:     YES   NO  
Dysphasia:      YES   NO  
Dysphagia:      YES   NO  
Other cortical signs:     YES   NO  
(apraxia, visual deficit, cortical sensory)    
Urinary incontinence:    YES   NO  
Can lift arm against gravity:   YES   NO  
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Glasgow Coma Scale 
 
 Circle one score for each of the categories: 
CATEGORY: DESCRIPTION: SCORE: 
Eye opening None E1 
 To painful stimulus E2 
 To command/voices E3 
 Spontaneously with blinking E4 
Motor response None M1 
 Arm extension to painful stimulus M2 
 Arm flexion to painful stimulus M3 
 Arm withdraws from painful stimulus M4 
 Hand localizes painful stimulus M5 
 Obeys commands M6 
Verbal response None V1 
 Sounds but no recognizable words V2 
 Inappropriate words/expletives  V3 
 Confused speech V4 
 Normal  V5 
 
Barthel Score 
 
 Circle one score for each of the categories: 
CATEGORY: 
DESCRIPTION: 
SCOR
Bowels Incontinent or needs enemas 0 
 Occasional  incontinence (< once per week) 1 
 Continent 2 
Bladder Incontinent/unable to manage catheter 0 
 Occasional accident ( < once per day) 1 
 Continent 2 
Grooming Needs help with shaving, washing, hair or teeth 0 
 Independent 1 
Toilet use Dependent 0 
 Needs some help  1 
 Independent on, off dressing and cleaning 2 
Feeding Dependent 0 
 Needs some help (e.g. with cutting, spreading) 1 
 Independent if food provided within reach 2 
Transfer (e.g. bed 
or chair) 
Unable and no sitting balance 0 
 Needs major help 1 
 Needs minor help 2 
 Independent 3 
Mobility Unable 0 
 Wheelchair independent indoors 1 
 Walks with help or supervision 2 
 Independent (but may use aid) 3 
Dressing Dependent 0 
 Needs some help 1 
 Independent including fasteners 2 
Stairs Unable 0 
 Needs some help or supervision 1 
 Independent up and down 2 
Bathing Dependent 0 
 Independent in bath or shower 1 
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Modified Rankin Score 
 
 Circle your choice of score from the following list of options: 
DESCRIPTION: SCORE: 
No symptoms 0 
Minor symptoms which do not interfere with lifestyle 1 
Some restriction to lifestyle, but look after themselves 2 
Significant restriction to lifestyle, preventing total independence 3 
Severe handicap preventing independent existence but not requiring constant attention 4 
Severe handicap, totally dependent, requiring attention night and day 5 
 
NIH Scale 
 
 Circle one score for each of the categories: 
CATEGORY: DESCRIPTION SCORE 
Conscious level Awake 0 
 Drowsy, somnolent 1 
 Stupor (rousable to correct localization of painful stimulus) 2 
 No reaction or extensor or flexor spastic response 3 
Response to questions (month, age) Both answers correct 0 
 One answer correct 1 
 Both answers wrong or no response 2 
Eye movement Normal 0 
 Partial gaze palsy 1 
 Complete gaze palsy (also to oculocephalic  maneuver)                                                                   2 
Facial palsy Normal 0 
 Slight 1 
 Moderate 2 
 Complete 3 
Limb ataxia (affected side) Normal 0 
 One limb ataxic 1 
 Both limbs ataxic 2 
Neglect Normal 0 
 Partial neglect (inattention) on side 1 
 Complete hemi-neglect (several sensory modalities) 2 
Aphasia Normal 0 
 
Mild dysphasia (word finding difficulty, paraphasia, 
grammatical errors) 
1 
 Motor (Broca) or sensory (Wernickle) aphasia or variants 2 
 Complete aphasia, muteness 3 
Attempted Posture (affected lower limb) Unremarkable (5s) 0 
 Droops 1 
 Lower limb flops (5s) 2 
 Postural attempt impossible 3 
Reaction to Verbal Order 
(open or shut eyes, hand grip) 
Both correct 0 
 One correct 1 
 No reaction or incorrect action 2 
Visual fields Full 0 
 Incomplete hemianopia 1 
 Complete hemianopia 2 
Attempted posture (affected arm) Unremarkable (10s) 0 
 Pronation 1 
 90° posture fails <10s, rapid droop 2 
 Postural attempt fails 3 
Sensation Normal 0 
 Hypesthesia 1 
 Anaesthesia 2 
Dysarthria Normal 0 
 Dysarthric but easily understood 1 
 Severe dysarthria, barely intelligible 2 
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Scandinavian Stroke scale 
 
 Circle one score for each of the categories: 
CATEGORY: DESCRIPTION: SCORE: 
Consciousness Fully conscious  6 
 Somnolent, can be awaked to full conscience 4 
 Reacts to verbal command, but is not fully conscious 2 
Eye movement No gaze palsy 4 
 Gaze palsy present 2 
 Conjugate eye deviation 0 
Arm motor, power * Raises arm with normal strength 6 
 Raises arm with reduced strength 5 
 Raises arm with flexion in elbow 4 
 Can move, but not against gravity 2 
 Paralysis 0 
Hand motor, power * Normal strength 6 
 Reduced strength in full range 4 
 Some movement, fingertips do not reach palm 2 
 Paralysis 0 
Leg motor power * Normal strength 6 
 Raises straight leg with reduced strength 5 
 Raises leg with flexion of knee 4 
 Can move, but not against gravity 2 
 Paralysis 0 
Orientation Correct for time, place and person 6 
 2 of these 4 
 1 of these 2 
 Completely disorientated 0 
Speech No aphasia 10 
 Limited vocabulary or incoherent speech 6 
 More than yes/no, but not longer sentences 3 
 Only yes/no or less 0 
Facial palsy None/dubious 2 
 Present 0 
Gait Walks 5 in without aids 12 
 Walks with aids 9 
 Walks with help of another person 6 
 Sits without support 3 
 Bedridden/wheelchair 0 
 
* Motor power is assessed only on the affected side 
 
LOCALISATION OF STROKE OR TIA:  Clinically - before CT seen  
 
 
COMPLETE ANTERIOR CIRCULATION (TACS/I)   
 
 Select one  PARTIAL ANTERIOR (PACS/I)       
 
POSTERIOR CIRCULATION (POCS/I)      
 
LACUNAR (LACS/I)         
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FROM THE CHARTS OR RECORDS 
 
 Pyrexial      YES  NO  
(anytime since admission) 
 BP on admission:      /  
  (cas or admission ward)   
 BP 24 hours after admission:      /   
 BP on discharge:        /    
 
 
MEDICATION  (names only - no dosages necessary) 
 
 On admission:  
 
 
  
 
 
  
 
 
  
 
 At time of assessment by stroke team:  
 
 
  
 
 
  
 
 
  
 
 
ECG      
 
 ECG:  NOT DONE   NORMAL    ABNORMAL   
 
             ATRIAL FIBRILLATION/FLUTTER  LVH  
   
 Select all abnormalities:   ST/T WAVE CHANGE    ACUTE MI 
   
   OLD MI     
 LBBB/RBBB/LEFT AXIS  
   OTHER      
 
Specify 
if other:  
 
 
RADIOLOGY 
 
 Chest x-ray: NOT DONE   NORMAL    ABNORMAL       
 
LUNG   CARDIAC  
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> > > > > > > > > > > PLEASE FILL THIS IN BEFORE LOOKING AT THE CT SCAN < < < < < < < < < < < 
 
 
 
 
 What stroke type do you suspect the patient has had? 
 
HAEMORRHAGE     INFARCT     SAH      CAN’T SAY  
 
 
 Do you already know the findings of the CT scan?    YES   NO   
 
 
ALLEN AND SIRIRAJ SCORES  
 
Onset: 
LOSS OF CONSCIOUSNESS   
HEADACHE WITHIN 2 HOURS   
VOMITING      
NECK STIFFNESS     
Level of Consciousness: 
ALERT       
DROWSY       
UNCONSCIOUS     
 Select/complete  Plantar Response: 
all relevant boxes: BOTH FLEXOR/SINGLE EXTENSOR  
      BOTH EXTENSOR     
 Diastolic BP 24 hours after admission:   mm Hg 
Atherama Markers: 
ANGINA       
CLAUDICATION     
DIABETES HISTORY     
History of hypertension present:  YES  NO  
Previous event TIA or Stroke:  YES  NO  
Heart disease: 
AORTIC OR MITRAL MURMUR    ATRIAL FIBRILLATION  
  
CARDIOMEGALY (CHEST X-RAY)   MI WITHIN 6 MONTHS  
  
CARDIAC FAILURE     
 CARDIOMYOPTHY    
 
END ALLEN AND SIRIRAJ SCORES 
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CT scan - head   
 
 CT scan:   DONE   NOT DONE         
 
How many CT scans were done?   1   2   > 2  
Was contrast used?   YES  NO  
CT scan done: 0 – 24 HOURS   24 – 48 HOURS   48 - 72 HOURS   
    3 – 7 DAYS        > 7 DAYS  
 
CT scan:  NORMAL    ABNORMAL  
 
 
Specify:  
 
 
OTHER RELEVANT INVESTIGATIONS 
Bloods & CSF                   X                         X 
FBC Normal   Abnormal     Hb  WCC  
       Plts.    
 
Blood 
glucose (on 
admission) 
Normal   Abnormal      mmol/l   
 
ESR Not done  Done     mm/hour   
 
Urea/Creat-
inine/ Elecs. 
Normal   Abnormal     Na  K+  
       Urea  Creat.  
 
 
HIV Not done   Negative   Positive  CD4 count    
 
VDRL Not done   Negative  Positive      
 
INR/PTT  Not done   Normal   Abnormal  INR  PTT  
 
 
Hypercoag-
ulation screen 
Not done   Negative   Positive  Specify    
 
Collagen 
screen 
Not done   Negative   Positive  Specify    
 
Lipids – 
non fasting 
Not done   Normal   Abnormal  Cholesterol  mmol/l  
 
Lipids – 
fasting  
Not done   Normal   Abnormal  Cholesterol  Tg  
       HDL  LDL  
 
CSF Not done   Normal   Abnormal   Specify    
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TREATMENT 
Antiplatelet agents:  
ASPIRIN          
 Select all relevant boxes:  ASPIRIN + DIPYRIDAMOLE      
TICLOPIDINE           
CLOPIDOGREL      
Anticoagulation:       
 Heparin:     YES  NO     
PROPHYLACTIC DOSE    FULL DOSE     IV   
 SC   
 
 Warfarin:     YES  NO  
 Oxygen:     YES  NO  
 Antibiotics:     YES  NO   
 Anti-pyretics:    YES  NO  
 Insulin:     YES  NO  
 Surgery:     YES  NO   
 
Specify:  
 
 
 Neuroprotective agents:  YES   NO  
 
Agent:        
 
 
 
 Steroids prescribed (for stroke): YES  NO  
 
 Mannitol:    YES  NO  
 
 IV fluids:  
Up at time of assessment ?   YES  NO  
IV fluids contain glucose?   YES  NO  
 
 Anti-hypertensives: 
Patient on anti-hypertensives prior to admission?  YES  NO  UNKNOWN  
Anti-hypersensitives continued during admission?    YES  NO  
 
Is there evidence to suggest that the patient is a known hypertensive (history, end-organ damage, old 
notes)?          YES  NO 
 UNKNOWN  
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 Patient hypertensive on admission?       YES  NO  UNKNOWN  
 
Anti-hypertensives given within the first week?     YES  NO  
 
ANTI-HYPERTENSIVES GIVEN OTHER THAN B BLOCKER, DIURETICS, ICCB, ACE INHIBITOR: 
 
 
 Anti-hypertensives started after 1
st
 week?    YES  NO  UNKNOWN  
 
 Patient on anti-hypertensives at discharge?  YES  NO  UNKNOWN  
 
 
ASSESSMENT OF PROFESSIONALS ALLIED TO MEDICINE: 
 
Physiotherapy     
Within 24 Hours    YES  NO  
Speech therapy     
Within 24 hours    YES  NO   
Occupational therapy   
 Select all relevant boxes:  Within 24 hours    YES  NO    
Dietician     
Within 24 hours    YES  NO    
 
ASSESSMENT: 
 
Stroke Type: (only complete if CT scan available) 
TIA       HAEMORRHAGE  
   
 Select one: ISCHAEMIC INFARCT   UNCERTAIN (NO CT)  
  
SAH      RETINAL ARTERY OCCLUSION
  
MULTI-INFARCT PICTURE  
 
Complications:  
PAINFUL SHOULDER SYNDROME        
RECURRENT STROKE     
PNEUMONIA           
DVT         
 Select all relevant boxes:  MYOCARDIAL INFARCT          
SEIZURES       
DEPRESSION         
BEDSORES       
PROGRESSING STROKE (SYMPTOMS  
AND SIGNS EVOLVE OVER HOURS)  
OTHER       
 
Specify: 
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Aetiology of ischaemic stroke: 
 Large vessel atherothromboembolic:   PROBABLE     POSSIBLE  
 Cardioembolic:         PROBABLE     POSSIBLE  
 Small vessel (lacunar):     PROBABLE     POSSIBLE  
 Acute ischaemic stroke of other aetiology:  YES  NO  
 
Specify:  
 
 
 Acute ischaemic stroke of unknown cause:  
(incomplete workup)          YES 
 NO  
 
 Acute ischemic stroke of unknown cause:  
(no probable aetiology despite complete workup)      YES  NO  
 
 Acute ischaemic stroke of unknown aetiology:  
(more than one likely aetiology and a single likely aetiology cannot be determined)  YES  NO  
  
 
Specify: 
 
 Aetiology of intracerebral haemorrhage: 
 
 
 
 
 Aetiology of SAH: 
 
 
 
 
 
 
 
 
 
 > > > > > > > COMPLETE BELOW ONLY IF YOU KNOW THE DETAILS OF THE FULL ADMISSION < < < < < <  
 
 
Duration of Hospitalisation: 
ADMISSION WARD      ………… DAYS  
 Select all appropriate boxes:  MEDICAL WARD         ………… DAYS  
STROKE UNIT           ………… DAYS  
OTHER WARD     ………… DAYS  
 
                    TOTAL   ……………..………  DAYS  
 Death:     YES  NO  
 
 Cause:  
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 Discharge: 
 Discharge to:  HOME CARE          REHABILITATION CENTER    OTHER  
  
Specify: 
 
 
 Home carer available  YES  NO  
Partner?    YES  NO  
 
Specify: 
 
 
 Aspirin: 
 Should Aspirin be prescribed?   YES  NO  
 Was Aspirin prescribed?    YES  NO  
 
 
> > > > > > > > > > > > > > > > > > > DO NOT COMPLETE THIS SECTION < < < < < < < < < < < < < < < < < < < < 
 
 
  
 Patient of interest?  YES  NO  
 
Reason: 
 
 
 Final diagnosis:  STROKE  
     TIA   
   RAO   
     OTHER    (Include events within the last 6 months 
only.  
 Multiple diagnoses may be coded) 
  
 Reason: 
 
 
 First-ever-in-a-lifetime stoke:   YES  NO  UNABLE TO ASSESS  
DEFINITE   PROBABLE    POSSIBLE  
     
Use the following codes: 
 
Code 1 = possible (not for RAO) 
Code 2 = probable (not for RAO) 
Code 3 = definite 
Code 9 = not applicable 
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SUMMARY OF ASSESSMENT BY STROKE TEAM 
Thank you for referring your patient to the Stroke Team! 
 
 
 
 
 
 Date seen:  .  . 20  Patient hospital number:     
 
  HISTORY (key features that make this a vascular event, or not): 
 
 
 
 
 
EXAMINATION:  
 Cortical signs present: YES  NO  
A/Dysphasia   Parietal lobe signs  
Other  
   Specify: 
 
 
 Cranial nerves involved:  YES   NO  
       List: 
 
 
 Motor signs:  YES   NO  
 
LEFT    RIGHT    BILATERAL  
ARM    LEG  
 
 Sensory signs:  YES   NO  
 
LEFT    RIGHT    BILATERAL  
ARM    LEG  
 
 Cerebellar signs:  YES    NO  
 
LEFT    RIGHT   BILATERAL   AXIAL  
 
 Other key features: 
 
 
ASSESSMENT: 
 
 TIA         STROKE         INFARCTION         HAEMORRHAGE             SAH  NOT SURE  
 FIRST EVER IN A LIFETIME            RECURRENT  
 ANTERIOR CIRCULATION:   YES   NO   
 PARTIAL ANTERIOR CIRCULATION:  YES   NO  
 LACUNAR    YES   NO      
 TOTAL ANTERIOR CIRCULATION:    YES   NO  
 POSTERIOR CIRCULATION:   YES   NO  
 
SUGGESTION/S: 
 
 Further investigation/s:  
 
 Treatment: 
 
 Referral:  
 
 
 
 SIGN:  
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